{"10301O":{"商品名稱":"土茯苓(10301O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10302O":{"商品名稱":"大青葉(10302O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10303O":{"商品名稱":"山查(10303O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10305O":{"商品名稱":"山藥(10305O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10306O":{"商品名稱":"三七(10306O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10307O":{"商品名稱":"川芎(10307O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10308O":{"商品名稱":"川楝子(10308O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10309O":{"商品名稱":"大腹皮(10309O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10401O":{"商品名稱":"丹參(10401O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10403O":{"商品名稱":"木瓜(10403O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10405O":{"商品名稱":"火麻仁(10405O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10406O":{"商品名稱":"牛膝(10406O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10407O":{"商品名稱":"女貞子(10407O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10408O":{"商品名稱":"五味子(10408O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10410O":{"商品名稱":"天麻(10410O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10502O":{"商品名稱":"白朮(10502O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10503O":{"商品名稱":"白芍(10503O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10505O":{"商品名稱":"白芷(10505O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10506O":{"商品名稱":"白芨(10506O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10507O":{"商品名稱":"白茅根(10507O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10508O":{"商品名稱":"白鮮皮(10508O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10509O":{"商品名稱":"石斛(10509O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10510O":{"商品名稱":"石菖浦(10510O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10513O":{"商品名稱":"玄參(10513O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10514O":{"商品名稱":"生地黃(10514O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10515O":{"商品名稱":"蒺藜(白蒺藜) (10515O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10601O":{"商品名稱":"合歡皮(10601O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10602O":{"商品名稱":"地龍(10602O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10603O":{"商品名稱":"肉蓯蓉(10603O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10701O":{"商品名稱":"何首烏(10701O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10702O":{"商品名稱":"杏仁(10702O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10705O":{"商品名稱":"牡丹皮(10705O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10706O":{"商品名稱":"牡蠣(10706O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10708O":{"商品名稱":"貝母(浙) (10708O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10709O":{"商品名稱":"赤芍(10709O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10710O":{"商品名稱":"車前子(10710O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10711O":{"商品名稱":"辛夷(10711O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10712O":{"商品名稱":"延胡索(10712O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10713O":{"商品名稱":"吳茱萸(10713O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10714O":{"商品名稱":"旱蓮草(10714O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10715O":{"商品名稱":"忍冬(忍冬藤)(10715O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10802O":{"商品名稱":"板藍根(10802O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10803O":{"商品名稱":"羌活(10803O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10805O":{"商品名稱":"夜交藤(10805O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10901O":{"商品名稱":"厚朴（川）(10901O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10902O":{"商品名稱":"威靈仙(10902O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10903O":{"商品名稱":"枸杞子(10903O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10905O":{"商品名稱":"紅花（川）(10905O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10906O":{"商品名稱":"香附(10906O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10907O":{"商品名稱":"枳殼(10907O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"10908O":{"商品名稱":"枳實(10908O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11001O":{"商品名稱":"夏枯草(11001O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11003O":{"商品名稱":"桔梗(11003O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11005O":{"商品名稱":"桑寄生(11005O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11007O":{"商品名稱":"柴胡(11007O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11010O":{"商品名稱":"浮小麥(11010O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11013O":{"商品名稱":"骨碎補(11013O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11014O":{"商品名稱":"栝簍根(天花粉)(11014O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11102O":{"商品名稱":"苦參根(11102O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11103O":{"商品名稱":"白花蛇舌草(11103O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11104O":{"商品名稱":"魚腥草(11104O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11106O":{"商品名稱":"淫羊藿(11106O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11108O":{"商品名稱":"麥芽(11108O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11109O":{"商品名稱":"麥門冬(11109O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11201O":{"商品名稱":"防風(11201O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11202O":{"商品名稱":"決明子(11202O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11203O":{"商品名稱":"茵陳(11203O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11204O":{"商品名稱":"茯苓(11204O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11205O":{"商品名稱":"茯神(11205O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11206O":{"商品名稱":"黃芩(11206O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11207O":{"商品名稱":"黃耆(晉) (11207O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11208O":{"商品名稱":"黃連(11208O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11213O":{"商品名稱":"絲瓜絡(11213O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11214O":{"商品名稱":"菊花(11214O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11215O":{"商品名稱":"蘇子(紫蘇子)(11215O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11303O":{"商品名稱":"路路通(11303O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11401O":{"商品名稱":"槐花(11401O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11403O":{"商品名稱":"蒲黃(11403O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11404O":{"商品名稱":"酸棗仁(11404O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11501O":{"商品名稱":"阿膠(11501O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11502O":{"商品名稱":"葛根(11502O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11503O":{"商品名稱":"菟絲子(11503O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11601O":{"商品名稱":"蒼耳子(11601O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11701O":{"商品名稱":"獨活(11701O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11702O":{"商品名稱":"龍骨(11702O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11705O":{"商品名稱":"薏苡仁(11705O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11801O":{"商品名稱":"陳皮(11801O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"11802O":{"商品名稱":"雞血藤(11802O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"12001O":{"商品名稱":"黨參(12001O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"12101O":{"商品名稱":"續斷(12101O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"12201O":{"商品名稱":"藿香(12201O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"12901O":{"商品名稱":"鬱金(12901O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20201O":{"商品名稱":"七寶美髯丹(20201O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20202O":{"商品名稱":"二陳湯(20202O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20204O":{"商品名稱":"八味帶下方(20204O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20302O":{"商品名稱":"小承氣湯(20302O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20303O":{"商品名稱":"小青龍湯(20303O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20304O":{"商品名稱":"小建中湯(20304O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20306O":{"商品名稱":"川芎茶調散(20306O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20401O":{"商品名稱":"五苓散(20401O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20403O":{"商品名稱":"六味地黃丸(20403O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20405O":{"商品名稱":"天王補心丹(20405O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20408O":{"商品名稱":"天麻鉤藤飲(20408O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20409O":{"商品名稱":"少腹逐瘀湯(20409O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20501O":{"商品名稱":"真人活命飲(20501O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20502O":{"商品名稱":"加味逍遙散(20502O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20504O":{"商品名稱":"半夏白朮天麻湯(20504O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20505O":{"商品名稱":"半夏厚朴湯(20505O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20506O":{"商品名稱":"半夏瀉心湯(20506O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20508O":{"商品名稱":"四物湯(20508O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20509O":{"商品名稱":"平胃散(20509O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20511O":{"商品名稱":"玉女煎(20511O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20512O":{"商品名稱":"玉屏風散(20512O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20514O":{"商品名稱":"甘麥大棗湯(20514O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20516O":{"商品名稱":"甘露飲(20516O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20517O":{"商品名稱":"生脈散(20517O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20518O":{"商品名稱":"白虎湯(20518O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20519O":{"商品名稱":"右歸丸(20519O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20520O":{"商品名稱":"四逆散(20520O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20522O":{"商品名稱":"甘露消毒丹(20522O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20601O":{"商品名稱":"百合固金湯(20601O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20603O":{"商品名稱":"血府逐瘀湯(20603O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20702O":{"商品名稱":"杏蘇散(20702O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20703O":{"商品名稱":"杞菊地黃丸(20703O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20704O":{"商品名稱":"辛夷清肺湯(20704O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20705O":{"商品名稱":"辛夷散(20705O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20706O":{"商品名稱":"身痛逐瘀湯(20706O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20801O":{"商品名稱":"定喘湯(20801O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20803O":{"商品名稱":"知柏地黃丸(20803O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20804O":{"商品名稱":"羌活勝濕湯(20804O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20805O":{"商品名稱":"金鎖固精丸(20805O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20901O":{"商品名稱":"洗肝明目散(20901O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20902O":{"商品名稱":"香砂六君子(20902O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20904O":{"商品名稱":"芎歸膠艾湯(20904O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"20905O":{"商品名稱":"保和丸(20905O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21002O":{"商品名稱":"桂枝伏苓丸(21002O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21003O":{"商品名稱":"桂枝芍藥知母湯(21003O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21006O":{"商品名稱":"桂枝湯(21006O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21007O":{"商品名稱":"桂附(八味)地黃丸(21007O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21008O":{"商品名稱":"桑菊飲(21008O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21010O":{"商品名稱":"柴胡加龍骨牡礪湯(21010O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21012O":{"商品名稱":"柴胡疏肝湯(21012O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21015O":{"商品名稱":"消風散(21015O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21018O":{"商品名稱":"桂枝加龍骨牡蠣湯(21018O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21019O":{"商品名稱":"桃紅四物湯(21019O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21101O":{"商品名稱":"參苓白朮散(21101O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21102O":{"商品名稱":"苓桂朮甘湯(21102O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21104O":{"商品名稱":"清上防風湯(21104O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21105O":{"商品名稱":"清心蓮子散(21105O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21106O":{"商品名稱":"清咽利膈湯(21106O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21108O":{"商品名稱":"清燥救肺湯(21108O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21111O":{"商品名稱":"麻子仁丸(21111O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21113O":{"商品名稱":"清冠一號(21113O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21202O":{"商品名稱":"防風通聖散(21202O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21204O":{"商品名稱":"荊防敗毒散(21204O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21207O":{"商品名稱":"疏經活血湯(21207O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21212O":{"商品名稱":"黃連解毒湯(21212O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21301O":{"商品名稱":"溫經湯(21301O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21302O":{"商品名稱":"溫膽湯(21302O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21303O":{"商品名稱":"當歸芍藥散(21303O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21304O":{"商品名稱":"當歸拈痛湯(21304O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21305O":{"商品名稱":"當歸飲子(21305O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21306O":{"商品名稱":"補中益氣湯(21306O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21307O":{"商品名稱":"補陽還五湯(21307O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21402O":{"商品名稱":"酸棗仁湯(21402O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21403O":{"商品名稱":"銀翹散(21403O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21501O":{"商品名稱":"葛根黃芩黃連湯(21501O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21502O":{"商品名稱":"葛根湯(21502O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21602O":{"商品名稱":"豬苓湯(21602O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21603O":{"商品名稱":"龍膽瀉肝湯(21603O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21604O":{"商品名稱":"龜鹿二仙膠(21604O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21701O":{"商品名稱":"獨活寄生湯(21701O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"21801O":{"商品名稱":"歸脾湯(21801O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"22202O":{"商品名稱":"藿香正氣丸(22202O)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"3MA01E":{"商品名稱":"3M Avagard 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"5FU01I":{"商品名稱":"5-Fu 1g\/20ml Vial (Fluorouracil)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90109M":{"商品名稱":"醫用笑氣 47L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90111M":{"商品名稱":"小型醫用氧氣 3.4L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90112M":{"商品名稱":"中型醫用氧氣 10L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90113M":{"商品名稱":"大型醫用氧氣 40L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90114M":{"商品名稱":"氣槽醫用液化氧氣","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90115M":{"商品名稱":"醫用液化氧氣 175L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90116M":{"商品名稱":"小型醫用二氧化碳 3.4L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90117M":{"商品名稱":"中型醫用二氧化碳 10L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90118M":{"商品名稱":"大型醫用二氧化碳 40L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90119M":{"商品名稱":"小型醫用笑氣 10L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90202M":{"商品名稱":"氧氣 16%","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"90203M":{"商品名稱":"隨身型醫用氧氣 2.8L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ABI01I":{"商品名稱":"Abiplatin 50mg\/100ml Vial","腎功能不良劑量調整":"cisplatin should not be given until Scr is >1.5 mg\/dL and\/or BUN is <25 mg\/dL \r<br>Clcr 10-50: 給 75% of dose\r<br>Clcr <10 : 給 50% of dose\r<br>H\/D: 洗腎後給50% of dose \r<br>(CAPD): 給 50% of dose\r<br>(CRRT): 給75% of dose","小兒建議劑量":"有兒童劑量，詳洽仿單。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ABI02O":{"商品名稱":"Abilify 5mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"躁鬱症：\r<br>2mg QD x2days > 5mg QD > MAX 15mg QD\r<br>自閉症之急躁易怒：\r<br>2mg QD x2days > 5mg QD > MAX 15mg QD\r<br>妥瑞氏症：\r<br><50kg者2mg QD x2days > 5mg QD > MAX 10mg QD\r<br>>50kg者2mg QD x2days > 5mg QD > MAX 20mg QD","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ABI03O":{"商品名稱":"ABILIFY 15mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"躁鬱症：\r<br>2mg QD x2days > 5mg QD > MAX 15mg QD\r<br>自閉症之急躁易怒：\r<br>2mg QD x2days > 5mg QD > MAX 15mg QD\r<br>妥瑞氏症：\r<br><50kg者2mg QD x2days > 5mg QD > MAX 10mg QD\r<br>>50kg者2mg QD x2days > 5mg QD > MAX 20mg QD","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ABI04I":{"商品名稱":"Abilify maintena 400mg Syringe","腎功能不良劑量調整":"不需依患者的腎功能(輕至重度腎功能不全，腎絲球過濾率GFR為15-90 mL\/min)狀況來調整Abilify maintena的劑量。\r<br>Abilify maintena在GFR<15 mL\/min的患者尚未評估，沒有ESRD患者使用本品的臨床資料。","小兒建議劑量":"Abilify maintena尚未在18歲以下的兒童病患進行研究。","提示內容":"肌肉注射\r<br>建議起始和維持劑量為每個月400 mg (至少在前一次注射的26天後投與下一個劑量)\r<br>在第一個劑量注射後，須接受連續14 天的口服aripiprazole (10~20 mg)，以確保在ABILIFY MAINTENA 初始治療期間aripiprazole 可達到治療濃度。\r<br>藥液應於再配製後30分鐘內用畢。不要揉注射部位。","抗生素手冊":"暫無資料"},"ABR01I":{"商品名稱":"Abraxane 100mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"ABRAXANE使用於兒童患者的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACA01O":{"商品名稱":"Acarose 50mg Tab#","腎功能不良劑量調整":"Acarbose不可使用於嚴重腎功能不全的病患(creatinine clearance <25ml\/min)\r<br>[>25 ml\/min]: 50-200mg tid\r<br>[<25]: Avoid\r<br>HEMO: No data","小兒建議劑量":"暫無資料","提示內容":"ClCr< 25 ml\/min禁用","抗生素手冊":"暫無資料"},"ACA02O":{"商品名稱":"A-Cal 500mg Tab","腎功能不良劑量調整":"Dosing: Renal Impairment CrCl <25 mL\/minute: Dosage adjustments may be necessary depending on the serum calcium levels.","小兒建議劑量":"未滿3個月之嬰兒不得服用。\r<br>6 歲以上未滿12 歲，每次1\/2錠; \r<br>3 歲以上未滿6 歲，每次1\/4 綻﹔\r<br>3 歲以下之嬰幼兒，請洽醫師診治，不宜自行使用。\r<br>單次劑量( 1 錠)之酸中和能力為9. 0 mEq 以上。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACD01I":{"商品名稱":"ACD Solution-C Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACE01I":{"商品名稱":"Acemycin 500mg\/2ml Vial#","腎功能不良劑量調整":"Susceptible infection: 7.5 mg\/kg IV q8 to 12h.\r<br>[CRCL > 60 ml\/min]:  q8h,   [40-60]:  q12h,  \r<br>[20-40]:  q24h ,   [10-20]:  q48h,   [< 10 ]: q48-72h . \r<br>HEMO:  dose after dialysis or administer 2\/3 normal dose as a supplemental dose post-dialysis","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"建議量: 7.5 mg per kg q12h<br>renal dysfunction: 使用一周後建議監測血中濃度<br>使用二周後必須監測血中濃度"},"ACE02I":{"商品名稱":"Acetamol 1gm Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童每次30mg\/kg Q6h，每日最大量120mg\/kg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACE04M":{"商品名稱":"Acetic Acid Soln 5% 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACE04O":{"商品名稱":"Acemet 60mg Cap","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACE05M":{"商品名稱":"Acetic Acid 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACE05O":{"商品名稱":"Acetazolamide 250mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 250mg q6-12h\r<br>[10-50]: Q12h\r<br>[<10 ml\/min]: Avoid\r<br>HEMO:No data","小兒建議劑量":"高山症預防兒童建議劑量：2.5mg\/kg Q12H","提示內容":"藥名與Acetaminophen相近, 可能會KEY錯, 需注意\r<br>Sulfa drug\r<br>\r<br>(週報2019\/03\/01發行)\r<br> Acetazolamide 250mg BID可做為高碳酸血症COPD 病人的呼吸刺激劑","抗生素手冊":"暫無資料"},"ACE07O":{"商品名稱":"Acetal 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACL01E":{"商品名稱":"Aclovir Cream 5% 5gm","腎功能不良劑量調整":"仿單未提及","小兒建議劑量":"成人及兒童每天塗灰意部5次（約隔4小時1次）連續使用5天， 2日未痊癒， 則可連續使用10天","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACL01I":{"商品名稱":"Aclasta 5mg\/100ml Vial#","腎功能不良劑量調整":"Clcr >35 mL\/minute: No adjustment required.\r<br>Clcr <35 mL\/minute: Use is not recommended","小兒建議劑量":"不可使用","提示內容":"骨質疏鬆症:每年注射一次 5 mg , 以 IV infusion輸注>15 min\r<br>禁用於ClCr<35 mL\/min 及證實具有急性腎功能不全的病患","抗生素手冊":"暫無資料"},"ACT01I":{"商品名稱":"Actemra 200mg\/10ml vial#","腎功能不良劑量調整":"Renal Impairment: No dose adjustment is required in patients with mild renal impairment. Actemra has not been studied in patients with moderate to severe renal impairment","小兒建議劑量":"*RA: Adults and children ≧ 2 yrs: initially, 4 mg\/kg q4w; increased to 8 mg\/kg q4w based on clinical response. (不超過 800 mg).\r<br>*Systemic juvenile idiopathic arthritis (SJIA): Children ≧ 2 yrs: \r<br>< 30 kg: 12 mg\/kg q2w.\r<br>≧ 30 kg: 8 mg\/kg q2w.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACT01O":{"商品名稱":"Actos 30mg Tab#","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>不須調整劑量\r<br>心衰竭與水腫病患不宜","小兒建議劑量":"對小兒安全性及效用尚未確立。","提示內容":"Symptomatic HF:不建議使用; Class III or IV 心衰竭病人禁用\r<br>Max. dose: 45mg\/day. (1#BID需建議)","抗生素手冊":"暫無資料"},"ACT02I":{"商品名稱":"Actilyse 50mg\/50ml Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACT02O":{"商品名稱":"ACTEIN Effervescent 600mg Tab","腎功能不良劑量調整":"Oral, I.V.: No dosage adjustment provided in manufacturer's labeling.","小兒建議劑量":"Patients should receive an aerosolized bronchodilator 10-15 minutes prior to acetylcysteine\r<br>給予氣化支氣管擴張劑15分鐘後再給予Actein。","提示內容":"預防顯影劑引起之腎毒性：600-1,200 mg Q12H使用4個劑量\r<br>(於使用顯影劑前開始服用至打完顯影劑)\r<br>\r<br>COPD常用劑量為1#BID","抗生素手冊":"暫無資料"},"ACT03I":{"商品名稱":"Actrapid HM(RI) 1000iu\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Diabetes mellitus: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACT04I":{"商品名稱":"Actrapid HM(RI) 1iu (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Diabetes mellitus: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACT06O":{"商品名稱":"Actein  Granules 200mg\/3gm Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童: 0.5~1包 BID~QID，依年齡而定; 成人: 1包 TID\r<br>---------------------------------------------------------\r<br><5 kg: 1\/4pk QID; \r<br>5-15kg: 1\/3pk QID; \r<br>15-25 kg: 1\/2pk QID; \r<br>>25 kg: 1pk TID-QID\r<br>---------------------------------------------------------\r<br>Acetaminophen overdose: oral:initial, 140 mg\/kg ORALLY, then 70 mg\/kg every 4 hours for 17 doses\r<br>starting 4 hours after loading dose.","提示內容":"預防顯影劑引起之腎毒性：600-1,200 mg Q12H使用4個劑量\r<br>(於使用顯影劑前開始服用至打完顯影劑)\r<br>COPD常用劑量為2 pack TID\r<br>\r<br><5 kg: 1\/4包 QID; 5-15kg: 1\/3包 QID; 15-25 kg: 1\/2包 QID; >25 kg: 1包 TID-QID","抗生素手冊":"暫無資料"},"ACT07I":{"商品名稱":"Actemra 80mg\/4ml vial#","腎功能不良劑量調整":"Renal Impairment: No dose adjustment is required in patients with mild renal impairment. Actemra has not been studied in patients with moderate to severe renal impairment","小兒建議劑量":"*RA: Adults and children ≧ 2 yrs: initially, 4 mg\/kg q4w; increased to 8 mg\/kg q4w based on clinical response. (不超過 800 mg).\r<br>*Systemic juvenile idiopathic arthritis (SJIA): Children ≧ 2 yrs: \r<br>< 30 kg: 12 mg\/kg q2w.\r<br>≧ 30 kg: 8 mg\/kg q2w.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACT08I":{"商品名稱":"ACTEMRA 162mg\/0.9ml Pen#","腎功能不良劑量調整":"Clcr>50ml\/min：不需調整劑量。\r<br>其他族群未有研究。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACT09I":{"商品名稱":"ACTEMRA 400MG\/20ML VIAL","腎功能不良劑量調整":"Renal Impairment: No dose adjustment is required in patients with mild renal impairment. Actemra has not been studied in patients with moderate to severe renal impairment","小兒建議劑量":"*RA: Adults and children ≧ 2 yrs: initially, 4 mg\/kg q4w; increased to 8 mg\/kg q4w based on clinical response. (不超過 800 mg).\r<br>*Systemic juvenile idiopathic arthritis (SJIA): Children ≧ 2 yrs: \r<br>< 30 kg: 12 mg\/kg q2w.\r<br>≧ 30 kg: 8 mg\/kg q2w.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACU01E":{"商品名稱":"Acular Oph Soln 0.5% 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於12歲以下之安全性及療效尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACY01E":{"商品名稱":"Acyclovir Cream 5% 5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ACY02O":{"商品名稱":"Acylo 400mg Tab","腎功能不良劑量調整":"單純性皰疹: Clcr< 10 ml\/min: 200 mg Q12H。\r<br>\r<br>帶狀皰疹: 10<Clcr<25 ml\/min: 800 mg Q6-8H\r<br>\r<br>                   Clcr<10 ml\/min: 800 mg Q12H","小兒建議劑量":"用於治療單純性?疹感染，或是免疫機能不全時，用於預防單純性?疹感染，2 歲以上兒童應使用成人劑量，2歲以下兒童應使用成人劑量的一半。對免疫功能健全的兒童，使用本劑以抑制單純性?疹復發或治療帶狀?疹感染，尚無資料可查。","提示內容":"暫無資料","抗生素手冊":"abs. 15% to 30%<br>建議量: 800 mg q4h<br>Ccr less than 25: 800 mg q8h<br>Ccr less than 10, HD or PD: 800 mg q12h"},"ACZ01E":{"商品名稱":"Aczo Gel 5% 10gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADA01O":{"商品名稱":"Adalat 5mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADA04O":{"商品名稱":"Adalat Oros 30mg Tab","腎功能不良劑量調整":"無須依腎功能不全調整劑量。\r\r<br>temporarily discontinue therapy if 24-hour urine protein >3 g or for other toxicities when clinically indicated.","小兒建議劑量":"對小孩的用藥安全尚未確立","提示內容":"緩釋劑型，30-60mg QD(max. 120 mg\/day)。","抗生素手冊":"暫無資料"},"ADC01I":{"商品名稱":"Adcetris 50mg Vial","腎功能不良劑量調整":"應避免嚴重腎功能不全的病人使用 ADCETRIS 併用化療。","小兒建議劑量":"ADCETRIS 用於 18 歲以下兒童病人的安全性與療效尚未確立。\r<br>曾在非臨床試驗中，曾發現胸腺削減的現象","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADD01I":{"商品名稱":"Addaven 10ml amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"禁用於15公斤以下兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADE01I":{"商品名稱":"Adenocor 6mg\/2ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"3 mg IV bolus->6 mg->12mg","抗生素手冊":"暫無資料"},"ADE01O":{"商品名稱":"Adempas FC 2mg Tab#","腎功能不良劑量調整":"腎功能不全: 本品於肌酸酐廓清率<15 mL\/min或透析病患的安全性及療效，尚未證實","小兒建議劑量":"兒童使用: 本品用於兒童病患的安全性及療效尚未確立","提示內容":"1-2.5 mg TID   不可與nitrates, PDE-5 inhibitors同時併用\r<br>\r<br>用於肺動脈高血壓(PAH, WHO Group 1)\r<br>及慢性血栓栓塞性肺高壓(CTEPH, WHO Group 4)","抗生素手冊":"暫無資料"},"ADE02O":{"商品名稱":"ADEMPAS FC 2.5mg Tab#","腎功能不良劑量調整":"腎功能不全: 本品於肌酸酐廓清率<15 mL\/min或透析病患的安全性及療效，尚未證實","小兒建議劑量":"兒童使用: 本品用於兒童病患的安全性及療效尚未確立","提示內容":"1-2.5 mg TID   不可與nitrates, PDE-5 inhibitors同時併用\r<br>\r<br>用於肺動脈高血壓(PAH, WHO Group 1)\r<br>及慢性血栓栓塞性肺高壓(CTEPH, WHO Group 4)","抗生素手冊":"暫無資料"},"ADI07I":{"商品名稱":"ADIMFLU-S (QIS) 0.5mL(自費四價流感)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"肌肉注射。\r<br>接種量：3 歲以上兒童及成人：一劑 0.5mL。\r<br>未滿 9 歲兒童，若先前未曾注射過流感疫苗者，需接種 2 次，且間隔至少 4 週。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADI08I":{"商品名稱":"AdimFlu-S QIS (公費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"肌肉注射。\r<br>接種量：3 歲以上兒童及成人：一劑 0.5mL。\r<br>未滿 9 歲兒童，若先前未曾注射過流感疫苗者，需接種 2 次，且間隔至少 4 週。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADR01I":{"商品名稱":"Adriblastina Rapid Solu. 10mg Vial#","腎功能不良劑量調整":"因為艾黴素經由腎臟排泄的比率低，所以有中度腎功能不全者無須改變建議劑量。\r<br>","小兒建議劑量":"孩童:1天靜注30mg\/㎡共3天，每4週重覆1次，總共的累積量不可超過550mg\/㎡。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADR02I":{"商品名稱":"Adrenalin 1mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童─肌注0.3mg，需要時每隔15分鐘注射一次；緊急時亦可靜注","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADR04I":{"商品名稱":"Adriamycin 10mg\/5ml vial","腎功能不良劑量調整":"因為艾黴素經由腎臟排泄的比率低，所以有中度腎功能不全者無須改變建議劑量。\r<br>","小兒建議劑量":"孩童:1天靜注30mg\/㎡共3天，每4週重覆1次，總共的累積量不可超過550mg\/㎡。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADV01O":{"商品名稱":"Advagraf PR 0.5mg Cap","腎功能不良劑量調整":"Tarclolimus的藥動學不受腎功影響，因此無須調整劑量。然由於tacrolimus可能有腎毒性，所以建議應仔細監測腎功能。","小兒建議劑量":"因安全資料有限，故不建議18歲以下的兒童使用Advagraf","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADV02O":{"商品名稱":"ADVAGRAF PR 1mg Cap","腎功能不良劑量調整":"Tarclolimus的藥動學不受腎功影響，因此無須調整劑量。然由於tacrolimus可能有腎毒性，所以建議應仔細監測腎功能。","小兒建議劑量":"因安全資料有限，故不建議18歲以下的兒童使用Advagraf","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ADV03O":{"商品名稱":"ADVAGRAF PR 5mg Cap","腎功能不良劑量調整":"Tarclolimus的藥動學不受腎功影響，因此無須調整劑量。然由於tacrolimus可能有腎毒性，所以建議應仔細監測腎功能。","小兒建議劑量":"因安全資料有限，故不建議18歲以下的兒童使用Advagraf","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AET02I":{"商品名稱":"Aethoxysklerol 20mg\/2ml amp","腎功能不良劑量調整":"There are no dosage adjustments provided in manufacturer’s labeling.","小兒建議劑量":"There are no data and therefore Aethoxysklerol is not recommended for use in children.","提示內容":"取代Aethoxysklerol 40mg\/2ml amp藥品，貨到開檔使用。\r<br>不能直接靜脈給予, 需於開刀房執行。為了避免病房護理師誤打→將處方及藥品集中待開刀房傳送人員簽收領走\r<br>若有醫師詢問，須提醒舊有品項濃度為2%，新品項為1%。","抗生素手冊":"暫無資料"},"AFI01O":{"商品名稱":"Afinitor 5mg Tab#","腎功能不良劑量調整":"目前尚未針對腎功能不全之患者進行Afinitor臨床試驗。預期腎功能不全不會對藥物曝藥量造成影響,也不需要調整其everolimus的使用劑量。\r<br>","小兒建議劑量":"在孩童患者之安全性及有效性尚未建立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AGG01I":{"商品名稱":"Aggrastat 12.5mg\/50ml Vial#","腎功能不良劑量調整":"ACS: 0.4 mcg\/kg\/min IV x 30 minutes, then 0.1 mcg\/kg\/min \r<br>[<30 ml\/min]: 0.2 mcg\/kg\/min x 30 minutes, then 0.05 mcg\/kg\/min.\r<br>Clcr< 30 mL\/min的病人使用AGGRASTAT時，劑量必須降低.","小兒建議劑量":"兒童使用AGGRASTAT的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AGG02I":{"商品名稱":"Agglutex 25000iu\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AGG03I":{"商品名稱":"Agglutex 1000iu\/0.2ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AGI01I":{"商品名稱":"Agifutol 500mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"臨床用法: 1.5-3g QD IV(1.5g\/m2) 可不做建議 (用於化療病人中和cisplatin的毒性)","抗生素手冊":"暫無資料"},"AGR01O":{"商品名稱":"Agrylin 0.5mg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AJO01I":{"商品名稱":"Ajovy 225mg\/1.5ml Pen","腎功能不良劑量調整":"尚未針對肝\/腎功能不全病人進行專門之臨床試驗。","小兒建議劑量":"尚未建立使用於兒童病人的安全性與有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AKU01O":{"商品名稱":"AKuriT-3 275\/75\/150 Tab#","腎功能不良劑量調整":"Clcr<10 不建議使用","小兒建議劑量":"因為安全的使用條件尚未建立，不建議 Ethambutol使用在 13歲以下孩童。\r<br>","提示內容":"空腹使用;  30-37kg 2 tab QD，38-54kg 3 tab QD，55-70kg 4 tab QD，≧71kg 5 tab QD (max)。","抗生素手冊":"暫無資料"},"AKU02O":{"商品名稱":"AKuriT-4 275\/75\/400\/150 Tab#","腎功能不良劑量調整":"腎功能不全者，不應開立AKT-4，以避免 PZA過量","小兒建議劑量":"因為安全的使用條件尚未建立，不建議 Ethambutol使用在 13歲以下孩童。\r<br>","提示內容":"空腹使用;  30-37kg 2 tab QD，38-54kg 3 tab QD，55-70kg 4 tab QD，≧71kg 5 tab QD (max)。","抗生素手冊":"暫無資料"},"AKY01O":{"商品名稱":"Akynzeo 300\/0.5 mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立未滿18歲的安全性及有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALB01E":{"商品名稱":"Albothyl 1-ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALB01M":{"商品名稱":"Albothyl 100ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALB05I":{"商品名稱":"AlbuRx 25% 50ml(Albumin)","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; use with caution.","小兒建議劑量":"兒童與青少年(0-18歲)之劑量應視患者個體之需求調整。<br>Note: 5% should be used in hypovolemic patients or intravascularly-depleted patients. 25% should be used in patients in whom fluid and sodium intake must be minimized.<br>- Hypovolemia: I.V.: 0.5-1 g\/kg\/dose (10-20 mL\/kg\/dose of albumin 5%); maximum dose: 6 g\/kg\/day\"","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC01I":{"商品名稱":"Alcohol 99.5% Inj. Vial\/5ml","腎功能不良劑量調整":"仿單未記載","小兒建議劑量":"仿單未記載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC02E":{"商品名稱":"Alcos-Anal Supp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC03E":{"商品名稱":"Alcaine 0.5% 15ml","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"依照大人劑量\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC04E":{"商品名稱":"Alcos-Anal Oint 20gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC13E":{"商品名稱":"Alcohol 95% 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC16E":{"商品名稱":"Alcohol 75% 4L\/Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC17E":{"商品名稱":"Alcohol 75% 200mL","腎功能不良劑量調整":"外用。仿單無載明","小兒建議劑量":"小孩須由成人輔導使用，請置於兒童觸摸不到之處。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALC19E":{"商品名稱":"Alcohol 95% 4L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALD02O":{"商品名稱":"Aldactone 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALD03E":{"商品名稱":"Aldara Cream 5% 250mg","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"Perianal warts\/condyloma acuminata: Topical: AldaraR: Children >=12 years: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALD03O":{"商品名稱":"Aldactin 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"1~3mg\/kg bid~qid\r<br>","提示內容":"禁忌症: 病人 ClCr <10 mL\/min\r<br>注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"ALE01I":{"商品名稱":"Aleviatin 250mg\/5ml Amp","腎功能不良劑量調整":"Phenytoin level in serum may be difficult to interpret in renal failure. Monitoring of free (unbound) concentrations or adjustment to allow interpretation is recommended\r<br>","小兒建議劑量":"\"Status epilepticus: I.V.:\r<br>Infants and Children: Loading dose: 15-20 mg\/kg, then begin maintenance therapy usually 12 hours after loading dose<br><br>\r<br>Adolescents: Refer to adult dosing.\r<br><br><br>Anticonvulsant (nonemergent use): Oral:\r<br><br><br>Loading dose: Children and Adolescents: Refer to adult dosing.<br><br>\r<br>Maintenance dose:<br><br>\r<br>Infants and Children: Initial maintenance dose: 5 mg\/kg\/day in 2-3 divided doses; usual maintenance dose range: 4-8 mg\/kg\/day; maximum daily dose: 300 mg. Some experts suggest higher maintenance doses may be necessary in infant and young children (range: 8-10 mg\/kg\/day in divided doses).<br><br>Adolescents: Refer to adult dosing\"\r<br>","提示內容":"Loading dose: 15-20mg\/kg (in normal saline), IV infusion at 50mg\/min \r<br>Maintenance dose: 5-10mg\/kg\/day (in normal saline), IV infusion at 25~50 mg\/min)\r<br>Phenytoin為CYP3A4 Inducers (Strong)及P-glycoprotein\/ABCB1 Inducers 可能會造成下列藥品之血中濃度減少應避免併用：Rivaroxaban、Apixaban、DABIGATRAN、Edoxaban\r<br>Ciprofloxacin可能會造成Phenytoin血中濃度減少","抗生素手冊":"暫無資料"},"ALE01O":{"商品名稱":"Alecensa 150mg Cap","腎功能不良劑量調整":"輕至中度腎功能不良，不建議調整劑量。而重度功能不良者(Clcr<30 ml\/min)者則未有資料。","小兒建議劑量":"Alecensa用於兒童患者的安全性及有效性尚未確立。","提示內容":"藥委會通過急用零購藥品開檔使用\r<br>發放與處方皆以盒為單位 (28 tab\/box)。\r<br>治療ALK陽性的晚期非小細胞肺癌(NSCLC)(Zykadia 150mg Cap立克癌與Xalkori 250mg Cap截剋瘤適應症亦同)\r<br>建議劑量為600 mg BID，若出現無法耐受的不良反應，可調整為300~450mg BID使用。\r<br>可搭配食物整粒吞服，不可咀嚼或咬碎膠囊。","抗生素手冊":"暫無資料"},"ALF01I":{"商品名稱":"Alfentanil-hameln 1mg\/2ml Amp #2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALF01O":{"商品名稱":"Alfacalcidol 0.5mcg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"骨質疏鬆症：0.01~0.03mcg\/kg\r<br>其他疾病：0.05~0.1mcg\/kg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALF02I":{"商品名稱":"Alfentanil-hameln 0.5mg\/ml #2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALF03I":{"商品名稱":"Alfentanil PPCD 1mg\/2ml Amp #2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALF04I":{"商品名稱":"Alfentanil PPCD 0.5mg\/1ml #2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALG01O":{"商品名稱":"Algitab Chewable Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALG01S":{"商品名稱":"Alginos Oral Suspension 210ml\/Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALG02O":{"商品名稱":"Alglutol DR 333mg Tab","腎功能不良劑量調整":"Clcr 30-50ml\/min：1# TIDPC","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALI01I":{"商品名稱":"Alimta 500mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALI01O":{"商品名稱":"Alinamin-F 50 S.C. Tab#","腎功能不良劑量調整":"仿單未記載","小兒建議劑量":"Thiamine deficiency (beriberi): Children: 10-25 mg\/dose IM or IV daily (if critically ill), or 10-50 mg\/dose orally every day for 2 weeks, then 5-10 mg\/dose orally daily for 1 month\r<br>Riboflavin deficiency: Children: 3-10 mg\/day in divided doses","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALI02I":{"商品名稱":"Alimta 100mg Vial#","腎功能不良劑量調整":"腎功能不良患者:\r<br>Clcr≧45 ml\/min:不需調整劑量\r<br>Clcr<45 ml\/min:尚無法歸納建議劑量，故不應使用。\r<br>Clcr<80 ml\/min:併用NSAIDs與ALIMTA時，小心慎用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALK01O":{"商品名稱":"Alkeran 2mg Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童適應症相當罕見因此無法提供劑量原則\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALL01I":{"商品名稱":"Allergenic Extract (DP) 50000AU\/5ml Vial","腎功能不良劑量調整":"暫無相關資料","小兒建議劑量":"兒童和老人對過敏原注射劑的耐受性顯然良好，故對兒童與老年病人族群並無特殊建議事項","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALL01S":{"商品名稱":"All-Right Calcium Susp 180ml Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"成人: 10-15 ml\/d; \r<br>兒童: 10-15 ml\/d;\r<br>孕婦: 15 ml\/d; \r<br>乳幼兒: 2.5ml\/d\r<br>----------------------------------------\r<br>< 2yr:   1-2.5c.c. QD;\r<br>2-6yr:   2.5-5c.c. QD;\r<br>6-12yr:  5-10c.c. QD;\r<br>>12yr:  10-15 c.c. QD","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALL02I":{"商品名稱":"Allergenic Extract (DF) 100000AU\/10ml Vi","腎功能不良劑量調整":"仿單無資料","小兒建議劑量":"兒童和老人對過敏原注射劑的耐受性顯然良好，故對兒童與老年病人族群並無特殊建議事項","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALL02O":{"商品名稱":"Allegra 60mg Tab","腎功能不良劑量調整":"[Clcr >50 ml\/min]:  60mg bid or 180mg QD\r<br>[10-50 ml\/min]: 60mg Q12-24h\r<br>[<10 ml\/min and HEMO]: 60mg Q24h\r<br>","小兒建議劑量":"\"季節性過敏性鼻炎：<br>\r<br>6至 11歲的兒童：建議劑量為每次 30 公絲，一天兩次。對腎功能減弱之患者的建議起始劑量為每次 30 公絲，一天一次。 <br>\r<br>\r<br>慢性自發性蕁麻疹：\r<br>6至11歲的兒童：建議劑量為每次30或60 公絲，一天兩次。對腎功能減弱之患者的建議起始劑量為每次 30 公絲，一天一次。\r<br><br><br>Fexofenadine hydrochloride 用於 6 歲以下之病童的安全性及有效性尚未確立。 \"\r<br>","提示內容":"建議劑量為 60 mg BID或 180 mg QD, 腎功能不全應調整為 60 mg起 QD","抗生素手冊":"暫無資料"},"ALO01I":{"商品名稱":"Aloxi 0.25mg\/5ml Vial#","腎功能不良劑量調整":"老人\/肝功能障礙\/腎功能障礙者皆能使用。任何程度的腎功能不全使用Palonosetron時， 不須調整劑量。","小兒建議劑量":"目前並沒有在18歲以下的病患所進行之安全性與有效性的研究結果。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALP02E":{"商品名稱":"Alphagan P Oph Soln 0.15% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALU02O":{"商品名稱":"Aluminum Hydroxide 324mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALU03O":{"商品名稱":"Alunbrig 90mg Tab","腎功能不良劑量調整":"對於重度腎功能不全病人 (CLcr) 為 15 至 29 mL\/min]，Alunbrig 一天一次的劑量應降低約 50% (亦即 180 mg 降至 90 mg 或 90 mg 降至 60 mg)","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALU04O":{"商品名稱":"ALUNBRIG 180MG TAB","腎功能不良劑量調整":"對於重度腎功能不全病人 (CLcr) 為 15 至 29 mL\/min]，Alunbrig 一天一次的劑量應降低約 50% (亦即 180 mg 降至 90 mg 或 90 mg 降至 60 mg)","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ALV01I":{"商品名稱":"Alvosteo 20mcg\/80mcl; 28d","腎功能不良劑量調整":"No dosage adjustment required. Bioavailability and half-life increase with Clcr <30 mL\/minute. Use in severe renal impairment is contraindicated in the Canadian labeling","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AMA02O":{"商品名稱":"Amaryl 2mg Tab#","腎功能不良劑量調整":"Initial: 1 mg once daily; dose titration and maintenance dosing should be conservative to avoid hypoglycemia. \r<br>Consider alternative therapy if eGFR <15 mL\/minute\/1.73 m2 (Alsahli 2015).\r<br>ADA 建議Glimepiride 起始劑量每日1mg, 避免低血糖","小兒建議劑量":"兒童：因為體重及低血糖的副作用不建議使用。\r<br>","提示內容":"Max. dose: 8 mg\/day","抗生素手冊":"暫無資料"},"AMA03O":{"商品名稱":"AMARYL M 2\/500mg Tab#","腎功能不良劑量調整":"正常劑量：1Tab QD\r<br>禁忌: ( eGFR ）< 30 應減量使用","小兒建議劑量":"本藥用於兒童的安全性與有效性尚未建立。\r<br>","提示內容":"複方藥品, 內含Metformin需注意\r<br>(1)每日最高劑量: 速效劑型：3000 mg；緩釋劑型：2000mg\r<br>(2)腎絲球體過濾率（eGFR）介於30-45 ml\/min\/1.73 m2應減量使用\r<br>(3)腎功能不全患者，腎絲球體過濾率（eGFR）小於30 ml\/min\/1.73 m2禁用)","抗生素手冊":"暫無資料"},"AMB01I":{"商品名稱":"Ambisome 50mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"劑量: 3-5mg\/ kg\/day\r<br>稀釋過濾後，將所需藥品瓶數全部注入D5W中, 輸注時間大於120分鐘","抗生素手冊":"建議量: 3 to 6 mg per kg once daily"},"AMI01I":{"商品名稱":"AMINOL 12X  200ml","腎功能不良劑量調整":"腎病患者的投與量及速度，應特別注意","小兒建議劑量":"仿單無記載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AMI01O":{"商品名稱":"Amizide Tab","腎功能不良劑量調整":"Hyperkalemia with GFR<30, especially in DM. Metabolic acidosis.\r<br>[Clcr >50 ml\/min]: 1~2 tab daily. Max.: 4 tab\r<br>[10-50ml\/min]: 50% \r<br>[<10 ml\/min]and HEMO : Avoid","小兒建議劑量":".兒童: 應用於兒童之安全性尚未確立，故暫勿用於小兒。","提示內容":"其中Amiloride 5mg 為保鉀型利尿劑, 注意可能同時開立同類藥物\r<br>注意服用thiazide類可能有高尿酸血症的發生","抗生素手冊":"暫無資料"},"AMI02I":{"商品名稱":"Aminophylline (濟生) 250mg\/10ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"一般兒童劑量: 支氣管擴張劑－靜脈注射，每公斤體重5mg或每平方公尺體表面積150mg，每六小時一次。\r<br>急性發作－\r<br>負載劑量-6個月以下嬰兒：由醫師依個體決定。 6個月以上16歲以下兒童：靜脈輸注，每公斤體重6mg，輸注時間須在20分鐘以上。\r<br>維持劑量-6個月以下嬰兒：由醫師依個體決定。 6個月以上9歲以下兒童：靜脈輸注，每小時、每公斤體重1.2mg，為時12小時；然後每公斤體重lmg，每小時一次。 9歲至16歲兒童：靜脈輸注，每小時、每公斤體重lmg，為時12小時，然後每公斤體重800mcg(0.8mg)每小時一次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AMI05I":{"商品名稱":"Aminosteril N-Hepa 8% 500ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AMI12I":{"商品名稱":"Aminopoly-H 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AMI13I":{"商品名稱":"Aminosteril Infant 10% 100ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AMI15I":{"商品名稱":"Aminoven 15% 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Aminoven 15%不可用於兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AMO01I":{"商品名稱":"AmoClav 1.2g Vial","腎功能不良劑量調整":"Clcr>30: 不須調整。\r<br>[10-30]: 1.2g, then 600mg q12h. \r<br>[<10]: 1.2g, then 600mg q24","小兒建議劑量":"3個月大至12歲兒童: 通常為q8h， 每次 30mg\/kg的Amoclav，對較嚴重的感染症，可提升至q6h\r<br>0-3個月大嬰兒: 劑量為 q12h，每次 30mg\/kg的Amoclav，之後可增為 q8h","提示內容":"暫無資料","抗生素手冊":"建議量:  1.2 gm q8h<br>Ccr less 30: 1vial q12h<br>Ccr less 10 or HD: 1 vial qd"},"AMO01O":{"商品名稱":"Amoxicillin 250mg Cap YungShin","腎功能不良劑量調整":"PO:[CRCL >30ml\/min ]: No change. \r<br>[10-29 ]: q8-12h.  \r<br>[<10 ]: q24h.   \r<br>HEMO:  250 to 500mg q24h plus additional dose after dialysis.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"建議量:  1 gm q8h<br>Ccr less 30: 1 gm q12h<br>Ccr less 10 or HD: 1 gm qd"},"AMO02O":{"商品名稱":"Amoxicillin 250mg Cap TBC","腎功能不良劑量調整":"PO:[CRCL >30ml\/min ]: No change. \r<br>[10-29 ]: q8-12h.  \r<br>[<10 ]: q24h.   \r<br>HEMO:  250 to 500mg q24h plus additional dose after dialysis.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"建議量:  1 gm q8h<br>Ccr less 30: 1 gm q12h<br>Ccr less 10 or HD: 1 gm qd"},"AMO02S":{"商品名稱":"Amolin Susp 25mg\/ml;60ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小兒: 20-40mg\/kg\/d (0.8-1.6ml\/kg\/d) divided in 3-4\r<br>doses; 成人: 250mg (10ml)TID-QID\r<br>--------------------------------------------------------------------\r<br>3 months: 20-30 mg(0.8~1.2ml)\/kg\/d in 2 divided doses; \r<br>>3 months & Childn: 25-50 mg(1~2ml)\/kg\/d in 2 to\r<br>3 divided doses.\r<br>Acute otitis media due to highly resistant strains of S. pneumoniae :\r<br>80-90 mg(3.2~3.6ml)\/kg\/d in 2 divided doses.\r<br>---------------------------------------------------------------------\r<br>簡易換算:\r<br>< 1 month : 2.5ml Q6-8H\r<br>1-6 months : 3-5ml Q6-8H\r<br>6 months-1.5 yr : 5-7.5ml Q6-8H\r<br>1.5-6 yr : 7.5-10ml Q6-8H","提示內容":"一般感染: 20-40mg\/kg\/d Q6-8H \r<br>急性中耳炎: 80-90 mg\/kg\/d Q12H","抗生素手冊":"80 to 90 mg per kg per day for q8h to q12h"},"AMO04S":{"商品名稱":"AMOLIN SUSP 50MG\/ML;60ML","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小兒: 20-40mg\/kg\/d divided in 3-4 doses; 成人: 250mg TID-QID\r<br>--------------------------------------------------------------------\r<br>3 months: 20-30 mg\/kg\/d in 2 divided doses; \r<br>>3 months & Childn: 25-50 mg\/kg\/d in 2 to\r<br>3 divided doses.\r<br>Acute otitis media due to highly resistant strains of S. pneumoniae :\r<br>80-90 mg\/kg\/d in 2 divided doses.","提示內容":"暫無資料","抗生素手冊":"80 to 90 mg per kg per day for q8h to q12h"},"AMP01O":{"商品名稱":"Ampicillin 500mg Cap","腎功能不良劑量調整":"除腎功能嚴重受損者外，一般腎功能不良者，通常不需減少劑量\r<br>Clcr >50 mL\/minute: Administer every 6 hours\r<br>Clcr 10-50 mL\/minute: Administer every 6-12 hours\r<br>Clcr <10 mL\/minute: Administer every 12-24 hours","小兒建議劑量":"嬰兒及體重20 公斤以下之兒童－每公斤體重12.5~25mg，每6 小時一次，或公斤體重16.7~33.3mg，每8 小時一次。\r<br>「注意」有些嬰兒及兒童每日劑量需高達每公斤體重200mg，分次服用，依感染類型及嚴重性而定。\r<br>\r<br>Usual dosage range: Infants and Children:\r<br>Oral: 50-100 mg\/kg\/day in doses divided every 6 hours (maximum: 2-4 g\/day)","提示內容":"暫無資料","抗生素手冊":"小兒: 100 to 300 mg per kg per day 分 q4h to q6h<br>Ccr less 30: 1 to 2 gm q8h<br>Ccr less 10 or HD: altered to q12h"},"AMP02I":{"商品名稱":"Ampholipad 50mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"建議量: 3 to 6 mg per kg once daily"},"AMP03I":{"商品名稱":"Ampolin 500mg Vial","腎功能不良劑量調整":"Oral \/ IV: \r<br>[CRCL >50  ml\/min]: no change. \r<br>[30-49]: q6-8 hours.\r<br>[10-29 ]: q8-12 hours. \r<br>[<10]: q12-24 hours.  \r<br>HEMO: usual dose q12-24 h. Schedule dose after dialysis on dialysis days.","小兒建議劑量":"25-50mg\/kg\/d q6h 細菌性腦膜炎：100-200mg\/kg\/d\r<br>-----------------------------------------------------------\r<br>簡易換算: 50-200mg\/kg\/d divided in 2-4 doses","提示內容":"成人劑量 \r<br>心內膜炎: 2g Q4H (12g\/day)\r<br>\r<br>小兒劑量\r<br>一般劑量: 25-200mg\/kg\/d Q6H, 細菌性腦膜炎:150-300mg\/kg\/d Q4-6H\r<br>心內膜炎: 200-300mg\/kg\/d Q4-6H","抗生素手冊":"小兒: 100 to 300 mg per kg per day 分 q4h to q6h<br>Ccr less 30: 1 to 2 gm q8h<br>Ccr less 10 or HD: altered to q12h"},"AMT01O":{"商品名稱":"Amtrel Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"注意病人是否有高血鉀的症狀\r<br>複方成分, 注意處方是否有重複使用同類藥品\r<br>與Neprilysin inhibitor (如Entresto)不可併用，如需轉換需間隔至少36小時，否則有引發血管性水腫的風險。","抗生素手冊":"暫無資料"},"AND01O":{"商品名稱":"Androcur 50mg Tab#","腎功能不良劑量調整":"Has not been studied in patients with renal impairment. Use with caution\r<br>","小兒建議劑量":"發育成熟前不得使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AND03E":{"商品名稱":"Androgel gel 1% 5gm Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"僅外用。男性 之重度COPD病人若症狀惡化到無法自行使用吸入劑，呼吸治療科就會檢測睪固酮濃度低於正常值時，就會處方Androgel，以提升睪固酮濃度，增加病人骨骼肌的質與量來改善症狀。","抗生素手冊":"暫無資料"},"ANE03I":{"商品名稱":"Anexate 0.5mg\/5ml Amp#","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer’s labeling; however, pharmacokinetics are not significantly affected by renal failure (CrCl <10 mL\/minute) or hemodialysis.\r<br>","小兒建議劑量":"\"大於一歲的孩童：<br>為了在大於一歲的孩童身上反轉benzodiazepines所誘導的意識鎮靜作用，建議起始劑量為靜脈注射0.01 mg\/kg (一直到0.2 mg)，注射超過15秒。若第一次靜脈注射完後45秒內，病人仍未達到所需的意識程度，可再次注射0.01 mg\/kg (直到0.2 mg)，視情況需要可以60秒鐘間隔重覆注射(最高可額外加4次)，直到最大總劑量為0.05 mg\/kg或1 mg，以較低者為準。劑量應依病人的反應而個別調整。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANG02I":{"商品名稱":"Angidil 10mg\/10ml Amp","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童：通常使用0.1% ANGIDIL之溶劑50ml加在500ml之5%葡萄糖或生理食鹽水溶液之內\r<br>","提示內容":"建議用量為 2~7mg\/hr by infusion after dilution，Max: 10mg\/hr。(本院常用5-15mcg\/min)","抗生素手冊":"暫無資料"},"ANO01E":{"商品名稱":"Anoro Ellipta 55\/22mcg inhalation; 30d","腎功能不良劑量調整":"腎功能受損患者或中度肝功能受損患者，都不須調整劑量","小兒建議劑量":"不適用於兒童，用於兒童病患的安全性與療效尚未確立。","提示內容":"1 puff QD使用\r<br>不可用於氣喘病人\r<br>本品為乾粉吸入劑型請注意病人是否可經口深吸氣(可能無法從氣切管吸入)","抗生素手冊":"暫無資料"},"ANP01I":{"商品名稱":"Anpo 50mg\/5ml Amp","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"不建議兒童服用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANP01O":{"商品名稱":"Anpo 10mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"不建議兒童服用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANS01O":{"商品名稱":"Ansures ER 500mg Tab","腎功能不良劑量調整":"eGFR介於30-45 applicable","小兒建議劑量":"孩童:不建議使用本品\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT01I":{"商品名稱":"Antifect 1g Vial#","腎功能不良劑量調整":"Usual Dosing (Adults) : 500 mg ~ 2 gram q12h IV . Febrile neutropenic p't:劑量可提高50~100%\r<br>[Clcr 30-60 ml\/min ]: 500mg~2 grams q24h. \r<br>[11-29 ml\/min ]: 500 mg~1 gram q24h. \r<br>[<11 ml\/min ]: 250~500 mg q24h. \r<br>HEMO: 250~ 500 mg q24h. \r<br>PD: 1-2 grams q48h","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"4th cephas 對ESBL失敗率高<br>建議量: 2 to 3 g q8h<br>Ccr less 30: 2 g qd<br>Ccr less 10 or HD: 1 g qd"},"ANT01O":{"商品名稱":"Antilon 60mg F.C. Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用","小兒建議劑量":"\"Myasthenia gravis:<br><br>\r<br>\r<br>Oral: Children: 7 mg\/kg\/24 hours divided into 5-6 doses. Most clinicians reserve sustained release dosage form for bedtime dose only.\r<br>\r<br>I.M., slow I.V. push: Children: 0.05-0.15 mg\/kg\/dose<br><br>\r<br>Reversal of nondepolarizing muscle relaxants: I.V.: Children: Dosing range: 0.1-0.25 mg\/kg\/dose (full recovery usually occurs <=15 minutes, but >=30 minutes may be required).<br><br>\r<br>\r<br>Note: Atropine sulfate (0.6-1.2 mg) I.V. immediately prior to pyridostigmine to minimize side effects:\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT02E":{"商品名稱":"Antigerm Sol 40mg\/ml 5L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT03I":{"商品名稱":"Antivenin of D. acutus(Lyophilized)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT04E":{"商品名稱":"Antol Eye drops 1% 5ml Bot","腎功能不良劑量調整":"仿單未記載","小兒建議劑量":"劑量仿單未載明。\r<br>本品不能用於先前對atropine產生嚴重全身反應之小孩。\r<br>本品應置於小孩拿不到的地方。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT06I":{"商品名稱":"Antivenin of B.multicincutus and N.naga","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT06O":{"商品名稱":"Antibiophilus 250mg Cap#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"成人一天2至8顆，一天3~4次。12歲以上，適用成人劑量。6歲以上未滿12歲，適用成人劑量1\/2。3歲以上未滿6歲，適用成人劑量1\/4。小於3歲，請洽醫師診治，不宜自行使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT07I":{"商品名稱":"Antivenin of Tr.mucrosqamatus and Tr.gra","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANT09S":{"商品名稱":"Anti-Phen 24mg\/ml; 60ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3-6yr: 3ml; 6-12yr: 6.5ml; >13yr: 10ml; Q4H \r<br>max 5 doses\/d\r<br>(註：仿單劑量與文獻資料有較大差異)\r<br>--------------------------------------------------------------\r<br>Infants & Childn: 10-15 mg\/kg\/dose (~0.5 ml\/kg\/dose) Q4-6H as needed; max 5 doses\/d; 12yr & Adults: 325-650 mg Q4-6H or 1000 mg 3-4 times\/d; max 4 g\/d\r<br>--------------------------------------------------------------\r<br>簡易換算: (BW\/2)c.c. Q4H PRN if BT >38.5℃\r<br>max 5 doses\/d","提示內容":"10-15 mg\/kg\/dose Q4-6H\r<br> 簡易算法: (BW\/2)ml\/dose Q4H prn if BT >38.5℃ (max 5 doses\/d) \r<br>*中毒劑量: 100mg\/kg\/24hr","抗生素手冊":"暫無資料"},"ANT10S":{"商品名稱":"Anti-Phen Syrup 1ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3-6yr: 3ml; 6-12yr: 6.5ml; >13yr: 10ml; Q4H \r<br>max 5 doses\/d\r<br>(註：仿單劑量與文獻資料有較大差異)\r<br>--------------------------------------------------------------\r<br>Infants & Childn: 10-15 mg\/kg\/dose (~0.5 ml\/kg\/dose) Q4-6H as needed; max 5 doses\/d; 12yr & Adults: 325-650 mg Q4-6H or 1000 mg 3-4 times\/d; max 4 g\/d\r<br>--------------------------------------------------------------\r<br>簡易換算: (BW\/2)c.c. Q4H PRN if BT >38.5℃\r<br>max 5 doses\/d","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ANX01I":{"商品名稱":"Anxicam 2mg\/1ml Amp #4","腎功能不良劑量調整":"I.M., I.V.: Risk of propylene glycol toxicity. Monitor closely if using for prolonged periods of time or at high doses.\r<br>\r<br>Mild-to-moderate disease: Use with caution.\r<br>Severe disease or failure: Use is not recommended. [uptodate]","小兒建議劑量":"18歲以下的孩童: 劑量未確定。\r<br>Uptodate中有些unlabeled use dosage for Chemotherapy-associated nausea and vomiting; Status epilepticus","提示內容":"一般劑量: 0.044mg\/kg或總量2mg, 以等體積的N\/S或注射用水稀釋。\r<br>(IV rate < 2mg\/min)","抗生素手冊":"暫無資料"},"ANX03O":{"商品名稱":"Anxiedin 1mg Tab#4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童使用Lorazepam安全性尚未建立，不推薦使用於12歲以下的兒童\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"API01I":{"商品名稱":"Apidra SoloStar 300 iu\/3ml#","腎功能不良劑量調整":"人體對Insulin glulisine的血糖反應不會受腎肝功能不全的影響,腎功能不全患者可能會降低胰島素需求量","小兒建議劑量":"Diabetes mellitus, type 1: Children >=4 years and Adolescents: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"API02I":{"商品名稱":"Apidra 1 iu (小單位檔)","腎功能不良劑量調整":"人體對Insulin glulisine的血糖反應不會受腎肝功能不全的影響,腎功能不全患者可能會降低胰島素需求量\r<br>","小兒建議劑量":"Diabetes mellitus, type 1: Children >=4 years and Adolescents: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"APO01O":{"商品名稱":"Apo-Atomoxetine 25mg Cap","腎功能不良劑量調整":"不需劑量調整","小兒建議劑量":"6歲以下兒童或體重<70Kg：起始劑量0.5 mg\/kg\/天(至少3天)，然後增加至1.2 mg\/kg\/天。可以一次服用，或分一半早晚服用。最高劑量1.4mg\/kg或100mg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"APO04O":{"商品名稱":"APO-ATOMOXETINE 40MG CAP","腎功能不良劑量調整":"不需劑量調整","小兒建議劑量":"6歲以下兒童或體重<70Kg：起始劑量0.5 mg\/kg\/天(至少3天)，然後增加至1.2 mg\/kg\/天。可以一次服用，或分一半早晚服用。最高劑量1.4mg\/kg或100mg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"APR01O":{"商品名稱":"Apresoline 10mg Tab","腎功能不良劑量調整":"\"- CrCl 10-50 mL\/minute: Administer every 8 hours.<br>- CrCl <10 mL\/minute: Administer every 8-16 hours in fast acetylators and every 12-24 hours in slow acetylators.<br>- Hemodialysis effects: Supplemental dose is not necessary.<br>- Peritoneal dialysis effects:","小兒建議劑量":"\"- Hypertension: Oral: Initial: 0.75-1 mg\/kg\/day in 2-4 divided doses; increase over 3-4 weeks to maximum of 7.5 mg\/kg\/day in 2-4 divided doses; maximum daily dose: 200 mg\/day<br>- Acute hypertension: I.M., I.V.: 0.1-0.2 mg\/kg\/dose (not to exceed 20 mg) every 4-6 hours as needed, up to 1.7-3.5 mg\/kg\/day in 4-6 divided doses\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"APR02O":{"商品名稱":"APRESOLINE 25mg Tab","腎功能不良劑量調整":"\"- CrCl 10-50 mL\/minute: Administer every 8 hours.<br>- CrCl <10 mL\/minute: Administer every 8-16 hours in fast acetylators and every 12-24 hours in slow acetylators.<br>- Hemodialysis effects: Supplemental dose is not necessary.<br>- Peritoneal dialysis effects:","小兒建議劑量":"\"- Hypertension: Oral: Initial: 0.75-1 mg\/kg\/day in 2-4 divided doses; increase over 3-4 weeks to maximum of 7.5 mg\/kg\/day in 2-4 divided doses; maximum daily dose: 200 mg\/day<br>- Acute hypertension: I.M., I.V.: 0.1-0.2 mg\/kg\/dose (not to exceed 20 mg) every 4-6 hours as needed, up to 1.7-3.5 mg\/kg\/day in 4-6 divided doses\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"APR05O":{"商品名稱":"APROVEL 300mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"\"六歲以下不使用,6-12歲 起始劑量75mg 最多150mg每天<br><br>>=6-12 years: Initial: 75 mg once daily; may be titrated to a maximum of 150 mg once daily\"\r<br>","提示內容":"注意病人是否有高血鉀的症狀\r<br>每日最高劑量為300mg(1#)，若超過1#應確認","抗生素手冊":"暫無資料"},"APR06O":{"商品名稱":"Aprezin 10mg Tab","腎功能不良劑量調整":"\"- CrCl 10-50 mL\/minute: Administer every 8 hours.<br>- CrCl <10 mL\/minute: Administer every 8-16 hours in fast acetylators and every 12-24 hours in slow acetylators.<br>- Hemodialysis effects: Supplemental dose is not necessary.<br>- Peritoneal dialysis effects:","小兒建議劑量":"\"- Hypertension: Oral: Initial: 0.75-1 mg\/kg\/day in 2-4 divided doses; increase over 3-4 weeks to maximum of 7.5 mg\/kg\/day in 2-4 divided doses; maximum daily dose: 200 mg\/day<br>- Acute hypertension: I.M., I.V.: 0.1-0.2 mg\/kg\/dose (not to exceed 20 mg) every 4-6 hours as needed, up to 1.7-3.5 mg\/kg\/day in 4-6 divided doses\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ARA01O":{"商品名稱":"Arax 25mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 50-100mg qid\r<br>[< 50]:  50%\r<br>HEMO: Dose for Ccr<10","小兒建議劑量":"\"Note: Adjust dose based on patient response.\r<br>- Antiemetic: I.M.: 1.1 mg\/kg\/dose\r<br>- Preoperative sedation:<br>Oral: 0.6 mg\/kg\/dose\r<br><br>I.M.: 1.1 mg\/kg\/dose\r<br><br>- Pruritus, anxiety: Oral:<br>\r<br><6 years: 50 mg daily in divided doses\r<br><br>>=6 years: 50-100 mg daily in divided dose\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ARC01O":{"商品名稱":"Arcoxia 60mg Tab#","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"目前尚未研究過 etoricoxib 在小兒病患(<12 歲)體內的藥物動力學。一項針對青少年(12 至17 歲)所進行的藥物動力學研究(N=16)顯示，每日服用一次60 公絲之etoricoxib 的體重40 至60 公斤的青少年，以及每日服用一次90 公絲之etoricoxib 的體重>60 公斤的青少年，其體內的藥物動力學概況和每日服用一次90 公絲之etoricoxib 的成人相似。目前尚未確立Etoricoxib 在小兒病患中的安全性及有效性。\r<br>","提示內容":"一般用法為60-90mg QD，若急性痛風或經痛每天使用到120mg 不應超過8天\r<br>ClCr<30mL\/min不建議使用","抗生素手冊":"暫無資料"},"ARH01O":{"商品名稱":"Arheuma 20mg Tab#","腎功能不良劑量調整":" No specific dosage adjustment is recommended.  Patients should be monitored closely for adverse effects requiring dosage adjustment. \r<br>輕度腎臟功能不全之病患不需要調整劑量。","小兒建議劑量":"安全性及有效性尚未確立\r<br>","提示內容":"起始劑量:100mg QD for 3 days, 維持劑量: 10-20mg QD\r<br>肝功能不全之病患禁用．使用此藥需監測肝功能及白血球數","抗生素手冊":"暫無資料"},"ARI02O":{"商品名稱":"Arimidex 1mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ARI03O":{"商品名稱":"Aricept 10mg Tab#","腎功能不良劑量調整":" No adjustment provided in manufacturer’s labeling. Limited data suggest severe renal impairment does not adversely affect donepezil clearance\r<br>","小兒建議劑量":"尚無適當且控制良好之試驗，探討幼兒服用AriceptR的安全性與療效性。\r<br>","提示內容":"有心搏過慢的風險, 注意病人是否併用b-blocker, CCB等使心跳徐緩之藥品","抗生素手冊":"暫無資料"},"ARO01O":{"商品名稱":"Aromasin 25mg Tab#","腎功能不良劑量調整":"在有嚴重腎功能不全的患者(CLcr < 30毫升\/分鐘),exemestane的全身暴露量約 比健康志願者高出兩倍。基於exemestane的安全性,本品無須調整劑量。\r<br>","小兒建議劑量":"兒童不建議使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ART01E":{"商品名稱":"Artiss solution for Sealant 2ml\/Syringe","腎功能不良劑量調整":"無資料","小兒建議劑量":"適應症說明可用於成人及兒童患者，無針對兒童提供劑量，應以植皮需黏合面積給藥。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ART02E":{"商品名稱":"Artelac Eye Drops 0.32% 10ml#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Instil 1drop into the conjunctival sac 3-5times daily or more frequently if required.\r<br>","提示內容":"腸胃科可能開立14(15)瓶 ST\r<br>主要用於ESD：Endoscopic Submucosal Dissection（內視鏡黏膜下剝離術）","抗生素手冊":"暫無資料"},"ASA01E":{"商品名稱":"Asacol 500mg Supp#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童和青少年患者使用之安全性及有效性尚未完全建立。2歲以下兒童應避免使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ASA01I":{"商品名稱":"Asadin Inj 10mg\/10ml Vial","腎功能不良劑量調整":"Clcr >30 : No dosage adjustment provided in manufacturer’s labeling.\r<br>Clcr <30 : Use with caution (systemic exposure to metabolites may be higher); may require dosage reduction; monitor closely for toxicity.\r<br>Dialysis patients: Has not been studied","小兒建議劑量":"I.V.: Children ?4 years (U.S. labeling) or ?5 years (Canadian labeling): Refer to adult dosing\r<br>另有兒童劑量，詳見仿單","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ASA02E":{"商品名稱":"Asacol 2gm\/100ml Enema#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ASA02O":{"商品名稱":"Asacol 800mg gastro-resistant Tab","腎功能不良劑量調整":"血漿肌肝酸或蛋白尿含量升高患者應小心服用；嚴重腎損傷者(GFR值小於30 毫升\/每分鐘\/1.73 ㎡)不予使用。建議所有Asacol 治療之患者，應於治療前及治療初期定期作腎功能評估。一般建議開始治療後之14 天內就要作此種評估，之後每隔四週再重複評估12 個星期。","小兒建議劑量":"兒童不適用此劑量與劑型 , children must be able to swallow capsule ,Capsule Delayed Release Delzicol: 400 mg Oral","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ASC01O":{"商品名稱":"Ascofen 100mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"尚無臨床使用之資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ASI01I":{"商品名稱":"Asiphylline 250mg\/10ml Amp","腎功能不良劑量調整":"不須依腎功能劑量調整。","小兒建議劑量":"一般兒童劑量: 支氣管擴張劑－靜脈注射，5mg\/kg或150mg\/bsa m2 Q6H。\r\r<br>急性發作－\r負載劑量- 6個月以上16歲以下兒童：靜脈輸注，6mg\/kg，輸注時間須在20分鐘以上。維持劑量-1.2~1.0mg\/kg\/hr, 為時12小時--> 1~0.8mg\/kg\/hr，每小時一次。","提示內容":"[急性發作]\r<br>起始劑量：6mg\/kg(IV infusion>20 min)\r<br>維持劑量：0.6 mg\/kg\/hr for 12hr, then 0.3mg\/kg\/hr\r<br>\r<br>小兒一般劑量: 5mg\/kg或150mg\/m2 Q6H。\r<br>[急性發作]\r<br>起始劑量: 6個月-16歲：6mg\/kg(靜脈輸注>20 min)。\r<br>維持劑量: 6個月-9歲：1.2mg\/kg\/hr for 12hr, then 1mg\/kg\/hr。\r<br>                9-16歲: 1mg\/kg\/hr for 12hr, then 0.8mg\/kg\/hr","抗生素手冊":"暫無資料"},"ASI02I":{"商品名稱":"Asimplex 250mg Vial","腎功能不良劑量調整":"[Clcr >50 ml\/min]: 5-10mg\/kg Q8h\r<br>[25-50 ml\/min]: 5-10mg\/kg q12h\r<br>[10-25 ml\/min]: 5-10mg\/kg q24h\r<br>[<10 ml\/min]: 2.5 to 5mg\/kg q24h\r<br>HEMO: 2.5 - 5 mg\/kg IV q24h (dose after dialysis).","小兒建議劑量":"兒童劑量\r<br>3個月至12歲之間的兒童，應根據其體表面積計算劑量。\r<br>單純性皰疹(皰疹性腦炎除外)或是水痘帶狀皰疹的兒童，應每8小時使用250mg\/m2的靜脈輸注。免疫功能不全而腎功能正常，應每8小時，給予500mg\/m2體表面積的靜脈輸注。腎功能不全的兒童，應依受損程度適當調整劑量。\r<br>\r<br>新生兒劑量\r<br>新生兒感染單純皰疹時應每8小時給予10mg\/kg體重。\r<br>Zovirax靜脈輸注療程通常持續5天，但這可根據病人的條件及反應調整治療劑量。\r<br>治療皰疹性腦炎及新生兒單純皰疹感染同常持續10天。預防給藥期間視危險期而定","提示內容":"暫無資料","抗生素手冊":"建議量: 10 mg per kg q8h<br>小兒: 20 mg per kg q8h<br>Ccr less than 50: q12h<br>Ccr less than 25: qd<br>Ccr less than 10, HD or PD: 劑量減半 qd"},"ASP03O":{"商品名稱":"Aspirin Protect 100mg Tab#","腎功能不良劑量調整":"Severe impairment (GFR less than 10 mL\/min): Avoid use","小兒建議劑量":"Kawasaki disease :\r<br>80-100 mg\/kg\/day in 4 divided doses in combination with immune globulin IV within the first 10 days of fever. When fever subsides, dosage should be decreased to 3-5 mg\/kg once daily.","提示內容":"成人一般劑量: 500mg IV infusion for 24 hrs\r<br>\r<br>ACS:  Loading  dose 300mg ST\r<br>不得使用於12 歲以下兒童。\r<br>18 歲以下兒童不可用於病毒性引起之發燒(如水痘或流感)\r<br>→可能會引起雷氏症候群(Reye's Syndrome)。\r<br>\r<br>*小兒Kawasaki disease: 急性期(併用IVIG) 30-100 mg\/kg\/d","抗生素手冊":"暫無資料"},"ASP05O":{"商品名稱":"Aspirin(強生) FC 100mg Tab","腎功能不良劑量調整":"Analgesia or anti-inflammatory uses: The manufacturer recommends avoiding in patients with CrCl <10 mL\/minute. However, may use with caution and monitor renal function or consider the use of an alternative analgesic\/anti-inflammatory agent \r<br>","小兒建議劑量":"Kawasaki disease :\r<br>80-100 mg\/kg\/day in 4 divided doses in combination with immune globulin IV within the first 10 days of fever. When fever subsides, dosage should be decreased to 3-5 mg\/kg once daily.","提示內容":"ACS:Loading dose 300mg ST \r<br> 不得使用於12 歲以下兒童。\r<br>18 歲以下兒童不可用於病毒性引起之發燒(如水痘或流感)\r<br>→可能會引起雷氏症候群(Reye's Syndrome)。\r<br>\r<br>*小兒Kawasaki disease: 急性期(併用IVIG) 30-100 mg\/kg\/day Q6H\r<br>接著 3-5 mg\/kg\/day for 6 to 8 weeks (*Micromedex)","抗生素手冊":"暫無資料"},"ATA02O":{"商品名稱":"Atanaal 5mg Cap","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein >3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"此劑型不建議用來快速降血壓\r<br>\r<br>*急性高血壓建議用藥：\r<br>Labetalol(Trandate), Clonidine(Catapress), Captopril(Ceporin) 或 Amlodipine(Norvasc)","抗生素手冊":"暫無資料"},"ATH01S":{"商品名稱":"Athmin Syrup 0.2mg\/ml;60ml Bot#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"6 mo~3yr: 0.25ml\/kg BID;\r<br> >3yr:         5ml BID\r<br>----------------------------------------------\r<br>簡易換算: (BW\/4)c.c. BID","提示內容":"小兒劑量 6 mo~3yr: 0.25ml\/kg BID; >3yr: 5ml BID 簡易換算: (BW\/4)c.c. BID","抗生素手冊":"暫無資料"},"ATI01O":{"商品名稱":"Ativan 0.5mg Tab #4","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童使用Lorazepam安全性尚未建立，不推薦使用於12歲以下的兒童","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ATI02O":{"商品名稱":"Ativan 1mg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ATI03O":{"商品名稱":"Atinol FC 100mg Tab","腎功能不良劑量調整":"Clcr 15-35QOD","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ATO02O":{"商品名稱":"ATOZET 10\/20mg Tab#","腎功能不良劑量調整":"腎功能不全病史可能是發生statin類藥相關肌病的促發因子之一。對這類患者應嚴密監視是否發生骨骼肌影響(仿單)。","小兒建議劑量":"ATOZET用於兒童病患的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ATR01I":{"商品名稱":"Atropine 1mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"預防化療藥品Campto(Irinotecan)引起之急性膽鹼症候群","抗生素手冊":"暫無資料"},"ATR03E":{"商品名稱":"Atrovent UDV 500mcg\/2ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ATR05E":{"商品名稱":"Atropine Eye Drops 0.01% 30amp\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"發放與處方皆以盒為單位。\r<br>藥委會通過急用零購藥品開檔使用","抗生素手冊":"暫無資料"},"AUB01O":{"商品名稱":"Aubagio 14mg Tab","腎功能不良劑量調整":"不需調整劑量。","小兒建議劑量":"使用於兒科病患的安全性與療效未知。","提示內容":"治療成人復發、緩解型多發性硬化症\r<br>是本院引進的第六種針對multiple sclerosis (MS)的免疫調節劑 (immunomodulators), 其他五種分別為Betaferon, Rebif, Copaxone, Gilenya, Tysabri\r<br>劑量與給藥方式: 建議每天一次, 每次7mg 或14mg, 可與食物或不與食物併用\r<br>安全性監測\r<br>-開始療程前六個月內需檢驗轉氨與膽紅素濃度, 療程開始後至少每月監測ALT達六個月\r<br>-開始療程前六個月內需做CBC檢驗, 之後的監測應根據感染之徵象和症狀來進行\r<br>-開始療程前應作結核菌素皮膚測驗或作血液測試結核分枝桿菌感染,篩檢是否有潛在結核菌感染\r<br>-具生育能力之女性, 在開始療程前應排除懷孕狀況\r<br>-開始療程前需量血壓, 療程開始後也須定期量血壓\r<br>有一點很重要的是, 若用藥期間懷孕或發生肝損傷等, 除需停藥外, 應進行加速藥物排出步驟","抗生素手冊":"暫無資料"},"AUG03O":{"商品名稱":"Augmentin 1g Tab#","腎功能不良劑量調整":"PO:[CRCL >30 ]: no change \r<br>[10-30 ]: 250-500 mg q12h. Do not use the 875 mg tablet. \r<br>[<10 ml\/min]: 250-500 mg q24h. Do not use the 875 mg tablet.   \r<br>Hemodialysis:  250\/125 to 500\/125mg q24h. Give additional dose after dialysis.","小兒建議劑量":"Augmentin 1g錠劑並不逼議使於12歲以下兒童。\r<br>建議使用水劑。","提示內容":"常用劑量:1g Q12H, 需注意頻次若為Q8H可能要聯絡。\r<br>若腎功能ClCr<30 ml\/min，建議用他藥替代(ex:Unasyn 375mg tab)","抗生素手冊":"暫無資料"},"AUG04S":{"商品名稱":"Augmentin Syrup 457mg\/5ml;35ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"2-6yr(13-21kg): 2.5-5ml Q12H; \r<br>7-12yr(22-40kg): 5-10ml Q12H\r<br>(急性中耳炎: 1 ml\/kg\/d 分兩次服用)\r<br>---------------------------------------------------------------\r<br>簡易換算:\r<br>急性中耳炎: (BW\/2)c.c. bid.\r<br>一般: (BW\/4)c.c. bid","提示內容":"小兒劑量(以Amoxicillin 80mg\/ml計算)\r<br>一般劑量:25-45 mg\/kg\/d Q12H。嚴重中耳炎劑量: 80-90mg\/kg\/d Q12H。\r<br>簡易換算: 急性中耳炎:(BW\/2)ml BID, 一般: (BW\/4)ml BID.","抗生素手冊":"40 to 45mg per kg q8h to q12h 以 amoxi 計<br>高劑量: 2倍量頻次不變"},"AVA01E":{"商品名稱":"Avamys Nasal Spray 27.5ug\/50uL;120D","腎功能不良劑量調整":"No dosage adjustment is required in patients with renal impairment. \r<br>","小兒建議劑量":"2至11歲兒童：建議起始劑量為55微克一天一次，兩邊鼻孔各使用一個噴霧劑量(每個噴霧劑量為27.5微克)。若患者對55微克一天一次未出現有效的反應，可給予110微克一天一次(兩邊鼻孔各兩個噴霧劑量)。當症狀得到適當控制，可將劑量減至55微克一天一次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AVA02I":{"商品名稱":"Avastin 100mg\/4ml Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AVA03I":{"商品名稱":"Avastin (恩慈) 100mg\/4ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AVA04I":{"商品名稱":"Avaxim 80U\/0.5ml Syringe (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AVE01I":{"商品名稱":"Avelox 400mg\/250ml#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"並未有小兒族群使用 moxifloxacin 藥物動力學的研究\r<br>","提示內容":"腎功能不良無需調整劑量 注意 QT prolong藥品交互作用 \r<br>避免併服礦物質,制酸劑.(鈣製劑或牛奶則不影響吸收 \r<br>→如需併用需間隔至少2小時以上","抗生素手冊":"建議量: 400 mg qd<br>留意 DDI 誘發 TdP "},"AVE01O":{"商品名稱":"Avelox 400mg Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"並未有小兒族群使用 moxifloxacin 藥物動力學的研究\r<br>","提示內容":"腎功能不良無需調整劑量 注意 QT prolong藥品交互作用 \r<br>避免併服礦物質,制酸劑.(鈣製劑或牛奶則不影響吸收 \r<br>→如需併用需間隔至少2小時以上","抗生素手冊":"建議量: 400 mg qd<br>留意 DDI 誘發 TdP "},"AVO01O":{"商品名稱":"Avodart 0.5mg Cap#","腎功能不良劑量調整":"腎功能不全的病人不需調整劑量\r<br>","小兒建議劑量":"禁用於兒童\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AYV01O":{"商品名稱":"Ayvakit 300mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AZA01E":{"商品名稱":"Azarga Eye drops Susp 5ml","腎功能不良劑量調整":"未針對 AZARGAR 點眼液用於重度腎功能不全（肌酸酐廓清率低於 30 ml\/min）的病人或用於高血氯性酸中毒的病人進行研究。由於 brinzolamide 及其主要代謝物主要經由腎臟排出體外，因此 AZARGAR 點眼液禁止使用於重度腎功能不全的病人。","小兒建議劑量":"由於缺乏安全性與效果的資料，不建議將AZARGA點眼液用於18歲以下的孩童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AZE01E":{"商品名稱":"Azetin Spray 140mcg\/dose;120d Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兩次兩鼻孔各噴一下，每天使用兩次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AZE02E":{"商品名稱":"Azeic-A Cream 20% 12gm Tube","腎功能不良劑量調整":"不用調整","小兒建議劑量":"Apply bid. In the event of excessive skin irritation, reduce amount of cream\/application or reduce application to once a day until irritation ceases or interrupt treatment temporarily for a few days.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"AZI01S":{"商品名稱":"Azithrom Susp 40mg\/mL;15mL","腎功能不良劑量調整":"輕至中度腎功能損害（GFR 10-80 mL\/min）的患者：不須調整劑量，\r<br>併有嚴重腎功能損害（GFR＜10 mL\/min）：應謹慎用藥","小兒建議劑量":"<45kg 10mg\/kg\/d (0.25ml\/kg\/d); QD*3d\r<br>>45kg 12.5ml; QD*3d\r<br>-------------------------------------------\r<br>簡易換算 : 0.25ml\/kg\/d QD x 3day\r<br>","提示內容":"暫無資料","抗生素手冊":"須空腹<br>10 mg per kg qd for 3 days<br>loading: 10 mg per kg then 5 mg per kg for 4 days"},"AZI02O":{"商品名稱":"Aziciin 250mg Tab","腎功能不良劑量調整":"No adjustments required in renal failure.  Use caution in patients with Clcr <10 ml\/minute.   \r<br>Hemodialysis:  No adjustments required in renal failure.","小兒建議劑量":" Children 10 mg\/kg daily for 3 days.","提示內容":"暫無資料","抗生素手冊":"500 mg qd for 3 days<br>Legionnaires disease for 1 week"},"AZO03E":{"商品名稱":"Azopt Oph Susp 1% 5ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAI01I":{"商品名稱":"Bain Inj. 10mg\/1ml amp","腎功能不良劑量調整":"因為NALBUPHINE HYDROCHLORIDE 是在腎臟代謝並經由肝臟排泄，所以NALBUPHINE HYDROCHLORIDE 用在有腎臟或肝臟功能障礙的病人時，必須小心且減量使用。(仿單)","小兒建議劑量":"小於十八歲之病童使用本品之安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAK01O":{"商品名稱":"Baktar Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Sulfa drug","抗生素手冊":"UTI 以 fluoroquinolones 替代<br>Ccr less than 30: qd<br>Ccr less than 15 or HD or PD: qod"},"BAL01I":{"商品名稱":"Balance 4.25% \/1.75mmol\/L Dialysis 2L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL02I":{"商品名稱":"Balance 1.5% \/1.75mmol\/L Dialysis 2L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL03I":{"商品名稱":"Balance 2.3% \/1.75mmol\/L Dialysis 2L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL04I":{"商品名稱":"Balance 1.5% \/1.25mmol\/L Dialysis 2L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL05I":{"商品名稱":"Balance 2.3% \/1.25mmol\/L Dialysis 2L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL06I":{"商品名稱":"Balance 4.25% \/1.25mmol\/L Dialysis 2L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL07I":{"商品名稱":"Balance 1.5% \/1.75mmol\/L Dialysis 2.5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL08I":{"商品名稱":"Balance 2.3% \/1.75mmol\/L Dialysis 2.5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL09I":{"商品名稱":"Balance 1.5% \/1.25mmol\/L Dialysis 5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL10I":{"商品名稱":"Balance 2.3% \/1.25mmol\/L Dialysis 5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL11I":{"商品名稱":"Balance 1.5% \/1.25mmol\/L Dialysis 2.5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL12I":{"商品名稱":"Balance 2.3% \/1.25mmol\/L Dialysis 2.5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL13I":{"商品名稱":"Balance 1.5% \/1.75mmol\/L Dialysis  5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAL14I":{"商品名稱":"Balance 2.3% \/1.75mmol\/L Dialysis 5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAM01I":{"商品名稱":"Bamlanivimab\/Etesevimab Vial Set","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAR02O":{"商品名稱":"Baraclude 0.5mg Tab#","腎功能不良劑量調整":"Clcr對應每日投與劑量\r<br>: 不曾使用過核?\/【對lamivudine反應不佳時】\r<br>>50ml\/min: 0.5mg\/d\/【1mg】\r<br>30~50:      0.25mg  \/【0.5mg】\r<br>10~30:      0.15mg  \/【0.3mg】\r<br><10，HD，CAPD: 0.05mg\/【0.1mg】","小兒建議劑量":"Entecavir 用於 16歲以下兒童患者的安全性與療效尚未確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAR02S":{"商品名稱":"Baritop 120","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAR03O":{"商品名稱":"BARACLUDE 1MG TAB#","腎功能不良劑量調整":"Clcr對應每日投與劑量\r<br>: 不曾使用過核?\/【對lamivudine反應不佳時】\r<br>>50ml\/min: 0.5mg\/d\/【1mg】\r<br>30~50:      0.25mg  \/【0.5mg】\r<br>10~30:      0.15mg  \/【0.3mg】\r<br><10，HD，CAPD: 0.05mg\/【0.1mg】\r<br>\r<br>肝功能缺損毋須調整劑量","小兒建議劑量":"Entecavir 用於 16歲以下兒童患者的安全性與療效尚未確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BAR03S":{"商品名稱":"Baritop LV 300gm Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BCG02I":{"商品名稱":"BCG Vaccine(公費)","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"0.1ml 左上臂三角肌中央皮內 出生二十四小時，體重2500gm以上即可接種\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEE01O":{"商品名稱":"Beesix 50mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"Adequate Intake (AI): Oral (IOM, 1998): Infants:\r<br><br><br>1-6 months: 0.1 mg\/day\r<br><br><br>7-12 months: 0.3 mg\/day<br><br>\r<br>Recommended daily allowance (RDA): Oral (IOM, 1998): Children:<br><br>\r<br>1-3 years: 0.5 mg<br><br>\r<br>4-8 years: 0.6 mg<br><br>\r<br>9-13 years: 1 mg<br><br>\r<br>14-18 years:\r<br><br><br>Females: 1.5 mg<br><br>\r<br>Males: 1.3 mg\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEF01O":{"商品名稱":"Befon 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEL01E":{"商品名稱":"Belolin Oint 3.5mg\/7gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEN02I":{"商品名稱":"Benlysta 120mg Vial","腎功能不良劑量調整":"根據已知資訊，輕度、中度及重度腎功能不全者皆無需調整劑量。但由於缺乏資料，請謹慎使用於重度腎功能不全的病人。","小兒建議劑量":"紅斑性狼瘡兒童病人(<5歲)的療效及安全性尚未確立。18歲以下成人和兒童活動性狼瘡腎炎病人的療效及安全性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEN03I":{"商品名稱":"BENLYSTA 400MG VIAL","腎功能不良劑量調整":"根據已知資訊，輕度、中度及重度腎功能不全者皆無需調整劑量。但由於缺乏資料，請謹慎使用於重度腎功能不全的病人。","小兒建議劑量":"紅斑性狼瘡兒童病人(<5歲)的療效及安全性尚未確立。18歲以下成人和兒童活動性狼瘡腎炎病人的療效及安全性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEN13O":{"商品名稱":"Bensau 100mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEO01I":{"商品名稱":"Beovu 120mg\/mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEO02I":{"商品名稱":"Beovu (恩慈) 120mg\/mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BER01I":{"商品名稱":"Beriplex P\/N 500IU Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前尚無兒童用藥的經驗","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BER05E":{"商品名稱":"BeroDUAL N Metered Aerosol 200d#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童需有醫師處方並在大人監護下才可使用。6歲以上兒童建議劑量同成人。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BES01E":{"商品名稱":"Besonin Nasal Spray 64mcg\/d;120d","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BES01I":{"商品名稱":"Besponsa 1mg Vial","腎功能不良劑量調整":"不須調整劑量","小兒建議劑量":"尚未建立對於0-18歲以下兒童病人的安全性和療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BET02I":{"商品名稱":"Betamethasone 4mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Rinderon amp替代藥\r<br>外觀與Dexamethasone 5mg\/1ml Amp相似","抗生素手冊":"暫無資料"},"BET02O":{"商品名稱":"BETMIGA PR 50MG TAB","腎功能不良劑量調整":"重度腎功能不全患者(Clcr <30): 每日劑量不可超過 25mg 。 \r<br>末期腎病患者Clcr<15或H\/D患者: 不建議使用。","小兒建議劑量":"對兒童患者的安全性和有效性尚未確立","提示內容":"25-50mg QD\r<br>ClCr < 15 mL\/min 不建議使用, ClCr 15-29 : 25mg QD","抗生素手冊":"暫無資料"},"BET04E":{"商品名稱":"Better-Iodine Oint 10gm","腎功能不良劑量調整":"沒有特別寫\r<br>","小兒建議劑量":"視情況減量使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BET07O":{"商品名稱":"BETALOC ZOK 100MG TAB","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"使用的經驗相當有限\r<br>","提示內容":"嚴重低血壓, 嚴重心搏過慢及第二或第三期的心臟傳導阻斷為使用禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)","抗生素手冊":"暫無資料"},"BET12O":{"商品名稱":"Betaloc Zok 25mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"使用的經驗相當有限\r<br>","提示內容":"嚴重低血壓, 嚴重心搏過慢及第二或第三期的心臟傳導阻斷為使用禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)","抗生素手冊":"暫無資料"},"BET14E":{"商品名稱":"Betadine Throat Spray 0.45% 50ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未滿六歲請勿使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEV01E":{"商品名稱":"Bevespi Aerosphere 7.2\/5mcg Inh; 120d#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不適用於兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BEX01I":{"商品名稱":"Bexsero Vaccine 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BFL01I":{"商品名稱":"Bfluid 1000ml Bag","腎功能不良劑量調整":"仿單暫無資料","小兒建議劑量":"對小兒的安全性尚未建立(無使用經驗)。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIB01I":{"商品名稱":"Bibag-4008 650g Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIB02I":{"商品名稱":"BIBAG-4008 900g Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIB03I":{"商品名稱":"Bibag-5008 650g Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIB04I":{"商品名稱":"BIBAG-5008 900g Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIC03I":{"商品名稱":"Bicillin L-A 2.4MIU\/4ml Susp Inj","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer’s labeling; use with caution.\r<br>Micromedex-\r<br>10~50 (mL\/min) 75% dose at usual intervals   \r<br><10 (mL\/min) 20~50% dose at usual intervals","小兒建議劑量":"鏈球菌(A群)上呼吸道感染\r<br>體重27 kg以下兒童患者─單次0.6MIU\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIC04I":{"商品名稱":"Bicart 650g Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIC05I":{"商品名稱":"Bicart 1150g Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIC06I":{"商品名稱":"Bicarbonate Powder 650g Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIC07I":{"商品名稱":"Bicarbonate Powder 500g Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIN01O":{"商品名稱":"Binin-U 5mg Tab","腎功能不良劑量調整":"\"No dosage adjustment provided in the manufacturer's labeling.<br>Hemodialysis\/peritoneal dialysis: Supplemental dose is not necessary.\"\r<br>","小兒建議劑量":"2. 兒童(3～12歲或15～40kg)：a.初劑量每日0.5mg。需要時可每隔5～7天增加0.5mg。每日劑量可分2～3次使用。此年齡層的劑量尚未確立。b.3～6歲兒童的其他建議劑量：激動不安和過動，每日口服0.01～0.03mg\/kg，幼童自閉症，每日0.5～4mg。\r<br>Children 0.1mg\/3kg daily in 3 divided doses orally.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIO01E":{"商品名稱":"Biodyne Oint 10gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIO02O":{"商品名稱":"Bio-Cal Plus Chewable Tab","腎功能不良劑量調整":"仿單無記載\r<br>Dosing: Renal Impairment Use caution in severe renal impairment.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIP01O":{"商品名稱":"Biperin 2mg Tab","腎功能不良劑量調整":"查無資料","小兒建議劑量":"對幼兒和小孩投與:本劑給藥相關安全性資料尚未建立，故宜小心謹慎給藥。查Micromedex有EPS症狀注射給藥，但無口服給藥資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIP02I":{"商品名稱":"Bipiden 5mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"若開立1 amp STAT則注意病人是否有使用Metoclopramide 或是抗精神病藥物","抗生素手冊":"暫無資料"},"BIP03O":{"商品名稱":"Bipiden 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIS01E":{"商品名稱":"Bisacodyl 10mg Supp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIS01O":{"商品名稱":"Bismuth 324mg Tab VPP","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIS02E":{"商品名稱":"Bisadyl 10mg Supp","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling. Use with caution in patients with impaired renal function.[uptodate]","小兒建議劑量":"便秘\r<br>成人及10歲以上的兒童：1-2錠(5-10mg)。\r<br>4-10歲兒童：1錠(5mg)。\r<br>4歲以下兒童：建議使用1\/2栓劑(5mg)。\r<br>\r<br>Rectal (suppository): Children:\r<br><2 years: 5 mg as a single dose\r<br>>2 years: 10 mg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIS02S":{"商品名稱":"Bisolvon Soln 1ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"< 6yr 2ml TID; 6~14yr 4ml TID;  > 14yr 4~8ml TID。\r<br>----------------------------------------------\r<br>Oral:\r<br><2yr: 1 mg (0.5ml) TID; \r<br>2-6yr: 4 mg (2ml) BID or 2 mg (1ml) TID; \r<br>6-12yr: 4mg (2ml) TID; \r<br>>12 yr & Adults: 8 mg(4ml) TID;\r<br>Inhalation:\r<br><2yr: 0.33ml BID;  2-6 yr: 0.66ml BID;\r<br>6-12yr: 1 mL BID; >12yr & Adults: 2-4mL BID","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIS03O":{"商品名稱":"Bismuth 324mg Tab GCPC","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BIS03S":{"商品名稱":"Bisolvon Solu 2mg\/ml;50ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"< 6yr 2ml TID; 6~14yr 4ml TID;  > 14yr 4~8ml TID。\r<br>----------------------------------------------\r<br>Oral:\r<br><2yr: 1 mg (0.5ml) TID; \r<br>2-6yr: 4 mg (2ml) BID or 2 mg (1ml) TID; \r<br>6-12yr: 4mg (2ml) TID; \r<br>>12 yr & Adults: 8 mg(4ml) TID;\r<br>Inhalation:\r<br><2yr: 0.33ml BID;  2-6 yr: 0.66ml BID;\r<br>6-12yr: 1 mL BID; >12yr & Adults: 2-4mL BID","提示內容":"吸入: >12yr & Adults: 2-4mL BID\r<br>(本院醫師處方常用 2mLQID)","抗生素手冊":"暫無資料"},"BIS04O":{"商品名稱":"Bisacodyl 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"4-10歲兒童：1錠。\r<br>4歲以下建議使用5mg栓劑。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BLE01I":{"商品名稱":"Bleocin 15mg Vial#","腎功能不良劑量調整":"腎功能不良應減量","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BLO01O":{"商品名稱":"Blopress 8mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"BLO02O":{"商品名稱":"Bloodfull Tab","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"兒童減半服用\r<br>","提示內容":"內含鐵劑, 注意是否有併用Fluoroquinolone類或四環黴素類抗生素","抗生素手冊":"暫無資料"},"BLO03O":{"商品名稱":"BLOPRESS PLUS 16\/12.5mg Tab","腎功能不良劑量調整":" 本品不建議使用在嚴重腎功能受損(肌酸酐廓清率≦30mL\/min)或重度肝功能受損之病患","小兒建議劑量":"尚未建立Blopress 加強錠16\/12.5 毫克使用於兒童年齡自新生兒至18 歲身上的有效性與安全性研究。無相關資料。","提示內容":"為複方藥品(Angiotensin II 接受體抗拮劑＋利尿劑)，本院有同成分的Angiotensin II 接受體抗拮劑商品名：Blopress 8mg Tab，藥名相近發藥請注意","抗生素手冊":"暫無資料"},"BOK01O":{"商品名稱":"Bokey 100mg Em Cap","腎功能不良劑量調整":"Severe impairment (GFR less than 10 mL\/min): Avoid use","小兒建議劑量":"暫無資料","提示內容":"ACS: Loading dose 300mg ST \r<br> 不得使用於12 歲以下兒童。\r<br>18 歲以下兒童不可用於病毒性引起之發燒(如水痘或流感)\r<br>→可能會引起雷氏症候群(Reye's Syndrome)。\r<br>\r<br>*小兒Kawasaki disease: 急性期(併用IVIG) 30-100 mg\/kg\/day Q6H\r<br>接著 3-5 mg\/kg\/day for 6 to 8 weeks (*Micromedex)","抗生素手冊":"暫無資料"},"BON01O":{"商品名稱":"Bonamine 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BON03I":{"商品名稱":"Bonviva 3mg\/3ml Syringe#","腎功能不良劑量調整":"Clcr ?30 mL\/minute: No dosage adjustment necessary.\r<br>\r<br>Clcr <30 mL\/minute: Use not recommended","小兒建議劑量":"暫無資料","提示內容":"骨質疏鬆症: 3個月注射一次, 以15 至30 秒的時間靜脈注射3 mg","抗生素手冊":"暫無資料"},"BOO01I":{"商品名稱":"Boostrix 0.5ml Syringe","腎功能不良劑量調整":"仿單無記載","小兒建議劑量":"適用於四歲以上者之追加疫苗接種，以預防白喉、破傷風及百日咳。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BOT01I":{"商品名稱":"Botox 100u Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BOT02I":{"商品名稱":"Botox 1u#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling.\r<br>","小兒建議劑量":"\"本類藥品限以下適應症使用，每一個案每一年需重新評估一次，惟用於成人中風後之手臂痙攣時，需經事前審查核准後使用(98\/5\/1)。<br>1.使用於眼瞼痙攣或半面痙攣：<br>(1)限12歲以上，經區域以上（含）教學醫院之眼科、神經內科或小兒神經科專科醫師診斷為眼瞼痙攣或半面痙攣之病患使用。<br>(2)需符合Spasm Intensity Scale 3級（含）以上，另有病歷記載病史6個月以上者可申請治療。(94\/6\/1)<br>(3)每次注射最高劑量：眼瞼痙攣為每側20單位，半面痙攣為每側30單位。每年最多注射3次為原則。<br>\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BOT03I":{"商品名稱":"Botox 1u (專科)","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling.\r<br>","小兒建議劑量":"\"本類藥品限以下適應症使用，每一個案每一年需重新評估一次，惟用於成人中風後之手臂痙攣時，需經事前審查核准後使用(98\/5\/1)。<br>1.使用於眼瞼痙攣或半面痙攣：<br>(1)限12歲以上，經區域以上（含）教學醫院之眼科、神經內科或小兒神經科專科醫師診斷為眼瞼痙攣或半面痙攣之病患使用。<br>(2)需符合Spasm Intensity Scale 3級（含）以上，另有病歷記載病史6個月以上者可申請治療。(94\/6\/1)<br>(3)每次注射最高劑量：眼瞼痙攣為每側20單位，半面痙攣為每側30單位。每年最多注射3次為原則。<br>\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BOT04I":{"商品名稱":"Botox (恩慈) 100u Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BOW01O":{"商品名稱":"Bowklean Powder 16.2g\/pack","腎功能不良劑量調整":"腎功能不良或正在併用會影響腎功能藥物的患者時應特別小心。應告知患者服用期間與服藥後補充充足水分的重要性。此類患者應考慮是否於用藥前與大腸鏡檢查後進行(電解質、肌酸酐與 BUN)檢驗。腎功能嚴重下降的患者(Clcr< 30 mL\/min)，鎂離子可能會蓄積於血漿中。","小兒建議劑量":"BowkleanR Powder 用於兒科患者的安全性與有效性尚未獲得確立。","提示內容":"不可直接吞服粉末。直接喝下未溶解的散劑會提高噁心、嘔吐、脫\r<br>水與電解質異常的風險。","抗生素手冊":"暫無資料"},"BRE01E":{"商品名稱":"Breztri Aerosphere 160\/7.2\/5mcg Inh; 120","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未核准用於兒童","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRI01O":{"商品名稱":"BRILINTA FC 90MG TAB#","腎功能不良劑量調整":"腎功能不全患者無須調整劑量。\r<br>未曾在接受透析的患者中進行研究","小兒建議劑量":"Ticagrelor未曾在兒童族群中進行評估","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRI02I":{"商品名稱":"Bridion 200mg\/2ml Vial","腎功能不良劑量調整":"Clcr > 30 ml\/min :無須調整劑量。\r<br>\r<br>Clcr < 30 ml\/min: 不建議使用。","小兒建議劑量":"不建議施用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRI02O":{"商品名稱":"Brintellix 10mg Tab","腎功能不良劑量調整":"腎功能不全病人，毋須調整劑量，但仍建議小心使用(仿單)","小兒建議劑量":"使用於18歲以下的安全性及療效性尚未明確。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRI03I":{"商品名稱":"Briviact 50mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRI03O":{"商品名稱":"Briviact FC 100mg Tab","腎功能不良劑量調整":"輕度至重度損傷：無需調整劑量。\r<br>\r<br>需要透析的終末期腎病：不推薦使用（尚未研究）。","小兒建議劑量":">=50kg: init. dose 25~50mg BID, maint. dose 25~100mg BID\r<br>20~50kg: init. dose 0.5~1mg\/kg BID, maint. dose 0.5~2mg\/kg BID\r<br>11~20kg: init. dose 0.5~1.25mg\/kg BID, maint. dose 0.5~2.5mg\/kg BID","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRI04O":{"商品名稱":"Brilinta FC 60mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRO02I":{"商品名稱":"Brosym For Inj 2Gm\/Vial","腎功能不良劑量調整":"仿單-(Clcr)而定：每日最高劑量\r<br>[Clcr >30] :      (2g+2g) Q12h\r<br>[Clcr 15-30]:   (1g+1g)  Q12h\r<br>[Clcr ≦15]:   (500mg+500mg)  Q12h\r<br>廠商資料\r<br>Clcr>30 :           (2g+2g) Q12~q8h\r<br>Clcr<30 or HD: (2g+2g) Q12h\r<br>CRRT:               (1g+1g) Q6h","小兒建議劑量":"仿單未註明","提示內容":"暫無資料","抗生素手冊":"無法穿透BBB,膽道濃度高<br>建議量: 4 g q8h<br>Ccr less 30: 4 g q12h<br>Ccr less 15 or HD: 2 g q12h"},"BRO02O":{"商品名稱":"Broen-C Enteric F.C. Tab","腎功能不良劑量調整":"資料庫未記載。.\r<br>遇有重症的肝、腎機能障礙不全時，不可使用本劑。(仿單)","小兒建議劑量":"仿單、資料庫未記載。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRO07S":{"商品名稱":"Brown Mixture Liq. 120ml Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"成人通常每次服用10ml ，一日3-4次，\r<br>兒童視年齡酌減。\r<br>\r<br>本品對1歲以下嬰兒不宜長期服用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRO08S":{"商品名稱":"Brown Mixture Liq. 1ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"成人通常每次服用10ml ，一日3-4次，\r<br>兒童視年齡酌減。\r<br>\r<br>本品對1歲以下嬰兒不宜長期服用。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BRU01O":{"商品名稱":"Brukinsa 80mg Cap","腎功能不良劑量調整":"輕度或中度腎功能不全病人無需調整劑量 ；\r<br>臨床試驗未建立重度腎功能不全或透析病人使用Zanubrutinib的安全性及療效。","小兒建議劑量":"尚未建立兒童使用 Zanubrutinib的安全性和療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BSS01E":{"商品名稱":"BSS Plus 250ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BSS02E":{"商品名稱":"BSS irrigating soln 15ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BSS03E":{"商品名稱":"BSS Plus 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BSS05E":{"商品名稱":"BSS 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUP01I":{"商品名稱":"Bupivacaine 100mg\/20ml Vial Aguettant","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUP01O":{"商品名稱":"Bupion SR 150mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Bupropion SR錠用於18歲以下患者的安全性及有效性尚未確立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUR01I":{"商品名稱":"Burinex 2mg\/4ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Continuous IV infusion : 1 mg IV load, then 0.5 to 2 mg\/hour\r<br>→因此可能遇到48mg\/day的處方\r<br>注意病人是否有低血鉀的症狀","抗生素手冊":"暫無資料"},"BUR01O":{"商品名稱":"Burinex 1mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"0.5-2 mg QD-QID, max. dose: 10 mg\/day\r<br>\r<br>注意病人是否有低血鉀的症狀","抗生素手冊":"暫無資料"},"BUS01I":{"商品名稱":"Buscopan 20mg\/1ml Amp","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling. However, caution is recommended due to increased risks of adverse effects.\r<br>","小兒建議劑量":"\"Scopolamine hydrobromide:<br>\r<br>- Antiemetic: SubQ: 0.006 mg\/kg\r<br>- Preoperative: I.M., I.V., SubQ:<br>\r<br>Children 6 months to 3 years: 0.1-0.15 mg<br>\r<br>Children 3-6 years: 0.2-0.3 mg\r<br>- In severe case: 0.3 - 0.6 mg\/kg, slow IV, IM or SubQ several times daily\r<br>Max daily dose: 1.5 mg\/kg\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUS01O":{"商品名稱":"Buscopan S.C. 10mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling. However, caution is recommended due to increased risks of adverse effects.\r<br>","小兒建議劑量":"6歲以上兒童劑量比照成人\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUS03O":{"商品名稱":"Busix 1mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUS04O":{"商品名稱":"Bushiton SC 10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUT02O":{"商品名稱":"Butin 2.5mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BUW01O":{"商品名稱":"Buwecon 0.125mg Tab","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling, use with caution.\r<br>","小兒建議劑量":"2~12歲兒童：一次1\/2~1錠，每4小時或需要時一次，每日不超過6錠。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BYF01I":{"商品名稱":"Byfavo (內含) 20mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"BYF02I":{"商品名稱":"Byfavo (自費) 20mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAB01O":{"商品名稱":"Cabometyx 60mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"使用於孩童病人的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAC01I":{"商品名稱":"Cacare Inj 1mcg\/ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAD02O":{"商品名稱":"CADUET 5\/20MG TAB#","腎功能不良劑量調整":"腎功能不全患者無須調整劑量(仿單)","小兒建議劑量":"針對兒童使用CADUET (複方產品)的安全性及有效性尚未做過研究。(仿單)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAL01E":{"商品名稱":"Calmsit Cream 15gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAL02O":{"商品名稱":"Calcium Carbonate (Y.S) 500mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAM04I":{"商品名稱":"Campto 100mg\/5ml Vial#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Children <10 kg: 20 mg\/kg 三週打一次\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAM05O":{"商品名稱":"Camisan 250mg Tab#","腎功能不良劑量調整":"250mg po qd.\r<br>[<50 ml\/min and HEMO]: Manufacturer: not recommended in patients with CRCL <50.\r<br>Clcr<50: 250mg qod","小兒建議劑量":"<20kg 62.5mg qd, 20~40kg 125mg qd, >40kg 250mg qd\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAN01O":{"商品名稱":"Canaglu 100mg Tab#","腎功能不良劑量調整":"使用於中度腎功能不全病人的療效可能不足，因此必須謹慎判斷給藥之必要性。\r<br>eGFR>60: 無需調整劑量\r<br>eGFR30~60: 100mg QD\r<br>eGFR<30: 若尿白蛋白>300mg\/d，原本已服用本藥者，可繼續服用100mg QD; 若尿白蛋白<300mg\/d, 不建議使用本品治療。\r<br>ESRD & H\/D:禁止使用。","小兒建議劑量":"使用於出生時體重輕的新生兒、新生兒、嬰兒、幼兒或孩童的安全性尚未確立","提示內容":"1. 100mg\/day\r<br>2.注意是否有脫水、生殖泌尿道感染之情況\r<br>3. eGFR<30 mL\/min\/1.73 m2不建議；ESRD及透析禁用)\r<br>4.急性腎損傷病人禁用","抗生素手冊":"暫無資料"},"CAP02O":{"商品名稱":"Capoten 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAP04O":{"商品名稱":"Caprelsa 100mg Tab","腎功能不良劑量調整":"中、重度腎功能不良者 (Clcr < 50ml\/min): 起始劑量應降至每日200mg。\r<br>\r<br>中、重度肝功能不全者不建議使用本品，因安全性及療效性尚未確定。","小兒建議劑量":"尚未確定使用於小兒患者的安全性及療效性。","提示內容":"1.治療無法進行手術切除的局部侵犯或轉移性甲狀腺髓質癌，並且為症狀性及疾病侵襲性的患者\r<br>2.注意QT interval 延長\r<br>3.Child?Pugh B 級和Child?Pugh C 級肝功能不全患者，不建議使用\r<br>4.CrCL<50mL\/min從200mg\/day起\r<br>5..不應壓碎。可將錠劑放進一杯含2 盎司(60ml以上)水中，攪拌約10分鐘直至錠劑崩散(不會完全溶解)","抗生素手冊":"暫無資料"},"CAR01O":{"商品名稱":"Carbomix 61.5g Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"PO or via NG tube.\r<br>Single dose:\r<br>1-12 yrs, 25-50 g or 0.5-1 g\/kg; infants, 10-25 g or 0.5-1 g\/kg.\r<br>Multiple doses:\r<br>< 13 yrs, initially, 10-25 g; followed by 1-2 g\/kg every 2-4 hrs","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAR03O":{"商品名稱":"Carvedilol HEXAL 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"嚴重低血壓, 嚴重心搏過慢及第二或第三期的心臟傳導阻斷為使用禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)\r<br>\r<br>不應使用於氣喘或有呼吸道阻塞性疾病的病人","抗生素手冊":"暫無資料"},"CAR04O":{"商品名稱":"Cartil 30mg Tab","腎功能不良劑量調整":"\"本品由腎臟及膽汁排泄，故若長期使用或腎、肝功能不全之<br>患者，使用本品時應隨時監視之。\"\r<br>","小兒建議劑量":"幼兒使用本品之安全性尚未建立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAR05O":{"商品名稱":"Carbizo 10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAR06S":{"商品名稱":"Cardiacin Elixir 0.05mg\/ml;60ml#","腎功能不良劑量調整":"【CHF 0.5~0.8 ng\/ml; 心律: 0.8-2ng\/ml】","小兒建議劑量":"直接或和以開水吞服皆可，其用法如下，一日量分作3-4次服用。L:初日量; M: 維持量\r<br>1個月以上: (L)2-4ml; (M)1ml\r<br>3個月以上: (L)4-6ml; (M) 1.5-2ml\r<br>12個月以上: (L)6-8ml; (M) 2ml\r<br>2~3歲:          (L)8ml; (M) 2-3ml\r<br>4~6歲 :         (L)10-12ml; (M)3-4ml","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAR07O":{"商品名稱":"Cardol (Sotalol) 160mg Tab","腎功能不良劑量調整":"[Clcr >50 ml\/min]: 80mg q12h,2nd dose:120-160mg q12h\r<br>[10-50 ml\/min]: Q24-48h\r<br>[<10 ml\/min]: Q48-72h\r<br>HEMO: Dose after dialysis","小兒建議劑量":"暫無資料","提示內容":"注意 QT prolong藥品交互作用 \r<br>氣喘或有呼吸道阻塞性疾病, 心搏過緩, 心臟傳導阻斷, 心臟衰竭為禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)\r<br>\r<br>與cardolol藥名很像, 注意醫師是否開立正確","抗生素手冊":"暫無資料"},"CAR08O":{"商品名稱":"Cardolol 40mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"Proliferating infantile hemangioma (Hemangeol): Infants >=2 kg: Oral: Note: Initiate treatment at age 5 weeks to 5 months; doses should be administered at least 9 hours apart. Refer to product labeling for detailed weight-based dosing tabulation.<br><br>\r<br>\r<br>Week 1: 0.15 mL\/kg (~0.6 mg\/kg) twice daily\r<br>\r<br><br><br>Week 2: 0.3 mL\/kg (~1.1 mg\/kg) twice daily<br><br>\r<br>\r<br>Week 3 (maintenance): 0.4 mL\/kg (~1.7 mg\/kg) twice daily; maintain this dose for 6 months. Readjust dose periodically as the child's weight increases. Treatment may be reinitiated if hemangiomas recur.<br><br>\r<br>Hypertension (unlabeled use): Oral: Initial: 0.5-1 mg\/kg\/day in divided doses every 6-12 hours; increase gradually every 5-7 days; maximum: 16 mg\/kg\/24 hours<br><br>\r<br>\r<br>Migraine headache prophylaxis (unlabeled use): Oral: Initial: 2-4 mg\/kg\/day or<br><br>\r<br>\r<br>?35 kg: 10-20 mg 3 times\/day<br><br>\r<br>\r<br>>35 kg: 20-40 mg 3 times\/day<br><br>\r<br>\r<br>Tachyarrhythmias (unlabeled use):<br><br>\r<br>\r<br>Oral: Initial: 0.5-1 mg\/kg\/day in divided doses every 6-8 hours; titrate dosage upward every 3-7 days; usual dose: 2-6 mg\/kg\/day; higher doses may be needed; do not exceed 16 mg\/kg\/day or 60 mg\/day\r<br>\r<br><br><br>I.V.: 0.01-0.1 mg\/kg\/dose slow IVP over 10 minutes; maximum dose: 1 mg for infants; 3 mg for children<br><br>\r<br>Thyroid storm (unlabeled use): Oral: Children: 0.5 mg\/kg\/dose every 4-8 hours; titrate to effective dose (Eyal, 2008)\r<br>\r<br><br><br>Thyrotoxicosis (unlabeled use): Oral:<br><br>\r<br>\r<br>Children: 10-40 mg every 6 hours; titrate to effective dose (Eyal, 2008)<br><br>\r<br>\r<br>Adolescents: Refer to adult dosing.\r<br>\r<br><br><br>Hypercyanotic spells (TOF) (unlabeled use):<br><br>\r<br>\r<br>Oral: Palliation: Initial: 1 mg\/kg\/day every 6 hours; if ineffective, may increase dose after 1 week by 1 mg\/kg\/day to a maximum of 5 mg\/kg\/day, if patient becomes refractory, may increase slowly to a maximum of 10-15 mg\/kg\/day. Allow 24 hours between dosing changes.\r<br>\r<br><br><br>I.V.: 0.01-0.2 mg\/kg\/dose infused over 10 minutes; maximum dose: 5 mg\"\r<br>","提示內容":"注意氣喘或有呼吸道阻塞性疾病, 心搏過緩, 心臟傳導阻斷, 心臟衰竭為禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)\r<br>\r<br>與cardol藥名很像, 注意醫師是否開立正確","抗生素手冊":"暫無資料"},"CAS01I":{"商品名稱":"REGN-COV2 Vial Set","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAS02S":{"商品名稱":"Castor Oil 30ml Bot (Oleum Ricini)","腎功能不良劑量調整":"仿單未提及。Metabolism\/Transport Effects: None known","小兒建議劑量":"成人及12歲以上：一次15至60ml、\r<br>2歲以上未滿12歲：一次5至15ml；一日一次。\r<br>2歲以下：請洽醫師診治，不宜自行使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAS03O":{"商品名稱":"Casodex 50mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAT01E":{"商品名稱":"Cationorm Oph Emul 30Amp\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAT01O":{"商品名稱":"Catapres 75mcg Tab","腎功能不良劑量調整":"Bradycardia may occur in renal failure p't; using lower doses & monitor closely\r<br>[>50 ml\/min]: 0.1-0.6mg Q12h\r<br>[10-50]:  Q12-24h\r<br>[<10 ]: Q24h\r<br>HEMO:  Dose after dialysis","小兒建議劑量":"\"Hypertension:<br><br>\r<br>Oral: Immediate release:<br>\r<br>Weight-directed dosing: Children and Adolescents 1-17 years: Initial: 5-10 mcg\/kg\/day in divided doses every 8-12 hours; increase gradually as needed; usual range: 5-25 mcg\/kg\/day in divided doses every 6 hours; max\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAT02O":{"商品名稱":"Cataflam 25mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR<45:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~45: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁用?","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CAT03O":{"商品名稱":"Catilon 40mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CBO01E":{"商品名稱":"C.B. Oint (Strong) 5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兩歲以下兒童之使用必須詢問醫生或藥師\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEF01I":{"商品名稱":"Ceftriaxone 1g Vial","腎功能不良劑量調整":"只有在腎衰竭末期(Clcr<10 ml\/min)的情況下每日劑量不可超過2g。透析的患者一般不須給予額外的劑量。","小兒建議劑量":"新生兒(<14天)：20-50mg\/kg QD, MAX 50mg\/kg\r<br>嬰兒小孩(14天至12歲)：20-80mg\/kg QD\r<br>小孩體重大於50kg就必須使用成人的一般劑量。\r<br>-----------------------------------------------------------------------\r<br>Neonates:\r<br>Postnatal age : < 7 days: 50 mg\/kg QD\r<br>postnatal : > 7 days: < 2000g: 50 mg\/kg QD\r<br>                                    > 2000g: 50-75 mg\/kg QD\r<br>Infants and children: 50-75 mg\/kg\/d Q12-24H\r<br>-----------------------------------------------------------------------\r<br>Meningitis: (75xBW) mg QD\r<br>(50xBW) mg Q12H","提示內容":"暫無資料","抗生素手冊":"3rd cephas 呼吸道菌首選<br>常用量: 2 g qd<br>Max: 2 g q12h"},"CEF01O":{"商品名稱":"Ceflour FC 250mg Tab","腎功能不良劑量調整":"usual dose: 250-500mg q12h, \r<br>[CRCL >10 ml\/min]: no changes.  \r<br>[<10 ]: give 250mg q24h.   \r<br>Hemodialysis:  Give 250 mg q24h. Repeat the dose after dialysis.","小兒建議劑量":"兒童(大於3個月大):通常125mg BID或10mg\/kg BID (Max: 250mg daily); \r<br>\r<br>兒童(大於2歲): 中耳炎時可給予250mg BID或15mg\/kg BID (Max. : 500mg daily)","提示內容":"暫無資料","抗生素手冊":"建議量:  500 mg q12h<br>Ccr less 30 or HD PD: 500 mg qd"},"CEF06I":{"商品名稱":"Cefa 1gm Vial","腎功能不良劑量調整":"[Usual]: 500mg~1.5g q8~6h. [Max.12 g\/day]: \r<br>[Clcr:35-54 ]: Max. interval: q8h. 500mg~1.5g q8h.\r<br>[Clcr:11-34 ]: 500mg~1.5g x 1, then 0.5~ 1g q12h\r<br>[ <10 and HEMO]: 500mg~1g q24h\r<br>PD: 500mg q12h","小兒建議劑量":"兒童: 20-50mg\/kg\/d BID\r<br>---------------------------------------------------------\r<br>Neonates: ≦ 7days: 40mg\/kg\/day Q12H, \r<br>> 7 days: ≦ 2000g: 40mg\/kg\/day Q12H, \r<br>> 2000g: 60mg\/kg\/day Q8H;\r<br>Infants and children: 50-100mg\/kg\/day Q8H, max dose 6g\/d\r<br>---------------------------------------------------------\r<br>簡易換算: 20-100mg\/kg\/d divided in 2-3 doses.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEF07I":{"商品名稱":"Cefuroxime 750mg Vial#","腎功能不良劑量調整":"Usual Dosing (Adults),CRCL >20 ml\/min : IV: 750 mg to 1.5 gm IV q8h.\r<br>[10-20 ]: 750 mg q12h. \r<br>[<10]: 750 mg q24h. \r<br>HEMO : 750mg q24h. Repeat the dose at the end of dialysis. \r<br>PD: 750 mg q24h.","小兒建議劑量":"嬰兒及兒童: 30-100mg\/kg\/d 分三或四次注射   新生兒:30-100mg\/kg\/d 分二或三次注射\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEF09O":{"商品名稱":"Cefixmycin 100mg Cap#","腎功能不良劑量調整":"[>60 ml\/min]: 400mg\/day \r<br>[21-60]: 300mg\/day\r<br>[ 20 ml\/min]: 200mg\/day \r<br>HEMO :  200-300mg divided qd or bid","小兒建議劑量":"≧ 30kg 50-100mg BID\r<br>重症: 200mg BID\r<br>--------------------------------------------------------\r<br>Infants and children: 8mg\/kg\/day Q12-24H, max dose 400mg\/d;\r<br>Adolescents and adults: 400mg\/d Q12-24H\r<br>-------------------------------------------------------\r<br>8-16yr: 1# QD-Q12H;\r<br>> 16yr: 2# QD-Q12H","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEL02O":{"商品名稱":"Cellcept 250mg Cap","腎功能不良劑量調整":"腎功能不良的人避免給予每天兩次每次高於一克的劑量\r<br>","小兒建議劑量":"BSA 1.25 m2 to 1.5 m2: 750 mg twice daily BSA >1.5 m2: 1000 mg twice daily\r<br>","提示內容":"Cellcept  與MgO (或氧化鋁)同時服用會降低cellcept吸收","抗生素手冊":"暫無資料"},"CEL04O":{"商品名稱":"Celebrex 200mg Cap","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>*eGFR<45:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>*30~45: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br>*<15且尚未透析::?","小兒建議劑量":"\"(JIA): Oral: Children >=2 years:<br>\r<br>>=10 kg to <=25 kg: 50 mg twice daily<br>\r<br>>25 kg: 100 mg twice daily\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEL05O":{"商品名稱":"CELLCEPT 500MG TAB","腎功能不良劑量調整":"腎功能不良的人避免給予每天兩次每次高於一克的劑量\r<br>","小兒建議劑量":"BSA 1.25 m2 to 1.5 m2: 750 mg twice daily BSA >1.5 m2: 1000 mg twice daily\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEP03O":{"商品名稱":"Cephadol 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEP04O":{"商品名稱":"Ceporin 25mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 25-50 mg q8h 2nd dose: 50-150mg q8-12h\r<br>[10-50]: 75% Q12-18h\r<br>[<10 ]: 50% Q24h \r<br>HEMO:  Dose after dialysis","小兒建議劑量":"暫無資料","提示內容":"常用劑量: 25 mg TID, 應空腹使用, 避免食物影響吸收\r<br>注意病人是否有高血鉀的症狀\r<br>與Neprilysin inhibitor (如Entresto)不可併用，如需轉換需間隔至少36小時，否則有引發血管性水腫的風險。","抗生素手冊":"暫無資料"},"CEP05O":{"商品名稱":"Cephalexin 500mg Cap","腎功能不良劑量調整":"Usual Dosing\r<br>[CRCL >30 ] (Adults) :250~500mg po q6h. \r<br>    [Severe infections]: 1 gm q6h.\r<br>[10-30 ]: 250-500 mg q8-12h. \r<br>[<10 ]: 250-500mg q12-24h.  \r<br>HEMO : 250-500mg q12-24h (Dose should be given after dialysis on dialysis days).","小兒建議劑量":"25-50mg\/kg\/d QID\r<br>Severe infection: 50-100mg\/kg\/d Q6-8H, max. dose 4g\/d;\r<br>Otitis media: 75-100mg\/kg\/d Q6H\r<br>----------------------------------\r<br>簡易換算: (BW\/20)#Q6H  ，> 8yr: 1# Q6-8H","提示內容":"一般: 25-50mg\/kg\/d Q6-8H\r<br>嚴重感染: 50-100mg\/kg\/d Q6-8H\r<br>中耳炎: 75-100mg\/kg\/d Q6H; max. dose 4g\/d","抗生素手冊":"建議量:  500 mg to 1 gm q6h<br>Ccr less 30: 1 gm q8h or q12h<br>Ccr less 10 or HD: 1 gm qd"},"CER02O":{"商品名稱":"Ceretal 400mg Tab#","腎功能不良劑量調整":"Clcr 30~50 : 400mg bid\r<br>Clcr 10~30: 400mg qd~bid \r<br>Clcr <10: 400mg qd~qod\r<br>HEMO:   None","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CER03I":{"商品名稱":"Cerebrolysin 10ml Amp","腎功能不良劑量調整":"嚴重腎功能不良禁用。","小兒建議劑量":"Childn 0.1 mL\/kg IM once daily up to 4 wk. Individual treatment cycles should be separated w\/ 2-mth treatment-free intervals.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CER03O":{"商品名稱":"Certican 0.25mg Tab","腎功能不良劑量調整":"No dosage adjustment is required.\r<br>","小兒建議劑量":"There are no adequate data of the use of Certican in children and adolescents to support its use in patients in these age groups.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CER04I":{"商品名稱":"Cervarix(公費) 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"9歲以下孩童不建議施打。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CER04O":{"商品名稱":"CERTICAN 0.5mg Tab","腎功能不良劑量調整":"No dosage adjustment is required.\r<br>","小兒建議劑量":"There are no adequate data of the use of Certican in children and adolescents to support its use in patients in these age groups.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CET01S":{"商品名稱":"Cetirizine Oral Soln 60mg\/60ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"≧ 6yr: 10ml QD; \r<br>2~5yr: 2.5ml in morning & evening or 5ml QD\r<br>---------------------------------------------------------------\r<br>6-12mo:        2.5ml QD; \r<br>12mo~< 2yr: 2.5ml QD~q12h; \r<br>2~5yr:            2.5ml QD~q12h or 5ml QD; \r<br>≧ 6yr:           5~10ml QD","提示內容":"< 2歲: 2.5ml QD-Q12H; 2~5歲: 2.5ml QD-Q12H或5ml QD;>6歲: 5-10ml QD","抗生素手冊":"暫無資料"},"CET03S":{"商品名稱":"Cetirizine Oral Soln 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"≧ 6yr: 10ml QD; \r<br>2~5yr: 2.5ml in morning & evening or 5ml QD\r<br>---------------------------------------------------------------\r<br>6-12mo:        2.5ml QD; \r<br>12mo~< 2yr: 2.5ml QD~q12h; \r<br>2~5yr:            2.5ml QD~q12h or 5ml QD; \r<br>≧ 6yr:           5~10mlQD","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CEX01O":{"商品名稱":"Cexime 100mg Cap#","腎功能不良劑量調整":"Clcr\r<br>[>60 ml\/min]：400mg\/day \r<br>[21-60]：300mg\/day\r<br>  [<20  ]：200mg\/day \r<br>  HEMO :  200-300mg divided qd or bid","小兒建議劑量":"≧ 30kg 50-100mg BID\r<br>--------------------------------------------------------\r<br>Infants and children: 8mg\/kg\/day Q12-24H, max dose 400mg\/d;\r<br>Adolescents and adults: 400mg\/d Q12-24H\r<br>-------------------------------------------------------\r<br>8-16yr: 1# QD-Q12H;\r<br>> 16yr: 2# QD-Q12H","提示內容":"暫無資料","抗生素手冊":"建議量: 400 mg qd or 200 mg q12h<br>Ccr less than 50: 300 mg q12h to qd<br>Ccr less than 10: 200 mg to 400 mg qd<br>HD: 300 mg to 400 mg qd"},"CHA01E":{"商品名稱":"Chanton Enema 15% 20ml Ball","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3 歲以上未滿6 歲適用成人劑量之 1\/2。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHA01O":{"商品名稱":"Chalian Powder 5g Pack","腎功能不良劑量調整":"仿單、資料庫未提及。Monitoring Parameters: Close monitoring of serum electrolytes (potassium, sodium, calcium, magnesium) is necessary; ECG","小兒建議劑量":"Childn 0.5-1 g\/kg daily in divided doses. \r<br>Neonate 0.5-1 g\/kg daily, given rectally.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHA02O":{"商品名稱":"Champix 0.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHA03O":{"商品名稱":"CHAMPIX 1mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHE01S":{"商品名稱":"Chemo Young 4ml Bot; 14Bot\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHI01I":{"商品名稱":"Chirocaine 50mg\/10ml Amp","腎功能不良劑量調整":"目前尚未有針對腎臟衰竭病人的試驗。","小兒建議劑量":"依照不同部位與深度劑量多有不同，請參考仿單。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHL01S":{"商品名稱":"Chloral Hydrate Oral Soln 3g\/30mL Bot","腎功能不良劑量調整":"Contraindicated in patients with marked renal impairment.\r<br>中重度腎功能不全病人(Clcr<50 mL\/min)，避免使用。","小兒建議劑量":"(本品100mg\/mL), Oral, May be given rectally if oral route is not available.\r<br>1. EEG 查檢：25~50 mg\/kg\/dose，檢查前30~60 分鐘服用。需要時30 分鐘後，可再追加劑量，最大總劑量100 mg\/kg 或1g(嬰兒)~2g(兒童)。\r<br>2. 檢查前之鎮靜(non-painful procedure)：50~75 mg\/kg\/dose 檢查前30~60 分鐘服用，需要時30 分鐘後，可再追加劑量，最大總劑量120 mg\/kg，或1g(嬰兒 )~2g(兒童)。\r<br>3. 新生兒：25 mg\/kg\/dose，追加劑量需謹慎使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHL02E":{"商品名稱":"Chloramphenicol 0.25% Eye Drops 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Chloramphenicol對新生兒可能導致腹部膨脹、發紺、血管萎縮等副作用，應避免使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHL03O":{"商品名稱":"Chloraminophene 2mg Cap#","腎功能不良劑量調整":"Adults:<br>\r<br>CrCl >50 mL\/minute: No adjustment necessary.<br>CrCl 10-50 mL\/minute: Administer 75% of dose.<br>CrCl <10 mL\/minute: Administer 50% of dose.<br>Peritoneal dialysis (PD): Administer 50% of dose\r<br>","小兒建議劑量":"3. 孩童：1天0.1～0.2mg\/kg，或1天4.5mg\/㎡。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHL03S":{"商品名稱":"Chloral Hydrate 10% 1mL(晟德)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHL04E":{"商品名稱":"Chlorhexidine Liq (無色) 2% 200ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHL07E":{"商品名稱":"Chlorhexidine Liq (藍色) 2% 200ml Bot","腎功能不良劑量調整":"仿單未載明","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHL08E":{"商品名稱":"Chloramphenicol 0.25% Oph Drops 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Chloramphenicol對新生兒可能導致腹部膨脹、發紺、血管萎縮等副作用，應避免使用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHO01O":{"商品名稱":"Choles powder 9gm Pack#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; however, use with caution in renal impairment; may cause hyperchloremic acidosis\r<br>","小兒建議劑量":"Children: 240 mg\/kg\/day in 3 divided doses","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CHY01E":{"商品名稱":"Chyndacin Gel 10mg\/gm 20gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIA01O":{"商品名稱":"CIALIS 20mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIA02O":{"商品名稱":"Cialis FC 5mg Tab","腎功能不良劑量調整":"輕微及中度腎功能損害的病患不需調整劑量。\r<br>[Clcr: 31-50ml\/min]: Initial dose 5 mg once daily - Max. dose 10 mg not to be given more frequently than every 48 hours.\r<br>[< 30 or hemodialysis]: Maximum dose 5 mg. 對嚴重腎功能損害病患不建議每天給予一次犀利士之治","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIM01I":{"商品名稱":"Cimzia 200mg\/1ml Syringe#","腎功能不良劑量調整":"未曾進行過此族群使用Cimzia 的研究。現有資料不足以提供劑量建議。","小兒建議劑量":"目前尚未建立Cimzia 用於年齡< 18 歲之兒童以及青少年的安全性及療效。目前尚無相關資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIN01I":{"商品名稱":"Cinolone 200mg\/100ml Vial","腎功能不良劑量調整":"(Adults)[CRCL >30ml\/min]: 200-400 mg IV q12h. [Febrile neutropenia]: 400 mg IV q8h.\r<br>[5-30 ml\/min ]: (IV): 200-400mg q18-24h or give 200mg q12h.  \r<br>HEMO : (IV): 200-400mg q24h or 200mg q12h. Schedule dose after dialysis on dialysis days.","小兒建議劑量":"禁止使用","提示內容":"暫無資料","抗生素手冊":"建議量: 400 mg q12h<br>Ccr less than 30, HD or PD: qd"},"CIN02O":{"商品名稱":"Cinolone 250mg Tab","腎功能不良劑量調整":"(Adults)[CRCL >30 ]: (Oral): 250- 750mg q12h. \r<br>[5-30 ]: (Oral): 250 q12h or, 250-500mg q18 to 24 hours. \r<br>HEMO(Oral): 250mg q12h or 250-500mg q24h. Schedule dose after dialysis on dialysis days.","小兒建議劑量":"禁止使用\r<br>","提示內容":"注意 QT prolong藥品交互作用 \r<br>250-500 mg BID, 避免併服牛奶, 礦物質, 制酸劑 (如需併用需間隔至少2小時以上) \r<br>Ciprofloxacin可能會造成Phenytoin血中濃度減少","抗生素手冊":"建議量: 500 mg q12h 須空腹<br>Ccr less than 30, HD or PD: qd"},"CIP01O":{"商品名稱":"Ciproxin 250mg Tab#","腎功能不良劑量調整":"(Adults)[CRCL >30 ]: (Oral): 250- 750mg q12h. \r<br>[5-30 ]: (Oral): 250 q12h or, 250-500mg q18 to 24 hours. \r<br>HEMO(Oral): 250mg q12h or 250-500mg q24h. Schedule dose after dialysis on dialysis days.","小兒建議劑量":"禁止使用\r<br>","提示內容":"注意 QT prolong藥品交互作用 \r<br>250-500 mg BID, 避免併服牛奶, 礦物質, 制酸劑 (如需併用需間隔至少2小時以上) \r<br>Ciprofloxacin可能會造成Phenytoin血中濃度減少","抗生素手冊":"暫無資料"},"CIP02I":{"商品名稱":"Ciproxin 200MG\/100ML BOT","腎功能不良劑量調整":"(Adults)[CRCL >30ml\/min]: 200-400 mg IV q12h. [Febrile neutropenia]: 400 mg IV q8h.\r<br>[5-30 ml\/min ]: (IV): 200-400mg q18-24h or give 200mg q12h.  \r<br>HEMO : (IV): 200-400mg q24h or 200mg q12h. Schedule dose after dialysis on dialysis days.","小兒建議劑量":"禁止使用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIS02I":{"商品名稱":"Cisplatin 50mg\/50ml Vial","腎功能不良劑量調整":"cisplatin should not be given until Scr is >1.5 mg\/dL and\/or BUN is <25 mg\/dL \r<br>Clcr 10-50: 給 75% of dose\r<br>Clcr <10 : 給 50% of dose\r<br>H\/D: 洗腎後給50% of dose \r<br>(CAPD): 給 50% of dose\r<br>(CRRT): 給75% of dose","小兒建議劑量":"有兒童劑量，詳洽仿單。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIT01I":{"商品名稱":"Citosol 300mg Amp#4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIT01O":{"商品名稱":"Citao-S FC 10mg Tab","腎功能不良劑量調整":"輕微或中度的腎功能受損患者，毋須調整劑量\r<br>但對於嚴重腎功能受損患者(CLCR小於30ml\/min.)須小心注意。","小兒建議劑量":"孩童及青少年（小於18歲者）：\r<br>不建議使用，因此族群的安全與療效性資料尚未研究，曾有兒童使用本藥時發生自殺意念或行為之報告。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CIV01E":{"商品名稱":"Cividoid Gel 20gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLA01I":{"商品名稱":"Claforan IV Inj 2gm Vial","腎功能不良劑量調整":"(Adults)\r<br>[CRCL >50]:  [Uncomplicated]: 1 g IV\/IM q12h. [Moderate to severe]: 1-2 g IV\/IM q8h. \r<br>[Severe]: 2g IV q6-8h. \r<br>[Life-threatening]: 2 g IV q4h\r<br>\r<br>[10-50 ml\/min ]: 1-2 g q8-12h. \r<br>[<10 ml\/min] :    1-2 g  q24h\r<br>H\/D:        500mg ~ 2g q24h","小兒建議劑量":"嬰兒及兒童: 50-100mg\/kg\/d BID-QID, \r<br>非常嚴重感染時150-200mg\/kg\/d。\r<br>早產兒: max dose 50mg\/kg\/d。\r<br>----------------------------------------------------------\r<br>50-200mg\/kg\/d divided into 2-4 doses.","提示內容":"簡易換算: 50-200mg\/kg\/d divided into 2-4 doses.","抗生素手冊":"建議量:  2 gm q6h<br>小兒: 40 mg per kg q6h to q4h Max: 2 gm q6h<br>Ccr less than 50: 2 gm q8h<br>Ccr less than 30: 2 gm q12h<br>Ccr less than 10, HD or PD: 1 gm qd"},"CLA04O":{"商品名稱":"Claricin 250mg Tab#","腎功能不良劑量調整":"腎功能不全的病患慎用\r<br>","小兒建議劑量":"\"成人及大於12歲之孩童：一般劑量為250mg，每天二次，持續七天，嚴重感染時可增加至500mg，每天二次，持續14天。<br>小於12歲之孩童：不可使用(可用Klaricid小兒用懸液劑)<br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 500 mg q12h<br>Ccr less than 30: 500 mg qd<br>Ccr less than 10, HD or PD: 250 mg qd"},"CLI01I":{"商品名稱":"Clindamycin 300mg\/2ml Amp","腎功能不良劑量調整":"嚴重腎疾病及代謝異常之患者，長期使用 Clindamycin 治療時，應定期作腎功能試驗、血液檢查及監視血中濃度。\r<br>","小兒建議劑量":"\"孩童：滿一個月以上者，IM 或 IV <br>\r<br>\r<br>嚴重感染：15~25 mg\/kg\/24hrs，或 350 mg\/m2\/ 24hrs，分 3 或 4 次投藥。 <br>\r<br>\r<br>更嚴重感染：25~40 mg\/kg\/24hrs，或 450 mg\/m2\/ 24 hrs，分 3 或 4 次投藥。 <br>\r<br>\r<br>幼兒：不滿一個月者 <br>15~20 mg\/kg\/24hrs，分 3 或 4 次投藥。 <br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLI02I":{"商品名稱":"Clincin Inj. 300mg\/2ml Amp","腎功能不良劑量調整":"Mild to moderate impairment: No dosage adjustment necessary。\r<br>患有嚴重腎病或肝病之病人，應小心使用。","小兒建議劑量":"小孩（一個月以上）:一般是15-25mg\/ kg\/day(350mg\/kg\/day) ﹔較嚴重時25-40mg\/ kg\/day\r<br>(450mg\/m2\/day)， 分成三～四相等劑量。","提示內容":"暫無資料","抗生素手冊":"建議量: 900 mg to 600 mg q8h<br>小兒: 13 mg per kg q8h<br>10% 經 urine 排除"},"CLI03I":{"商品名稱":"CLINIMIX N17G35E 1500mL BAG","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLI04I":{"商品名稱":"Clinimix N9G15E 1500mL Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO01E":{"商品名稱":"Clobex shampoo 60ml Bot","腎功能不良劑量調整":"老人可能有較高頻次會出現肝、腎、或心臟功能減低，對老年病人的使用劑量須審慎選。無腎功能劑量調整資料。","小兒建議劑量":"長期使用於廣泛部位會造成全身性的吸收，產生腎上腺皮質機能亢進現象。尤其是使用在嬰兒、孩童、及封閉包紮情況。建議孩童每周複診。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO01O":{"商品名稱":"Clomid 50mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO01S":{"商品名稱":"Clodrin Oral Soln 3g\/30mL Bot","腎功能不良劑量調整":"Contraindicated in patients with marked renal impairment.","小兒建議劑量":"腦波檢查(EEG):\r<br>嬰兒(1個月至＜1歲)及兒童:口服25-50mg\/kg。\r<br>總計最高劑量不超過100mg\/kg且嬰兒不超過1g，兒童不超過2g。\r<br>無痛檢查處置前之鎮靜(處置前30-60分鐘投予):\r<br>嬰兒(1個月至＜1歲):口服30-50mg\/kg。總計最高劑量不超過100mg\/kg且嬰兒不超過1g。\r<br>兒童:口服50-60mg\/kg，若有需要，30分鐘後可額外給予10-20mg\/kg。總計最高劑量不超過100mg\/kg且兒童不超過2g。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO02E":{"商品名稱":"Clobetasol Oint 3.5mg\/7gm","腎功能不良劑量調整":"仿單無提及。(外用品)","小兒建議劑量":"嬰兒及小兒應避免長期使用本劑，以免發生其副腎之壓抑作用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO02O":{"商品名稱":"Clozaril 25mg Tab#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling (has not been studied); use with caution.\r<br>","小兒建議劑量":"兒童安全性及藥效尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO02S":{"商品名稱":"Clodrin 10% 1ml (小單位檔)","腎功能不良劑量調整":"Contraindicated in patients with marked renal impairment.","小兒建議劑量":"腦波檢查(EEG):\r<br>嬰兒(1個月至＜1歲)及兒童:口服25-50mg\/kg。\r<br>總計最高劑量不超過100mg\/kg且嬰兒不超過1g，兒童不超過2g。\r<br>無痛檢查處置前之鎮靜(處置前30-60分鐘投予):\r<br>嬰兒(1個月至＜1歲):口服30-50mg\/kg。總計最高劑量不超過100mg\/kg且嬰兒不超過1g。\r<br>兒童:口服50-60mg\/kg，若有需要，30分鐘後可額外給予10-20mg\/kg。總計最高劑量不超過100mg\/kg且兒童不超過2g。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO03E":{"商品名稱":"Clomazole 500mg Vag Tab","腎功能不良劑量調整":"仿單未記載","小兒建議劑量":"仿單未記載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO03O":{"商品名稱":"Clopine 25mg Tab#","腎功能不良劑量調整":"Canadian labeling: Initial dose of 12.5 mg once daily is recommended with mild to moderate impairment; contraindicated in severe impairmen","小兒建議劑量":"Children and Adolescents: Treatment of refractory childhood-onset schizophrenia or schizoaffective disorder: Limited data available: Oral: Initial: 12.5 mg once or twice daily; increase daily dose as tolerated every 3-5 days (usually by 25 mg increments) to a target dose of 125-475 mg\/day in divided doses (based on patient’s age, size, and tolerability)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO04E":{"商品名稱":"Clobex Shampoo 125ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO07E":{"商品名稱":"Clotrimazole 500mg Vag Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童不宜使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CLO08O":{"商品名稱":"CLOPINE 100mg Tab#","腎功能不良劑量調整":"有腎臟方面等疾病時，最初劑量需降低，且在增加劑量上需緩慢\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COA01O":{"商品名稱":"Coaprovel 300\/12.5mg Tab","腎功能不良劑量調整":"Clcr < 30 ml\/min 病患不建議使用。","小兒建議劑量":"無使用於兒童或青少年的安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COD01E":{"商品名稱":"Codemycin Eye Oint 3.5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COD01O":{"商品名稱":"Codeine 30mg Tab #2","腎功能不良劑量調整":"Clcr 10-50 mL\/minute: Administer 75% of dose\r<br>Clcr <10 mL\/minute: Administer 50% of dose","小兒建議劑量":"[衛]本品用於兒童，僅限臨床效益大於風險時使用\r<br>(1)早產兒、1歲以下嬰兒及1~2歲幼兒，不建議使用(2)2~12歲兒童，依年齡減量使用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COF01O":{"商品名稱":"Cofarin 1mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COL01O":{"商品名稱":"Colchicine 0.5mg Tab#","腎功能不良劑量調整":"Clcr 30-80: 預防及治療皆無須調整劑量\r<br>Clcr <30: 預防: 起始劑量0.25 mg QD；治療: 無須調整，每兩週至多只能重複一次療程\r<br>透析：預防:起始劑量0.25 mg 1W2D；治療: 單次投予0.5 mg，重複療程需至少間隔2週","小兒建議劑量":"暫無資料","提示內容":"若醫師開立Colchicine 0.5mg 1# BID-QID未有預停用時間,追蹤2-3天後未減低劑量\r<br>則與醫師確認用量, 並告知不良反應風險\r<br>1.急性痛風發作:0.5mg BID。\r<br>2.有發作預感時，在前3hr給0.5 mg\/hr，總共3~6粒為止。或是先給1.0mg(2顆)，1 hr後再給予0.5mg，之後視情況用藥(最多TID)，直到症狀緩解。\r<br>3.預防發作：1 tab QD-BID；ClCr 35-49 ml\/min：1# QD；ClCr 10-34 ml\/min：1# Q2-3D\r<br>\r<br>Colchicine併用其他交互作用藥品之劑量調整\r<br>1.併用強效CYP3A4 抑制劑 (Clarithromycin、Itraconazole、Ritonavir)\r<br>   (1)預防痛風：0.25 mg，每天或每隔天使用一次\r<br>   (2)治療痛風：先0.5mg，1小時後再給予0.25 mg，重複療程需間隔至少3天\r<br>2.併用中效CYP3A4 抑制劑(Aprepitant、Diltiazem、Erythromycin、Fluconazole、Grapefruit Juice、Verapamil)\r<br>   (1)預防痛風：0.25 mg，一天1-2次或0.5 mg，一天1次\r<br>   (2)治療痛風：單次給予1mg，重複療程需間隔至少3天\r<br>3.併用P-gp抑制劑 (Cyclosporine、Ranolazine、Amiodarone)\r<br>   (1)預防痛風：0.25 mg，每天或每隔天使用一次\r<br>   (2)治療痛風：單次給予0.5 mg，重複療程需間隔至少3天\r<br>\r<br>(週報2018\/01\/05 發行)用於硬皮症(Systemic Sclerosi","抗生素手冊":"暫無資料"},"COL02E":{"商品名稱":"Colasa Enema 2gm\/100ml","腎功能不良劑量調整":"仿單無明確建議調整劑量。建議在開始使用本品治療前及治療過程中要定期評估病患的腎功能。已知腎功能障礙或有腎臟病史的患者使用本品時要特別小心謹慎.\r<br>","小兒建議劑量":"4?g?once daily at bedtime\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COL02I":{"商品名稱":"Colimycin 2MU Vial","腎功能不良劑量調整":"每瓶約 66.8mg\/vial, \r<br>CrCL 80-100: 5mg\/kg\/day q6-12h給藥\r<br>CrCl  40-70  : 2.5-3.8mg\/kg\/day q12h給藥  \r<br>CrCl  25-40  : 2.5mg\/kg\/day q12-24h給藥  \r<br>CrCl  10-25  : 1.5mg\/kg\/day (建議頻次為q36h)","小兒建議劑量":"\"Neonatal Note: Dosage expressed in terms of colistin base.<br>\r<br>General dosing, susceptible infection: I.M., I.V.: 2.5-5 mg\/kg\/day divided every 6-12 hours, 兒童劑量同成人<br><br>\r<br>Pulmonary infection: Limited data available: Inhalation: 4 mg\/kg\/dose every 12 hours has been \"\r<br>","提示內容":"(以colistin base=66.8 mg計算) 2.5-5 mg\/kg Q12H-Q6H\r<br>ClCr 40-70: 2.5-3.8mg\/kg\/day q12h; ClCr 25-40: 2.5mg\/kg\/day q12-24h\r<br>ClCr 10-25 : 1.5mg\/kg\/day q36h\r<br>\r<br>(週報2018\/03\/09發行)\r<br>吸入使用可在給藥前15分鐘先給予支氣管擴張劑。配製方式為將藥品溶解於4–6毫升生理食鹽水或無菌注射用水作為吸入液\r<br>吸入使用建議劑量如下： \r<br>體重<40 kg: 0.5 MIU (40 mg) of CMS Q12H \r<br>體重>40 kg: 1.0 MIU (80 mg) of CMS Q12H \r<br>復發或嚴重肺部感染: 2.0 MIU (160 mg) of CMS Q8H","抗生素手冊":"建議量: 2.5 mg per kg iv q12h<br>Ccr less than 50: qd<br>Ccr less than 10, HD or PD: qod "},"COM02E":{"商品名稱":"Combivent UDV Inh Soln 2.5ml Amp#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling (has not been studied); use with caution.\r<br>","小兒建議劑量":"No dosage adjustment provided in manufacturer's labeling (has not been studied); use with caution.\r<br>","提示內容":"成分與Ipratran及Ventolin Nebulizing重複, 需注意","抗生素手冊":"暫無資料"},"COM02I":{"商品名稱":"COVID-19 Vaccine BNT (兒童公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COM03E":{"商品名稱":"Combigan Eye Drops 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COM04O":{"商品名稱":"Comtan 200mg Tab","腎功能不良劑量調整":" No dosage adjustment necessary; dialysis patients were not studied\r<br>","小兒建議劑量":"18歲以下兒童不建議使用本品\r<br>","提示內容":"需與Madopar 同時服用, 每次使用200 mg, 配合Madopar的頻次","抗生素手冊":"暫無資料"},"CON01I":{"商品名稱":"Conray 60;150ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON01O":{"商品名稱":"Conslife Sugar Coated Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON02I":{"商品名稱":"Conray 60;50ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON04O":{"商品名稱":"Conquer 100mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"\"Adult & children  Eradication of whipworm, roundworm & hookworm 100mg bid for 3days. Eradication of pinworm 100mg. Further dose may be given 3weeks later if eradication is<br>incomplete.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON06O":{"商品名稱":"CONCOR 5mg Tab","腎功能不良劑量調整":"Clcr <40 mL\/minute: Oral: Initial: 2.5 mg\/day; increase cautiously \r<br>[>50 ml\/min]: 5mg q24h, 2nd dose: 5-20mg q24h\r<br>[10-50]: 75%\r<br>[<10 ]: 50%\r<br>HEMO: Dose after dialysis","小兒建議劑量":"暫無資料","提示內容":"嚴重低血壓, 嚴重心搏過慢及第二或第三期的心臟傳導阻斷為使用禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)","抗生素手冊":"暫無資料"},"CON07O":{"商品名稱":"Concerta ER 18mg Tab #3","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"CONCERTA 不能用於六歲以下兒童。 CONCERTA 每天服用一次。因服藥十二小時後仍有療效,故本品須於早上服用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON08O":{"商品名稱":"Concor 1.25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"嚴重低血壓, 嚴重心搏過慢及第二或第三期的心臟傳導阻斷為使用禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)","抗生素手冊":"暫無資料"},"CON09O":{"商品名稱":"CONCERTA ER 27MG TAB #3","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"CONCERTA 不能用於六歲以下兒童。 CONCERTA 每天服用一次。因服藥十二小時後仍有療效,故本品須於早上服用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON10O":{"商品名稱":"Const-K ER 750mg (10mEq) Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON11O":{"商品名稱":"CONCERTA ER 36MG TAB #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON12O":{"商品名稱":"Convulex 300mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CON13O":{"商品名稱":"Contrave ER 8\/90mg Tab","腎功能不良劑量調整":"中重度腎功能不全 MAX:  1# BID","小兒建議劑量":"不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COP02I":{"商品名稱":"Copaxone 40mg\/1ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不可使用在孩童","提示內容":"只能皮下注射\r<br>每週的同樣天數投藥(至少隔48小時注射，如週一、週三、週五)。\r<br>COPAXONE 40mg\/1ml Syringe的用法為一周三次","抗生素手冊":"暫無資料"},"COR01O":{"商品名稱":"Cortisone Acetate 25mg Tab","腎功能不良劑量調整":"\"Hemodialysis: Supplemental dose is not necessary.<br>Peritoneal dialysis: Supplemental dose is not necessary\"\r<br>","小兒建議劑量":"\"Children:<br>Anti-inflammatory or immunosuppressive: 2.5-10 mg\/kg\/day or 20-300 mg\/m2\/day in divided doses every 6-8 hours<br>Physiologic replacement: 0.5-0.75 mg\/kg\/day or 20-25 mg\/m2\/day in divided doses every 8 hours\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COR02O":{"商品名稱":"Coralan FC 5mg Tab#","腎功能不良劑量調整":"對於Clcr > 15 ml\/min患者，毋需調整劑量。低於Clcr 15時，尚無可得的資料，因此應謹慎用於此類患者。","小兒建議劑量":"對於18歲以下兒童的療效與安全性資料尚未確立，目前無可得資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COR03O":{"商品名稱":"Cortiment MMX PR 9mg Tab","腎功能不良劑量調整":"尚未在肝功能不全和腎功能不全病人中進行Cortiment 9 mg的試驗，因此這類病人應小心謹慎使用本藥品","小兒建議劑量":"尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COR05I":{"商品名稱":"Cordarone 150mg\/3ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"限以D5W稀釋(容器需為玻璃或PP瓶, 不可為PVC)濃度至少為1 amp in 250ml D5W, 不可太低\r<br>濃度大於3mg\/ml 由周邊輸注時容易發生周邊靜脈炎。目前建議濃度大於2mg\/ml需經中央靜脈給予\r<br>起始劑量: 5 mg\/kg,24 hrs可重複注射2-3次。 \r<br>維持劑量：10-20mg\/kg (600-800mg\/24hrs，up to 1.2 g\/24hrs)\r<br>注意 QT prolong藥品交互作用","抗生素手冊":"暫無資料"},"COR05O":{"商品名稱":"Cordarone 200mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"起始劑量: 1 tab TID (600 mg\/day) for 10 days\r<br>維持劑量: 0.5-2 tab\/day\r<br>注意 QT prolong藥品交互作用","抗生素手冊":"暫無資料"},"COS02E":{"商品名稱":"Cosopt Oph Soln 5ml Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前尚無COSOPT用於小於兩歲之兒童病患的安全性及療效的資料\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COS02I":{"商品名稱":"Cosentyx SC 150mg\/mL Syringe","腎功能不良劑量調整":"並未執行正式研究肝或腎功能不全對 secukinumab 藥物動力學的影響。","小兒建議劑量":"COSENTYX使用於兒童病患的安全性和有效性尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COU12S":{"商品名稱":"Cough Mixture 120ml#","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"成人 5~15ml TID; 兒童酌減。\r<br>-------------------------------------------------\r<br>簡易換算: 1 c.c.\/kg\/day: 分成3-4。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COU13S":{"商品名稱":"Cough Mixture 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"成人 5~15ml TID; 兒童酌減。\r<br>-------------------------------------------------\r<br>簡易換算: 1 c.c.\/kg\/day: 分成3-4。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV01I":{"商品名稱":"Covorin Injection 50mg\/5ml Amp","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV02I":{"商品名稱":"COVID-19 Vaccine AZ (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前無18歲以下用藥資料，不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV03I":{"商品名稱":"COVID-19 Vaccine Moderna (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6歲以上第一第二基礎劑0.25mll。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV04I":{"商品名稱":"COVID-19 Vaccine MVC (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV05I":{"商品名稱":"COVID-19 Vaccine BNT (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未確立 BNT162b2疫苗在未滿12歲之兒童使用的安全性和有效性。目前實證資料有限。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV06I":{"商品名稱":"COVID-19 Vaccine Moderna (嬰幼公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV07I":{"商品名稱":"COVID-19 Vaccine BNT (嬰幼公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV08I":{"商品名稱":"COVID-19 Moderna BA1 (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV09I":{"商品名稱":"COVID-19 Moderna BA4\/5 (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV10I":{"商品名稱":"COVID-19 Moderna XBB (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6個月到4歲，沒打過任何COVID-19疫苗：0.25mL IM 2 dose between 28d。\r<br>6個月到4歲，有打過任何OVID-19疫苗：0.25mL IM single dose。\r<br>5歲至11歲：0.25mL IM single dose。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COV11I":{"商品名稱":"COVID-19 Novavax XBB (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"COW01O":{"商品名稱":"Cowbalin 100mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"\"Adult & children  Eradication of whipworm, roundworm & hookworm 100mg bid for 3days. Eradication of pinworm 100mg. Further dose may be given 3weeks later if eradication is<br>incomplete.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CRA01E":{"商品名稱":"Cravit Oph Soln 25mg\/5ml Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"跟成人一樣\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CRA02O":{"商品名稱":"Cravit 500mg Tab#","腎功能不良劑量調整":"TB治療指引: 當Clcr<30時，levofloxacin不須改變劑量，但頻率改每週3次。病人如接受血液透析，透析當天的建議於透析後吃。 \r<br>---\r<br>[20-49 ]: 250~500mg x 1, then 125mg q24h~250mg q12h. \r<br>[10-19 ]: ...., then 125mg q48h~q12h\r<br>[<10]:  ..., 125mg q48h~q12h [1]","小兒建議劑量":"<5 years: 8-10 mg\/kg\/dose twice daily\r<br>>=5 years: 10 mg\/kg\/dose once daily; maximum dose: 750 mg\/day\r<br>","提示內容":"500 mg QD, 避免併服牛奶, 礦物質, 制酸劑 (併用需間隔至少2小時以上) 。\r<br>注意 QT prolong藥品交互作用","抗生素手冊":"建議量: 500 mg qd<br> Ccr less than 50: 半劑量 qd<br>Ccr less than 20, HD or PD: 半劑量 qod"},"CRA03I":{"商品名稱":"Cravit 500mg\/100ml Vial#","腎功能不良劑量調整":"依不同適應症原常見劑量為\r<br>250mg QD \/ 500mg QD \/ 500mg Q12H\r<br>若腎功能受損時，則給予原劑量loading，接著給予以下列維持劑量\r<br>Clcr \r<br>50~20:125mg QD     \/ 250mgQD \/ 250mg Q12h\r<br>19-10: 125mg Q48h \/ 125mg QD \/ 125mg Q12h\r<br><10: 125mg Q48h   \/ 125mg QD  \/ 125mg QD","小兒建議劑量":"Cravit禁用於兒童及生長期青少年","提示內容":"500 mg QD, 避免併服牛奶, 礦物質, 制酸劑 (併用需間隔至少2小時以上) 。\r<br>注意 QT prolong藥品交互作用","抗生素手冊":"建議量: 500 mg to 750 mg qd<br>Ccr less than 50: 半劑量 qd<br>Ccr less than 20, HD or PD: 半劑量 qod"},"CRA04O":{"商品名稱":"Crashtone Granules 5g","腎功能不良劑量調整":"嚴重腎功能障礙伴隨尿少症或氮血症者禁用  腎功能不良者慎用\r<br>","小兒建議劑量":"需適宜的調整劑量\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CRE01O":{"商品名稱":"Crestor 10mg Tab#","腎功能不良劑量調整":"【腎功能不全患者的劑量】\r<br>輕度至中度腎功能不全患者無須調整劑量。對於有重度腎功能不全（CLcr < 30 mL\/\r<br>min\/1.73 m2）而未接受血液透析的患者，CRESTORR 應以5 mg每天一次開始治療，\r<br>不可超過10 mg每天一次","小兒建議劑量":"\"Note: Doses should be individualized according to the baseline LDL-cholesterol levels, the recommended goal of therapy, and patient response; adjustments should be made at intervals of 4 weeks or more.<br>\r<br>Heterozygous familial hypercholesterolemia (HeFH):<br><br>U.S. labeling: Children and Adolescents 10-17 years (females >1 year postmenarche): Oral: 5-20 mg once daily; maximum: 20 mg daily<br><br>\r<br>Dosage adjustment for rosuvastatin with concomitant cyclosporine, gemfibrozil, atazanavir\/ritonavir, or lopinavir\/ritonavir: Refer to adult dosing.\r<br><br><br>Canadian labeling: Children and Adolescents 10-17 years (females >1 year postmenarche): Oral: 5-10 mg once daily; maximum: 10 mg daily\"\r<br>","提示內容":"若開立Crestor 10 mg 4# before contrast\r<br>→為了預防顯影劑引起之腎病變 –micromedex\r<br>a) Acute coronary syndrome: 40 mg orally on admission followed by 20 mg orally daily in addition to standard preventative measures\r<br>b) Diabetes and chronic kidney disease: 10 mg orally daily for 5 days (2 days before and 3 days after contrast administration) \r<br>ClCr < 30 ml\/min(未接受血液透析):起始劑量5 mg QD，不可超過10 mg QD","抗生素手冊":"暫無資料"},"CRE02O":{"商品名稱":"Cretrol 10\/20mg Tab#","腎功能不良劑量調整":"輕度至中度腎功能不全病人無須調整劑量。對於有重度腎功能不全（肌酸酐清除率CLcr＜30毫升\/分鐘\/1.73米2）而未接受血液透析的病人，本品的劑量不可超過10\/10毫克每日一次","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CTL01O":{"商品名稱":"Metformin XR (CTL XR) 500mg Tab","腎功能不良劑量調整":"eGFR介於30-45 applicable","小兒建議劑量":"目前CTL XR錠對小兒患者的安全性及有效性尚未建立。","提示內容":"Metfomin依台灣仿單每日最高劑量為速效劑型：3000 mg；緩釋劑型：2000mg\r<br>腎絲球體過濾率（eGFR）介於30-45 ml\/min\/1.73 m2應減量使用\r<br>腎絲球體過濾率（eGFR） <30 mL\/minute\/1.73 m2  禁止使用","抗生素手冊":"暫無資料"},"CUB01I":{"商品名稱":"Cubicin 500mg Vial","腎功能不良劑量調整":"cSSSI and S. aureus Bloodstream Infections \r<br>[>30 mL\/min]: 4~6 mg\/kg q24 h\r<br>[<30 mL\/min\/HEMO \/CAPD)]:4~6 mg\/kg q48 h","小兒建議劑量":"\"Dosing: Neonatal<br>Gram-positive infection, severe: Very limited data available: PMA >=32 weeks: I.V.: 6 mg\/kg\/dose every 12 hours for 10-14 days was used in two neonates [patient age: PMA 32 weeks (PNA: 8 weeks) and PMA: 35 weeks (PNA: 3 weeks)] with normal\"\r<br>","提示內容":"暫無資料","抗生素手冊":"組織穿透差不適pneumonia<br>endocarditis: 8 to 12 mg per kg qd<br>soft tissue: 4 to 6 mg per kg qd<br>Ccr less than 30, HD or PD: qod<br>DDI: statins following up CPK"},"CUR01I":{"商品名稱":"Curam 1.2g Vial","腎功能不良劑量調整":"Clcr>30: 不須調整。\r<br>[10-30]: 1.2g, then 600mg q12h. \r<br>[<10]: 1.2g, then 600mg q24","小兒建議劑量":"3個月大至12歲兒童: 通常為q8h， 每次 30mg\/kg的Curam，對較嚴重的感染症，可提寰至q6h\r<br>0-3個月大嬰兒: 劑量為 q12h，每次 30mg\/kg的Curam，之後可增為 q8h","提示內容":"1.2g Q8H. (嚴重感染可調整為 1.2g Q6H)\r<br>ClCr[10-30]: 1.2g, then 600mg q12h.\r<br> [<10]: 1.2g, then 600mg q24h","抗生素手冊":"建議量:  1 vial q8h<br>小兒: 30 mg per kg q8h 以 amoxi 計<br>Ccr less than 30: q12h<br>Ccr less than 10, HD or PD: qd"},"CUR01O":{"商品名稱":"Curam FC 1g Tab#","腎功能不良劑量調整":"腎功能受損病人的使用劑量：只可使用於Clcr> 30 ml\/min的病人","小兒建議劑量":"不建議使用於12歲以下的兒童。","提示內容":"暫無資料","抗生素手冊":"建議量:  1# q8h<br>Ccr less 30 or HD: clavulanate 排除較amox快易造成治療失敗"},"CUS02E":{"商品名稱":"Cusimolol 0.5% 5ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":".尚未對兒童使用進行臨床研究，故不建議兒童使用本品\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CVV01I":{"商品名稱":"CVVH Soln A 3000ml Bag","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"使用時利用血液幫浦，配合補充液甲（CVVH Solution A）使用，比例為 1：1。 本藥限由醫師使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CVV03I":{"商品名稱":"CVVH B Sod Chloride 0.45% 2760ml Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYA01I":{"商品名稱":"Cyanocobalamin (Vit.B12) 1mg\/1ml Amp#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling.","小兒建議劑量":"Vitamin B12 deficiency: I.M., deep SubQ: Dosage in children is not well established: 0.2 mcg\/kg for 2 days, followed by 1000 mcg daily for 2-7 days, followed by 100 mcg weekly for 1 month;[4]","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYC01O":{"商品名稱":"Cyclin 100mg Cap","腎功能不良劑量調整":"腎功能不良者減量使用或延長間隔\r<br>","小兒建議劑量":"不建議使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYM01I":{"商品名稱":"Cymevene 500mg Vial#","腎功能不良劑量調整":"CMV retinitis誘導劑量 x 14-21 days. : \r<br>[Clcr > 70] : 5 mg\/kg q12h \r<br>[50-69 ]: 2.5 mg\/kg q12h.\r<br>[25-49 ]: 2.5 mg\/kg q24h.\r<br>[10-24 ]: 1.25 mg\/kg q24h.\r<br>[<10]:1.25 mg\/kg 1W3D 透析後。\r<br>維持劑量請以上劑量減半使用。","小兒建議劑量":"ganciclovir在兒科的安全性與藥效未經確認，包括用於治療先天性或新生兒的CMV感染。對兒童使用Cymevene必須極度謹慎，因為有長期致癌和生殖毒性的潛在可能，治療的好處必須超過其危險性。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYM02O":{"商品名稱":"Cymbalta 30mg Cap#","腎功能不良劑量調整":"腎功能障礙—不建議末期腎臟疾病病患或嚴重腎功能障礙病患(肌酸酐廓清率< 30 mL\/min)使用 Cymbalta\r<br>","小兒建議劑量":"\"兒童之安全性尚未確立。小孩、青少年和年輕成人服用抗憂鬱劑可能增加自殺意念及行為。(5.1)監測自殺意念及行為的惡化及出現(5.1) <br>Cymbalta 尚未被核准用於治療孩童病患。(8.4)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYP01S":{"商品名稱":"Cypromin Soln 0.4mg\/ml;120ml#","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer’s labeling\r<br>","小兒建議劑量":"2-6yr: 5ml q8h-q12h, max 30ml\/d; \r<br>7-14yr: 10ml bid-tid, max 40ml\/d; \r<br>成人: 10ml tid, max 0.5mg\/kg\/d\r<br>-------------------------------------------------------------------\r<br>Allergic: 0.25 mg\/kg\/d in 2-3 divided doses OR\r<br>2-6yr: 2 mg (5ml) Q 8-12 H (max 12 mg (30ml)\/d)\r<br>7-14yr: 4 mg (10ml) Q 8-12 H (max 16 mg (40ml)\/d)\r<br>-------------------------------------------------------------------\r<br>簡易換算: 1 c.c.\/kg\/day: 分成3-4 次。","提示內容":"2-6歲: 5ml q8h-q12h; 7-14歲: 10ml bid-tid\r<br>簡易換算: 1 c.c.\/kg\/day: 分成3-4次。","抗生素手冊":"暫無資料"},"CYP02S":{"商品名稱":"Cypromin Soln 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"2-6yr: 5ml q8h-q12h, max 30ml\/d; \r<br>7-14yr: 10ml bidtid, max 40ml\/d; \r<br>成人: 10ml tid, max 0.5mg\/kg\/d\r<br>-------------------------------------------------------------------\r<br>Allergic: 0.25 mg\/kg\/d in 2-3 divided doses OR\r<br>2-6yr: 2 mg (5ml) Q 8-12 H (max 12 mg (30ml)\/d)\r<br>7-14yr: 4 mg (10ml) Q 8-12 H (max 16 mg (40ml)\/d)\r<br>-------------------------------------------------------------------\r<br>簡易換算: 1 c.c.\/kg\/day: 分成3-4 次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYR01I":{"商品名稱":"Cyramza 100mg\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYR03I":{"商品名稱":"Cyramza (恩慈) 100mg\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYT01I":{"商品名稱":"Cytotect CP Biotest 50ml\/Bot","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling; use with caution. Infuse at minimum rate possible.\r<br>","小兒建議劑量":"Prophylaxis of CMV disease in kidney, liver, lung, pancreas, or heart transplant: Children and Adolescents: I.V.: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"CYT02O":{"商品名稱":"Cytotec  200mcg Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"安全性和有效性尚未確立\r<br>","提示內容":"若用於婦產科引產時，應自費使用。\r<br>引產給藥劑量 詳見台灣婦產科醫學會建議Misoprostol (Cytotec R) 產科 使用指引 2020.07. 2 3 公告版\r<br>引產給藥途徑  PV：經陰道給藥  SL：舌下含服  PO ：口服   BUCC：口腔頰黏膜給藥\r<br>*有陰道出血或感染跡象時避免經陰道給藥\r<br>建議的給藥途徑並未包含經直腸給藥，主要是因為經直腸途徑給藥的藥物動力學效率不高","抗生素手冊":"暫無資料"},"CYT04I":{"商品名稱":"Cytosar 500mg Vial#","腎功能不良劑量調整":"\"Aronoff, 2007 (cytarabine 100-200 mg\/m2): Children and Adults: No adjustment necessary<br>Smith, 1997 (high-dose cytarabine >=2 g\/m2\/dose): For serum creatinine 1.5-1.9 mg\/dL or increase (from baseline) of 0.5-1.2 mg\/dL: Reduce dose to 1 g\/m2\/dose\"\r<br>","小兒建議劑量":"\"CNS prophylaxis: I.T.:<br>\r<br><1 years: 20 mg per dose<br>\r<br>1 to <2 years: 30 mg per dose<br>\r<br>2 to <3 years: 50 mg per dose\r<br><br>>=3 years: 70 mg per dose<br>\r<br>CNS prophylaxis (ALL): Other age-specific regimens reported from literature:\r<br>Gaynon, 1993: Administer on day 0 of inductio\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAC01I":{"商品名稱":"Dacarbazine 200mg Vial#","腎功能不良劑量調整":"仿單雖無註明，但某此文獻有下列建議[ from Uptodate]\r<br>Clcr 46-60 mL\/minute: Administer 80% of dose\r<br>Clcr 31-45 mL\/minute: Administer 75% of dose\r<br>Clcr <30 mL\/minute: Administer 70% of dos","小兒建議劑量":"\"Children:<br>Pediatric solid tumors: 200-470 mg\/m2\/day over 5 days every 21-28 days<br>Hodgkin's disease: 375 mg\/m2 on days 1 and 15 of treatment course, repeat every 28 days\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAC02I":{"商品名稱":"Dacogen (恩慈) 50mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAC03I":{"商品名稱":"Dacogen 50mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAF01O":{"商品名稱":"Daflon FC 1gm Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAI01E":{"商品名稱":"Daivonex Oint 0.005% 30gm#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAI03E":{"商品名稱":"Daivobet Oint 30gm Tube#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAL01O":{"商品名稱":"Dalmadorm 15mg Cap #4","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; use with caution.\r<br>","小兒建議劑量":"\"Hypnotic: <br>\r<br><15 years: Dose not established<br>\r<br>>=15 years: 15 mg at bedtime\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAM01O":{"商品名稱":"Dampurine 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAN03I":{"商品名稱":"Dantrolene 20mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAR01I":{"商品名稱":"Darzalex 100mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"DARZALEX用於兒童病人的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAU01I":{"商品名稱":"Daunoblastina 20mg Vial","腎功能不良劑量調整":"The manufacturer's labeling recommends the following adjustment: Scr >3 mg\/dL: Administer 50% of normal dose","小兒建議劑量":"幼童：開始治療時，每天每公斤體重適用1公絲，以靜脈注射(IV)連續使用4 ~ 5天，同時每天血液檢查及期間性骨髓檢查。休息8 ~ 10天後，再開始第二或第三次的治療。\r<br>維持治療：每公斤體重1 ~ 2公絲；以靜脈注射，每星期使用1 ~2次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DAY01O":{"商品名稱":"Dayvigo 5mg Tab","腎功能不良劑量調整":"輕度、中度或重度腎功能不全的病人無需調整劑量。","小兒建議劑量":"不建議小兒病人使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEA01O":{"商品名稱":"Deanxit Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於小孩、青少年和青年人時，應評估服用抗憂鬱劑之自殺等風險與效益。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEC03O":{"商品名稱":"Decone 0.5mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; use with caution. Hemodialysis or peritoneal dialysis: Supplemental dose is not necessary","小兒建議劑量":"Children, 0.02-0.3 mg\/kg\/day or 0.6-9 mg\/m2\/day in 3-4 doses.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEF01I":{"商品名稱":"Definity 2ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未知藥品對兒科病人是否安全有效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEL02O":{"商品名稱":"Delibs 50mg Tab","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEL03O":{"商品名稱":"Delcopan SR 60mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不適用於12歲以下之兒童。","提示內容":"止咳: max. dose為120mg\/day","抗生素手冊":"暫無資料"},"DEM01I":{"商品名稱":"Demerol 50mg\/1ml Amp(Pethidine) #2","腎功能不良劑量調整":"Avoid use in renal impairment\r<br>[>50 ml\/min]: 50-100mg q3-4h\r<br>[10-50]: 75%\r<br>[<10 ]:  50%\r<br>HEMO:  Avoid","小兒建議劑量":"Children 1mg\/kg (max 100mg 4hrly). Amp Children 1.1-1.76mg\/kg SC\/IM, may be repeated 3-4hrly. Pre-op sedation induction Children 1-2.2mg\/kg SC\/IM 30-90min before the beginning of anesth. Obstetric analgesia 50-100mg SC\/IM. May repeat at 1-3hrly interval.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEP01I":{"商品名稱":"Depakine 400mg Vial#","腎功能不良劑量調整":"\"考量游離型 valproic acid<br>血中濃度的增加，應減低劑量。\"\r<br>","小兒建議劑量":"\"三歲以下的孩童若接受 valproate sodium 治<br>療，在治療前應先評估治療效益和可能引起病<br>人發生肝病及胰臟炎的危險。若評估後仍須使<br>用本藥治療，則建議採取單一藥品的治療方式\"\r<br>","提示內容":"Mepem與Depakine併用會降低Depakine的血中濃度, 影響療效 補充：INVANZ、FINBAX亦會有此交互作用","抗生素手冊":"暫無資料"},"DEP01O":{"商品名稱":"Depakine 200mg Tab","腎功能不良劑量調整":"\"腎功能不全之病人，考量游離型 valproic acid<br>血中濃度的增加，應減低劑量。 <br>腎功能不全之病人，考量游離型 valproic acid<br>血中濃度的增加，應減低劑量。 <br>\"\r<br>","小兒建議劑量":"不適用於六歲以下的孩童\r<br>","提示內容":"Mepem與Depakine併用會降低Depakine的血中濃度, 影響療效 補充：INVANZ、FINBAX亦會有此交互作用","抗生素手冊":"暫無資料"},"DEP02O":{"商品名稱":"Depakine Chrono 500mg Tab","腎功能不良劑量調整":"\"腎功能不全之病人，考量游離型 valproic acid<br>血中濃度的增加，應減低劑量。 \"\r<br>","小兒建議劑量":"本藥不適用於六歲以下的孩童\r<br>","提示內容":"Mepem與Depakine併用會降低Depakine的血中濃度, 影響療效 補充：INVANZ、FINBAX亦會有此交互作用","抗生素手冊":"暫無資料"},"DEP03O":{"商品名稱":"Depyretin 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEP04S":{"商品名稱":"Depakine Soln 8gm\/40ml Bot","腎功能不良劑量調整":"\"腎功能不全之病人，考量游離型 valproic acid<br>血中濃度的增加，應減低劑量。 \"\r<br>","小兒建議劑量":"兒童: 正常劑量為每日 30mg\/kg\r<br>\r<br>用法: Depakine可以每日兩次給藥。","提示內容":"Mepem與Depakine併用會降低Depakine的血中濃度, 影響療效 補充：INVANZ、FINBAX亦會有此交互作用","抗生素手冊":"暫無資料"},"DER03E":{"商品名稱":"Derma Cream 4% 7gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- 本品不建議使用於12歲以下兒童，除非有醫師指示或監視使用。<br>- 嬰兒及孩童不得使用本品。<br>- Dosing: Pediatric Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DES01I":{"商品名稱":"Desferal 500mg Vial","腎功能不良劑量調整":"\"CrCl >50 mL\/minute: No adjustment required<br>\r<br>CrCl 10-50 mL\/minute, CRRT: Administer 25% to 50% of normal dose<br>\r<br>CrCl<10 mL\/minute, hemodialysis, peritoneal dialysis: Avoid use\"\r<br>","小兒建議劑量":"\"Neonatal<br>\r<br>Acute iron intoxication: Very limited data available: I.V. infusion: 5 mg\/kg\/hour; dosing based on a case report of an oral ferrous sulfate overdose in a former premature neonate ;  Chronic iron overload:<br>General dosing: Manufacturer’s labeling: \"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DES03I":{"商品名稱":"Desferrioxamine 500mg Vial","腎功能不良劑量調整":"\"CrCl >50 mL\/minute: No adjustment required<br>\r<br>CrCl 10-50 mL\/minute, CRRT: Administer 25% to 50% of normal dose<br>\r<br>CrCl<10 mL\/minute, hemodialysis, peritoneal dialysis: Avoid use\"\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DET02O":{"商品名稱":"DETRUSITOL SR 4mg Cap","腎功能不良劑量調整":"GFR<30ml\/min:未結合型tolterodine和5-hydroxymethyl代謝物之AUC大約增高二倍且其他代謝物之血清濃度顯著的增高﹙高達12 倍﹚持續膠囊: \r<br>Clcr 10-30 mL\/min : 2 mg once daily\/ \r<br>Clcr <10 : Use is not recommended; has not been studied.","小兒建議劑量":"安全性和療效尚未確立\r<br>","提示內容":"建議劑量 4 mg QD\r<br> (若開立 4 mg BID 需做建議, 因可能增加QT prolongation風險)\r<br>抗膽鹼類藥物, 注意老年人以及尿滯留病人之使用","抗生素手冊":"暫無資料"},"DEV01E":{"商品名稱":"Devirus Oph Oint 3% 4.5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEX01O":{"商品名稱":"Dex-CTM 2mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling\r<br>","小兒建議劑量":"通常成人及12歲以上小孩，每次1錠，6-11歲每次1\/2錠，2-5歲，每次1\/4錠，每4-6小時服用一次，並依年齡症狀酌予增減之。 \r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEX02I":{"商品名稱":"Dexamethasone 5mg\/1ml Amp","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer’s labeling; use with caution. Hemodialysis or peritoneal dialysis: Supplemental dose is not necessary\r<br>","小兒建議劑量":"\"Dosing: Pediatric<br>\r<br>Antiemetic (prior to chemotherapy): Refer to individual protocols and emetogenic potential: I.V.: 10 mg\/m2\/dose every 12-24 hours on days of chemotherapy for severely emetogenic chemotherapy courses\r<br><br>Anti-inflammatory and\/or immunosuppres\"\r<br>","提示內容":"婦產科會開立IM: 6 mg Q12H for a total of 4 doses, \r<br>目的是促進有早產跡象的胎兒肺泡成熟, 預防早產兒發生呼吸窘迫症","抗生素手冊":"暫無資料"},"DEX03I":{"商品名稱":"Dextrose 10% 500mL Bag Otsuka","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEX03O":{"商品名稱":"Dexamethasone 0.5mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; use with caution. Hemodialysis or peritoneal dialysis: Supplemental dose is not necessary","小兒建議劑量":"Children, 0.02-0.3 mg\/kg\/day or 0.6-9 mg\/m2\/day in 3-4 doses.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DEX04I":{"商品名稱":"Dexmedetomidine 200mcg\/2ml Vial Ever","腎功能不良劑量調整":"No specific guidelines available; however, dexmedetomidine pharmacokinetics were not different in patients with severe renal impairment compared to those with normal renal function\r<br>","小兒建議劑量":"仿單:不建議用於小於18歲的兒童                                                                                                                               uptodate:Children (limited data): Loading d\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA01O":{"商品名稱":"Diapin 2mg Tab#4","腎功能不良劑量調整":"No dose adjustment recommended; decrease dose if administered for prolonged periods","小兒建議劑量":"口服，1-2.5 mg或每公斤體重0.04 mg-2mg，每平方公尺體表面積1.17-6mg，一天3-4次，視需要及耐受性逐漸增加劑量","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA02O":{"商品名稱":"Diamox 250mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA03O":{"商品名稱":"Diane-35 21tab\/Box","腎功能不良劑量調整":" Specific guidelines not available; use with caution.\r<br>","小兒建議劑量":"避免兒童觸摸\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA04I":{"商品名稱":"Diagnogreen Inj 25mg Vial","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA04O":{"商品名稱":"Diamicron MR 30mg Tab","腎功能不良劑量調整":"輕度至中度腎臟功能不全之病人：從臨床試驗結果證實，這類病人可使用與腎臟功能正常病人之相同治療劑量，但須密切監測病人的反應。\r<br>\r<br>eGFR>15 可服用, 但須增加監測血糖頻率, 須要時可調整劑量，須避免低血糖","小兒建議劑量":"只限成人使用。尚無使用於孩童的臨床試驗報告或資料。\r<br>","提示內容":"Diamicron MR 為長效劑型，不建議磨粉使用","抗生素手冊":"暫無資料"},"DIA05I":{"商品名稱":"Dianeal 1.5% Dex 5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA05O":{"商品名稱":"Diazepam 2mg Tab#4","腎功能不良劑量調整":"o dose adjustment recommended; decrease dose if administered for prolonged periods.\r<br>","小兒建議劑量":"一般兒童劑量：6歲以下兒童不宜使用。6歲及6歲以上兒童－口服，1-2.5 mg或每公斤體重0.04 mg-2mg，每平方公尺體表\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA06I":{"商品名稱":"Dianeal 2.5% Dex 5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA07I":{"商品名稱":"Dianeal 1.5% Dex 1.5L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA08I":{"商品名稱":"Dianeal 2.5% Dex 1.5L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA09I":{"商品名稱":"Dianeal 4.25% Dex 1.5L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA10I":{"商品名稱":"Dianeal 1.5% Dex 2L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA11I":{"商品名稱":"Dianeal 2.5% Dex 2L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA12I":{"商品名稱":"Dianeal 4.25% Dex 2L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA13I":{"商品名稱":"Dianeal 1.5% Dex 2.5L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA14I":{"商品名稱":"Dianeal 2.5% Dex 2.5L Ultrabag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA15I":{"商品名稱":"Dianeal Low Ca 1.5% Dex 5L(低鈣)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA16I":{"商品名稱":"Dianeal Low Ca 2.5% Dex 5L(低鈣)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA17I":{"商品名稱":"Dianeal Low Ca 1.5% Dex 1.5L Ultrabag(低","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA18I":{"商品名稱":"Dianeal Low Ca 2.5% Dex 1.5L Ultrabag(低","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA19I":{"商品名稱":"Dianeal Low Ca 4.25% Dex 1.5L Ultrabag(","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA20I":{"商品名稱":"Dianeal Low Ca 1.5% Dex 2L Ultrabag(低鈣","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA21I":{"商品名稱":"Dianeal Low Ca 2.5% Dex 2L Ultrabag(低鈣","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA22I":{"商品名稱":"Dianeal Low Ca 4.25% Dex 2L Ultrabag(低","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA23I":{"商品名稱":"Dianeal Low Ca 1.5% Dex 2.5L Ultrabag(低","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA24I":{"商品名稱":"Dianeal Low Ca 2.5% Dex 2.5L Ultrabag(低","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA25I":{"商品名稱":"Dianeal Pd2 1.5%;2.5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA27I":{"商品名稱":"Dianeal Pd2 2.5%;2.5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA28I":{"商品名稱":"Dianeal 4.25% Dex 5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIA29I":{"商品名稱":"Diagnogreen (眼科) Inj 25mg Vial","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"暫無資料","提示內容":"本品開立時獨立處方箋，單位憑處方至藥庫領取公藥至單位存放，藥局不印藥袋，不需發放。","抗生素手冊":"暫無資料"},"DIB02O":{"商品名稱":"Dibose 100mg Tab","腎功能不良劑量調整":"不可使用於嚴重腎功能不全的病患\r<br>(creatinine clearance < 25 ml\/min)。\r<br>[>25 ml\/min]: 50-200mg tid\r<br>[<25]: Avoid\r<br>HEMO: No data","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIC02O":{"商品名稱":"Dicetamin 50mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小兒依年齡、包裝事宜增減\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIC03O":{"商品名稱":"Diclocin 250mg Cap","腎功能不良劑量調整":"\"No specific adjustment provided in manufacturer’s labeling; a reduction in total dosage should be considered in renal impairment.<br>Not dialyzable (0% to 5%); supplemental dose is not necessary.<br>Peritoneal dialysis effects: Supplemental dose is not necess","小兒建議劑量":"\"兒童體重＜40公斤： 每次每公斤3.125－6.25mg，每6小時服用一次 <br>兒童體重＞40公斤： 同成人劑量\"\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 500 mg q6h<br>主要經肝臟排泄<br>以1st cephas代替減少其副作用"},"DIF01E":{"商品名稱":"Difflam Forte Spray 3.0mg\/ml; 15ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIF01I":{"商品名稱":"Diflucan 100mg\/50ml Vial#","腎功能不良劑量調整":"[CRCL >50 ]: 200-400mg QD, No change. \r<br>[<50 ml\/min, no HD]: 50%   \r<br>HEMO: 200-400mg QD, after H\/D","小兒建議劑量":"16歲以下的小孩不建議使用。但若治療的醫師認為膚肯治療是必要的，則一歲以上且腎功能正常的小孩，其日劑量如下：用於表面念珠菌感染的日劑量為：\r<br>1~2mg\/kg，全身性念珠菌或囊球菌感染的日劑量為3~6mg\/kg，小孩之建議劑量是依成人每公斤體重所需之劑量推算而得，然而5~13歲小孩之初步研究顯示Fluconazole之排除速率可能較成人為快，因此對於嚴重或致命的感染，可能需要較高的劑量，有少數的小孩日劑量可能需要用到12mg\/kg，但總劑量不可超過成人最高劑量400mg。對於腎功能不全的小孩，日劑量視腎功能受損程度酌予減量","提示內容":"150 mg once 或Loading dose: 200 to 800 mg\r<br>maintenance: 200 to 800 mg once daily\r<br>ClCr <=50 mL\/minute (no dialysis): Reduce dose by 50%","抗生素手冊":"建議量: 200 to 800 mg daily<br>Ccr less than 50: 劑量減半<br>Ccr less 25: 四分之一劑量<br>HD:  洗完正常量"},"DIF02E":{"商品名稱":"Differin Gel 0.1% 15g Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIF02O":{"商品名稱":"Dificid 200mg Tab#","腎功能不良劑量調整":"不須調整劑量。由於在本族群的臨床數據有限，嚴重腎功能不全患者使用Dificid必須謹慎小心。","小兒建議劑量":"18歲以下兒童使用fidaxomicin的療效與安全性尚未建立。目前尚無資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIG02O":{"商品名稱":"Digosin 0.25mg Tab","腎功能不良劑量調整":"【可監測血中濃度】以確認療效及預防毒性\r<br>[Clcr >50 ml\/min]： 0.25~0.5mg q24h\r<br>[10-50]：25-75% q36h\r<br>[<10 ]  ：10-25% q48h \r<br>HEMO： None","小兒建議劑量":"毛地黃著效劑量：口服：孩童：新生兒─每公斤40～60mcg；1個月至2歲者每公斤60mcg。\r<br>2. 維持劑量：口服\/靜注：成人─每天0.125-0.5mg(平均劑量每天0.25mg)。小孩─為毛地黃著效劑量的20%-30%。\r<br>(另有水劑)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIL01O":{"商品名稱":"Dilantin 100mg Cap","腎功能不良劑量調整":"Phenytoin level in serum may be difficult to interpret in renal failure. Monitoring of free (unbound) concentrations or adjustment to allow interpretation is recommended\r<br>","小兒建議劑量":"\"Status epilepticus: I.V.:<br><br>\r<br>Infants and Children: Loading dose: 15-20 mg\/kg, then begin maintenance therapy usually 12 hours after loading dose<br><br>\r<br>\r<br>Adolescents: Refer to adult dosing.<br><br>\r<br>\r<br>Anticonvulsant (nonemergent use): Oral:<br><br>\r<br>\r<br>Loading dose: Children and Adolescents: Refer to adult dosing.<br><br>\r<br>\r<br>Maintenance dose:\r<br><br><br>Infants and Children: Initial maintenance dose: 5 mg\/kg\/day in 2-3 divided doses; usual maintenance dose range: 4-8 mg\/kg\/day; maximum daily dose: 300 mg. Some experts suggest higher maintenance doses may be necessary in infant and young children (range: 8-10 mg\/kg\/day in divided doses).<br><br>\r<br>Adolescents: Refer to adult dosing\"\r<br>","提示內容":"一般劑量100mg TID(up to 600mg daily) \r<br>需監測血中濃度並適時調整劑量\r<br>Phenytoin為CYP3A4 Inducers (Strong)及P-glycoprotein\/ABCB1 Inducers 可能會造成下列藥品之血中濃度減少應避免併用：Rivaroxaban、Apixaban、DABIGATRAN、Edoxaban\r<br>Ciprofloxacin可能會造成Phenytoin血中濃度減少","抗生素手冊":"暫無資料"},"DIL04O":{"商品名稱":"Dilatrend 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIL05O":{"商品名稱":"Diltisser 30mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIL06O":{"商品名稱":"Dilatrend 6.25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"需要再查仿單","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIM02M":{"商品名稱":"Dimethyl sulfoxide (DMSO) 10ml amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIM04O":{"商品名稱":"Dimotil Repe Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Dimotil Repe 內含 metoclopramide 5mg\r<br>→可能有EPS方面副作用, 老年人或Parkinson病人需慎用\r<br>\r<br>雙層錠(內層含Pancreatin 212.5 mg)不建議磨粉使用","抗生素手冊":"暫無資料"},"DIO01O":{"商品名稱":"Diovan FC 160mg Tab","腎功能不良劑量調整":"不需要調整劑量,Clcr < 10 ml\/min 則尚未有證據證實其使用之安全性\r<br>","小兒建議劑量":"仍未確認其對兒童及青少年 ( 十八歲以下) 的安全性和藥效\r<br>","提示內容":"注意病人是否有高血鉀的症狀\r<br>與Entresto 100mg Tab均含Valsartan","抗生素手冊":"暫無資料"},"DIP01O":{"商品名稱":"DIPYRIDAMOLE S.C. 75MG TAB","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"Oral: Children ?12 years: Refer to adult dosing.\r<br>Children: 3-6 mg\/kg\/day in 3 divided doses","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIP02O":{"商品名稱":"Dipyridamole S.C. 25mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.","小兒建議劑量":"一般兒童劑量：目前尚未建立。","提示內容":"1tab TID, 空腹(飯前1小時)使用, 吸收較快","抗生素手冊":"暫無資料"},"DIP03O":{"商品名稱":"Diphenidol 25mg Tab","腎功能不良劑量調整":"\"對藥物過敏之病人及腎機能有重篤障害者不宜使用。 <br>\"\r<br>","小兒建議劑量":"可依年齡症狀適宜增減之(飯後投與)。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIP04O":{"商品名稱":"Dipyridamole SC 25mg Tab Standard","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIP05I":{"商品名稱":"Diphenhydramine HCl 30mg\/1ml Amp","腎功能不良劑量調整":"腎功能不全者應延長給藥間隔（interval）；\r<br>輕度（GFR＞50 mL\/min）：間隔6小時；\r<br>中度（GFR 10-50 mL\/min）：間隔6-12小時；\r<br>重度（GFR＜10 mL\/min）：間隔12-18小時。","小兒建議劑量":"早產兒（premature infants）及新生兒（neonate）、不建議使用。\r<br>兒童不宜使用本品。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIP06I":{"商品名稱":"Dipeptiven for IV 100ml Bot","腎功能不良劑量調整":"creatinine清除率小於25不能使用\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIP07I":{"商品名稱":"DIPHERELINE PR 11.25MG\/2ML VIAL","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer’s labeling. However, renal impairment increases systemic exposure to triptorelin.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIP08I":{"商品名稱":"Diphereline PR 3.75mg\/2ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"性早熟: < 20 Kg: 1\/2 Vial IM Q4W\r<br>              20-30 Kg: 2\/3 Vial IM Q4W\r<br>              >30 Kg: 1 Vial IM Q4W","提示內容":"1.本次引進是供性早熟兒童健保使用(意指女童8 歲以前及男童10 歲以前)。\r<br>2.劑量 \r<br><20kg兒童 每4週(28天)給予一次減半(1\/2)劑量。\r<br>20~30kg兒童 每4週(28天)給予一次三分之二(2\/3)的劑量。\r<br>>30kg兒童 每4週(28天)施行一次肌肉注射。\r<br>(本院另有同成分高劑量的DIPHERELINE PR 11.25MG\/2ML VIAL，唯兩者適應症等並不完全相同)","抗生素手冊":"暫無資料"},"DIQ01E":{"商品名稱":"Diquas Oph soln 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前尚未有用於出生體重低嬰兒、新生兒、嬰幼兒貨兒童的安全性資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIT01O":{"商品名稱":"Ditropan 5mg Tab","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"Children: >5 years: Immediate release: 5 mg twice daily; maximum: 5 mg 3 times daily\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DIV01E":{"商品名稱":"Divigel 0.1% GEL 1gm\/pack#","腎功能不良劑量調整":"仿單無提及","小兒建議劑量":"仿單無提及","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOB02O":{"商品名稱":"Dobecon SC 100mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOG01O":{"商品名稱":"Dogmatyl 200mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOG02O":{"商品名稱":"Dogmatyl 50mg Tab","腎功能不良劑量調整":"降低使用劑量\r<br>","小兒建議劑量":"療效及安全性尚未完全確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOL02O":{"商品名稱":"Dolcol 250mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"仿單: 500 mg to 2 gm daily dosage"},"DOM01E":{"商品名稱":"Domper 10mg Supp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"12歲以下兒童及12歲以上體重小於35kg之青少年：\r<br>1次最多10mg，每日最多3次。\r<br>(衛署公告20141112)","提示內容":"成人及12yr 以上青少年(WT>35kg): 10-30 mg BID \r<br>12歲以下或WT<35kg青少年: 10 mg TID","抗生素手冊":"暫無資料"},"DON01O":{"商品名稱":"Prednisolone (Donison) 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"成人初期一日4-6錠，分4次，或分2次，繼續此量數日至症狀好轉後，每2-3日遞減半錠或一錠，直到最低有效維持量，最低有效維持量通常為一日半錠至四錠。如在維持量投給中，有症狀再發之症候，則須漸次增加用量以抑制症狀。上述各量為Cortisone的1\/3-1\/5量。\r<br>----------------------------------------------------------\r<br>簡易計算: 1-2mg\/kg\/d 分3-4次給","提示內容":"小兒劑量：0.1-2 mg\/kg\/d QD-QID","抗生素手冊":"暫無資料"},"DOP01O":{"商品名稱":"Dopadine 100mg Tab","腎功能不良劑量調整":"Day1 200mg than, \r<br>Clcr 30~50: 100mg qd\r<br>Clcr 15~30: 100mg qod\r<br>Clcr <15: 100mg 1W2D\r<br>HEMO: 100mg 1W2D","小兒建議劑量":"新生兒及一歲以下的嬰兒之安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOP02I":{"商品名稱":"Dopamin 200mg\/5ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"一般兒童劑量尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOR01I":{"商品名稱":"Dormicum 15mg\/3ml Amp #4","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"0.08-0.2mg\/kg在麻醉誘導前30-60分鐘給予\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOR03O":{"商品名稱":"Dormicum FC 7.5mg Tab #4","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"?Infants >6 months and Children: Single dose: 0.25-0.5 mg\/kg once\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOR04I":{"商品名稱":"Dormicum 5mg\/1ml Amp #4","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"0.08-0.2mg\/kg在麻醉誘導前30-60分鐘給予\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOR04O":{"商品名稱":"Dorison 4mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小孩初劑量每次半片，每天一次。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOR99I":{"商品名稱":"Dormicum (試驗) 5mg\/1ml Amp #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOS01O":{"商品名稱":"Dostinex 0.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOT01I":{"商品名稱":"Dotarem 20ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOT02I":{"商品名稱":"Dotarem 60ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOX01I":{"商品名稱":"Doxor Lyo Inj 10mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOX01O":{"商品名稱":"Doxaben 2mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer’s labeling\r<br>","小兒建議劑量":"到目前為止沒有小孩使用的經驗\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOX02O":{"商品名稱":"Doxymycin 100mg Ec Cap","腎功能不良劑量調整":"腎臟機能不全者，使用此藥相當安全\r<br>","小兒建議劑量":"\"Children <8 years:<br>\r<br>Treatment: I.V.: 2.2 mg\/kg\/dose every 12 hours (maximum dose: 100 mg\/dose); may switch to oral therapy (same dosing) when clinically appropriate (CDC, 2001)\r<br><br>Prophylaxis; postexposure (inhalation or cutaneous): Oral: 2.2 mg\/kg\/dose every\"\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 100 mg to 200 mg q12h<br>age over than 8 years old: 2 mg per kg q12h<br>主要經胃腸道排除<br>atypical pneumonia 因副作用首選erythro "},"DOX03O":{"商品名稱":"Doxaben XL 4mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer’s labeling\r<br>","小兒建議劑量":"到目前為止沒有小孩使用的經驗\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DOX04O":{"商品名稱":"Doxepin 25mg Cap","腎功能不良劑量調整":"There are no dosage adjustments provided in manufacturer’s labeling","小兒建議劑量":"孩童給藥之安全性尚未確立，故不建議對12歲以下孩童給藥。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DRO01I":{"商品名稱":"Dropel 2.5mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUL01E":{"商品名稱":"Dulcolax 10mg Supp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUL01O":{"商品名稱":"Dulcolax 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUO01E":{"商品名稱":"Duofilm 15ml Bot","腎功能不良劑量調整":"仿單未載明","小兒建議劑量":"仿單未載明","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUO01O":{"商品名稱":"Duodart 0.5mg\/0.4mg Cap","腎功能不良劑量調整":"CrCl 10-30 mL\/minute\/1.73 m2: No dosage adjustment necessary.\r<br>CrCl <10 mL\/minute\/1.73 m2: No dosage adjustment provided in the manufacturer’s labeling (has not been studied).","小兒建議劑量":"禁用於兒童病患","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUP01I":{"商品名稱":"Dupixent 300mg\/2ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"本品使用於兒童患者(<18歲)的安全性及療效性尚未確立。","提示內容":"適應症為異位性皮膚炎及氣喘，本次引進供異位性皮膚炎之個案使用【請注意! 1盒有2支】【冰箱藥，不可震搖】\r<br>藥品保存室溫下不超過25°C最多達14天\r<br>起始劑量<60kg之12-17歲青少年400 mg；成人及?60kg之12-17歲青少年 600 mg \r<br>後續劑量(隔週給藥)<60kg之12-17歲青少年200 mg；成人及?60kg之12-17歲青少年 300 mg","抗生素手冊":"暫無資料"},"DUP04O":{"商品名稱":"Dupin 5mg Tab #4","腎功能不良劑量調整":"o dose adjustment recommended; decrease dose if administered for prolonged periods.\r<br>","小兒建議劑量":"一般兒童劑量：\r<br>6歲以下兒童不宜使用。\r<br>6歲及6歲以上兒童－口服，1-2.5 mg或每公斤體重0.04 mg-2mg，每平方公尺體表面積1.17-6mg，一天3-4次，視需要及耐受性逐漸增加劑量","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUR01E":{"商品名稱":"Durogesic TTS 25mcg\/h #2","腎功能不良劑量調整":"靜脈給予腎臟移植患者fentanyl 的研究數據顯示fentanyl 的清除率可能會降低。腎功能不全患者使用DUROGESICR 時，應嚴密監控是否有fentanyl 的中毒徵象，必要時可降低劑量。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUR01I":{"商品名稱":"Duratocin 100mcg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"剖腹產嬰兒出生後施打，只能施打一劑。\r<br>(注意: 在嬰兒出生前任何一產程都不適宜使用carbetocin)","抗生素手冊":"暫無資料"},"DUR02E":{"商品名稱":"DUROGESIC TTS 50mcg\/h #2","腎功能不良劑量調整":"靜脈給予腎臟移植患者fentanyl 的研究數據顯示fentanyl 的清除率可能會降低。腎功能不全患者使用DUROGESICR 時，應嚴密監控是否有fentanyl 的中毒徵象，必要時可降低劑量。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUR03E":{"商品名稱":"Durogesic D-TRANS 12mcg\/h #2","腎功能不良劑量調整":"少於10%的fentanyl會以原型自腎臟排出。不同於morphine，DUROGESICR沒有活性代謝物會由腎臟排出。腎功能受損之病患給予DUROGESICR應注意是否有fentanyl中毒之情況，必要時應降低劑量。\r<br>","小兒建議劑量":"DUROGESICR僅能使用於對類鴉片藥物有耐受性的病童(年齡為2-16歲)，該病童須正接受至少相當於每日30 mg的口服嗎啡劑量。欲將病童自口服或靜脈注射類鴉片藥物轉換成DUROGESICR時，請參考等止痛劑量換算和依每日口服嗎啡劑量推算而得的DUROGESICR推薦劑量。未研究兩歲以下兒童使用DUROGESICR的情形。DUROGESICR只能用於對類鴉片藥物有耐受性的兩歲以上兒童。為避免兒童意外攝入，要小心選擇DUROGESICR的使用部位，並密切監測貼片的黏著性。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUR04E":{"商品名稱":"Duraphat Dental Susp 500mg\/10ml Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DUR05E":{"商品名稱":"Duratears Oph Oint 3.5gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DYM01E":{"商品名稱":"Dymista Nasal Spray 137\/50mcg\/d;120d Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DYN01I":{"商品名稱":"Dynastat 40mg Vial","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"尚未在18歲以下的病人進行研究，因此不宜用於這些病人","提示內容":"(週報2018\/04\/20 發行)\r<br>Dynastat於食藥署核准之適應症為「短期(不宜超過四天)使用於外科手術後疼痛之緩解」，要注意使用天數\r<br>可以使用NS、D5W、D5HS調配藥品，調配完成注射液僅能靜脈注射或肌肉注射，不可冷藏冷凍，25°C可保存24小時。","抗生素手冊":"暫無資料"},"DYS01I":{"商品名稱":"Dysport 500u Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"DYS02I":{"商品名稱":"Dysport 1u (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"有小兒腦性麻痺引起之肌肉痙攣之適應症。限用於2歲以上的兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EAR01E":{"商品名稱":"Earflo Otic Soln 3mg\/ml;5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"Acute otitis media with tympanostomy tubes: Children >1 year to 12 years: Instill 5 drops (0.25 mL) into the affected ear(s) twice daily for 10 days<br><br>\r<br>\r<br>Chronic suppurative otitis media with perforated tympanic membranes: Adolescents ?12 years and Adults: Instill 10 drops (0.5 mL) into the affected ear(s) twice daily for 10-14 days\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EAS01E":{"商品名稱":"Easy Antiseptic Liq 2% 200ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EAS01I":{"商品名稱":"Easydopa 400mg\/250ml Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童不宜使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EAS02E":{"商品名稱":"Easy Antiseptic Soln 2% 30ml Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"【術前淨身使用】消毒滅菌液\r<br>發藥時請附用藥指導單，以利病人正確進行術前淨身","抗生素手冊":"暫無資料"},"EAS03E":{"商品名稱":"Easy Antiseptic Liq (橘色) 2% 550ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ECO01E":{"商品名稱":"Econalone Cream","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Tinea pedis: Children >=12 years and Adolescents: Topical: Foam: Apply sufficient amount to cover affected area once daily for 4 weeks\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ECO03E":{"商品名稱":"Econazine Cream 10gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Tinea pedis: Children >=12 years and Adolescents: Topical: Foam: Apply sufficient amount to cover affected area once daily for 4 weeks\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EDA01O":{"商品名稱":"Edarbi 40mg Tab","腎功能不良劑量調整":"腎功能不全:尚無易得平R錠用於重度腎功能不全與末期腎病患者的經驗，故應小心使用。血液透析無法排除 azilsartan。輕度或中度腎功能不全患者無需調整劑量。宜定期監測血鉀。","小兒建議劑量":"兒科族群: 易得平R錠用於 0 至 < 18 歲兒童與青少年之安全性與療效，尚未確立。","提示內容":"40mg QD-BID, 若開立1#Q8H需聯絡\r<br>注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"EDI01O":{"商品名稱":"Ediol FC 1mg Tab","腎功能不良劑量調整":"For most products, there are no dosage adjustments provided in the manufacturer’s labeling (has not been studied).","小兒建議劑量":"Female hypogonadism: Oral: 0.5-2 mg\/day in a cyclic regimen (3 weeks on drug, 1 week off)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EFE02O":{"商品名稱":"EFFEXOR XR 75mg Cap","腎功能不良劑量調整":"[>50 ml\/min]: 75-375 mg q24h\r<br>[<50]: 50%\r<br>HEMO:  50%","小兒建議劑量":"尚未建立小兒用藥的安全性與有效性\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EFE03O":{"商品名稱":"Effexor XR 37.5mg Cap#","腎功能不良劑量調整":"\"(GFR)=<br>GFR=10-70 mL\/min, 降低25-50%用量開始治療 , 血液透析法治療之患<br>者，建議以降低50%之用量開始治療\"\r<br>","小兒建議劑量":"尚未建立小兒用藥的安全性與有效性\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EFI01O":{"商品名稱":"EFIENT 5MG TAB","腎功能不良劑量調整":"無需腎功能劑量調整。在中重度腎功能不良病人為高出血風險族群，使用時請小心。\r<br>\r<br>Hemodialysis: Not dialyzable (NCS\/SCCM [Frontera 2016])(UpToDate)","小兒建議劑量":"尚未建立出生體重過低的嬰兒、新生兒、哺乳嬰兒、嬰兒或兒童的安全性。","提示內容":"我國核准之用法為 Loading dose 20 mg, maintenance dose 3.75mg，台灣建議劑量較美國為低, 主因是本藥有種族差異,","抗生素手冊":"暫無資料"},"EFI02O":{"商品名稱":"Efient 3.75mg Tab#","腎功能不良劑量調整":"無需腎功能劑量調整。在中重度腎功能不良病人為高出血風險族群，使用時請小心。\r<br>\r<br>Hemodialysis: Not dialyzable (NCS\/SCCM [Frontera 2016])(UpToDate)","小兒建議劑量":"尚未建立出生體重過低的嬰兒、新生兒、哺乳嬰兒、嬰兒或兒童的安全性。","提示內容":"我國核准之用法為 Loading dose 20 mg, maintenance dose 3.75mg，台灣建議劑量較美國為低, 主因是本藥有種族差異,","抗生素手冊":"暫無資料"},"EFU01E":{"商品名稱":"Efucon Gel 7.5mg\/gm; 15gm","腎功能不良劑量調整":"仿單未提及","小兒建議劑量":"小兒的安全性和效果尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELD01O":{"商品名稱":"Eldepryl 10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELI01I":{"商品名稱":"Eligard 22.5mg Syringe","腎功能不良劑量調整":"未對肝或腎功能不全患者進行臨床研究。","小兒建議劑量":"ELIGARD禁用於婦女和兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELI02E":{"商品名稱":"Elidel Cream 1% 10gm Tube#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Atopic dermatitis (mild-to-moderate):?Children ?2 years and Adolescents: Topical: Refer to adult dosing\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELI02I":{"商品名稱":"Eligard 7.5mg Syringe","腎功能不良劑量調整":"未對肝或腎功能不全患者進行臨床研究。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELI02O":{"商品名稱":"ELIQUIS FC 5MG TAB#","腎功能不良劑量調整":"輕中度腎功能不全:不需調整劑量, 5mg bid\r<br>Scr≧1.5且BW≦60公斤或年齡≧80歲:2.5mg bid\r<br>Clcr15~29重度腎功能不全:2.5mg BID。\r<br>Clcr<15 或正在接受洗腎: 缺乏資料，因此不建議使用。","小兒建議劑量":"用於兒童病患的安全性及有效性尚未確立","提示內容":"處方中若NOAC(Rivaroxaban、Apixaban、DABIGATRAN、Edoxaban)與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>轉換說明：1.若要從warfarin轉換至apixaban，仿單建議只要INR< 2.0即可直接轉換成apixaban。2.從apixaban轉warfarin，因為apixaban會影響INR，故同時併用warfarin與apixaban時無法用INR來監測warfarin的效果。停用apixaban後，在下一次原訂給藥時間，同時併用warfarin與抗凝血針劑(heparin或LMWH)做過渡性治療，直至達到適宜的INR時，即可停止抗凝血針劑的使用。","抗生素手冊":"暫無資料"},"ELI03E":{"商品名稱":"Elisone Cream 0.1% 5g","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELI03O":{"商品名稱":"Eliquis FC 2.5mg Tab#","腎功能不良劑量調整":"輕中度腎功能不全的患者不需調整劑量，但血清肌酸酐濃度≧1.5mg\/dl的患者若同時併有體重≦60公斤或年齡≧80歲，應降低劑量為2.5毫克每日兩次。<br>\r<br>重度腎功能不全的患者應謹慎使用。目前並無任何用於肌酸酐廓清率<15 ml\/min或正在接受洗腎之患者方面的資料，因此不建議使用。","小兒建議劑量":"用於兒童病患的安全性及有效性尚未確立","提示內容":"處方中若NOAC(Rivaroxaban、Apixaban、DABIGATRAN、Edoxaban)與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>轉換說明：1.若要從warfarin轉換至apixaban，仿單建議只要INR< 2.0即可直接轉換成apixaban。2.從apixaban轉warfarin，因為apixaban會影響INR，故同時併用warfarin與apixaban時無法用INR來監測warfarin的效果。停用apixaban後，在下一次原訂給藥時間，同時併用warfarin與抗凝血針劑(heparin或LMWH)做過渡性治療，直至達到適宜的INR時，即可停止抗凝血針劑的使用。","抗生素手冊":"暫無資料"},"ELM02O":{"商品名稱":"Elmesatt 2mg Tab","腎功能不良劑量調整":"Contraindicated in severe renal impairment\r<br>","小兒建議劑量":"對小孩無使用經驗 尚未確立其安全性","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELO01E":{"商品名稱":"Elomet Cream 0.1% 5gm","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"每天塗抹一次,薄薄一層塗抹於患部\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELT01O":{"商品名稱":"Eltroxin 50mcg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"先天性甲狀腺功能不足之嬰兒，適當的初劑量為每日給予ELTROXIN 25 微克，每隔2-4 週增加25 微克直至溫和性的毒性症狀出現為止，隨後再稍微降低劑量。對於幼年型黏液水腫所使用之劑量亦相同，惟一歲以上之孩童期劑量可採用2.5-5 微克\/每公斤體重\/每日之計算方式","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ELT02O":{"商品名稱":"Eltroxin 100mcg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"Children,\r<br>Growth and puberty complete, 1.7 mcg\/kg\/day.\r<br>> 12 yrs., ≧ 150 mcg or 2-3 mcg\/kg\/day;\r<br>6-12 yrs., 100-125 mcg or 4-5 mcg\/kg\/day;\r<br>1-5 yrs., 75-100 mcg or 5-6 mcg\/kg\/day;\r<br>6-12 mos, 50-75 mcg or 6-8 mcg\/kg\/day;\r<br>3-6 mos, 25-50 mcg or 8-10 mcg\/kg\/day;\r<br>1-3 mos, 10-15 mcg\/kg\/day;","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EMA01E":{"商品名稱":"Emadine 0.05% Oph Soln 5ml","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling\r<br>","小兒建議劑量":" Children >=3 years: Refer to adult dosing\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EME01O":{"商品名稱":"Emetrol 10mg Tab","腎功能不良劑量調整":"Severe impairment (serum creatinine >0.6 mmol\/L or 6 mg\/dL): Reduce dosing frequency to 1-2 times daily with prolonged therapy. Dose reduction may also be necessary\r<br>","小兒建議劑量":"「12歲以下兒童」及「12歲以上體重小於35kg之青少年」：1次0.25mg\/kg，每日最多3次\r<br>\r<br>(by衛署公告201411)","提示內容":"成人及12yr 以上青少年(WT>35kg): 10 mg TID","抗生素手冊":"暫無資料"},"EME02O":{"商品名稱":"Emend 80mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EME03O":{"商品名稱":"Emend 125mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EMG01I":{"商品名稱":"Emgality 120mg\/1ml Pen","腎功能不良劑量調整":"輕度至中度腎功能不全和肝功能不全病人無須調整劑量","小兒建議劑量":"尚未確立於兒科病人的安全性與療效","提示內容":"1.頑固性偏頭痛， 是”預防”用藥\r<br>2.建議劑量為一次注射240 mg (連續兩次皮下注射，每次120 mg)做為負荷劑量(loading dose)，之後每月皮下注射120 mg的劑量","抗生素手冊":"暫無資料"},"EML01E":{"商品名稱":"Emla Cream 5% 5gm Tube","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童\r<br>約每10cm2使用1g 最多至1小時\r<br>(不可以更久)\r<br>\r<br>有異位性皮膚炎的兒童，敷用時間要縮短至30分鐘\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENB01I":{"商品名稱":"ENBREL 50mg Syringe#","腎功能不良劑量調整":"無需調整劑量","小兒建議劑量":"尚未對不足2歲的兒童進行試驗。Juvenile idiopathic arthritis: Children ?2 years: SubQ: 0.8 mg\/kg (Max.: 50 mg\/dose) QW or 0.4 mg\/kg (maximum: 25 mg\/dose) BIW.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENB02I":{"商品名稱":"Enbrel 25mg Syringe#","腎功能不良劑量調整":"無需調整劑量。\r<br>","小兒建議劑量":"尚未對不足2歲的兒童進行試驗。Juvenile idiopathic arthritis: Children ?2 years: SubQ: 0.8 mg\/kg (Max.: 50 mg\/dose) QW or 0.4 mg\/kg (maximum: 25 mg\/dose) BIW.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"END02I":{"商品名稱":"ENDOXAN 500MG VIAL","腎功能不良劑量調整":"\"嚴重肝、腎功能不全的病人需要降低劑量，血清膽紅素值為 3.1-5mg\/100ml者，降低 25%的劑量；腎絲球過濾速<br>率小於 10ml\/minute者，則降低 50%的劑量。Cyclophosphamide 是可被透析的。\"","小兒建議劑量":"孩童─誘導：2～8mg\/kg或60～250mg\/㎡分數次投與，共6天或6天以上。維持量：10～15mg\/kg，每7～10天1次。或30mg\/kg每3～4週1次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"END02O":{"商品名稱":"Endoxan 50mg Tab#","腎功能不良劑量調整":"\"嚴重肝、腎功能不全的病人需要降低劑量，血清膽紅素值為 3.1-5mg\/100ml者，降低 25%的劑量；腎絲球過濾速<br>率小於 10ml\/minute者，則降低 50%的劑量。Cyclophosphamide 是可被透析的。\"\r<br>","小兒建議劑量":"孩童─成人：2～8mg\/kg或60～250mg\/㎡，共6天或6天以上\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"END03I":{"商品名稱":"Endoxan 200mg Vial#","腎功能不良劑量調整":"\"嚴重肝、腎功能不全的病人需要降低劑量，血清膽紅素值為 3.1-5mg\/100ml者，降低 25%的劑量；腎絲球過濾速<br>率小於 10ml\/minute者，則降低 50%的劑量。Cyclophosphamide 是可被透析的。\"\r<br>","小兒建議劑量":"孩童─誘導：2～8mg\/kg或60～250mg\/㎡分數次投與，共6天或6天以上。維持量：10～15mg\/kg，每7～10天1次。或30mg\/kg每3～4週1次。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENG01I":{"商品名稱":"Engerix-B (自費) 20mcg\/1ml Vial","腎功能不良劑量調整":"腎功能不全患者(包括正在進行血液透析的患者)的基礎免疫接種劑量為四劑加倍劑量(2 x 20 μg)的疫苗；第一劑於選定時間接種，再於接種第一劑的1個月、2個月、及6個月之後各接種一劑。","小兒建議劑量":"\"10 μg的劑量(0.5毫升懸浮液)適用於新生兒、嬰兒、以及19歲(含)以下的兒童。<br>不過，對11歲至15歲(含)的兒童，在接種疫苗期間發生B型肝炎感染的風險很低以及確定可遵照醫囑完成疫苗接種程序的情況下，亦可採用2劑時間表施打每劑20 μg的疫苗。<br>- 11歲至15歲(含)的兒童:<br>對11歲至15歲(含)的兒童，或可採用第0、6個月的時間表施打每劑20 μg的疫苗。不過，在這種情況下，可能要到接種第二劑之後才能達到預防B型肝炎的效果。因此，只有在接種疫苗期間發生B型肝炎感染的風險很低以及確定可完成兩劑疫苗接種程序的情況下才可採用這種時間表。如果這兩項條件都無法確定(例如正在進行血液透析的患者、前往流行地區旅行者、以及與受感染者有親密接觸的人)，則應採用三劑時間表或加速時間表施打每劑10 μg的疫苗。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENG03I":{"商品名稱":"Engerix-B 10 10mcg\/0.5ml(公費) vial","腎功能不良劑量調整":"- 腎功能不全患者，包括正在進行血液透析的患者: 腎功能不全患者(包括正在進行血液透析的患者)的基礎免疫接種劑量為四劑加倍劑量(2 x 20 μg)的疫苗；第一劑於選定時間接種，再於接種第一劑的1個月、2個月及6個月之後各接種一劑。此免疫接種時間表可加以調整，以確保B型肝炎?","小兒建議劑量":"\"10 μg的劑量(0.5毫升懸浮液)適用於新生兒、嬰兒、以及19歲(含)以下的兒童。<br>不過，對11歲至15歲(含)的兒童，在接種疫苗期間發生B型肝炎感染的風險很低以及確定可遵照醫囑完成疫苗接種程序的情況下，亦可採用2劑時間表施打每劑20 μg的疫苗。<br>- 11歲至15歲(含)的兒童:<br>對11歲至15歲(含)的兒童，或可採用第0、6個月的時間表施打每劑20 μg的疫苗。不過，在這種情況下，可能要到接種第二劑之後才能達到預防B型肝炎的效果。因此，只有在接種疫苗期間發生B型肝炎感染的風險很低以及確定可完成兩劑疫苗接種程序的情況下才可採用這種時間表。如果這兩項條件都無法確定(例如正在進行血液透析的患者、前往流行地區旅行者、以及與受感染者有親密接觸的人)，則應採用三劑時間表或加速時間表施打每劑10 μg的疫苗。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENH01I":{"商品名稱":"Enhertu 100mg\/5mL Vial","腎功能不良劑量調整":"輕度(肌酸酐清除率[CLcr] >= 60 且< 90 mL\/min)或中度(CLcr >= 30 且< 60 mL\/min)腎功能不全的病人不需調整劑量。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENH02I":{"商品名稱":"Enhertu (恩慈)100mg\/5mL Vial","腎功能不良劑量調整":"輕度(肌酸酐清除率[CLcr] >=60 且< 90 mL\/min)或中度(CLcr >= 30 且< 60 mL\/min)腎功能不全的病人不需調整劑量。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENO01E":{"商品名稱":"Enoxolone Gingival Paste 80gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未針對三歲以上，十六歲以下兒童進行臨床研究。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENS01I":{"商品名稱":"Enspryng 120mg Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENT01I":{"商品名稱":"Entyvio 300mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"免疫抑制劑\/治療潰瘍性結腸炎\r<br>【冷藏藥】使用4.8 毫升注射用無菌水配製，輕輕晃動藥瓶至少15 秒，配置後在室溫下靜置最多30分鐘，將5 ml藥液加入NS 250ml Bag中給藥。","抗生素手冊":"暫無資料"},"ENT01O":{"商品名稱":"Entresto  100mg Tab#","腎功能不良劑量調整":"(eGFR < 30 mL\/min\/1.73 m2) 患者之建議起始劑量，為50mg BID。依據患者耐受情況，每 2 ~ 4 週加倍劑量，達到每日兩次 200 毫克的目標維持劑量。輕度或中度腎功能不全患者，不需要調整起始劑量。\r<br>中度肝功能不良需開始調整，嚴重肝功能不佳者不建議使用。","小兒建議劑量":"兒童患者使用尚未確立 ENTRESTOR 用於兒童患者的安全性及療效。","提示內容":"50-100 mg BID\r<br>與Diovan均含Valsartan\r<br>禁止在糖尿病患者上同時併用aliskiren(RASILEZR)\r<br>禁止與 ACEI 併用, 若兩者需轉換需間隔36hr以上","抗生素手冊":"暫無資料"},"ENT02I":{"商品名稱":"Entyvio (恩慈) 300mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENT02O":{"商品名稱":"ENTRESTO 200MG TAB#","腎功能不良劑量調整":"(eGFR < 30 mL\/min\/1.73 m2) 患者之建議起始劑量，為50mg BID。依據患者耐受情況，每 2 ~ 4 週加倍劑量，達到每日兩次 200 毫克的目標維持劑量。輕度或中度腎功能不全患者，不需要調整起始劑量。\r<br>中度肝功能不良需開始調整，嚴重肝功能不佳者不建議使用。","小兒建議劑量":"兒童患者使用尚未確立 ENTRESTOR 用於兒童患者的安全性及療效。","提示內容":"50-100 mg BID\r<br>與Diovan均含Valsartan\r<br>禁止在糖尿病患者上同時併用aliskiren(RASILEZR)\r<br>禁止與 ACEI 併用, 若兩者需轉換需間隔36hr以上","抗生素手冊":"暫無資料"},"ENT03O":{"商品名稱":"Entresto 50mg Tab#","腎功能不良劑量調整":"(eGFR < 30 mL\/min\/1.73 m2) 患者之建議起始劑量，為50mg BID。依據患者耐受情況，每 2 ~ 4 週加倍劑量，達到每日兩次 200 毫克的目標維持劑量。輕度或中度腎功能不全患者，不需要調整起始劑量。\r<br>中度肝功能不良需開始調整，嚴重肝功能不佳者不建議使用。","小兒建議劑量":"兒童患者使用尚未確立 ENTRESTOR 用於兒童患者的安全性及療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENV01I":{"商品名稱":"EnVAX-A71 Vaccine 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ENV02I":{"商品名稱":"Envacgen Vaccine 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EPB01O":{"商品名稱":"Epbutol 400mg Tab#","腎功能不良劑量調整":"TB治療指引: 當Clcr<30時，Ethambutol不須改變劑量，但頻率改每週3次。病人如接受血液透析，透析當天的建議於透析後吃。\r<br>\r<br>熱病:\r<br>15-25mg\/kg q24h (MAX: 2500mg\/day)\r<br>[10~50ml\/min ]: Normal dose q24-36h\r<br>[<10 ]: Normal dose q48h.\r<br>HEMO:  Normal dose after dialysis","小兒建議劑量":"\"Infants and Children:Tuberculosis, active: (Note: Used as part of a multidrug regimen); treatment regimens consist of an initial 2-month phase, followed by a continuation phase of 4 or 7 additional months; frequency of dosing may differ depending on phase of therapy<br><br>\r<br>\r<br>HIV negative: 15-20 mg\/kg\/day once daily (maximum: 1 g\/day) or 50 mg\/kg\/dose twice weekly (maximum: 2.5 g\/dose) (MMWR, 2003)\r<br>\r<br>HIV-exposed\/-infected: 15-25 mg\/kg\/day once daily (maximum: 2.5 g\/day) (CDC, 2009)<br><br>\r<br>\r<br>MAC, secondary prophylaxis or treatment in HIV-exposed\/-infected: 15-25 mg\/kg\/day once daily (maximum: 2.5 g\/day) with clarithromycin (or azithromycin) with or without rifabutin (CDC, 2009)<br><br>\r<br>Nontuberculous mycobacterial infection: 15-25 mg\/kg\/day once daily (maximum: 2.5 g\/day)\"\r<br>","提示內容":"15-25mg\/kg q24h (MAX: 2500mg\/day); ClCr<30 ml\/min, 頻次改為TIW","抗生素手冊":"暫無資料"},"EPC01O":{"商品名稱":"Epclusa 400\/100mg Tab","腎功能不良劑量調整":"對輕度或中度腎功能不全的患者，不須調整劑量。目前尚未針對重度腎功能不全或患有須接受血液透析治療之末期腎病的患者評估過Epclusa的安全性與療效。","小兒建議劑量":"Epclusa 用於18 歲以下之兒童與青少年的安全性與療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EPH01I":{"商品名稱":"Ephedrine 40mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Children 0.5 mg\/kg IM\/SC or 16.7 mg\/m2 every 4-6 hr.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EPI01E":{"商品名稱":"Epirenin Solution 500ML","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling\r<br>","小兒建議劑量":"\"Dosing: Neonatal Cardiopulmonary resuscitation (Kattwinkel, 2010):<br>I.V.: 0.01-0.03 mg\/kg (0.1-0.3 mL\/kg of 1:10,000 solution) every 3-5 minutes as needed<br><br>\r<br>Endotracheal: Note: I.V. route preferred: E.T.: 0.05-0.1 mg\/kg (0.5-1 mL\/kg of 1:10,000 solution) ev\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EPI02E":{"商品名稱":"Epirenin Solution 1mg\/1ml","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling\r<br>","小兒建議劑量":"\"Dosing: Neonatal Cardiopulmonary resuscitation (Kattwinkel, 2010):<br>I.V.: 0.01-0.03 mg\/kg (0.1-0.3 mL\/kg of 1:10,000 solution) every 3-5 minutes as needed<br><br>\r<br>Endotracheal: Note: I.V. route preferred: E.T.: 0.05-0.1 mg\/kg (0.5-1 mL\/kg of 1:10,000 solution) ev\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EPI02I":{"商品名稱":"Epicin Inj 10mg Vial#","腎功能不良劑量調整":"中度腎臟損傷並不需要降低劑量，因為Epirubicin 以此途徑排除的量有限\r<br>The manufacturer's labeling recommends lower doses (dose not specified) in patients with severe renal impairment (serum creatinine >5 mg\/dL).","小兒建議劑量":"仿單及文獻未提及","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EPI03I":{"商品名稱":"EPICIN INJ 50mg Vial#","腎功能不良劑量調整":"中度腎臟損傷並不需要降低劑量，因為Epirubicin 以此途徑排除的量有限\r<br>The manufacturer's labeling recommends lower doses (dose not specified) in patients with severe renal impairment (serum creatinine >5 mg\/dL).","小兒建議劑量":"仿單及文獻未提及","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EQU01O":{"商品名稱":"Equfina 50mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ERA01I":{"商品名稱":"Eraxis 100mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"第一天 200 mg, 接著每天一次IV 100 mg, 使用至少4-6週\r<br>輸注速率, 建議為< 1.1 mg\/min,\r<br>→100mg 需>90min(1.5h), 200mg 需>180min(3hr)","抗生素手冊":"loading: 100 to 200 mg than 50 to 100 mg qd<br>flow rate: less 1.1 mg per min 因副作用<br>DDI: QTc prolongation"},"ERA01O":{"商品名稱":"Eraflu 75mg Cap (疾管署公費)","腎功能不良劑量調整":"仿單, 2017熱病].\r<br>CrCl >60 mL\/min: 不需調整, 75mg BID\r<br>CrCl >30 to 60: 30 mg BID\r<br>CrCl >10 to 30: 30 mg QD\r<br>CrCl<10 : 不建議使用，除非是洗腎後給予\r<br>例行性血液透析: 建議每次透析後投予一劑30mg","小兒建議劑量":"1歲或以上兒童服用Tamiflu建議劑量\r<br>≦15公斤    : 30mg BID \r<br>>15-23公斤: 45mg BID\r<br>>23-40公斤: 60mg BID\r<br>>40公斤      : 75mg BID\r<br>[註:院內只有膠囊劑型，尚無懸浮液劑型]\r<br>","提示內容":"用法為 1 tab BID for 5 days,\r<br>→注意開立天數可能有誤\r<br>\r<br>ClCr 30-60 mL\/min：30mg BID,\r<br>ClCr 10-30mL\/min：30mg QD\r<br>HD:洗腎後投與30mg\r<br>\r<br>小兒劑量：\r<br><= 15kg：30mg；> 15-23kg：45mg；> 23-40kg：60mg","抗生素手冊":"暫無資料"},"ERA02O":{"商品名稱":"Eraflu 75mg Cap (自費)","腎功能不良劑量調整":"仿單, 2017熱病].\r<br>CrCl >60 mL\/min: 不需調整, 75mg BID\r<br>CrCl >30 to 60: 30 mg BID\r<br>CrCl >10 to 30: 30 mg QD\r<br>CrCl<10 : 不建議使用，除非是洗腎後給予\r<br>例行性血液透析: 建議每次透析後投予一劑30mg","小兒建議劑量":"1歲或以上兒童服用Tamiflu建議劑量\r<br>≦15公斤    : 30mg BID \r<br>>15-23公斤: 45mg BID\r<br>>23-40公斤: 60mg BID\r<br>>40公斤      : 75mg BID\r<br>[註:院內只有膠囊劑型，尚無懸浮液劑型]\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ERB02I":{"商品名稱":"Erbitux 100mg\/20ml Vial#","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer’s labeling.\r<br>","小兒建議劑量":"\"用於年齡小於18歲之兒童患者的安全性和效益尚未確定。第一階<br>段試驗的報告中，並未出現新的兒童患者使用之安全性問題。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ERB03I":{"商品名稱":"Erbitux (恩慈) 100mg\/20ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ERG01O":{"商品名稱":"Ergometrine 0.2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ERI02O":{"商品名稱":"Erispan-S 0.25mg Tab#4","腎功能不良劑量調整":"查無資料","小兒建議劑量":"小兒用藥注意事項：\r<br>針對低體重新生兒、嬰幼兒以及孩童之安全性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ERL01O":{"商品名稱":"Erleada 60mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於兒童病人的安全性及有效性尚未確立。","提示內容":"1. 240mg\/day\r<br>2.應整顆吞服\r<br>3.有具生育能力之女性伴侶的男性病人，在治療期間及使用最後一劑後的3個月內，應採取有效的避孕措施。應囑咐男性病人，與孕婦進行性行為時應使用保險套\r<br>4.可能會減弱生育力，在治療期間及使用最後一劑後的3個月內不要捐精","抗生素手冊":"暫無資料"},"ERO01O":{"商品名稱":"Erythromycin 250mg Tab#(舊)","腎功能不良劑量調整":"supplemental dose is not necessary in hemo- or peritoneal dialysis or in continuous arteriovenous or venovenous hemofiltration\r<br>","小兒建議劑量":"\"12.5 公斤以下兒童每公斤<br>體重之 1 次量為 10mg，6 小時一次。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ERY03O":{"商品名稱":"Erythromycin 250mg Cap#","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer's labeling.","小兒建議劑量":"小兒: 一次以每公斤體重本劑 10mg(力價)之劑量，一天4次內服。","提示內容":"250 mg QD或BID用於長期治療以預防COPD之惡化(有免疫調節的作用)\r<br>\r<br>(週報2018\/03\/02發行)[非適應症使用]\r<br> 用於刺激胃排空用法用量250-500mg TIDAC以不超過四週為限，並注意是否有藥效漸減的狀況。","抗生素手冊":"建議量: 500 mg q6h<br>小兒; 10 mg per kg q6h<br>抑制 statins 代謝及 theophylline 排除<br>留意 DDI 誘發 TdP "},"ESI01O":{"商品名稱":"Esidri Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ESM01I":{"商品名稱":"Esmeron 50mg\/5ml Vial","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"小兒病人的劑量：氟烷麻醉下兒童(1-14歲)和嬰兒(1-12月)對本品的敏感性與成人相似。嬰兒和兒童的起效較成人快，臨床作用時間兒童較成人短。尚未見有資料足以推薦用於新生兒(0-1個月)。\r<br>老年病人、肝臟和\/或膽道疾病，和\/或腎衰病人的劑量 ： 氣管插管劑量為0.6 mg\/kg。無論採取何種麻醉方法，推薦用於這些病人的維持劑量均為0.075-0.1 mg\/kg，滴注速率為5-6ug\/kg\/分。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ESM02I":{"商品名稱":"Esmolol 100mg\/10ml Vial","腎功能不良劑量調整":"No dosage adjustment necessary. Not removed by hemo- or peritoneal dialysis. Supplemental dose is not necessary.\r<br>","小兒建議劑量":"本劑用於孩童之安全性及有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ESM03I":{"商品名稱":"Esmolol 10mg\/1ml","腎功能不良劑量調整":"No dosage adjustment necessary. Not removed by hemo- or peritoneal dialysis. Supplemental dose is not necessary.\r<br>","小兒建議劑量":"本劑用於孩童之安全性及有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EST03O":{"商品名稱":"Estracyt 140mg Cap#","腎功能不良劑量調整":"腎功能不全者須小心\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EST04O":{"商品名稱":"Estromon 0.625mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"急用零購藥品，具健保價格之Conjugated estrogen。","抗生素手冊":"暫無資料"},"ESV01E":{"商品名稱":"Esvatin Vag 0.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ESZ01O":{"商品名稱":"Eszo 2mg Tab #4","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling (has not been studied); use with caution\r<br>","小兒建議劑量":"本藥對乳兒、幼兒、小兒之安全性尚未建立\r<br>","提示內容":"Lendormin與Eszo屬於同一類藥物\r<br>同時開立可能導致病人成癮情況, 請會診精神科醫師","抗生素手冊":"暫無資料"},"ETO01I":{"商品名稱":"Etomidate-Lipuro 20mg\/10ml Amp","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"Children up to the age of 15 and elderly patients are given a single dose of 0.15 to 0.2 mg of etomidate, corresponding to 0.075 to 0.1 ml of Etomidte-Lipuro per kg bodyweight. Also in patients belonging to these age groups, the exact dosage has to be adjusted acc. to the clinical effect.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ETO02I":{"商品名稱":"Etomidate 20mg\/10ml Vial","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling.","小兒建議劑量":"Children up to the age of 15 and elderly patients are given a single dose of 0.15 to 0.2 mg of etomidate, corresponding to 0.075 to 0.1 ml of Etomidte per kg bodyweight. Also in patients belonging to these age groups, the exact dosage has to be adjusted acc. to the clinical effect.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ETU01O":{"商品名稱":"Etumine 40mg Tab","腎功能不良劑量調整":"嚴重腎功能不全病人在治療初期宜使用較低劑量並緩慢地增加劑量","小兒建議劑量":"暫無資料","提示內容":"成分Clotiapine，與Clozapine(本院商品名為Clopine及Zapine) 拼法相像\r<br>每日最高劑量360毫克","抗生素手冊":"暫無資料"},"EUC01O":{"商品名稱":"Euclidan 50mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EUR01O":{"商品名稱":"Eurodin  2mg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EUR02O":{"商品名稱":"Euricon 50mg Tab#","腎功能不良劑量調整":"一般常用的劑量為每日 50 mg，最大劑量為每日 100 mg，\r<br>CCr <20 mL\/min 時，因缺乏效果宜避免使用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EVA01E":{"商品名稱":"Evac Enema","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EVE01I":{"商品名稱":"Evenity 105mg\/1.17ml; 2vial\/Box#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未確立兒科病人的安全性及有效性。","提示內容":"1.一盒有兩支，一支含105mg。一次使用量為210mg (兩支)，本品是以盒為發出單位，總量為1表示1盒(兩支)，同仁勿拆盒取藥。\r<br>2. SC 210mg於腹部、大腿或上臂。每個月施打一次\r<br>3. 治療時間不應超過12個月\r<br>4.過去一年曾發生心肌梗塞或中風的病人，不可使用","抗生素手冊":"暫無資料"},"EVI01O":{"商品名稱":"Evista 60mg Tab#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EVO01O":{"商品名稱":"Evoxac 30mg Cap#","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer’s labeling.\r<br>","小兒建議劑量":"兒童病患的安全性與有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EVU01I":{"商品名稱":"Evusheld 150mg\/1.5ml 2Vial\/Box (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"12歲以上且體重大於40公斤者同成人劑量。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EVU02I":{"商品名稱":"Evusheld 2Vial\/Box (無健保非本國)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXD01S":{"商品名稱":"Exdila Liquid 5mcg\/mL;60mL Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"<6yr: 0.25ml\/kg bid-tid; >6yr: 5ml QD-bid; \r<br>成人: 10ml QD-BID\r<br>----------------------------------------------------------\r<br>0.025 to 0.05 mg twice daily (5-10ml)\r<br>----------------------------------------------------------\r<br>簡易換算: <6 y\/o: (BW\/4)c.c. bid.\r<br>                  >6 y\/o: 5c.c. bid","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXE01E":{"商品名稱":"Exelderm Cream 10gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXE02E":{"商品名稱":"Exelderm Solution 1% 10ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXE03E":{"商品名稱":"Exelon Patch 4.6mg\/24hrs#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"不建議兒童服用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXE03O":{"商品名稱":"Exelon 1.5mg Cap#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"不建議兒童服用\r<br>","提示內容":"(週報2018\/03\/23 發行)\r<br>病人中止服Rivastigmine數天後，若想重新服藥，應從最低1.5mg 開始調整，每隔兩週逐漸增加到中止藥物前有良好耐受性的劑量","抗生素手冊":"暫無資料"},"EXE04O":{"商品名稱":"Exelon 3mg Cap#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用","小兒建議劑量":"不建議兒童服用","提示內容":"(週報2018\/03\/23 發行)\r<br>病人中止服Rivastigmine數天後，若想重新服藥，應從最低1.5mg 開始調整，每隔兩週逐漸增加到中止藥物前有良好耐受性的劑量","抗生素手冊":"暫無資料"},"EXE05O":{"商品名稱":"EXELON 4.5mg Cap#","腎功能不良劑量調整":"原則上不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用","小兒建議劑量":"不建議兒童服用","提示內容":"(週報2018\/03\/23 發行)\r<br>病人中止服Rivastigmine數天後，若想重新服藥，應從最低1.6mg 開始調整，每隔兩週逐漸增加到中止藥物前有良好耐受性的劑量","抗生素手冊":"暫無資料"},"EXF01O":{"商品名稱":"Exforge(二合一) 5\/80mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"複方成分, 注意處方是否有重複使用同類藥品\r<br>注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"EXM01O":{"商品名稱":"Exmem 10mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 5-20 mg\/day\r<br>[5-29]: 5mg bid\r<br>[HEMO ]:  Not recommended","小兒建議劑量":"Memantine 用於兒童和青少年之安全性及有效\r<br>性尚未被建立。(仿單)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXT01E":{"商品名稱":"Extracomb Cream 6gm","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"患部清理乾淨後，每日2~3次，適量均勻塗抹。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXT02I":{"商品名稱":"Extraneal PD Soln 2000mL Bag#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EXT03I":{"商品名稱":"Extraneal PD Soln 2000ml Ultrabag#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EYB01E":{"商品名稱":"Eybelis 0.002% 2.5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於兒童及青少年的安全性及療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EYL01I":{"商品名稱":"Eylea 2mg\/0.05mL Vial#","腎功能不良劑量調整":"無針對Eylea用於腎功能不全\/肝功能不全患者，進行過特定的試驗。\r<br>可用資料並未顯示這些病患需要調整劑量","小兒建議劑量":"尚未確立EYLEA使用於兒童及青少年的安全性及療效。無Eylea使用於兒童的溼性AMD適應症之相關使用經驗","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EYL02I":{"商品名稱":"Eylea (恩慈) 2mg\/0.05mL Vial","腎功能不良劑量調整":"無針對Eylea用於腎功能不全\/肝功能不全患者，進行過特定的試驗。\r<br>可用資料並未顯示這些病患需要調整劑量","小兒建議劑量":"尚未確立EYLEA使用於兒童及青少年的安全性及療效。無Eylea使用於兒童的溼性AMD適應症之相關使用經驗","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"EZE01O":{"商品名稱":"Ezetrol 10mg Tab#","腎功能不良劑量調整":"腎功能受損的病人不需要調整劑量。\r<br>","小兒建議劑量":"兒童、青少年(10至18歲)及成人間對於ezetimibe的吸收和代謝情形類似。由ezetimibe總濃度來看，青少年以及成人之間並無藥動學上的差異。目前並無小於十歲之兒童族群的藥動學資料。\r<br>","提示內容":"成分與Vytorin重複, 需注意","抗生素手冊":"暫無資料"},"FAB01I":{"商品名稱":"Fabrazyme 35mg Vial","腎功能不良劑量調整":"腎功能不足患者不需要調整劑量。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FAD01I":{"商品名稱":"Fadin 20mg Vial#","腎功能不良劑量調整":"[3]↓ dose or ↑ interval to q36-48h \r<br>(to limit potential CNS adverse effects).\r<br>[Clcr>50 ml\/min]: 20-40 mg qhs\r<br>[10~50]:  10~50%\r<br>[<10 ]: 10%\r<br>HEMO: Dose after dialysis","小兒建議劑量":"Should not be given to children\r<br>","提示內容":"一般劑量:20 mg Q12H; ClCr<50 mL\/min:劑量減半或給藥間隔延長(Q36-48H)","抗生素手冊":"暫無資料"},"FAD01O":{"商品名稱":"Fadin 20mg Tab","腎功能不良劑量調整":"↓ dose or ↑ interval to q36-48h (to limit potential CNS adverse effects).\r<br>[Clcr >50 ml\/min]: 20-40 mg qhs\r<br>[50~10]:  50-10%\r<br>[<10 ]: 10% (10mg QD或20mg QOD)\r<br>HEMO: Dose after dialysis","小兒建議劑量":"小兒使用的安全性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FAK01E":{"商品名稱":"Faktu Suppository","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FAM01O":{"商品名稱":"Famo 20mg Tab#","腎功能不良劑量調整":"↓ dose or ↑ interval to q36-48h (to limit potential CNS adverse effects).\r<br>[Clcr >50 ml\/min]: 20-40 mg qhs\r<br>[50~10]:  50-10%\r<br>[<10 ]: 10% (10mg QD或20mg QOD)\r<br>HEMO: Dose after dialysis","小兒建議劑量":"小兒使用的安全性尚未建立\r<br>","提示內容":"一般劑量:20 mg Q12H; ClCr<50 mL\/min:劑量減半或給藥間隔延長(Q36-48H)","抗生素手冊":"暫無資料"},"FAM02O":{"商品名稱":"Famvir 250mg Tab","腎功能不良劑量調整":"Herpes Zoster:(其它適應症請查文獻)\r<br>(Adults)Usual Dosing:500mg po q8h x 7 days.\r<br>[Clcr 40-59 ml\/min] : 500mg q12h.\r<br>[20-39 ml\/min]: 500mg q24h.  \r<br>[<20 ml\/min]: 250mg q24h. \r<br>HEMO:  125mg after each dialysis.","小兒建議劑量":"對兒童之安全性與療效方面的資料,目前尚不足夠,因此,不建議用於兒童。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FAS01I":{"商品名稱":"Faslodex 250mg\/5ml Syringe","腎功能不良劑量調整":"對於有輕度至中度腎功能不全的患者(肌酸酐清除率≧ 30 ml\/min)無須調整劑量。對有重度腎功能不全的患者(肌酸酐清除率<30 ml\/min)使用本藥的安全性和有效性尚未被評估，因此用於這些患者時應小心謹慎(見警語及使用特別注意事項)。 \r<br>","小兒建議劑量":"FASLODEX 不建議兒童或青少年使用，因為用於這個年齡層的安全性和療效尚未確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FAS02I":{"商品名稱":"Faslodex (恩慈) 250mg\/5ml Syringe","腎功能不良劑量調整":"對於有輕度至中度腎功能不全的患者(肌酸酐清除率≧ 30 ml\/min)無須調整劑量。對有重度腎功能不全的患者(肌酸酐清除率<30 ml\/min)使用本藥的安全性和有效性尚未被評估，因此用於這些患者時應小心謹慎(見警語及使用特別注意事項)。 \r<br>","小兒建議劑量":"FASLODEX 不建議兒童或青少年使用，因為用於這個年齡層的安全性和療效尚未確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FAS03I":{"商品名稱":"Fasturtec 1.5mg\/1ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"每天的建議劑量為每公斤體重 0.2 毫克。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FAS04I":{"商品名稱":"Fasenra 30mg\/1ml Syringe","腎功能不良劑量調整":"無需調整劑量。","小兒建議劑量":"尚未確立5~18歲患者安全性及療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FDG01I":{"商品名稱":"18F-FDG (1-12mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FDG02I":{"商品名稱":"18F-FDG 350mCi Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEB01O":{"商品名稱":"Feburic FC 80mg Tab#","腎功能不良劑量調整":"Febuxostat對於\r<br>輕至中度腎功能不全的患者毋須調整劑量;\r<br>\r<br>嚴重腎功能不全(Clcr 15-29 ml\/min):限40mg QD\r<br>\r<br>對於嚴重末期腎功能不全病人(Clcr <15 )之安全性及有效性尚未確立。\r<br>","小兒建議劑量":"尚未確立用於兒童病患的安全性和有效性\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEB02I":{"商品名稱":"Fe-Back 40mg\/2ml Amp","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"以體重的7%估計為全血量下去計算\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEB02O":{"商品名稱":"Febuton FC 80mg Tab","腎功能不良劑量調整":"Febuxostat對於\r<br>輕至中度腎功能不全的患者毋須調整劑量;\r<br>\r<br>嚴重腎功能不全(Clcr 15-29 ml\/min):限40mg QD\r<br>\r<br>對於嚴重末期腎功能不全病人(Clcr <15 )之安全性及有效性尚未確立。\r<br>","小兒建議劑量":"尚未確立用於兒童病患的安全性和有效性","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEL02O":{"商品名稱":"Felpin ER 5mg Tab","腎功能不良劑量調整":"No dosage adjustment necessary\r<br>","小兒建議劑量":"用於孩童治療之經驗有限。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEM01O":{"商品名稱":"Femara 2.5mg Tab#","腎功能不良劑量調整":"正常or嚴重腎功能不良病人須在監測下使用\r<br>","小兒建議劑量":"兒童不宜使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEN01E":{"商品名稱":"Fentanyl Patch 25mcg\/h(NBCD) #2","腎功能不良劑量調整":"\"Transdermal (patch): Degree of impairment (ie, CrCl) not defined in manufacturer's labeling.<br>Mild-to-moderate impairment: Initial: Reduce dose by 50%.<br>Severe impairment: Use not recommended.\"\r<br>","小兒建議劑量":"Chronic pain, moderate to severe: Transdermal patch: Children >=2 years who are opioid-tolerant receiving at least 60 mg oral morphine equivalents per day: Initial: 25 mcg\/hour system or higher, based on conversion to fentanyl equivalents and administration of equianalgesic dosage (see package insert for further information); use short-acting analgesics for first 24 hours with supplemental PRN doses thereafter (for breakthrough pain); dose may be increased after 3 days, based on the daily dose of supplementary PRN opioids required; use the ratio of 45 mg of oral morphine equivalents per day to a 12.5 mcg\/hour increase in transdermal patch dosage; change patch every 72 hours; Note: Dosing intervals less than every 72 hours are not recommended for children and adolescents. Initiation of the transdermal patch in children taking <60 mg of oral morphine equivalents per day has not been studied in controlled clinical trials; in open-label trials, children 2-18 years of age who were receiving at least 45 mg of oral morphine equivalents per day were started with an initial transdermal dose of 25 mcg\/hour (or higher, depending upon equianalgesic dose of opioid received).\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEN01I":{"商品名稱":"Fentanyl 0.5mg\/10ml Amp #2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEN02E":{"商品名稱":"FENTANYL TTS 50mcg\/h #2","腎功能不良劑量調整":"\"Transdermal (patch): Degree of impairment (ie, CrCl) not defined in manufacturer's labeling.<br>Mild-to-moderate impairment: Initial: Reduce dose by 50%.<br>Severe impairment: Use not recommended.\"\r<br>","小兒建議劑量":"Chronic pain, moderate to severe: Transdermal patch: Children>=2 years who are opioid-tolerant receiving at least 60 mg oral morphine equivalents per day: Initial: 25 mcg\/hour system or higher, based on conversion to fentanyl equivalents and administration of equianalgesic dosage (see package insert for further information); use short-acting analgesics for first 24 hours with supplemental PRN doses thereafter (for breakthrough pain); dose may be increased after 3 days, based on the daily dose of supplementary PRN opioids required; use the ratio of 45 mg of oral morphine equivalents per day to a 12.5 mcg\/hour increase in transdermal patch dosage; change patch every 72 hours; Note: Dosing intervals less than every 72 hours are not recommended for children and adolescents. Initiation of the transdermal patch in children taking <60 mg of oral morphine equivalents per day has not been studied in controlled clinical trials; in open-label trials, children 2-18 years of age who were receiving at least 45 mg of oral morphine equivalents per day were started with an initial transdermal dose of 25 mcg\/hour (or higher, depending upon equianalgesic dose of opioid received).\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEN03I":{"商品名稱":"Fentanyl 0.05mg\/1ml #2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEN06I":{"商品名稱":"Fentanyl (PPCD) 0.1mg\/2ml Amp #2","腎功能不良劑量調整":"decrease dose in patients with hepatic and\/or renal disease\r<br>","小兒建議劑量":"對於介於2-12歲兒童的麻醉引導及維持時劑量應降低至2-3ug\/kg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FEN07I":{"商品名稱":"Fentanyl (PPCD) 0.05mg\/1ml #2","腎功能不良劑量調整":"decrease dose in patients with hepatic and\/or renal disease\r<br>","小兒建議劑量":"對於介於2-12歲兒童的麻醉引導及維持時劑量應降低至2-3ug\/kg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FER01I":{"商品名稱":"Feronsure 3MIU\/0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FER02O":{"商品名稱":"Ferrin Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"複方貧血用藥(內含Iron (polysaccharide complex) 150mg 、Folic acid 1mg、Cyanocobalamin 0.025mg)\r<br>1 tab QD","抗生素手冊":"暫無資料"},"FER03O":{"商品名稱":"Ferrum Hausmann 100mg Chewable Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FIL01I":{"商品名稱":"Filgrastim 75mcg\/0.3ml Amp (G-CSF)#","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer's labeling.\r<br>","小兒建議劑量":"\"對兒童之投與：\r<br><br>(1) 對早產兒、新生兒、嬰兒投與的安全性尚未確立﹐所以不推薦投與（使用經驗少）。 <br>\r<br>(2) 對兒童的投與應注意觀察﹐謹慎使用。特別是對動員周邊血幹細胞捐贈者的使用經驗少。本劑的投與需考慮捐贈者的全身狀態﹐細心觀察謹慎投與。 <br>Note: Do not administer in the period 24 hours before to 24 hours after cytotoxic chemotherapy.<br>[Myelosuppressive chemotherapy recipients with nonmyeloid malignancies (Neupogen)]: SubQ, I.V.: 5 mcg\/kg\/day; doses may be increased by 5 mcg\/kg (for each chemotherapy cycle) according to the duration and severity of the neutropenia; continue for up to 14 days until the ANC reaches 10,000\/mm3. Discontinue if the ANC surpasses 10,000\/mm3 after the expected chemotherapy-induced neutrophil nadir. In clinical studies, efficacy was observed at doses of 4-8 mcg\/kg\/day.<br>[Bone marrow transplantation (Neupogen)]: SubQ, I.V.: 10 mcg\/kg\/day (administer >=24 hours after chemotherapy and >=24 hours after bone marrow infusion); adjust the dose according to the duration and severity of neutropenia; recommended steps based on neutrophil response:<br>When ANC >1000\/mm3 for 3 consecutive days: Reduce filgrastim dose to 5 mcg\/kg\/day<br>If ANC remains >1000\/mm3 for 3 more consecutive days: Discontinue filgrastim<br>If ANC decreases to <1000\/mm3: Resume at 5 mcg\/kg\/day<br>If ANC decreases to <1000\/mm3 during the 5 mcg\/kg\/day dose, increase filgrastim to 10 mcg\/kg\/day and follow the above steps<br>[Peripheral blood progenitor cell collection and therapy (Neupogen)]: SubQ: 10 mcg\/kg daily, usually for 6-7 days. Begin at least 4 days before the first apheresis and continue until the last apheresis; consider dose adjustment for WBC >100,000\/mm3<br>[Severe chronic neutropenia (Neupogen)]: Infants >=1 month, Children, and Adolescents: SubQ:<br>[Congenital]: Initial: 6 mcg\/kg twice daily; adjust the dose based on ANC and clinical response; mean dose: 6 mcg\/kg\/day<br>[Idiopathic]: Initial: 5 mcg\/kg\/day; adjust the dose based on ANC and clinical response; mean dose: 1.2 mcg\/kg\/day<br>[Cyclic]: Initial: 5 mcg\/kg\/day; adjust the dose based on ANC and clinical response; mean dose: 2.1 mcg\/kg\/day<br>[Treatment of radiation-induced myelosuppression of the bone marrow (unlabeled use)]: SubQ: 5 mcg\/kg\/day; continue until ANC >1000\/mm3 (Smith, 2006; Waselenko, 2004).<br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FIL02I":{"商品名稱":"FILGRASTIM 300mcg\/0.7ml Amp (G-CSF)#","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer's labeling.\r<br>","小兒建議劑量":"\"對兒童之投與：\r<br><br>(1) 對早產兒、新生兒、嬰兒投與的安全性尚未確立﹐所以不推薦投與（使用經驗少）。 \r<br><br>(2) 對兒童的投與應注意觀察﹐謹慎使用。特別是對動員周邊血幹細胞捐贈者的使用經驗少。本劑的投與需考慮捐贈者的全身狀態﹐細心觀察謹慎投與。 <br>Note: Do not administer in the period 24 hours before to 24 hours after cytotoxic chemotherapy.<br>[Myelosuppressive chemotherapy recipients with nonmyeloid malignancies (Neupogen)]: SubQ, I.V.: 5 mcg\/kg\/day; doses may be increased by 5 mcg\/kg (for each chemotherapy cycle) according to the duration and severity of the neutropenia; continue for up to 14 days until the ANC reaches 10,000\/mm3. Discontinue if the ANC surpasses 10,000\/mm3 after the expected chemotherapy-induced neutrophil nadir. In clinical studies, efficacy was observed at doses of 4-8 mcg\/kg\/day.<br>[Bone marrow transplantation (Neupogen)]: SubQ, I.V.: 10 mcg\/kg\/day (administer >=24 hours after chemotherapy and >=24 hours after bone marrow infusion); adjust the dose according to the duration and severity of neutropenia; recommended steps based on neutrophil response:<br>When ANC >1000\/mm3 for 3 consecutive days: Reduce filgrastim dose to 5 mcg\/kg\/day<br>If ANC remains >1000\/mm3 for 3 more consecutive days: Discontinue filgrastim<br>If ANC decreases to <1000\/mm3: Resume at 5 mcg\/kg\/day<br>If ANC decreases to <1000\/mm3 during the 5 mcg\/kg\/day dose, increase filgrastim to 10 mcg\/kg\/day and follow the above steps<br>[Peripheral blood progenitor cell collection and therapy (Neupogen)]: SubQ: 10 mcg\/kg daily, usually for 6-7 days. Begin at least 4 days before the first apheresis and continue until the last apheresis; consider dose adjustment for WBC >100,000\/mm3<br>[Severe chronic neutropenia (Neupogen)]: Infants ?1 month, Children, and Adolescents: SubQ:<br>[Congenital]: Initial: 6 mcg\/kg twice daily; adjust the dose based on ANC and clinical response; mean dose: 6 mcg\/kg\/day<br>[Idiopathic]: Initial: 5 mcg\/kg\/day; adjust the dose based on ANC and clinical response; mean dose: 1.2 mcg\/kg\/day<br>[Cyclic]: Initial: 5 mcg\/kg\/day; adjust the dose based on ANC and clinical response; mean dose: 2.1 mcg\/kg\/day<br>[Treatment of radiation-induced myelosuppression of the bone marrow (unlabeled use)]: SubQ: 5 mcg\/kg\/day; continue until ANC >1000\/mm3 (Smith, 2006; Waselenko, 2004).<br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FIN01I":{"商品名稱":"Finibax 0.25gm Vial#","腎功能不良劑量調整":"CrCl  >50 ml\/min : 500mg IV q8h\r<br>CrCl 50~30 : 250mg IV q8h\r<br>CrCl 10~30 : 250mg IV q12h\r<br>CrCl <10 and HEMO: No data","小兒建議劑量":"暫無資料","提示內容":"依臨床使用抗生素手冊第五版建議：在懷疑Pseudomonas aeruginosa 與 Acinetobacter baumannii感染時可使用1000mg Q8H(常用：500mg Q8H)，腎功能劑量調整以調整頻次為主","抗生素手冊":"建議量: 500 mg q8h<br>P aeruginosa and  A baumannii 需要 1 gm q8h<br> Ccr less than 50: 半劑量 q8h<br>Ccr less than 30: 半劑量 q12h<br>Ccr less than 10, HD or PD: 半劑量 qd"},"FIR01I":{"商品名稱":"Firmagon 80mg\/4ml Inj Vial","腎功能不良劑量調整":"對於老年人、輕度至中度的肝或腎功能不全病眷，無需調整劑量。\r<br>對於嚴重肝或腎功能不全的病人，建議審慎使用，因為無相關研究。","小兒建議劑量":"本品無相關適應症用於兒童和青少年。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLA01O":{"商品名稱":"Flagyl 250mg Tab","腎功能不良劑量調整":"usual dose:500 mg po\/IV q6-8h\r<br>[Clcr <10 ml\/min]:  500mg q12h.  \r<br>HEMO: 500mg q8-12h (usually q12h)\r<br>CRRT: Dose as for normal renal function.","小兒建議劑量":"安全性和有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLE02I":{"商品名稱":"Flexbumin 25% 50mL Bag","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; use with caution.","小兒建議劑量":"兒童與青少年(0-18歲)之劑量應視患者個體之需求調整。<br>Note: 5% should be used in hypovolemic patients or intravascularly-depleted patients. 25% should be used in patients in whom fluid and sodium intake must be minimized.<br>- Hypovolemia: I.V.: 0.5-1 g\/kg\/dose (10-20 mL\/kg\/dose of albumin 5%); maximum dose: 6 g\/kg\/day\"","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLI03E":{"商品名稱":"Flixotide Evohaler 50mcg\/d;120d","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- 大於4歲的兒童：50-250 mcg bid; 起始劑量50或100 mcg bid<br>- 1歲以上至4歲的兒童：50至100 mcg bidd; 起始劑量50或100 mcg bid\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLO01O":{"商品名稱":"Florinef 0.1mg Tab","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling; use with caution.\r<br>","小兒建議劑量":"\"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (Endocrine Society guidelines): Oral: Infants, Children, and Adolescents: 0.05-0.2 mg daily in 1-2 divided doses in combination with sodium chloride supplementation (Speiser, 2010)<br>\r<br>由於corticosteroid可抑制生長，因此應密切觀察接受corticosteroid長期治療之嬰兒、兒童與青少年<br>的生長及發育狀況。若出現水痘、麻疹或其他傳染性疾病，應小心使用。接受Florinef治療的兒童不應該接受疫苗接種。Corticosteroid也可能會影響內生性類固醇的分泌。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLO02O":{"商品名稱":"Floxsafe 400mg Tab (公費)","腎功能不良劑量調整":"不用調整","小兒建議劑量":"並未有小兒族群使用 moxifloxacin 藥物動力學的研究\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU01I":{"商品名稱":"Fludara Lyophilized 50mg\/2ml Vial#","腎功能不良劑量調整":"腎功能降低的病患應調整其使用劑量。\r<br>creatinine clearance)介於30與70 ml\/min 之間時，應降低劑量，最多可降到50%，且須仔細監控血液變化以測已知毒性。\r<br>Clcr <30: 不建議使用","小兒建議劑量":"因安全性與有效性尚未確立，本品不建議使用在小於18 歲的兒童病例。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU01O":{"商品名稱":"Flupine 0.25mg Tab#4","腎功能不良劑量調整":"仿單說明: 於腎功能障礙需謹慎投與。","小兒建議劑量":"對於小兒其安全性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU02E":{"商品名稱":"Flucason 0.02% 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU02O":{"商品名稱":"Flusine 500mg Tab","腎功能不良劑量調整":"Adults \r<br>CrCl >50 : 37.5 mg\/kg Q12H\r<br>CrCl 10-50 and CRRT : 37.5 mg\/kg Q12-24H\r<br>CrCl <10 : 37.5 mg\/kg Q24-48H, but monitor drug concentrations frequently\r<br>H\/D: Dialyzable (50% to 100%); administer dose post H\/D\r<br>PD: 0.5-1 g every 24 hours","小兒建議劑量":"另有兒童劑量。nfants, Children, and Adolescents:\r<br>General dosing, susceptible infections: Oral: 50-150 mg\/kg\/day in divided doses Q6H","提示內容":"暫無資料","抗生素手冊":"建議量: 25 mg per kg q6h<br>Ccr less than 40: q12h<br>Ccr less than 20: qd<br>Ccr less than 10, HD or PD: qod<br>罕單用經肝臟排泄<br>SE: 骨髓抑制<br>禁忌: 孕婦"},"FLU03E":{"商品名稱":"FLUCASON 0.1% 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU03O":{"商品名稱":"Fluitran 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"注意服用thiazide類可能有低血鉀, 高尿酸血症的發生","抗生素手冊":"暫無資料"},"FLU04O":{"商品名稱":"Fluzine 5mg Tab","腎功能不良劑量調整":" There are no dosage adjustments provided in manufacturer's labeling. Drug accumulation does not appear to be likely as flunarizine primarily undergoes hepatic metabolism and minimal urinary excretion.\r<br>","小兒建議劑量":"Migraine: The recommended dose in children weighing less than 40 kilograms is 5 milligrams orally daily as a single dose.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU05I":{"商品名稱":"Fluanxol Depot 20mg\/1ml Amp","腎功能不良劑量調整":"腎功能受損者，可以一般劑量投與。\r<br>","小兒建議劑量":"因缺乏臨床經驗，不建議使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU05O":{"商品名稱":"Fluanxol FC 3mg Tab","腎功能不良劑量調整":"腎功能受損者，可以一般劑量投與。\r<br>","小兒建議劑量":"因缺乏臨床經驗，不建議使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU06O":{"商品名稱":"Fluene 50mg Cap#","腎功能不良劑量調整":"[CRCL >50 ]: 200-400mg QD, No change. \r<br>[<50 ml\/min, no HD]: 50%   \r<br>HEMO: 200-400mg QD, after H\/D","小兒建議劑量":"16歲以下孩童不建議使用本劑，若必需使用時，劑量為：一歲以上且腎功能正常1-2 mg\/kg\/day(表皮) 3-6 mg\/kg\/day(全身)，腎功能不全者則依情形減量。\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 200 to 800 mg daily<br>Ccr less than 50: 劑量減半<br>Ccr less 25: 四分之一劑量<br>HD:  洗完正常量"},"FLU07I":{"商品名稱":"Fluorescite Inj 10% 5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU08O":{"商品名稱":"Flucil Granule 200mg\/5gm Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU09O":{"商品名稱":"Fluoxetine 20mg Cap (CYH)","腎功能不良劑量調整":"減少劑量，但沒有文獻明確指出減少的劑量或用法。","小兒建議劑量":"抑鬱症：每日10-20mg，若體重較輕建議從10mg開始，1週後調整至20mg。\r<br>強迫症：7歲以上每日10mg，2週後可往上調整至20mg，數週後可調整至30mg，若體重較重可以增加到60mg。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU11I":{"商品名稱":"Flumarin 1gm Vial#","腎功能不良劑量調整":"[>90 ml\/min]:1g Q6H\/2g Q12H\r<br>[50-90]: 1g Q8H\r<br>[10-50]:  1g Q12H\r<br>[<10]:  1g QD\r<br>HEMO: 1g after H\/D, (廠商提供)","小兒建議劑量":"通常小兒劑量以 1 日每公斤 60~80mg(力價)計算，分三~四次以靜脈注射或點滴靜注投與。 通常早產兒、新生兒以一次每公斤 20mg(力價)在出生三天內一日 2~3 次，出生四天後一日 3~4 次以靜脈注射或點滴靜脈注射投與。早產兒、新生兒、小兒可增量到 1 日 150mg(力價)\/kg，分三~四次投與。 \r<br>","提示內容":"暫無資料","抗生素手冊":"建議量:  2 g to 2 gm q6h<br>2.5gen or 3rd cephas for ESBL<br>Ccr less than 50: 1 gm q12h<br>Ccr less 25 or HD: 1 g qd"},"FLU11O":{"商品名稱":"Flucozyd 200mg Cap","腎功能不良劑量調整":"[CRCL >50 ]: 200-400mg QD, No change. \r<br>[<50 ml\/min, no HD]: 50%   \r<br>HEMO: 200-400mg QD, after H\/D","小兒建議劑量":"16歲以下孩童不建議使用本劑，若必需使用時，劑量為：一歲以上且腎功能正常1-2 mg\/kg\/day(表皮) 3-6 mg\/kg\/day(全身)，腎功能不全者則依情形減量。","提示內容":"暫無資料","抗生素手冊":"建議量: 200 to 800 mg daily<br>Ccr less than 50: 劑量減半<br>Ccr less 25: 四分之一劑量<br>HD:  洗完正常量"},"FLU17I":{"商品名稱":"Fluarix Tetra 0.5ml (自費)","腎功能不良劑量調整":"仿單無記載","小兒建議劑量":"六個月至未滿9歲且先前未曾接種流感疫苗的兒童，應於間隔至少4週後接種第二劑0.5ml。\r<br>目前尚未建立使用於未滿六個月孩童的安全性與有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU18I":{"商品名稱":"Flucelvax Quad (公費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童\r<br>年齡3歲以上的兒童：0.5毫升一劑。\r<br>年齡介於3-8歲歲且先前未曾接種過流感疫苗的兒童，應至少間隔4 週後再接種第2 劑疫苗0.5毫升。\r<br>年齡小於3歲的兒童：Flucelvax quad的安全性及療效資料尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU19I":{"商品名稱":"Flucelvax Quad (自費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童\r<br>年齡3歲以上的兒童：0.5毫升一劑。\r<br>年齡介於3-8歲歲且先前未曾接種過流感疫苗的兒童，應至少間隔4 週後再接種第2 劑疫苗0.5毫升。\r<br>年齡小於3歲的兒童：Flucelvax quad的安全性及療效資料尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU20I":{"商品名稱":"Flucelvax Quad 0.5ml (企業)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU22I":{"商品名稱":"Fluad Tetra (自費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FLU23I":{"商品名稱":"Flucelvax Quad (員工) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FOL01I":{"商品名稱":"Folsmycin powder for injection#","腎功能不良劑量調整":"Clcr <40 ml\/min者，建議調整劑量為每日劑量之20-70%\r<br>Clcr < 40: 70%\r<br>Clcr <30 : 60%\r<br>Clcr <20 : 40%\r<br>Clcr <10 : 20%\r<br>HD: 應於透析後給予2g fosfomycin","小兒建議劑量":"靜脈點滴注射:兒童每日每公斤體重100-200 mg (potency)分2次，溶於100-500 mL之稀釋液中，靜脈點滴注射1-2 小時。<br>\r<br>","提示內容":"暫無資料","抗生素手冊":"仿單: 2 to 4 gm daily dosage<br>小兒: 100 to 200 mg per kg daily dosage<br>Ccr less than 30: 60%"},"FOL01O":{"商品名稱":"Folic Acid 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"- Anemia: Oral, I.M., I.V., SubQ:\r<br>Infants: 0.1 mg\/day\r<br>Children <4 years: Up to 0.3 mg\/day\r<br>Children >4 years and Adults: Refer to adult dosing.\r<br>- Adequate intake (AI) (IOM, 1998): Expressed as folate equivalents: Oral: Infants:\r<br>1-6 months: 65 mcg\/day\r<br>7-12 months: 80 mcg\/day\r<br>- Recommended daily allowance (RDA) (IOM, 1998): Expressed as dietary folate equivalents: Oral: Children:\r<br>1-3 years: 150 mcg\/day\r<br>4-8 years: 200 mcg\/day\r<br>9-13 years: 300 mcg\/day\r<br>>=14 years: Refer to adult dosing.","提示內容":"使用MTX治療RA建議每週至少使用5 mg 的葉酸\r<br>→以減少相關不良反應(避免在MTX治療日投與)","抗生素手冊":"暫無資料"},"FOL02O":{"商品名稱":"Folina 15mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\" Folic acid antagonist (eg, trimethoprim, pyrimethamine) overdose: Refer to adult dosing.<br>\r<br>- Folate-deficient megaloblastic anemia: Refer to adult dosing.<br>\r<br>- High-dose methotrexate-rescue: Refer to adult dosing.<br>- Cofactor therapy in methanol toxicity (unlabeled use): Refer to adult dosing.<br>\r<br>- Prevention of pyrimethamine hematologic toxicity in HIV-positive patients (unlabeled uses; CDC, 2009): Infants and Children >1 month of age: Note: Leucovorin should continue for 1 week after pyrimethamine is discontinued.<br> Toxoplasmosis (Toxoplasma gondii):<br> Primary prophylaxis: Oral: 5 mg once every 3 days (in combination with pyrimethamine [with either dapsone or atovaquone])<br> \r<br>Secondary prophylaxis: Oral: 5 mg once every 3 days (in combination with pyrimethamine [with either sulfadiazine, atovaquone, or clindamycin])<br> \r<br>Treatment (congenital): Oral or I.M.: 10 mg with every pyrimethamine dose (in combination with either sulfadiazine or clindamycin); treatment duration: 12 months<br> \r<br>Treatment (acquired): Oral: Acute induction: 10-25 mg once daily (in combination with pyrimethamine [with either sulfadiazine, clindamycin, or atovaquone]) for >=6 weeks\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FOL03I":{"商品名稱":"Folina Injection 50mg\/5ml Vial","腎功能不良劑量調整":"當MTX的排泄不足則會導致累積而增加MTX毒性的危險; 即使少量MTX也可能導致嚴重的骨髓抑制和黏膜炎。因此須增加Leucovorin劑量或延長治療的時間時，也須小心偵側MTX的濃度。 There are no dosage adjustments provided in the manufacturer’s labeling.","小兒建議劑量":"Folic acid antagonist (eg, trimethoprim, pyrimethamine) overdose、Folate-deficient megaloblastic anemia、High-dose methotrexate-rescue、Cofactor therapy in methanol toxicity (off-label use): Refer to adult dosing.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FON01O":{"商品名稱":"Fonosil 10mg Tab#","腎功能不良劑量調整":"因為FOSINOPRIL有雙重排除途徑，所以對腎或肝功能損壞的病患一般不需降低劑量。\r<br>","小兒建議劑量":"Hypertension: Children >=6 years and Adolescents >50 kg: Oral: Initial: 5 to 10 mg once daily (maximum: 40 mg once daily)\r<br>","提示內容":"注意病人是否有高血鉀的症狀\r<br>與Neprilysin inhibitor (如Entresto)不可併用，如需轉換需間隔至少36小時，否則有引發血管性水腫的風險。","抗生素手冊":"暫無資料"},"FOR01I":{"商品名稱":"Forteo Inj 28d\/2.4ml#","腎功能不良劑量調整":"No dosage adjustment required. Bioavailability and half-life increase with Clcr <30 mL\/minute. Use in severe renal impairment is contraindicated in the Canadian labeling","小兒建議劑量":"\"不適用於<br>孩童病患\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FOR01O":{"商品名稱":"Forxiga 10mg Tab#","腎功能不良劑量調整":"(eGFR>45): 無須調整劑量。\r<br>(eGFR 25~45): 10mg QD。\r<br>(<25): 針對此類病人不建議開始治療。然而Foxiga治療後，若GFR降低至<25，可持續使用。\r<br>","小兒建議劑量":"尚未確定 Forxiga在 1 8歲以下兒童患者的安全性和療效。","提示內容":"1.用於第二型糖尿病、心衰竭(NYHA 分類第二至四級) 且心室射出分率降低(? 40%)的成人\r<br>2.注意是否有脫水、生殖泌尿道感染之情況\r<br>3. 5-10mg\/day\r<br>4.腎功能劑量(不同適應症有不同建議詳見仿單)。\r<br>重點eGFR30-45 mL\/min\/1.73m2糖尿病不建議，心衰竭可用；eGFR<30 mL\/min\/1.73 m2糖尿病禁用，心衰竭 不建議；ESRD及透析禁用","抗生素手冊":"暫無資料"},"FOR02O":{"商品名稱":"Forlax 10g pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"每天一包至兩包。每日劑量根據臨床反應調整，從每兩天一包(尤其是兒童)至最多一天兩包。兒童治療不應超過三個月。","提示內容":"(1)服用本藥可能減少其他藥物吸收, 因此服用腹樂疏與其他藥物間隔至少兩小時。\r<br>(2)有果糖不耐症遺傳疾病的患者不得服用。\r<br>(3)Off-label use用在小於8歲幼兒之便秘，建議劑量為0.2 - 0.8g\/kg\/day","抗生素手冊":"暫無資料"},"FOS01E":{"商品名稱":"Foster Inh. 100\/6mcg\/dose#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"1--2 puff Q12H","抗生素手冊":"暫無資料"},"FOS02E":{"商品名稱":"FOSTER NEXTHALER Inh. 100\/6mcg\/dose","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚無Foster NEXThaler使用於5-11歲兒童的臨床經驗，而使用於12-17歲青少年的相關資訊也相當有限。\r","提示內容":"1.本品為乾粉吸入劑型請注意病人是否可經口深吸氣(可能無法從氣切管吸入)\r<br>2.氣喘劑量 維持療法 1-2 Puff BID max. 4 Puff \/day。維持與緩解療法1Puff BID then氣喘發作吸入 1 劑，幾分鐘後症狀持續，再多吸入 1 劑，max. 8 Puff \/day。\r<br>3.COPD 劑量 2 Puff BID","抗生素手冊":"暫無資料"},"FOS04O":{"商品名稱":"Fosamax Plus 70mg\/5600 IU Tab#","腎功能不良劑量調整":"對於年老者或患有輕度至中度腎臟功能不全的病患(creatinine排除率35-60 mL\/min)不須調整劑量。FOSAMAX PLUS不建議使用於較嚴重腎功能不全之病患(creatinine排除率< 35 mL\/min)。","小兒建議劑量":"兒童：在兒童和成人所觀察到alendronate的口服生體可用率相當，然而，不建議將FOSAMAX PLUS使用於兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FOX02E":{"商品名稱":"Foxone Oph Susp 0.02% 10ml Bot","腎功能不良劑量調整":"仿單未載","小兒建議劑量":"仿單未載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FOY01I":{"商品名稱":"Foy For Injection 100mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"*胰臟炎:\r<br>1-3vial\/day(每vial至少溶於500ml的D5W或Ringer)\r<br>*開心手術:\r<br>或許能降低術中出血以及輸血的比率 (劑量: 2-4 mg\/kg\/hr) *(micromedex)\r<br>院內口服Foy 之使用方法為800mg 或 400mg in D5W(Vitagen 5%) 500ml QD，抑制消化產生發炎介質，進而抑制全身性發炎反應，更進一步預防多重器官衰竭","抗生素手冊":"暫無資料"},"FRA01I":{"商品名稱":"Fragmin 5000iu\/0.2ml","腎功能不良劑量調整":"Half-life is increased in patients with chronic renal failure, use with caution, accumulation can be expected; specific dosage adjustments have not been recommended. Accumulation was not observed in critically ill patients with severe renal insufficiency","小兒建議劑量":"本品適用於兒童的安全性和療效經驗有限。倘若 dalteparin使用於這些患者，必須監測抗Xa因子濃度\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FRE01I":{"商品名稱":"Fresofol 200mg\/20ml Amp#4","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"Dosage must be individualized based on total body weight and titrated to the desired clinical effect; wait at least 3-5 minutes between dosage adjustments to clinically assess drug effects; smaller doses are required when used with opioids; the following are general dosing guidelines\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FRE02I":{"商品名稱":"FRESOFOL 500mg\/50ml Vial#4","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"Dosage must be individualized based on total body weight and titrated to the desired clinical effect; wait at least 3-5 minutes between dosage adjustments to clinically assess drug effects; smaller doses are required when used with opioids; the following are general dosing guidelines\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FRE03I":{"商品名稱":"Fresofol Swedon 200mg\/20ml Amp#4","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"Dosage must be individualized based on total body weight and titrated to the desired clinical effect; wait at least 3-5 minutes between dosage adjustments to clinically assess drug effects; smaller doses are required when used with opioids; the following are general dosing guidelines\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FRI01O":{"商品名稱":"Frisium 10mg Tab #4","腎功能不良劑量調整":"\"No dosage adjustment provided in manufacturer’s labeling; however, a reduced dosage is recommended.<br><br>\"\r<br>","小兒建議劑量":"\"Lennox-Gastaut syndrome: Children >=2 years and Adolescents: Oral:<br>\r<br><=30 kg: Initial: 5 mg once daily for >=1 week, may then increase to 5 mg twice daily for >=1 week, then increase to 10 mg twice daily thereafter (maximum daily dose: 20 mg\/day)<br>\r<br>>30 kg: Initia\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUC01O":{"商品名稱":"Fucidin 250mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"禁止併用HMG-CoA 還原?抑制劑，可能引起致命的橫紋肌溶解症。使用本品的整個期間停用HMG-CoA 還原?抑制劑。在最後一次本品後七天才可以重新開始HMG-CoA 還原?抑制劑","抗生素手冊":"建議量: 500 mg q12h<br>小兒: 10 mg per kg q12h"},"FUC02E":{"商品名稱":"Fucidin Cream 2% 5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Topical: Children and Adolescents: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUC02O":{"商品名稱":"Fucon 10mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling. However, caution is recommended due to increased risks of adverse effects.\r<br>","小兒建議劑量":"6歲以上兒童劑量比照成人\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUC03E":{"商品名稱":"Fucidin Cream 2% 15gm","腎功能不良劑量調整":"仿單無資料","小兒建議劑量":"仿單無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUL01I":{"商品名稱":"Fulvestrant 250mg\/5ml Syringe","腎功能不良劑量調整":"對於有輕度至中度腎功能不全的患者(肌酸酐清除率≧ 30 ml\/min)無須調整劑量。對有重度腎功能不全的患者(肌酸酐清除率<30 ml\/min)使用本藥的安全性和有效性尚未被評估，因此用於這些患者時應小心謹慎(見警語及使用特別注意事項)。","小兒建議劑量":"不建議兒童或青少年使用，因為用於這個年齡層的安全性和療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUL02I":{"商品名稱":"Fulvestrant (恩慈) 250mg\/5ml Syringe","腎功能不良劑量調整":"對於有輕度至中度腎功能不全的患者(肌酸酐清除率≧ 30 ml\/min)無須調整劑量。對有重度腎功能不全的患者(肌酸酐清除率<30 ml\/min)使用本藥的安全性和有效性尚未被評估，因此用於這些患者時應小心謹慎(見警語及使用特別注意事項)。","小兒建議劑量":"不建議兒童或青少年使用，因為用於這個年齡層的安全性和療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUL03I":{"商品名稱":"Fulphila 6mg\/0.6ml Syringe","腎功能不良劑量調整":"Renal Impairment No dosage adjustment necessary.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUL04I":{"商品名稱":"Fulphila (恩慈) 6mg\/0.6ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUM01S":{"商品名稱":"Fumide Oral Sol 10mg\/ml;120ml#","腎功能不良劑量調整":"renal failure, chronic: initial, 80 to 120 mg ORALLY daily; MAX 1500 mg ORALLY daily.\r<br>","小兒建議劑量":"Neonatal\r<br>Edema:Oral: Doses of 1 mg\/kg\/dose 1-2 times\/day have been used\r<br>Infants and Children:\r<br>Oral: 2 mg\/kg once daily; if ineffective, may increase in increments of 1-2 mg\/kg\/dose every 6-8 hours; not to exceed 6 mg\/kg\/dose. In most cases, it is not necessary to exceed individual doses of 4 mg\/kg or a dosing frequency of once or twice daily","提示內容":"注意病人是否有低血鉀的症狀","抗生素手冊":"暫無資料"},"FUN01I":{"商品名稱":"Fungizone 50mg Vial","腎功能不良劑量調整":"[>50 ml\/min]: 0.4-1mg\/kg\/day Q24H\r<br>[10-50]: Q24H\r<br>[<10]:  Q24-36H\r<br>HEMO: no dosage adjustment","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"建議量: 0.5 to 1.5 mg per kg once daily"},"FUR02I":{"商品名稱":"Furoxime 750mg Vial#","腎功能不良劑量調整":"Usual Dosing (Adults),CRCL >20 ml\/min : IV: 750 mg to 1.5 gm IV q8h.\r<br>[10-20 ]: 750 mg q12h. \r<br>[<10]: 750 mg q24h. \r<br>HEMO : 750mg q24h. Repeat the dose at the end of dialysis. \r<br>PD: 750 mg q24h.","小兒建議劑量":"嬰幼兒: 30～100mg\/kg\/day，分3 或4 次給興。適用於大多數感染，腦膜炎最多可至 250mg\/kg\/day。\r<br>\r<br>新生兒: 30～100mg\/kg\/day，分2 或3 次給與。","提示內容":"暫無資料","抗生素手冊":"建議量:  1.5 gm q8h<br>Ccr less 30: 1.5 g q12h<br>Ccr less 10 or HD: 1.5 g qd"},"FUS01E":{"商品名稱":"Fusidic Acid Cream 100mg\/5gm","腎功能不良劑量調整":"仿單未記載","小兒建議劑量":"仿單未記載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUS01O":{"商品名稱":"Fusodate 250mg Tab","腎功能不良劑量調整":"依據fusidic acid代謝及排泄, 對於腎功能受損或正接受血液透析病人 不需調整劑量","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUS02E":{"商品名稱":"Fuskin Cream 100mg\/5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"仿單未記載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FUS03E":{"商品名稱":"Fusone Eye Drops 0.1% 0.5mL Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"FYT01I":{"商品名稱":"Fytosid 100mg\/5ml Vial#","腎功能不良劑量調整":">50ml\/min: 100%劑量\r<br><15~50 ml\/min: 75%劑量\r<br>沒有 Clcr<15的患者使用資料，此類患者應考慮再減低劑量。","小兒建議劑量":"用於小兒科患者的安全性及有效性尚未確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAD01I":{"商品名稱":"Gadovist 15ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAL01I":{"商品名稱":"Galium Citrate GA67 Inj 3mci","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAL02O":{"商品名稱":"Galvus Met 50\/850 Tab#","腎功能不良劑量調整":"Galvus Met 不建議使用於肌酸酐廓清率Clcr < 60 ml\/min的患者[1]\r<br>--【複方錠】--------------\r<br>．Vildagliptin：\r<br>(CrCl 50 mL\/min or greater): no dose adjustment necessary \r<br>Renal impairment, moderate, severe, or ESRD: 50 mg QD \r<br>．Metformin：\r<br>（eGFR 30-45 ml\/","小兒建議劑量":"Galvus MetR 不建議使用於小兒及青少年患者。因為缺乏相關資料，目前小兒患者及小於18 歲以下之青少年患者使用Galvus MetR 之安全性及療效尚未建立","提示內容":"一般劑量: 1 tab BID\r<br>複方藥品, 內含Metformin需注意\r<br>(1)每日最高劑量: 速效劑型：3000 mg；緩釋劑型：2000mg\r<br>(2)腎絲球體過濾率（eGFR）介於30-45 ml\/min\/1.73 m2應減量使用\r<br>(3)腎功能不全患者，腎絲球體過濾率（eGFR）小於30 ml\/min\/1.73 m2禁用)\r<br>投予含碘顯影劑時，應在檢查前後至少48小時停止使用，待腎功能經評估確定已恢復正常後，才能再服用","抗生素手冊":"暫無資料"},"GAL05I":{"商品名稱":"Galium Citrate GA67 Inj 1mci","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAN01I":{"商品名稱":"Gancicure Lyo 500mg Vial","腎功能不良劑量調整":"CMV retinitis誘導劑量 x 14-21 days. : \r<br>[Clcr > 70] : 5 mg\/kg q12h \r<br>[50-69 ]: 2.5 mg\/kg q12h.\r<br>[25-49 ]: 2.5 mg\/kg q24h.\r<br>[10-24 ]: 1.25 mg\/kg q24h.\r<br>[<10]:1.25 mg\/kg 1W3D 透析後。\r<br>維持劑量請以上劑量減半使用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAR01I":{"商品名稱":"Gardasil Vaccine 0.5ml Sringe","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAR02I":{"商品名稱":"Gardasil Vaccine(員工) 0.5ml","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAR03I":{"商品名稱":"GARDASIL 9 Vaccine 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"9至14歲，第0、2、6個月各肌肉注射一劑0.5ml的劑量共三劑或是第0、6~12月各肌肉注射一劑0.5ml的劑量共兩劑。8歲以下不建議施打。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAR04I":{"商品名稱":"GARDASIL 9 (員工) 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"9至14歲，第0、2、6個月各肌肉注射一劑0.5ml的劑量共三劑或是第0、6~12月各肌肉注射一劑0.5ml的劑量共兩劑。8歲以下不建議施打。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAR05I":{"商品名稱":"Gardasil 9 (公費) 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAS01O":{"商品名稱":"Gascon 40mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"≧ 3yr: 適用成人劑量(2# QID)；\r<br><3yr: 請洽醫師診治，不宜自行使用。\r<br>-----------------------------------------------------------\r<br>簡易換算:\r<br>< 6 months:    1\/4# TID;   \r<br>6 months-2yr: 1\/3#QID; \r<br>2-8yr:             1\/2# QID;    \r<br>> 8yr:               1# QID","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAS03I":{"商品名稱":"Gaster 20mg Amp#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAS06O":{"商品名稱":"Gasmin 40mg Tab","腎功能不良劑量調整":"There is no dosage adjustment provided in the manufacturer’s labeling. However, dosage adjustment unlikely due to the drug not being systemically absorbed.","小兒建議劑量":"3歲以上(含)，適用成人劑量；3歲以下之嬰幼兒，請洽醫師診治，不宜自行使用。\r<br>簡易換算:\r<br>< 6 months:    1\/4# TID;   \r<br>6 months-2yr: 1\/3#QID; \r<br>2-8yr:             1\/2# QID;    \r<br>> 8yr:               1# QID","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAS07O":{"商品名稱":"Gaslan 40mg Tab","腎功能不良劑量調整":"There is no dosage adjustment provided in the manufacturer’s labeling. However, dosage adjustment unlikely due to the drug not being systemically absorbed.","小兒建議劑量":"< 3 yr : 請洽醫師診治，不宜自行使用。\r<br>>3 yr : 適用成人劑量 (2# QID)\r<br>------------------------------------------------------\r<br>< 6 months : 1\/4# TID\r<br>6 months- 2yr : 1\/3# QID\r<br>2-8 yr : 1\/2# QID\r<br>> 8 yr : 1# QID","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAV01O":{"商品名稱":"Gavreto 100mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAZ01I":{"商品名稱":"Gazyva 1000mg\/40ml Vial","腎功能不良劑量調整":"腎功能不全：依據族群藥動學分析，基期肌酸酐清除率(CrCl)330 mL\/min時並未影響GAZYVA的藥動學。GAZYVA尚未針對基期CrCl <30 mL\/min的患者進行研究。","小兒建議劑量":"小兒使用:GAZYVA使用於兒童患者的安全性及療效資料尚未建立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAZ02I":{"商品名稱":"Gazyva 1000mg\/40ml Vial (恩慈)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GAZ03I":{"商品名稱":"Gazyva 1000mg\/40ml Vial (Cycle1 Day2)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEM01O":{"商品名稱":"Gemnpid 300mg Cap#","腎功能不良劑量調整":"Use caution when serum creatinine >2 mg\/dL\r<br>[>50 ml\/min]: 600mg bid\r<br>[10-50]:  75%\r<br>[<10 ]:  50% \r<br>HEMO:None","小兒建議劑量":"safety and efficacy not established in pediatric patients.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEM02I":{"商品名稱":"Gemzar 200mg Vial#","腎功能不良劑量調整":"曾有腎臟或肝臟功能不全之病患使用Gemzar時應謹慎，Gemzar尚未曾以嚴重腎功能或肝功能不全之病患做過研究。\r<br>","小兒建議劑量":"Gemzar尚未以兒童病患做過研究，因此幼年病患之安全性與有效性尚未得知。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEM03I":{"商品名稱":"Gemcitabine 200mg\/5ml Vial Sandoz","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN01E":{"商品名稱":"Gentamycin Cream 5mg\/5Gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Dermatologic infections: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN01O":{"商品名稱":"Genurso 100mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"*Biliary atresia: Infants: 10-15 mg\/kg\/day once daily\r<br>*Improvement in the hepatic metabolism of essential fatty acids in cystic fibrosis: Children: 30 mg\/kg\/day 分2次用\r<br>*TPN-induced cholestasis, treatment: Infants and Children: 30 mg\/kg\/day 分3次用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN02I":{"商品名稱":"Genotropin 16iu(5.3mg) Cart#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"每天0.7-1.0 mg\/m2 體表面積\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN03I":{"商品名稱":"GENOTROPIN 12mg Cart","腎功能不良劑量調整":"對於慢性腎功能不足的病人，開始治療前腎功能必須在正常值的百分之五十以下。為了確定生長障礙，在開始治療前應觀察其生長為期一年左右。在這段觀察期間內應建立腎功能不足的保守治療(包括控制酸血症、副甲狀腺機能亢進及營養狀態)，並在生長激素治療期間並應維持此保守治療?","小兒建議劑量":"皮下注射，注射部位應常更換以免皮下脂肪組織萎縮。\r<br>兒童因生長激素分泌不足所導致之生長障礙：通常建議劑量為每天0.025-0.035 mg\/kg 體重，或每天0.7-1.0 mg\/m2 體表面積。\r<br>各項治療詳見仿單資訊","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN04I":{"商品名稱":"GENOTROPIN (恩慈) 12mg Cart","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN05E":{"商品名稱":"Gendermin Oph Oint 15mg\/5gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN06E":{"商品名稱":"GenterMAY Cream 5mg\/5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Dermatologic infections: Refer to adult dosing.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN08O":{"商品名稱":"Geniquin 200mg Tab","腎功能不良劑量調整":"Use with caution; dosage adjustment may be necessary in severe dysfunction (Bernstein, 1992); specific guidelines not available.\r<br>","小兒建議劑量":"\"瘧疾－急性發作的治療：<br>\r<br>一歲以下的嬰兒：100毫克，然後每六至八小時間隔給藥三次，每次100毫克(總共400毫克)。 二歲至五歲兒童：400毫克，八小時後200毫克(總共600毫克)。 \r<br>六歲至十歲兒童：400毫克，間隔八小時再服用二次，每次服用200毫克(共800毫克)。 \r<br>十一歲至十五歲兒童：600毫克，八小時後服用200毫克，二十四小時後再用一克。 \"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN09O":{"商品名稱":"Genclone 7.5mg Tab #4","腎功能不良劑量調整":"於腎功能不良之病例中，雖然沒有發現到zopiclone或其代謝物的蓄積，但對腎功能損害之患者，其推薦起始劑量應為1\/2錠。","小兒建議劑量":"孩童及18歲以下之年輕人使用zopiclone之安全性及有效劑量尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN11I":{"商品名稱":"Gendobu 250mg\/20ml Vial","腎功能不良劑量調整":" There are no dosage adjustments provided in manufacturer’s labeling\r<br>","小兒建議劑量":"對孕婦與兒童之安全性亦未確定，宜避免使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEN12I":{"商品名稱":"Genso 25mg\/2.5ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GEO02O":{"商品名稱":"Geodon 40mg Cap","腎功能不良劑量調整":"no","小兒建議劑量":"用於18歲以下孩童的安全性和有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GES01O":{"商品名稱":"Gestrin 2.5mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GIK01O":{"商品名稱":"GI Klean Powder","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GIK02O":{"商品名稱":"Giko F.C. 9.6mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GIL01O":{"商品名稱":"Gilenya 0.5mg Cap#","腎功能不良劑量調整":"Gilenya 0.5 毫克的劑量適用於腎功能不全的病人。兩個代謝物(M2 和M3) 的全身性曝露量分別增加3 倍及13 倍。這些代謝物的毒性尚未被確認。\r<br>針對輕度至中度腎功能不全病人的研究尚未進行。","小兒建議劑量":"兒童\r<br>Gilenya 於18 歲以下多發性硬化症兒童病患的安全性及療效尚未建立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GIN01O":{"商品名稱":"Ginkgocentrate F.C. Tab 9.6mg#","腎功能不良劑量調整":"仿單無記載。","小兒建議劑量":"仿單無記載。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GIO01O":{"商品名稱":"GIOTRIF FC 40mg Tab","腎功能不良劑量調整":"尚未針對重度腎功能不全(Clcr<30ml\/min)病患進行研究。不建議用於重度腎功能不全的病患。","小兒建議劑量":"目前尚未確立GIOTRIF對小兒病患的安全性及有效性。","提示內容":"不可與食物同時服用，飯前至少1小時或飯後3小時後服用藥物\r<br>需監測腹瀉、皮膚相關不良事件、間質性肺病、肝功能受損、胃腸道穿孔、角膜炎是否發生","抗生素手冊":"暫無資料"},"GIO02O":{"商品名稱":"Giotrif FC 30mg Tab","腎功能不良劑量調整":"尚未針對重度腎功能不全(Clcr<30ml\/min)病患進行研究。不建議用於重度腎功能不全的病患。","小兒建議劑量":"目前尚未確立GIOTRIF對小兒病患的安全性及有效性。","提示內容":"不可與食物同時服用，飯前至少1小時或飯後3小時後服用藥物\r<br>需監測腹瀉、皮膚相關不良事件、間質性肺病、肝功能受損、胃腸道穿孔、角膜炎是否發生","抗生素手冊":"暫無資料"},"GIT01I":{"商品名稱":"Gitose 5% 250ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases\r<br>I.V.:<br>\r<br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>\r<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>\r<br>Adolescents: Refer to adult dosing.<br>\r<br>\r<br>Oral: Refer to adult dosing:<br>\r<br>- Treatment of hyperkalemia: I.V. (in combination with insulin):\r<br><br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed<br>\r<br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GIT02I":{"商品名稱":"Gitose 5% 500ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases<br>\r<br>I.V.:\r<br><br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Adolescents: Refer to adult dosing.<br>\r<br>Oral: Refer to adult dosing:<br>\r<br>- Treatment of hyperkalemia: I.V. (in combination with insulin):\r<br><br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed\r<br><br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GIT03I":{"商品名稱":"Gitose 5% 100ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases\r<br>I.V.:<br>\r<br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>\r<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>\r<br>Adolescents: Refer to adult dosing.<br>\r<br>\r<br>Oral: Refer to adult dosing:<br>\r<br>- Treatment of hyperkalemia: I.V. (in combination with insulin):\r<br><br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed<br>\r<br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLI01E":{"商品名稱":"Gliadel Wafer Implant 7.7mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對兒童的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLI03O":{"商品名稱":"Glivec 100mg Tab#","腎功能不良劑量調整":"Imatinib 及其代謝物只有少量經由腎臟排泄。由於imatinib 經由腎臟的清除率很低，預期腎功能不全並不會降低imatinib 的全身清除率。輕度或中度腎功能不全的病患之起始劑量，應投與最小的每日建議劑量400 毫克。雖然目前相關的資料十分有限( 請參閱“藥物動力學”與“藥效學”","小兒建議劑量":"\"尚無使用Glivec 於2 歲以下患有慢性骨髓性白血病及1 歲以下費城染色體陽性急性淋巴性白血病(Ph+ALL) 之兒童的資料。至於使用Glivec 於其他適應症之兒童的資料亦十分有限。<br>兒童的劑量必需根據其體表面積毫克\/ 平方公尺(mg\/m2)。慢性期CML、惡化期CML 及費城染色體陽性急性淋巴性白血病的兒童建議劑量分別為每天340 毫克\/ 平方公尺(mg\/m2)。然而，兒童每日總劑量不得超過600 毫克劑量。治療慢性骨髓性白血病及費城染色體陽性急性淋巴性白血病可依每日一次劑量之投予方式，對於慢性骨髓性白血病患者，可將其分成兩次投予－即於早晚各投予一次。\"\r<br>","提示內容":"飯中服用","抗生素手冊":"暫無資料"},"GLI04O":{"商品名稱":"Glibudon 500mg Tab(新)","腎功能不良劑量調整":"禁忌使用於男性 Scr>1.5 mg\/dL, 或女性Scr >1.4 mg\/dL,以防乳酸中毒\r<br>[成人劑量]: 500-850mg bid \r<br>[Clcr 90~50 ml\/min ]: 50% dosage\r<br>[10-50 ml\/min]: 25%\r<br>[<10 ml\/min]: Avoid \r<br>HEMO:Not applicable","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU02O":{"商品名稱":"GLUCOBAY 100mg Tab#","腎功能不良劑量調整":"醣祿錠不可使用於嚴重腎功能不全的病患(creatinine clearance < 25 ml\/min)。\r<br>[>25 ml\/min]: 50-200mg tid\r<br>[<25]: Avoid\r<br>HEMO: No data","小兒建議劑量":"暫無資料","提示內容":"ClCr< 25 ml\/min禁用","抗生素手冊":"暫無資料"},"GLU03I":{"商品名稱":"Vitagen 20%\/20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases<br>\r<br>I.V.:\r<br><br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Adolescents: Refer to adult dosing.<br>\r<br>Oral: Refer to adult dosing:<br>\r<br>- Treatment of hyperkalemia: I.V. (in combination with insulin):<br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed\r<br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU03O":{"商品名稱":"Glucomin XR 500mg Tab","腎功能不良劑量調整":"[1]腎功能損傷之老年人不宜使用本品\r<br>eGFR介於30-45 Avoid","小兒建議劑量":"目前對小兒患者的安全性及有效性尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU04I":{"商品名稱":"Vitagen 50%\/20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases<br>\r<br>I.V.:\r<br><br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Adolescents: Refer to adult dosing.\r<br><br>Oral: Refer to adult dosing:<br>\r<br>- Treatment of hyperkalemia: I.V. (in combination with insulin):\r<br><br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed<br>\r<br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU07I":{"商品名稱":"Glucose 5% 250ml Bot (PP)","腎功能不良劑量調整":"仿單無說明","小兒建議劑量":"仿單無說明","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU07O":{"商品名稱":"Glucophage 500mg Tab","腎功能不良劑量調整":"[1]腎功能損傷之老年人不宜使用本品\r<br>eGFR介於30-45 Avoid","小兒建議劑量":"孩童:不建議使用本品","提示內容":"投予含碘顯影劑時，應在檢查前後至少48小時停止使用，待腎功能經評估確定已恢復正常後，才能再服用\r<br>1.Max. dose 3000mg\/day\r<br>2.大於80歲老年患者不建議開始使用\r<br>3.CrCl 45-59ml\/min或 eGFR 45-59ml\/min\/1.73m2起始劑量為每日500mg或850mg，Max. dose 1000mg\/day\r<br>4. eGFR <30 mL\/minute\/1.73 m2  禁止使用","抗生素手冊":"暫無資料"},"GLU09I":{"商品名稱":"Vitagen Inj 10% 500ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases<br>\r<br>I.V.:\r<br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Adolescents: Refer to adult dosing.<br>\r<br>Oral: Refer to adult dosing:\r<br><br>- Treatment of hyperkalemia: I.V. (in combination with insulin):<br>\r<br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed<br>\r<br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU10I":{"商品名稱":"Glucose 5% 250ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU13I":{"商品名稱":"Vitagen Inj 5% 500ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases<br>\r<br>I.V.:<br>\r<br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Adolescents: Refer to adult dosing.<br>\r<br>Oral: Refer to adult dosing:<br>\r<br>- Treatment of hyperkalemia: I.V. (in combination with insulin):\r<br><br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed\r<br><br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU14I":{"商品名稱":"Vitagen Inj 5% 250ml 玻璃瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases\r<br><br>I.V.:<br>\r<br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>Adolescents: Refer to adult dosing.<br>\r<br>Oral: Refer to adult dosing:<br>\r<br>- Treatment of hyperkalemia: \r<br>I.V. (in combination with insulin):<br>\r<br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed<br>\r<br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU16I":{"商品名稱":"Glucose 5% 500ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU18I":{"商品名稱":"Dextrose 5%+0.33% Saline 500ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU25I":{"商品名稱":"Dextrose 5%\/0.9% Saline 500ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU26I":{"商品名稱":"Glucose 50% 500ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU27O":{"商品名稱":"Glucobay 50mg Tab","腎功能不良劑量調整":"[>25 ml\/min]: 50-200mg tid\r<br>[<25]: Avoid\r<br>HEMO: No data","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU28O":{"商品名稱":"Glustrong 250mg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"safety and effectiveness have not been established in children\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU29I":{"商品名稱":"Glucagen 1mg Vial","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"\"- Children > 25 kg or older than 6 to 8 years: inject all (1 ml)\r<br>- Children < 25 kg or younger than 6 to 8 years: inject half (? ml)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU30I":{"商品名稱":"Gluco-methionin B Inj 20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU31I":{"商品名稱":"Dextrose 5%\/0.45% Saline 500ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLU32I":{"商品名稱":"DextrosIET 5%\/0.9% SodII 500ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLY01E":{"商品名稱":"Glycerin Ball(Sumgel Enema)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小兒一次10 c.c.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLY01O":{"商品名稱":"Glycopyrodyn 1mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Clozapine Induced Sialorrhea常見是1mg BID\r<br>精神醫學部申請用以治療clozapine induced sialorrhea\r<br>藥委會通過零購品項開檔使用","抗生素手冊":"暫無資料"},"GLY01S":{"商品名稱":"Glycerin 100ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLY02I":{"商品名稱":"Glypressin(新) inj 0.1mg\/mL Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"無建議劑量相關數據","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLY02O":{"商品名稱":"Glyxambi 25\/5mg Tab#","腎功能不良劑量調整":"(eGFR) 低於30mL\/min\/1.73 m2 & 透析病人：不應使用 GLYXAMBI。\r<br>(eGFR) 大於或等於 30 的病人：無須調整劑量。\r<br>---【複方錠】---------\r<br>．Empagliflozin(SGLT-2i)：同上。\r<br>．Linagliptin：不需劑量調整","小兒建議劑量":"GLYXAMBI 在未滿 18 歲兒童病人使用的安全性及\r<br>有效性，尚未獲得確立。","提示內容":"1. 1# QD\r<br>2. eGFR <30 mL\/minute\/1.73 m2  不應使用\r<br>3. 注意胰臟炎、關節疼痛\r<br>4.注意是否有脫水、生殖泌尿道感染之情況","抗生素手冊":"暫無資料"},"GLY08I":{"商品名稱":"Glycopyrodyn Inj 0.2mg\/1ml Amp","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling. However, data suggest renal impairment reduces glycopyrrolate elimination; use with caution.\r<br>","小兒建議劑量":"\"- Reduction of secretions:<br>\r<br>Preoperative: I.M.:<br>\r<br><2 years: 4-9 mcg\/kg 30-60 minutes before procedure\r<br><br>>2 years: 4 mcg\/kg 30-60 minutes before procedure<br>Intraoperative: I.V.: 4 mcg\/kg not to exceed 0.1 mg; repeat at 2- to 3-minute intervals as needed.<br>\r<br>Chronic (unlabeled):<br>\r<br>Oral: 40-100 mcg\/kg\/dose 3-4 times\/day\r<br><br>I.M., I.V.: 4-10 mcg\/kg\/dose every 3-4 hours; maximum: 0.2 mg\/dose or 0.8 mg\/24 hours\r<br>- Drooling, chronic: Children 3-16 years: Oral solution (Cuvposa?): 0.02 mg\/kg 3 times\/day; titrate in increments of 0.02 mg\/kg every 5-7 days as tolerated, up to a maximum dose of 0.1 mg\/kg 3 times\/day, not to exceed 1.5-3 mg\/dose<br>\r<br>- Reversal of neuromuscular blockade: Refer to adult dosing\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GLY11I":{"商品名稱":"Glycetose 10% 300ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"GUT01O":{"商品名稱":"Gutron 2.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HAF01I":{"商品名稱":"Haforman Inj. 500ML軟袋","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HAL01I":{"商品名稱":"Haldol 5mg\/1ml Amp","腎功能不良劑量調整":"\"No dosage adjustment provided in the manufacturer's labeling.<br>Hemodialysis\/peritoneal dialysis: Supplemental dose is not necessary.\"\r<br>","小兒建議劑量":"0.1毫克\/3公斤體重，每天口服三次，可以依需要加以調整。\r<br>","提示內容":"老年人使用Haldol inj. AS可能是治療藥物引起delirium(譫妄)\r<br>仿單僅建議以IM方式給藥 (IV可能增強QT prolong的風險)\r<br>於安寧病人常使用SC的途徑,可不做疑義\r<br>(因安寧病人常有血液凝集異常的問題, 不適合IV或IM)","抗生素手冊":"暫無資料"},"HAL02I":{"商品名稱":"Halaven 1mg\/2ml Vial","腎功能不良劑量調整":"【腎】中度腎功能不全(Clcr 30-50): 建議劑量為 1.1mg\/m2\r<br>【肝】對輕度肝功能不全，患者給予HALAVENR 1.1 mg\/m2及中度肝功能不全患者給予0.7 mg\/m2","小兒建議劑量":"18歲以下之小兒患者使用HALAVENR之安全性及療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HAL02O":{"商品名稱":"Halcion 0.25mg Tab #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HAL03O":{"商品名稱":"Haldol 5mg Tab","腎功能不良劑量調整":"\"No dosage adjustment provided in the manufacturer's labeling.<br>Hemodialysis\/peritoneal dialysis: Supplemental dose is not necessary.\"\r<br>","小兒建議劑量":"2. 兒童(3～12歲或15～40kg)：a.初劑量每日0.5mg。需要時可每隔5～7天增加0.5mg。每日劑量可分2～3次使用。此年齡層的劑量尚未確立。b.3～6歲兒童的其他建議劑量：激動不安和過動，每日口服0.01～0.03mg\/kg，幼童自閉症，每日0.5～4mg。\r<br>Children 0.1mg\/3kg daily in 3 divided doses orally.","提示內容":"治療打嗝(Hiccup): 1-2mg TID","抗生素手冊":"暫無資料"},"HAR03O":{"商品名稱":"Harnalidge D 0.2mg Tab","腎功能不良劑量調整":"\"ClCr<10ml\/min應小心，因為尚未執行這類患者的臨床研<br>究\"\r<br>","小兒建議劑量":"暫無資料","提示內容":"用於泌尿道結石之病人, 可幫助把小顆結石排出\r<br>→衛教病人多補充水分","抗生素手冊":"暫無資料"},"HAR04O":{"商品名稱":"HARNALIDGE OCAS 0.4mg Tab","腎功能不良劑量調整":"治療嚴重腎功能不全的患者（肌酸酐清除率 <10 mL\/min）應小心，因為尚未執行這類患者的臨床研究。","小兒建議劑量":"暫無資料","提示內容":"1.注意姿勢性低血壓\r<br>2.白內障或青光眼手術前需暫停","抗生素手冊":"暫無資料"},"HAV02I":{"商品名稱":"Havrix 720u\/0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HAV03I":{"商品名稱":"Havrix 1440u\/1ml Vial (Adult)","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"\"1 歲至 18 歲(含 18 歲)者之孩童及青少年： <br>\r<br>孩童應使用另一品項： Havrix 720(0.5 毫升懸浮劑)單一劑量，用於基礎免疫。\r<br><br>Havrix採肌肉注射方式，並應注射於成人或孩童的三角肌部位，嬰兒則應注射於大腿前外側部位。 \"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HAV04I":{"商品名稱":"Havrix 720u\/0.5ml Syringe (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HBV03I":{"商品名稱":"H-B-VAX II (公費) 5mcg\/0.5ml Vaccine","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEM11I":{"商品名稱":"Hemoclot 500mg\/5mL  Amp","腎功能不良劑量調整":"[Clcr 20~50] IV：10mg\/kg 12 hourly.\r<br>[Clcr 10~20] IV：10mg\/kg 24 hourly.\r<br>[Clcr <10] IV：5mg\/kg 24hourly\r<br>[HEMO]：Avoid\r<br>~ref [5]","小兒建議劑量":"仿單未載。\r<br>Dental extraction in hemophiliacs: Adults & children,\r<br>Pre-op: IV 10 mg\/kg before tooth extraction, then 10 mg\/kg IV or 25 mg\/kg\/dose po tid-qid post operation for 2~8 days [uptodate]","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEM12I":{"商品名稱":"Hemodialysis Soln (No 110) 3.8L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEM13I":{"商品名稱":"Hemodialysis Soln (No 110) 10L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEM14I":{"商品名稱":"Hemodialysis Soln (No 111CB) 3.8L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEM16I":{"商品名稱":"Hemodialysis Soln (No 16) 3.8L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEM17I":{"商品名稱":"Hemodialysis Soln (No 17) 3.8L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEM18I":{"商品名稱":"Hemodialysis Soln (No 17) 10L Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP01I":{"商品名稱":"Heparin 25000iu\/5ml Vial","腎功能不良劑量調整":"No dosage adjustment required; adjust therapeutic heparin according to aPTT or anti-Xa activity","小兒建議劑量":"Children > 1 yr., LD, 75 U\/kg for 10 mins; MD, 20 U\/kg\/hr cIF to maintain the target aPTT.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP08I":{"商品名稱":"Hepatect CP 500iu\/10ml Vial","腎功能不良劑量調整":"對於腎損傷病人，應考慮停止靜脈注射免疫球蛋白。\r<br>","小兒建議劑量":"\"針對於母親為B型肝炎帶原之新生兒的免疫預防：\r<br>自出生之後至產生自動免疫期間，每公斤體重20-50 IU(至少100 IU)，建議使用B型肝炎疫苗，第一劑疫苗施打可時間與Hepatect CP同一天，但其注射部份應不同。<br>投予方式：於母親為B型肝炎帶原之新生兒的免疫預防之臨床經驗，靜脈注射且其注射速率為5至15分鐘施打2 mL Hepatect CP顯示有極好的耐受性。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP09I":{"商品名稱":"Heparin 1000iu\/0.2ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP11I":{"商品名稱":"HepatitisB ImmuneGlobulin (公費) 0.5ml","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"\"- HBsAg和 HBeAg陽性的母親，嬰兒出生後的預防：<br>B 型肝炎免疫球蛋白對嬰兒的預防效果，端視出生當天投藥與否。因此分娩前先確定母親是否為 HBsAg陽性非常重要。新生兒在生理情況穩定後，最好在 12 小時內，即可肌肉注射 B型肝炎免疫球蛋白（人類）(0.5 ml)。如果延遲到 48 小時以後才注射，B 型肝炎免疫球蛋白的效果明顯降低。B型肝炎疫苗應肌肉注射三劑，每劑 0.5 ml (10 μg)。第一劑在出生七天內接種，也可以同時用 B 型肝炎免疫球蛋白，但注射的部位不同。第二、第三劑疫苗則分別在第一劑用後一個、六個月接種。如果第一劑 B 型肝炎疫苗延後三個月使用，必須同時再使用一劑 0.5 ml B 型肝炎免疫球蛋白。如果拒絕接種疫苗，可於三個月、六個月時再次使用 0.5 ml的 B型肝炎免疫球蛋白。出生時使用過 B 型肝炎免疫球蛋白，應不會干擾嬰兒兩個月大時接種口服小兒麻痺疫苗及白喉─破傷風─百日咳三合一疫苗。<br>- 日常接觸急性 B型肝炎患者：<br>若照顧嬰兒者為急性 B型肝炎患者，12個月以下的嬰兒可給予預防治療 0.5 ml的人類 B型肝炎免疫球蛋白及疫苗。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP12I":{"商品名稱":"Hepac 25000U\/5ml Vial","腎功能不良劑量調整":"No dosage adjustment required; adjust therapeutic heparin according to aPTT or anti-Xa activity","小兒建議劑量":"Children > 1 yr., LD, 75 U\/kg for 10 mins; MD, 20 U\/kg\/hr cIF to maintain the target aPTT.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP13I":{"商品名稱":"Hepac 1000U\/0.2ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP15I":{"商品名稱":"Hepatitis B Immunoglobulin P 1ml","腎功能不良劑量調整":"仿單未載，查無資料","小兒建議劑量":"Neonates born to HBsAg (+) women: \r<br>0.5 mL given as soon as possible after birth (within 12 hrs), if HB vaccine is not used, repeated at 3 mo and 6 mo.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP16I":{"商品名稱":"Hepac Lock Flush 1000u\/10ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEP17I":{"商品名稱":"Hepac Plus 5000u\/20ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HER02I":{"商品名稱":"Herceptin 440mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用Herceptin的安全性及效果\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HER03I":{"商品名稱":"Herceptin 1mg#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用Herceptin的安全性及效果\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HER04I":{"商品名稱":"Herceptin 440mg Vial (恩慈)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HER05I":{"商品名稱":"Herceptin (恩慈) 1mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HER06I":{"商品名稱":"HERCEPTIN SC 600mg\/5mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立<18歲的小兒科病人使用Herceptin的安全性及效果。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HER07I":{"商品名稱":"HERCEPTIN SC(恩慈) 600mg\/5mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立<18歲的小兒科病人使用Herceptin的安全性及效果。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HER08I":{"商品名稱":"Herbesser Injection 50mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEX01I":{"商品名稱":"Hexabrix-320 100ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HEX03I":{"商品名稱":"Hexaxim Vaccine 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HID02O":{"商品名稱":"Hidrasec Granules 10mg Pack","腎功能不良劑量調整":"建議腎功能不全或肝功能不全患者應小心使用\r\r<br>(尚未進行研究)","小兒建議劑量":"以體重計算 1.5mg\/kg\/每次，一天投與3次。兒童建議每次不超過60mg，治療應持續直到有2次正常排便的記錄。治療期不應超過5天。尚無針對小於3個月大嬰兒進行臨床監測研究。\r<br>廠商另有建議:\r<br>< 9 kg : 10 mg\/ 次\r<br>9-13 kg : 20 mg\/次\r<br>13-27 kg : 30 mg\/次\r<br>> 27 kg : 60 mg\/次","提示內容":"1.5mg\/kg\/dose TID。\r<br>Max. dose:  <60mg\/dose，治療期不應超過5天。","抗生素手冊":"暫無資料"},"HIR02E":{"商品名稱":"Hirudoid Cream 40gm","腎功能不良劑量調整":"仿單未說明","小兒建議劑量":"仿單未說明","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HOL01I":{"商品名稱":"Holoxan 2gm Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"Also consult details concerning dosing in combination regimens. Note: To prevent bladder toxicity, ifosfamide should be given with the urinary protector mesna and hydration of at least 2 L of oral or I.V. fluid per day.<br>- Ewing sarcoma (unlabeled use): I.V.:<br>VAC\/IE regimen: IE: 1800 mg\/m2\/day for 5 days (in combination with mesna and etoposide) alternate with VAC (vincristine, doxorubicin, and cyclophosphamide) every 3 weeks for a total of 17 courses (Grier, 2003)<br>ICE-CAV regimen: ICE: 1800 mg\/m2\/day for 5 days every 3-4 weeks for 2 courses (in combination with carboplatin and etoposide [and mesna]), followed by CAV (cyclophosphamide, doxorubicin, and vincristine) (Milano, 2006)<br>VAIA regimen: 3000 mg\/m2\/day on days 1, 2, 22, 23, 43, and 44 for 4 courses (in combination with vincristine, doxorubicin, dactinomycin, and mesna) (Paulussen, 2001) or 2000 mg\/m2\/day for 3 days every 3 weeks for 14 courses (in combination with vincristine, doxorubicin, dactinomycin, and mesna) (Paulussen, 2008)<br>VIDE regimen: 3000 mg\/m2\/day over 1-3 hours for 3 days every 3 weeks for 6 courses (in combination with vincristine, doxorubicin, etoposide, and mesna) (Juergens, 2006)<br>IE regimen: 1800 mg\/m2\/day over 1 hour for 5 days every 3 weeks for 12 cycles (in combination with etoposide and mesna) (Miser, 1987)<br>ICE regimen: 1800 mg\/m2\/day for 5 days every 3 weeks for up to 12 cycles (in combination with carboplatin and etoposide [and mesna]) (van Winkle, 2005)<br>- Osteosarcoma (unlabeled use): I.V.:<br>Ifosfamide\/cisplatin\/doxorubicin\/HDMT regimen: 3000 mg\/m2\/day continuous infusion for 5 days during weeks 4 and 10 (preop) and during weeks 16, 25, and 34 (postop) (in combination with cisplatin, doxorubicin, methotrexate [high-dose], and mesna) (Bacci, 2003)<br>Ifosfamide\/cisplatin\/epirubicin regimen: Children ?15 years: 2000 mg\/m2\/day over 4 hours for 3 days (days 2, 3, and 4) every 3 weeks for 3 cycles (preop) and every 4 weeks for 3 cycles (postop) (in combination with cisplatin, epirubicin, and mesna) (Basaran, 2007)<br>IE regimen: 3000 mg\/m2\/day over 3 hours for 4 days every 3-4 weeks (in combination with etoposide and mesna) (Gentet, 1997)<br>ICE regimen: Children ?1 year: 1800 mg\/m2\/day for 5 days every 3 weeks for up to 12 cycles (in combination with carboplatin and etoposide [and mesna]) (van Winkle, 2005)<br>Ifosfamide\/HDMT\/etoposide regimen: 3000 mg\/m2\/day over 3 hours for 4 days during weeks 4 and 9 (3 additional postop courses were administered in good responders) (in combination with methotrexate [high-dose], etoposide, and mesna) (Le Deley, 2007)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HUM01O":{"商品名稱":"Humatin 250mg Cap  (公費)","腎功能不良劑量調整":"腎功能受損的患者應特別小心。","小兒建議劑量":"25-35mg\/kg\/day * 5 day↑, Q6H-Q8H, PC","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HUM08I":{"商品名稱":"Humira 40mg Syringe#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"每兩週皮下注射一次, 每次 40 mg","抗生素手冊":"暫無資料"},"HUM11I":{"商品名稱":"Humalog Mix 25 KwikPen 1 IU(小單位檔)","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling; insulin requirements may be reduced due to changes in insulin clearance or metabolism; monitor blood glucose closely.\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HUM12I":{"商品名稱":"Humalog Mix 25 KwikPen 300U\/3ml#","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling; insulin requirements may be reduced due to changes in insulin clearance or metabolism; monitor blood glucose closely.\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HUM14I":{"商品名稱":"HUMALOG MIX 50 300U\/3ml KwikPen#","腎功能不良劑量調整":"不需要作劑量調整","小兒建議劑量":"與成人劑量相同，並遵照醫囑使用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HUM15I":{"商品名稱":"HUMALOG MIX 50 1 IU (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HYA01I":{"商品名稱":"Hyalase 1500U amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HYC01I":{"商品名稱":"Hycamtin 4mg Vial#","腎功能不良劑量調整":"I.V.:\r<br>Clcr ?40 mL\/minute: No dosage adjustment necessary.\r<br>Clcr 20-39 mL\/minute: Reduce dose to 0.75 mg\/m2\/dose\r<br>Clcr <20 mL\/minute: No dosage adjustment provided in manufacturer’s U.S. labeling (insufficient data available for dosing recommendation);","小兒建議劑量":"兒童\r<br>針對以 2 至 7.5 mg\/m2 的劑量連續24 小時輸注或以0.75 至1.95 mg\/m2\/day 的劑量連續輸注72 小時的小兒患者，研究topotecan 的藥物動力學。在兩項研究中，廓清率與使用相同劑量的成人廓清率相似","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HYD02E":{"商品名稱":"Hydrocortisone Cream 100mg\/10gm","腎功能不良劑量調整":"仿單無建議","小兒建議劑量":"Atopic dermatitis: Topical: Children ?3 months: Hydrocortisone butyrate (Locoid LipocreamR): Apply thin film to affected area twice daily","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HYD03E":{"商品名稱":"H2O2 3% 450ml Bot (洸洋)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HYD04O":{"商品名稱":"Hydrea 500mg Cap#","腎功能不良劑量調整":"\"- Sickle cell anemia:<br>\r<br>CrCl >=60 mL\/minute: No dosage adjustment (of initial dose) necessary.<br>\r<br>CrCl <60 mL\/minute: Reduce initial dose to 7.5 mg\/kg\/day (Yan, 2005); titrate to response\/avoidance of toxicity (refer to usual dosing).\r<br><br>ESRD: Reduce initi","小兒建議劑量":"\"Note: Doses should be based on ideal or actual body weight, whichever is less (per manufacturer).<br>Sickle cell anemia (unlabeled use): Children >=6 months: Oral: Initial: 15-20 mg\/kg once daily; may increase by 5 mg\/kg\/day every 2-6 months to a maximum dose of 30-35 mg\/kg\/day (Ferster, 2001; Hankins, 2005; Kinney, 1999; Thornburg, 2009; Wang, 2001; Wang, 2011; Zimmerman, 2004)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HYD06O":{"商品名稱":"Hydrine 500mg Cap","腎功能不良劑量調整":"\"- Sickle cell anemia:<br>\r<br>CrCl >=60 mL\/minute: No dosage adjustment (of initial dose) necessary.<br>\r<br>CrCl <60 mL\/minute: Reduce initial dose to 7.5 mg\/kg\/day (Yan, 2005); titrate to response\/avoidance of toxicity (refer to usual dosing).\r<br><br>ESRD: Reduce initi","小兒建議劑量":"\"Note: Doses should be based on ideal or actual body weight, whichever is less (per manufacturer).<br>Sickle cell anemia (unlabeled use): Children >=6 months: Oral: Initial: 15-20 mg\/kg once daily; may increase by 5 mg\/kg\/day every 2-6 months to a maximum dose of 30-35 mg\/kg\/day (Ferster, 2001; Hankins, 2005; Kinney, 1999; Thornburg, 2009; Wang, 2001; Wang, 2011; Zimmerman, 2004)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"HYZ01O":{"商品名稱":"Hyzaar FC 100\/12.5 MG Tab#","腎功能不良劑量調整":" 本品不建議使用在嚴重腎功能受損(肌酸酐廓清率≦30mL\/min)或肝功能受損之病患","小兒建議劑量":"\"對兒童之安全性及有效性尚未確立。 <br>曾在子宮內暴露在 HYZAAR 使用下的未足月嬰兒：如果發生寡尿或低血壓，應首重維持血壓與腎灌注。可能需要換血或透析作為回復低血壓與\/或代替受損之腎功能的方法。\"\r<br>","提示內容":"複方成分, 注意處方是否有重複使用同類藥品\r<br>注意服用thiazide類可能有低血鉀, 高尿酸血症的發生","抗生素手冊":"暫無資料"},"IBI01O":{"商品名稱":"Ibimo C.R. 60mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IBR01O":{"商品名稱":"IBRANCE 125MG CAP","腎功能不良劑量調整":"對輕、中度或重度腎功能不全( [CrCl] ? 15 ml\/min) 的病人，並不須調整IBRANCE的劑量。對須接受血液透析治療的病人，目前並無足夠的資料可作為此病人族群的劑量調整建議依據","小兒建議劑量":"Ibrance用於兒童及<18歲之青少年的安全性及療效性尚未確立。","提示內容":"應與食物併服，最好是於用餐時服用\r<br>不可以與葡萄柚或葡萄柚汁併用\r<br>膠囊應整顆吞服不可打開","抗生素手冊":"暫無資料"},"IBR02O":{"商品名稱":"Ibrance 100mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Ibrance用於兒童及<18歲之青少年的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ICH01E":{"商品名稱":"Ichderm Cream 5%\/15gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童使用本乳膏之安全性尚未確立。\r<br>","提示內容":"副作用為嗜睡(22 %), 衛教需注意","抗生素手冊":"暫無資料"},"ICL01O":{"商品名稱":"Iclusig 15mg Tab","腎功能不良劑量調整":"肝功能不全患者(Child-Pugh A,B,C)使用之建議起始劑量為30mg QD。","小兒建議劑量":"本品對兒童患者的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IDO02S":{"商品名稱":"Idofen Susp 2400mg\/120ml Bot#","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"6mo-12yr: \r<br><39℃ 0.25ml\/kg Q6-8H, >39℃ 0.5ml\/kg Q6-8H, \r<br>max: 2ml\/kg\/d; \r<br>成人: 20ml Q4-6H。\r<br>-----------------------------------------------------------------\r<br>簡易換算: (BW\/3)c.c. Q6H PRN if BT >39℃","提示內容":"6個月-12歲: <39℃ 0.25ml\/kg Q6-8H, >39℃ 0.5ml\/kg Q6-8H\r<br>簡易算法: (BW\/3)ml\/dose Q6H prn if BT >39℃\r<br>max. 2ml\/kg\/d","抗生素手冊":"暫無資料"},"IMB01O":{"商品名稱":"Imbruvica 140mg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"1. 切勿打開、破壞或咀嚼膠囊\r<br>2.注意CYP450 3A4 抑制劑交互作用劑量調整","抗生素手冊":"暫無資料"},"IMD01O":{"商品名稱":"Imdur 60mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"60 mg QD, 可增加至120 mg QD\r<br>(但不建議60 mg BID, 可能增加硝酸鹽類的耐受性)\r<br>持續釋放劑型，磨粉可能導致藥物短時間大量釋出→建議可改用同成分的Isormol 1# BIDPC","抗生素手冊":"暫無資料"},"IMF01I":{"商品名稱":"Imfinzi 120mg\/2.4ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未確立用於18歲以下兒童或青少年病人的安全性和有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMF02I":{"商品名稱":"Imfinzi (恩慈) 120mg\/2.4ml vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未確立用於18歲以下兒童或青少年病人的安全性和有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMF03I":{"商品名稱":"IMFINZI 500MG\/10ML VIAL","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMF04I":{"商品名稱":"IMFINZI (恩慈) 500MG\/10ML VIAL","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMI02O":{"商品名稱":"Imigran FDT 50mg Tab","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied). However, dosage adjustment not expected due to extensive metabolism to inactive agents. (Uptodate)","小兒建議劑量":"兒童與青少年（ 18歲以下）：本藥對兒童與青少年的安全性和有效性尚未建立","提示內容":"偏頭痛發作時應及早給予。須至少間隔2 hr再追加劑量：24小時內不宜超過6錠。\r<br>不可與其它偏頭痛藥物併用(需間隔至少24小時)","抗生素手冊":"暫無資料"},"IMO01I":{"商品名稱":"Imovax Polio 0.5ml Syringe (IPV)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"基礎接種:6週齡、10週齡、14週齡各施打一劑\r<br>\r<br>追加接種:\r<br>滿1歲孩童:第一次追加應與前劑間隔至少6個月。第二次追加建議4歲後施打，且與前劑間隔至少6個月。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMO01O":{"商品名稱":"Imodium 2mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMO02I":{"商品名稱":"Imojev (自費) 0.5ml Syringe","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer's labeling.","小兒建議劑量":"●基礎接種：年齡等於或大於9個月者：注射一劑0.5ml之配製疫苗。\r<br>●追加接種：兒童：基礎接種之後應追加注射一劑以達到長期保護效果。追加接種的時間點最好在基礎接種之後12個月，最長可延至24個月。\r<br>●接種部位: 接種者的年齡>2 歲，建議之注射部位為上臂的三角肌。接種者的年齡介於9-24 個月，建議之注射部位為大腿的前外側。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMO02O":{"商品名稱":"Imovane 7.5mg Tab #4","腎功能不良劑量調整":"於腎功能不良之病例中，雖然沒有發現到zopiclone或其代謝物的蓄積，但對腎功能損害之患者，其推薦起始劑量應為1\/2錠。","小兒建議劑量":"孩童及18歲以下之年輕人使用zopiclone之安全性及有效劑量尚未確立。","提示內容":"成人：推薦劑量為7.5mg ，不可超過7.5mg之劑量。","抗生素手冊":"暫無資料"},"IMO03I":{"商品名稱":"Imojev (公費) 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"若接種者的年齡2 歲，建議之注射部位為上臂外側。\r<br>若接種者的年齡介於9-24 個月，則建議之注射部位為大腿的前外側。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMO04O":{"商品名稱":"Imolex 2mg Cap","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":".急性腹瀉:小孩初次量為每公斤0.08 mg，然後0.04 mg 每天2-3次. 慢性腹瀉:小孩每天1顆膠囊分兩次服用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IMU01O":{"商品名稱":"Imuran 50mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 1.5-2.5mg\/kg q24h \r<br>[10-50 and CRRT]: 75%\r<br>[<10 and CAPD ]: 50%\r<br>HEMO: Supplement 0.25 mg\/kg","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IND03O":{"商品名稱":"Inderal 40mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IND04O":{"商品名稱":"Indomen 25mg Cap","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"兒童忌用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IND05O":{"商品名稱":"Indivina 28Tab\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IND06O":{"商品名稱":"Indoy 25mg Cap","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"兒童忌用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INF06I":{"商品名稱":"Infanrix 0.5ml Vial(公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INL01O":{"商品名稱":"Inlyta FC 1mg Tab","腎功能不良劑量調整":"輕到重度腎功能受損患者的起始劑量不須調整。針對末期腎臟病(Clcr<15)患者應謹慎使用。","小兒建議劑量":"目前尚未針對<18歲的患者進行過INLYTA的研究。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INL02O":{"商品名稱":"INLYTA FC 5MG TAB","腎功能不良劑量調整":"輕到重度腎功能受損患者的起始劑量不須調整。針對末期腎臟病(Clcr<15)患者應謹慎使用。","小兒建議劑量":"目前尚未針對<18歲的患者進行過INLYTA的研究。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INN01I":{"商品名稱":"Innomustine Inj 100mg Vial#","腎功能不良劑量調整":"Clcr <40 mL\/minute: Use is not recommended in the U.S. and Canadian manufacturers' labeling. [uptodate]","小兒建議劑量":"對於兒童的療效及安全性尚未建立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INS01O":{"商品名稱":"Inspra F.C. Tablets 50mg#","腎功能不良劑量調整":"中度至重度腎功能不全(Clcr < 50 ) 禁用。(仿單)\r<br>\r<br>HF (post-MI):(Uptodate)\r<br>Clcr 31-50 mL\/min or Scr >2 mg\/dL (男性) or >1.8 mg\/dL (女性): 不須調整，但要小心使用\r<br>Clcr <30 : 禁用.","小兒建議劑量":"目前沒有充分的資料eplerenonc使用於兒童族群，故不建議小兒使用","提示內容":"注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"INS03I":{"商品名稱":"Insulatard HM(NPH) 1000iu\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Diabetes mellitus: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INS04I":{"商品名稱":"Insulatard HM(NPH) 1iu (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Diabetes mellitus: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INV01I":{"商品名稱":"Invanz 1gm Vial#","腎功能不良劑量調整":"Usual Dosing (Adults) :1g\/day\r<br>CCl<30 ml\/min and ESRD: 500mg QD","小兒建議劑量":"\"Infants >=3 months and Children:<br><br>\r<br>Community-acquired pneumonia and complicated urinary tract infections (including pyelonephritis): I.M., I.V.: 15 mg\/kg twice daily (maximum: 1 g daily); duration of total antibiotic treatment: 10-14 days (Note: Duration in\"\r<br>","提示內容":"一般劑量1000 mg QD, ClCr<30 ml\/min 需調整為500 mg QD\r<br>依張進祿《臨床使用抗生素手冊》的說明與s-lactams 共通過敏反應( cross-hypersensitivity reaction)的機率很低\r<br>與Depakine併用會降低Depakine的血中濃度, 影響療效","抗生素手冊":"建議量: 1 gm qd<br>Ccr less than 30, HD or PD: 500 mg qd "},"INV01O":{"商品名稱":"Invega ER 3mg Tab#","腎功能不良劑量調整":"腎功能損傷會降低排除，需依腎功能調整劑量:\r<br>[Clcr 50-79 mL\/min]: Max. dose: 6 mg QD.\r<br>[Clcr 10-49]: Max. dose: 3 mg qd.\r<br>[Clcr <10]: No data provided by manufacturer.","小兒建議劑量":"Schizophrenia:U.S. labeling:Adolescents 12-17 years: Oral: Initial: 3 mg once daily; titration not required (no known benefit to efficacy from higher doses [ie, 6 mg daily for patients <51 kg and 12 mg daily for patients >=51 kg]). If exceeding 3 mg daily, increases of 3 mg daily are recommended no more frequently than every 5 days\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INV02I":{"商品名稱":"Invega Sustenna 100mg\/1ml Syringe#","腎功能不良劑量調整":"輕度腎功能缺損(Clcr80~50): 本品的建議起始療程為於第1天投予 (1ml)，並於一週後投予 (0.75ml)，且兩劑皆應注射於手臂三角肌。之後則每月一次於三角肌或臀部肌肉注射 (0.5ml)。\r<br>(Clcr<50ml\/min):不建議用於中度或重度腎功能缺損的患者。","小兒建議劑量":"對<18歲之患者使用INVEGA SUSTENNA的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INV02O":{"商品名稱":"INVEGA ER 9mg Tab#","腎功能不良劑量調整":"腎功能損傷會降低排除，需依腎功能調整劑量:\r<br>[Clcr 50-79 mL\/min]: Max. dose: 6 mg QD.\r<br>[Clcr 10-49]: Max. dose: 3 mg qd.\r<br>[Clcr <10]: No data provided by manufacturer.","小兒建議劑量":"Schizophrenia:U.S. labeling:Adolescents 12-17 years: Oral: Initial: 3 mg once daily; titration not required (no known benefit to efficacy from higher doses [ie, 6 mg daily for patients <51 kg and 12 mg daily for patients >=51 kg]). If exceeding 3 mg daily, increases of 3 mg daily are recommended no more frequently than every 5 days\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INV03I":{"商品名稱":"INVEGA SUSTENNA 150mg\/1.5ml Syringe#","腎功能不良劑量調整":"輕度腎功能缺損(Clcr80~50): 本品的建議起始療程為於第1天投予 (1ml)，並於一週後投予 (0.75ml)，且兩劑皆應注射於手臂三角肌。之後則每月一次於三角肌或臀部肌肉注射 (0.5ml)。\r<br>(Clcr<50ml\/min):不建議用於中度或重度腎功能缺損的患者。","小兒建議劑量":"對<18歲之患者使用INVEGA SUSTENNA的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INV04I":{"商品名稱":"Invega Trinza 350mg Syringe","腎功能不良劑量調整":"不建議用於中度或重度腎功能不全（肌酸酐廓清率< 50 毫升\/ 分鐘）的病人","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INV05I":{"商品名稱":"INVEGA TRINZA 525mg Syringe","腎功能不良劑量調整":"不建議用於中度或重度腎功能不全（肌酸酐廓清率< 50 毫升\/ 分鐘）的病人","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"INV07I":{"商品名稱":"INVEGA HAFYERA 1000mg Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IOD02M":{"商品名稱":"Iodine 100g Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IOD05E":{"商品名稱":"Iodosorb Powder#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IOP01I":{"商品名稱":"Iopamiro 370#200ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IOP02I":{"商品名稱":"Iopamiro 370#100ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IOP03I":{"商品名稱":"Iopamiro 300#50ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IOP04I":{"商品名稱":"IOPAMIRO 370 (專科) 100ML BOT","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IOP05I":{"商品名稱":"Iopamiro 300 (專科) 50ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IPR02E":{"商品名稱":"Ipratran Inh Soln 500mcg\/2ml","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling (has not been studied).\r<br>","小兒建議劑量":"\"Asthma exacerbation, acute (NIH Asthma Guidelines, 2007):<br>\r<br>Nebulization:<br>\r<br>Children <=12 years: 250-500 mcg every 20 minutes for 3 doses, then as needed. Note: Should be given in combination with a short-acting beta-adrenergic agonist.<br>\r<br>Children >12 years: Refer to adult dosing.\r<br><br>Metered-dose inhaler:<br>\r<br>Children ?<=2 years: 4-8 inhalations every 20 minutes as needed for up to 3 hours. Note: Should be given in combination with a short-acting beta-adrenergic agonist.\r<br><br>Children >12 years: Refer to adult dosing\"\r<br>","提示內容":"成分與Combivent 重複, 需注意","抗生素手冊":"暫無資料"},"IRE01O":{"商品名稱":"Iressa 250mg Tab#","腎功能不良劑量調整":"No dosage adjustment necessary. Use caution in severe impairment (CrCl ?20 mL\/minute).\r<br>","小兒建議劑量":"IRESSA並不建議供兒童或青少年使用，因尚未對此族群進行安全性及有效性之研究。?\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"IRI01I":{"商品名稱":"Irino 100mg\/5ml Vial#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Children <10 kg: 20 mg\/kg 三週打一次\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ISO01E":{"商品名稱":"Isopto Carpine Oph Soln 2% 15ml Bot","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"仿單未提及","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ISO05I":{"商品名稱":"Isoket 10mg\/10ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ISO06O":{"商品名稱":"Isoniazide 100mg Tab#","腎功能不良劑量調整":"TB治療指引: isoniazid不須改變劑量、頻率，但吃isoniazid的病人應加開pyridoxine. \r<br>\r<br>熱病\/Uptodate\r<br>Usual Dosing (Adults) :TB: 300mg orally once daily.No adjustment in renal failure  \r<br>Hemodialysis: No adjustment -  on dialysis days, give dose after dialysis","小兒建議劑量":"暫無資料","提示內容":"Isonicotinyl Hydrazine 100mg Tab#缺貨，替代藥品開檔","抗生素手冊":"暫無資料"},"ISO07O":{"商品名稱":"IsoMIL(Verapamil) 40mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ISO08O":{"商品名稱":"ISOPTIN SR 240MG TAB","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ISO09O":{"商品名稱":"Isormol(Is-5-Mn) 20mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"每日早晚各一次，建議兩次劑量之間隔為7小時(為避免Nitrate類藥物耐受性產生)","抗生素手冊":"暫無資料"},"ISO11O":{"商品名稱":"Isonicotinyl Hydrazine 100mg Tab#","腎功能不良劑量調整":"TB治療指引: isoniazid不須改變劑量、頻率，但吃isoniazid的病人應加開pyridoxine. \r<br>\r<br>熱病\/Uptodate\r<br>Usual Dosing (Adults) :TB: 300mg orally once daily.No adjustment in renal failure  \r<br>Hemodialysis: No adjustment -  on dialysis days, give dose after dialysis","小兒建議劑量":"小兒按體重每公斤一日量1~4mg計算，分3-4次服用，視症狀得適宜增量之。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ISO12O":{"商品名稱":"Isobide 10mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"對兒童使用之有效性及安全性尚未被確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ISO13O":{"商品名稱":"Isoptin 40mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JAD01O":{"商品名稱":"Jadenu 360mg Tab#","腎功能不良劑量調整":"1. Scr >正常上限2倍或Clcr < 40ml\/min的患者不應使用Jadenu。\r<br>\r<br>2. 重度肝功能不全(Child-Pugh C) 患者不應使用Jadenu。\r<br>\r<br>3. 中度肝功能不全(Child-Pugh B) 患者的起始劑量應降低50%。","小兒建議劑量":"輸血型鐵質沉著症: 2歲以上建議起始劑量為14mg\/kg\/day，後續可以依反應調整劑量至7-28mg\/kg\/day。\r<br>\r<br>非輸血型海洋性貧血鐵質沉著症: 10歲以上建議起始劑量為7mg\/kg\/day，後續可以依反應調整劑量至7-14mg\/kg\/day。","提示內容":"1.屬鐵螯合劑，本院另有同成分低劑量的Exjade 125mg Tab (可溶錠)，兩者生體可用率不同，轉換時要注意\r<br>2.轉換本藥的劑量應較Exjade 低30%，並取最接近的整顆錠劑使用\r<br>3.無法吞服的病患，可將本藥 磨碎，並加入軟質食物，例如：優格或蘋果泥中一併服用。磨碎後應立刻使用完畢。\r<br>4.轉換劑型後的第一個月應每週監測血清肌酸酐(creatinine) 濃度","抗生素手冊":"暫無資料"},"JAK01O":{"商品名稱":"Jakavi 5mg Tab#","腎功能不良劑量調整":"．Clcr >30: 不用調整劑量。\r<br>．Clcr < 30  對嚴重腎功能不全 的骨髓纖維化病人: :起始劑量降低約 50%，建議起始劑量: 5mg BID\r<br>．HD: 建議起始劑量為單一劑量 15-20 mg，或給予兩劑 10mg(間隔12hr)，僅於每次血液透析結束後投予一次。\r<br>．不需要透析的 ESRD：避免使用。","小兒建議劑量":"兒童\r<br>Jakavi 用於18 歲以下兒童病患的安全性與療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JAK02O":{"商品名稱":"JAKAVI 20MG TAB","腎功能不良劑量調整":"．Clcr >30: 不用調整劑量。\r<br>．Clcr < 30  對嚴重腎功能不全 的骨髓纖維化病人: :起始劑量降低約 50%，建議起始劑量: 5mg BID\r<br>．HD: 建議起始劑量為單一劑量 15-20 mg，或給予兩劑 10mg(間隔12hr)，僅於每次血液透析結束後投予一次。\r<br>．不需要透析的 ESRD：避免使用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JAK03O":{"商品名稱":"JAKAVI 15MG TAB","腎功能不良劑量調整":"．Clcr >30: 不用調整劑量。\r<br>．Clcr < 30  對嚴重腎功能不全 的骨髓纖維化病人: :起始劑量降低約 50%，建議起始劑量: 5mg BID\r<br>．HD: 建議起始劑量為單一劑量 15-20 mg，或給予兩劑 10mg(間隔12hr)，僅於每次血液透析結束後投予一次。\r<br>．不需要透析的 ESRD：避免使用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JAL01E":{"商品名稱":"Jaline lotion 1-Gal Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JAN01O":{"商品名稱":"Januvia 100mg Tab#","腎功能不良劑量調整":"eGFR 30~45：50mg QD\r<br>eGFR 15~30：25mg QD\r<br>ESRD(eGFR<15),HEMO\/PD：25mg QD","小兒建議劑量":"目前並未曾進行過使用JANUVIA治療小兒病患的研究。 \r<br>","提示內容":"一般劑量: 100 mg QD; \r<br>ClCr 30-50 mL\/min: 50 mg QD, ClCr <30 mL\/min: 25 mg QD","抗生素手冊":"暫無資料"},"JAN02O":{"商品名稱":"JANUMET 50\/500 mg FC Tab#","腎功能不良劑量調整":"Metfromin：於腎功能損傷之老年人不宜使用本品\r<br>$禁忌使用於eGFR<30 QD\r<br>","小兒建議劑量":"對18歲以下的小而有效性和安全性尚未確立\r<br>","提示內容":"Sitagliptin一般劑量: 100 mg QD\r<br>ClCr 30-50 mL\/min: 50 mg QD, ClCr <30 mL\/min: 25 mg QD\r<br>複方藥品, 內含Metformin需注意\r<br>(1)每日最高劑量: 速效劑型：3000 mg；緩釋劑型：2000mg\r<br>(2)腎絲球體過濾率（eGFR）介於30-45 ml\/min\/1.73 m2應減量使用\r<br>(3)腎功能不全患者，腎絲球體過濾率（eGFR）小於30 ml\/min\/1.73 m2禁用)\r<br>投予含碘顯影劑時，應在檢查前後至少48小時停止使用，待腎功能經評估確定已恢復正常後，才能再服用","抗生素手冊":"暫無資料"},"JAR01O":{"商品名稱":"Jardiance 10mg Tab#","腎功能不良劑量調整":"Jardiance 不建議使用於eGFR<30 的患者. \r<br>eGFR<60患者:宜密切監測腎功能.","小兒建議劑量":"JardianceR 不建議使用於小兒及青少年患者。因為缺乏相關資料，目前小兒患者及小於18 歲以下之青少年患者使用JardianceR 之安全性及療效尚未建立","提示內容":"1.10-25mg QD\r<br>2.eGFR<30 mL\/min\/1.73 m2的病人禁用\r<br>3.注意是否有脫水、生殖泌尿道感染之情況","抗生素手冊":"暫無資料"},"JAR02O":{"商品名稱":"JARDIANCE DUO 12.5\/850mg Tab","腎功能不良劑量調整":"(eGFR >45): No dosage adjustment necessary. 至少年度監測腎功能。.\r<br>(eGFR <30): Use is contraindicated by the manufacturer.\r<br>Dialysis: Use is contraindicated.\r<br>---【複方錠】-------------------------\r<br>Empagliflozin: 同上\r<br>Metformin: 同上。eGFR30~45: 減量\/小","小兒建議劑量":"用於未滿18歲病患的安全性與有效性，尚未獲得確立","提示內容":"口服降血醣劑【複方】Empagliflozin(SGLT2)+Metformin\r<br>留意血管內容量減少的狀況，並監測治療後是否低血壓的症狀和徵象\r<br>留意生殖泌尿道感染。\r<br>eGFR <45 mL\/minute\/1.73 m2: Use is contraindicated.\r<br>投予含碘顯影劑時，應在檢查前後至少48小時停止使用，待腎功能經評估確定已恢復正常後，才能再服用\r<br>預定手術時，應考慮術前暫停至少三天","抗生素手冊":"暫無資料"},"JIN01O":{"商品名稱":"Jinarc 15mg 28tab\/Box","腎功能不良劑量調整":"目前尚未充分研究Jinarc對第5期慢性腎臟病(CKD)的安全性及療效，因此在腎功能不全進展至第5期慢性腎臟病(CKD)時，應停止進行tolvaptan治療。(仿單)","小兒建議劑量":"對兒童及青少年的安全性及療效性尚未確立。","提示內容":"本品須與JIN03O同時開立且數量須相同，會有兩個藥袋但只會發ㄧ盒JINARC【包裝為45mg+15mg】\r<br>1.早晨的一劑應在早餐的30分鐘前服用\r<br>2.本品與Samsca 15mg tab為同成份，但適應症不同。 \r<br>3.在開始治療前，先進行肝臟轉胺?及膽紅素的抽血檢查，且接下來 18 個月是持續每個月檢查一次，之後為每3個月定期檢查一次。","抗生素手冊":"暫無資料"},"JIN02O":{"商品名稱":"JINARC 30MG 28TAB\/BOX","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對兒童及青少年的安全性及療效性尚未確立。","提示內容":"本品須與JIN04O同時開立且數量須相同，會有兩個藥袋但只會發ㄧ盒JINARC【包裝為60mg+30mg】\r<br>1.早晨的一劑應在早餐的30分鐘前服用\r<br>2.本品與Samsca 15mg tab為同成份，但適應症不同。 \r<br>3.在開始治療前，先進行肝臟轉胺?及膽紅素的抽血檢查，且接下來 18 個月是持續每個月檢查一次，之後為每3個月定期檢查一次。","抗生素手冊":"暫無資料"},"JIN03O":{"商品名稱":"JINARC 45MG 28TAB\/BOX","腎功能不良劑量調整":"目前尚未充分研究Jinarc對第5期慢性腎臟病(CKD)的安全性及療效，因此在腎功能不全進展至第5期慢性腎臟病(CKD)時，應停止進行tolvaptan治療。 (仿單)","小兒建議劑量":"對兒童及青少年的安全性及療效性尚未確立。","提示內容":"本品須與JIN01O同時開立且數量須相同，會有兩個藥袋但只會發ㄧ盒JINARC【包裝為45mg+15mg】\r<br>1.早晨的一劑應在早餐的30分鐘前服用\r<br>2.本品與Samsca 15mg tab為同成份，但適應症不同。\r<br>3.在開始治療前，先進行肝臟轉胺?及膽紅素的抽血檢查，且接下來 18 個月是持續每個月檢查一次，之後為每3個月定期檢查一次。","抗生素手冊":"暫無資料"},"JIN04O":{"商品名稱":"JINARC 60MG 28TAB\/BOX","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對兒童及青少年的安全性及療效性尚未確立。","提示內容":"本品須與JIN02O同時開立且數量須相同，會有兩個藥袋但只會發ㄧ盒JINARC【包裝為60mg+30mg】\r<br>1.早晨的一劑應在早餐的30分鐘前服用\r<br>2.本品與Samsca 15mg tab為同成份，但適應症不同。 \r<br>3.在開始治療前，先進行肝臟轉胺?及膽紅素的抽血檢查，且接下來 18 個月是持續每個月檢查一次，之後為每3個月定期檢查一次。","抗生素手冊":"暫無資料"},"JIN05O":{"商品名稱":"JINARC 90MG 28TAB\/BOX","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對兒童及青少年的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JLA01I":{"商品名稱":"Joint Local Analgesic 80ml Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JUV01O":{"商品名稱":"Juvela N 200mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"JYN01I":{"商品名稱":"Jynneos MPOX (公費) Vaccine","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAD01I":{"商品名稱":"KADCYLA 160mg\/8ml Vial","腎功能不良劑量調整":"不曾針對KADCYLA進行過專門的腎功能不全試驗。CrCl <30 mL\/minute: No dosage adjustment provided in the manufacturer’s labeling (has not been studied)","小兒建議劑量":"KADCYLA使用於兒童病患的安全性及療效資料尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAD02I":{"商品名稱":"KADCYLA(恩慈) 160mg\/8ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAD03I":{"商品名稱":"Kadcyla(恩慈) 100mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAD04I":{"商品名稱":"Kadcyla 100mg\/5ml Vial#","腎功能不良劑量調整":"不曾針對KADCYLA進行過專門的腎功能不全試驗。CrCl <30 mL\/minute: No dosage adjustment provided in the manufacturer’s labeling (has not been studied)","小兒建議劑量":"KADCYLA使用於兒童病患的安全性及療效資料尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAI02O":{"商品名稱":"Kaicide 600mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Flukes:\r<br>Clonorchiasis; Opisthorchiasis:Oral: 25 mg\/kg\/dose 3 times daily at 4- to 6-hour intervals for 1 to 2 days \r<br>Fasciolopsiasis:Oral: 25 mg\/kg\/dose 3 times daily for 1 day\r<br>Paragonimiasis:Oral: 25 mg\/kg\/dose 3 times daily for 2 to 3 days","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAL01O":{"商品名稱":"Kalimate powder 5gm pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAN02I":{"商品名稱":"Kanjinti 420mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用Kanjinti的安全性及效果","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAN03I":{"商品名稱":"Kanjinti 1mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用Kanjinti的安全性及效果","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAN04I":{"商品名稱":"Kanjinti (恩慈) 420mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用Kanjinti的安全性及效果","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAN05I":{"商品名稱":"Kanjinti (恩慈) 1mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用Kanjinti的安全性及效果","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAP01O":{"商品名稱":"Kapetral FC 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KAR01E":{"商品名稱":"Kary Uni Oph Susp 0.25mg\/5ml Bot","腎功能不良劑量調整":"仿單無記載","小兒建議劑量":"適應症只有\"老人性\"白內障","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KCI01O":{"商品名稱":"K-Citrate Granules 5gm\/Pack","腎功能不良劑量調整":"仿單資料庫並無資料，應該患者血鉀情況調整劑量。\r<br>腎疾患者大劑量會引起高鉀血症及鹼中毒。","小兒建議劑量":"仿單及資料庫並無資料。","提示內容":"含高濃度的鉀，必須先加水稀釋後再服用(5g 泡180ml水), 注意限水病人使用。\r<br>腎功能不全病人易引起高血鉀症, 需慎用","抗生素手冊":"暫無資料"},"KEF01O":{"商品名稱":"Keflex 500mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KEL01E":{"商品名稱":"Kelac Oph Soln 0.5% 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於12歲以下之安全性及療效尚未確立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KEM02I":{"商品名稱":"Kemoplat 50mg\/100ml Vial#","腎功能不良劑量調整":"原廠仿單: should not be given until Scr <1.5 mg\/dL and\/or BUN is <25 mg\/dL \r<br>其它建議Aronoff, 2007:\r<br>Clcr 10-50 : 給 75% of dose\r<br>Clcr <10 : 給 50% of dose\r<br>H\/D:  給 50% of dose posthemodialysis\r<br>(CAPD): 給50% of dose\r<br>(CRRT): 給 75% of dose [uptodate","小兒建議劑量":"另有兒童劑量，詳見protocol","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KEM04I":{"商品名稱":"Kemocarb 150mg Vial#","腎功能不良劑量調整":"會加強腎毒性藥物的腎臟作用。Clcr<60需劑量調整。\r<br>Clcr 40-59 ml\/min: 250 mg\/m2\r<br>Clcr 16-40: 200mg\/m2\r<br>嚴重腎功能不全(<15)患者: 資料太少，無治療建議。","小兒建議劑量":"用於兒童患者的安全性及有效性尚未確立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KEP01I":{"商品名稱":"Keppra Inj 500mg\/5ml Vial","腎功能不良劑量調整":"(>80 g","小兒建議劑量":" 小兒族群 (6-12 歲) 癲癇病童單次使用(20mg\/kg)後，levetiracetam的半衰期為六小時。擬似身體肅清力(body clearance)比成人病患約高 30%\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KEP01O":{"商品名稱":"Keppra 500mg Tab","腎功能不良劑量調整":"[>80 g","小兒建議劑量":"Keppra 500mg Tab\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KEP01S":{"商品名稱":"Keppra Oral Soln 100mg\/ml;300ml Bot#","腎功能不良劑量調整":"中重度腎功能不良者建議調整劑量\r<br>","小兒建議劑量":"依體重計算，初始劑量為每天兩次，每次10mg\/kg. 視病人的臨床反應及耐受性，劑量可增加到最高每次30mg\/lk, 每日兩次。\r<br>(1) 體重20kg以下的孩童建議使用Keppra內服液劑。\r<br>(2) 體重50kg以上的孩童其劑量與成人相同。\r<br>---\r<br>嬰兒及四歲以下孩童：不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KER02O":{"商品名稱":"Kerendia FC 10mg Tab","腎功能不良劑量調整":"eGFR>=60 20mg QD\r<br>25<=eGFR<60 10mg QD\r<br>eGFR<25 DC","小兒建議劑量":"未在18歲以下的病人中確定Kerendia的安全性和療效","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KER03O":{"商品名稱":"KERENDIA FC 20MG TAB","腎功能不良劑量調整":"eGFR>=60 20mg QD\r<br>25<=eGFR<60 10mg QD\r<br>eGFR<25 DC","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KET01E":{"商品名稱":"KETO PAP 30mg 6piece\/Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"處方單位為一包(Pack)，每包內含有四片(piece)。\r<br>藥委會通過急用零購品項開檔使用，該品項為全自費\r<br>通常一日一次貼於患部，慢性疾患或嚴重疼痛的人，可以一日換貼兩到三次。可以切割。","抗生素手冊":"暫無資料"},"KET01I":{"商品名稱":"Ketalar 500mg\/10ml Inj #3","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Oral: 6-10 mg\/kg for 1 dose I.V.: Range: 0.5-2 mg\/kg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KET03I":{"商品名稱":"Ketalar 1-ml;50mg #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KET04O":{"商品名稱":"Ketosteril Tab","腎功能不良劑量調整":"每一顆約等於1.5g蛋白質。含50mg calcium.\r<br>使用請配合【低蛋白飲食】\r<br>健保給付: eGFR<15，每日至多使用六顆\r<br>0.28-0.43 g\/kg IBW protein + keto acide analogs to meet protein requirement(0.55-0.6g\/kg IBW)\r<br>(KDOQI 2019)\r<br>\r<br>","小兒建議劑量":"口服。遵照醫師處方使用或以每天每六公斤體重一粒，分成三次\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KET05I":{"商品名稱":"Keto 30mg\/1ml Amp","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15未透析者:禁用","小兒建議劑量":"infants >=1 month and Children <2 years:?Multiple-dose treatment: I.V.: 0.5 mg\/kg every 6-8 hours\r<br>","提示內容":"限用於短期止痛(≦5天), 不可用於退燒\r<br>起始劑量: 1 mg\/kg (max. 60 mg) \r<br>               接著 0.5 mg\/kg Q6-8H (max: 30 mg\/dose), 使用時間<48-72hr \r<br>單次劑量可30 mg IM 或15 mg IV\r<br>65歲以上老年人與腎功能不全者: \r<br>應將劑量減半為15 mg IV\/IM Q6H (max dose: 60 mg\/ day)","抗生素手冊":"暫無資料"},"KET99I":{"商品名稱":"Ketalar (試驗) 500mg\/10ml Inj #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KEY02I":{"商品名稱":"KeyBone 3mg\/3ml Syringe","腎功能不良劑量調整":"Clcr ?30 mL\/minute: No dosage adjustment necessary.\r<br>\r<br>Clcr <30 mL\/minute: Use not recommended","小兒建議劑量":"目前尚未曾針對<18歲的患者研究過藥物動力學。","提示內容":"Bonviva 3mg\/3ml Syringe 替代藥品開檔使用\r<br>骨質疏鬆症: 3個月注射一次, 以15 至30 秒的時間靜脈注射3 mg\r<br>不可用於SCr>200μmol\/L (2.3 mg\/dL) 或Clcr <30 mL\/min 的患者","抗生素手冊":"暫無資料"},"KEY03I":{"商品名稱":"KEYTRUDA 100mg\/4ml vial","腎功能不良劑量調整":"根據族群藥物動力學分析的結果，對腎功能不全的患者，並不須調整劑量","小兒建議劑量":"兒童之使用:KEYTRUDA用於兒童病患的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KGL01S":{"商品名稱":"K-Glu oral solution 20meq\/15ml","腎功能不良劑量調整":"嚴重腎臟疾病病人禁用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KID01S":{"商品名稱":"Kidsolone Oral Soln 1.344mg\/ml;60ml Bot","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"成人：起始劑量為每日5~60ml，視疾病而定。\r<br>兒童：起始劑量為0.14~2mg\/kg\/day，分成三～四次服用，視疾病而定。\r<br>--------------------------------------------------\r<br>簡易換算: 1 c.c.\/kg\/d divided in 3-4 doses.","提示內容":"簡易換算: 1 c.c.\/kg\/d divided in 3-4 doses","抗生素手冊":"暫無資料"},"KIS01O":{"商品名稱":"Kisqali 200mg Tab","腎功能不良劑量調整":"輕度(60≦eGFR<90)和中度(30≦eGFR<60)腎功能不全，對 ribociclib 的暴露量並無影響。","小兒建議劑量":"暫無資料","提示內容":"開始治療前應先評估心電圖 (ECG)會引起QT延長；治療前應先進行肝功能檢驗 (LFT)。治療前應先檢驗全血球計數 (CBC)\r<br>此藥的使用需並用Aromatase inhibitor。三顆 200 毫克膜衣錠) 連續 21 天，之後暫停治療 7 天，一個完整療程共計 28 天。\r<br>服藥後嘔吐或錯過一劑，當天不需補服另一劑，應整顆吞服(不可咀嚼、壓碎或剝開藥錠)\r<br>仿單中列有多種情形需調整劑量，請注意。\r<br>避免服用葡萄柚汁、石榴汁。","抗生素手冊":"暫無資料"},"KLA01O":{"商品名稱":"Klaricid XL 500mg Tab#","腎功能不良劑量調整":"Klaricid XL不可用於腎功能不全患者 (肌酸酐廓清率CLcr低於 30 mL\/min)。此族群病患或許可使用Clarithromycin tablets速放劑型。","小兒建議劑量":"十二歲以上之兒童：與成人劑量相同。\r<br>十二歲以下之兒童：使用Klaricid 小兒用懸液劑。(院內無)\r<br>Klaricid XL尚未對十二歲以下之兒童進行研究。","提示內容":"暫無資料","抗生素手冊":"建議量: 1 gm qd<br>須飯後"},"KLA02O":{"商品名稱":"Klaricid 250mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KLA03O":{"商品名稱":"Klarith F.C. 250MG Tab#","腎功能不良劑量調整":"IR=immidiate releases\r<br>Clcr > 30：不須調整劑量\r<br>Clcr <30：250mg QD~Q12H\r<br>HD：250mg QD~Q12H [3]\r<br>這些病患不得連續使用超過14天。","小兒建議劑量":"Usual dosage range: \r<br>Infants ?6 months, Children, and Adolescents: Oral: 7.5 mg\/kg every 12 hours (maximum: 500 mg\/dose) for 10 days (UpTodate)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KNO01O":{"商品名稱":"Knowful 400mg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KNO02I":{"商品名稱":"Knowful 1gm\/5ml Amp#","腎功能不良劑量調整":"Clcr 79~50: 2\/3 劑量，每日分2~3次服用\r<br>Clcr 49~30:  1\/3劑量，每日分2次服用\r<br>Clcr <30 : 1\/6劑量，每日1次\r<br>Clcr <20 : 禁用\"\r<br>","小兒建議劑量":"暫無資料","提示內容":"一般成人平均劑量為1gm TID\r<br>在初期注射投藥時，每天可達到10gm或15gm。依病情輕重而酌量使用。ClCr 79~50: 2\/3 劑量BID-TID,  ClCr 49~30: 1\/3劑量，BID\r<br>ClCr <30 : 1\/6劑量QD,  ClCr <20 : 禁用","抗生素手冊":"暫無資料"},"KOC01O":{"商品名稱":"Kocel 6gm Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6歲左右約成人劑量的一半。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KOM01O":{"商品名稱":"Kombiglyze XR 5mg\/1000mg Tab#","腎功能不良劑量調整":"Metformin 大部分經由腎臟排除，所以腎功能不全的程度越嚴重，在患者體內蓄積和乳酸中毒的風險越大。腎功能不全患者禁止使用 KOMBIGLYZE XR 治療[1]\r<br>---【複方錠】---------------------\r<br>．Metformin：禁用於eGFR<30者。eGFR 30~45: 應減量使用。\r<br>．Saxag","小兒建議劑量":"尚未確立兒童患者使用 KOMBIGLYZE XR 的安全性及療效。","提示內容":"投予含碘顯影劑時，應在檢查前後至少48小時停止使用，待腎功能經評估確定已恢復正常後，才能再服用\r<br>1.Daily MAX. DOSE : saxagliptin 5mg與持效型metformin 2000mg\r<br>2.必須整粒吞服，絕不可磨碎、切割或嚼碎\r<br>3.強效CYP3A4\/5抑制劑合併使用時，劑量限制是2.5 毫克\/1000毫克 一天一次\r<br>4.不可用於eGFR<30 mL\/minute\/1.73 m2的病人","抗生素手冊":"暫無資料"},"KRE02O":{"商品名稱":"Kremezin 2g Pack","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"12歲以下的兒童: 1g\/kg 活性碳。急性中毒時，依小孩之體重和中毒程度給予10-50g之活性碳，幼兒初劑量給予10-20g之活性碳，數分鐘根據醫師指示，可重複給藥，較大的小孩儘量給予30-50g的活性碳","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KRE03O":{"商品名稱":"Kremezin 2g 4Tab\/Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"KYP01I":{"商品名稱":"Kyprolis 30mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒科病人使用之安全及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAB01O":{"商品名稱":"Labtal 200mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"安全性及有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAC01O":{"商品名稱":"Lactam 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAC02I":{"商品名稱":"Lactated Ringer 0.5L 塑膠瓶","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAC03S":{"商品名稱":"Lactul Syrup 300ml Bot","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"嬰兒:一日劑量2.5-10 mL 小孩:一日劑量40-90 mL；","提示內容":"治療肝性腦病變可用直腸灌腸方式: \r<br>300 ml Lactulose 以 700 ml NS稀釋後灌腸, 並於直腸內留置30-60分鐘\r<br>Lactulose代謝後產生氣體可能惡化脹氣情形\r<br>→若同時併用Kascoal, 需注意病人病情變化","抗生素手冊":"暫無資料"},"LAC04S":{"商品名稱":"Lactul Syrup 1ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"嬰兒:一日劑量2.5-10 mL 小孩:一日劑量40-90 mL；","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAI01O":{"商品名稱":"Laidec F.C 50mg Tab","腎功能不良劑量調整":"尚未對這類病人作重覆投與之研究，不建議使用於腎功能不全病患","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAM01O":{"商品名稱":"Lamisil 250mg Tab#","腎功能不良劑量調整":"Usual Dose：250mg po qd.\r<br>Clcr[<50 ml\/min and HEMO：no dosage adjustments provided in the manufacturer's labeling[3]\r<br>\r<br>Clcr<50：250mg QOD [5]","小兒建議劑量":"<20kg 62.5mg qd, 20~40kg 125mg qd, >40kg 250mg qd\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAM02O":{"商品名稱":"Lamictal 50mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 起始50mg q12-24h, 維持 100-500mg qd\r<br>[10-50]:  75% \r<br>[<10 ]: 100mg qod\r<br>HEMO: 100mg after dialysis","小兒建議劑量":"成人及>12歲小孩對於那些沒有服用Sodium valproate者，初劑量授予50mg，一天一次，持續二星期。接著每天投予100mg，分兩次投予，持續二星期。其後，平時之維持劑量每天200～400mg分兩次投予，可達到最好的效果。併服depakine病人需減量1\/2。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAN02O":{"商品名稱":"Lanoxin 0.25mg Tab (Digoxin)","腎功能不良劑量調整":"【可監測血中濃度】以確認療效及預防毒性\r<br>[Clcr >50 ml\/min]： 0.25~0.5mg q24h\r<br>[10-50]：25-75% q36h\r<br>[<10 ]  ：10-25% q48h \r<br>HEMO： None","小兒建議劑量":"毛地黃著效劑量：口服：孩童：新生兒─每公斤40～60mcg；1個月至2歲者每公斤60mcg。\r<br>2. 維持劑量：口服\/靜注：成人─每天0.125-0.5mg(平均劑量每天0.25mg)。小孩─為毛地黃著效劑量的20%-30%。\r<br>(另有水劑)","提示內容":"注意病人是否有高血鉀的症狀(可能是中毒的情況)\r<br>若使用造成低血鉀的藥品，可能會造成毒性增加\r<br>Clarithromycin併用 digoxin 可能增加 digoxin 毒性,  digoxin劑量需減半","抗生素手冊":"暫無資料"},"LAN03I":{"商品名稱":"Lanoxin 0.5mg\/2ml Amp","腎功能不良劑量調整":"需監測血中濃度以確認療效及預防毒性\r<br>[>50 ml\/min]: 0.25~0.5mg q24h\r<br>[10-50]: 25-75% q36h\r<br>[<10 ]: 10-25% q48h \r<br>HEMO:  None","小兒建議劑量":"1. 毛地黃著效劑量：口服：孩童：新生兒─每公斤40～60mcg；1個月至2歲者每公斤60mcg。\r<br>2. 維持劑量：口服\/靜注：成人─每天0.125-0.5mg(平均劑量每天0.25mg)。小孩─為毛地黃著效劑量的20%-30%。\r<br>3. 注射劑量約為口服劑量的80%。靜脈投藥為最佳方式。肌肉注射並無優點，反而會引起注射部位疼痛。注射劑不稀釋或以注射用水、生理食?水、5%葡萄糖溶液、lactated Ringer's溶液稀釋4倍後，注射時間至少5分鐘以上。稀釋倍數不足時會引起沉澱。稀釋後要立即使用。","提示內容":"注意病人是否有高血鉀的症狀(可能是中毒的情況)\r<br>若使用造成低血鉀的藥品，可能會造成毒性增加\r<br>Clarithromycin併用 digoxin 可能增加 digoxin 毒性,  digoxin劑量需減半","抗生素手冊":"暫無資料"},"LAN03O":{"商品名稱":"Lansoprazole 30mg Cap CYH#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAS01O":{"商品名稱":"Lasix 40mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LAT01O":{"商品名稱":"Latuda 40mg Tab","腎功能不良劑量調整":"中度（肌酐酸清除率30至＜50毫升\/分）及嚴重（肌酐酸清除率＜30毫升\/分）的腎功能不全病患，建議需調整劑量。建議起始劑量為每日20毫克，每日劑量不得超過80毫克","小兒建議劑量":"暫無資料","提示內容":"應與食物併服（至少350大卡)，理由：在臨床試驗中Lurasidone是與食物併服的\r<br>腎功能不全（肌酐酸清除率30至＜50毫升\/分）及嚴重（肌酐酸清除率＜30毫升\/分）建議起始劑量為每日20毫克，每日劑量不得超過80毫克。\r<br>肝功能不全病患中度（肝硬化指數7到9）及嚴重（肝硬化指數10到15），建議起始劑量為每日20毫克。中度肝功能不全患者的每日劑量不得超過80毫克，嚴重肝功能不全患者的每日劑量不得超過40毫克","抗生素手冊":"暫無資料"},"LCA01I":{"商品名稱":"L-Carnit 1g\/5mL Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEE02O":{"商品名稱":"Leevk 100mg Tab","腎功能不良劑量調整":"Imatinib 及其代謝物只有少量經由腎臟排泄。由於imatinib 經由腎臟的清除率很低，預期腎功能不全並不會降低imatinib 的全身清除率。輕度或中度腎功能不全的病患之起始劑量，應投與最小的每日建議劑量400 毫克。雖然目前相關的資料十分有限( 請參閱“藥物動力學”與“藥效學”","小兒建議劑量":"\"尚無使用Glivec 於2 歲以下患有慢性骨髓性白血病及1 歲以下費城染色體陽性急性淋巴性白血病(Ph+ALL) 之兒童的資料。至於使用Glivec 於其他適應症之兒童的資料亦十分有限。<br>兒童的劑量必需根據其體表面積毫克\/ 平方公尺(mg\/m2)。慢性期CML、惡化期CML 及費城染色體陽性急性淋巴性白血病的兒童建議劑量分別為每天340 毫克\/ 平方公尺(mg\/m2)。然而，兒童每日總劑量不得超過600 毫克劑量。治療慢性骨髓性白血病及費城染色體陽性急性淋巴性白血病可依每日一次劑量之投予方式，對於慢性骨髓性白血病患者，可將其分成兩次投予－即於早晚各投予一次。\"\r<br>","提示內容":"本院另有同級品Glivec 100mg tab\r<br>配合一杯水於餐中服用可減少腸胃障礙。無法吞服者可泡於50C.C.之水或蘋果汁中溶解後服用。","抗生素手冊":"暫無資料"},"LEF01O":{"商品名稱":"Leflodal F.C. 500 mg Tab (公費)","腎功能不良劑量調整":"TB治療指引: 當Clcr<30時，levofloxacin不須改變劑量，但頻率改每週3次。病人如接受血液透析，透析當天的建議於透析後吃。 \r<br>---\r<br>[20-49 ]: 250~500mg x 1, then 125mg q24h~250mg q12h. \r<br>[10-19 ]: ...., then 125mg q48h~q12h\r<br>[<10]:  ..., 125mg q48h~q12h [1]","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEN03O":{"商品名稱":"Lendormin 250mcg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Lendormin與Eszo屬於同一類藥物\r<br>同時開立可能導致病人成癮情況, 請會診精神科醫師","抗生素手冊":"暫無資料"},"LEN04O":{"商品名稱":"LENVIMA 10MG CAP","腎功能不良劑量調整":"重度腎功能不全病人 (經由Cockcroft-Gault公式計算之肌酸酐清除率[CLcr] 少於30 mL\/min) 或重度肝功能不全病人 (Child-Pugh C):DTC為14 mg QD；RCC為10 mg QD。","小兒建議劑量":"小兒病人使用Lenvima之安全性及療效尚未確立。","提示內容":"本次引進是供一肝癌併骨轉移病人自費使用, 用法為10mg (1 cap) QD. Lenvatinib 目前雖未核准用於肝癌, 但已有相關臨床試驗\r<br>膠囊應整粒吞服，或溶解在小杯液體後服用。用藥期間應避免懷孕及哺乳。","抗生素手冊":"暫無資料"},"LEN05O":{"商品名稱":"Lenvima 4mg Cap","腎功能不良劑量調整":"重度腎功能不全病人 (經由Cockcroft-Gault公式計算之肌酸酐清除率[CLcr] 少於30 mL\/min) 或重度肝功能不全病人 (Child-Pugh C):DTC為14 mg QD；RCC為10 mg QD。","小兒建議劑量":"小兒病人使用Lenvima之安全性及療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEP01O":{"商品名稱":"Lepax FC 10mg Tab#","腎功能不良劑量調整":"輕微或中度的腎功能受損患者，毋須調整劑量\r<br>但對於嚴重腎功能受損患者(CLCR小於30ml\/min.)須小心注意。","小兒建議劑量":"孩童及青少年（小於18歲者）：\r<br>不建議使用，因此族群的安全與療效性資料尚未研究，曾有兒童使用本藥時發生自殺意念或行為之報告。","提示內容":"1. 5-10mg\/day Max. dose 20mg\/day\r<br>2. 65 歲以上、肝功能有問題、使用 omeprazole 或cimetidine Max. dose 10mg\/day\r<br>3.注意QT interval 延長","抗生素手冊":"暫無資料"},"LES03O":{"商品名稱":"Lescol XL 80mg Tab#","腎功能不良劑量調整":"Fluvastatin 乃經由肝臟清除，只有少於6% 的給藥劑量排出於尿中，因此，在輕至重度的腎功能不全患者身上，fluvastatin 的藥動學仍舊維持不變，所以，這些病人並不需要作劑量的調整。\r<br>","小兒建議劑量":"\"開始使用 Lescol \/ Lescol XL 治療前，必須先安排病人食用標準的降膽固醇飲食六個月，治療期間的飲食療法仍須持續。<br>建議的起始劑量為每天一次，每次 40 mg (一顆 40 mg Lescol膠囊) 或 80 mg (一錠Lescol XL 80 mg)，20 mg fluvastatin 的劑量 (一顆20 mg Lescol膠囊 ) 可適用於輕微的病例。<br>起始劑量必須根據個別的 LDL-C 基準濃度及建議的治療目標而定。<br>目前尚無在孩童和青少年併用 nicotinic acid、cholestyramine 或 fibrates 的研究。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LES05O":{"商品名稱":"Lesiton 5mg Cap","腎功能不良劑量調整":" Contraindicated in severe renal impairment","小兒建議劑量":"仿單未說明","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LET01O":{"商品名稱":"Letrozole FC 2.5mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童不宜使用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEU02I":{"商品名稱":"Leucovorin 500mg\/50ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEU05I":{"商品名稱":"Leuplin Depot 1M 3.75mg Syringe#","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied)","小兒建議劑量":"Precocious puberty (consider discontinuing by age 11 for females and by age 12 for males):SubQ (leuprolide acetate 5 mg\/mL solution): Initial: 50 mcg\/kg\/day; titrate dose upward by 10 mcg\/kg\/day if down-regulation is not achieved","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEU05O":{"商品名稱":"Leukeran 2mg Tab#","腎功能不良劑量調整":"\"Adults:<br>\r<br>CrCl >50 mL\/minute: No adjustment necessary.<br>CrCl 10-50 mL\/minute: Administer 75% of dose.<br>CrCl <10 mL\/minute: Administer 50% of dose.<br>Peritoneal dialysis (PD): Administer 50% of dose\"\r<br>","小兒建議劑量":"3. 孩童：1天0.1～0.2mg\/kg，或1天4.5mg\/㎡。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEU08I":{"商品名稱":"Leunase 10000KU Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對於兒童應小心使用，特別注意是否有不良反應產生，包含考慮其對性腺的潛在影響。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEV02I":{"商品名稱":"Levemir FlexPen 300iu\/3ml#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; insulin requirements may be reduced due to changes in insulin clearance or metabolism; monitor blood glucose closely.\r<br>","小兒建議劑量":"Diabetes mellitus, type 1: Children >=2 years and Adolescents: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEV02O":{"商品名稱":"Levitra 20mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEV03O":{"商品名稱":"Levonolon 500mg Tab(公費)","腎功能不良劑量調整":"TB治療指引: 當Clcr<30時，levofloxacin不須改變劑量，但頻率改每週3次。病人如接受血液透析，透析當天的建議於透析後吃。\r<br>","小兒建議劑量":"<5 years: 8-10 mg\/kg\/dose twice daily\r<br>>=5 years: 10 mg\/kg\/dose once daily; \r<br>maximum dose: 750 mg\/day\r<br>","提示內容":"疾管署公費個案藥品開檔使用。(成分為Levofloxacin, 供結核病病人使用)","抗生素手冊":"暫無資料"},"LEV04I":{"商品名稱":"Levemir FlexPen 1 iu (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LEX03O":{"商品名稱":"Lexapro 10mg Tab#","腎功能不良劑量調整":"輕微或中度的腎功能受損患者，毋須調整劑量，但對於嚴重腎功能受損患者(CLCR小於30ml\/min.)須小心注意。\r<br>","小兒建議劑量":"\"孩童及青少年（小於18歲者）：<br>不建議使用，因此族群的安全與療效性資料尚未研究，曾有兒童使用本藥時發生自殺意念或行為之報告。\"\r<br>","提示內容":"1. 5-10mg\/day Max. dose 20mg\/day\r<br>2. 65 歲以上、肝功能有問題、使用 omeprazole 或cimetidine Max. dose 10mg\/day\r<br>3.注意QT interval 延長","抗生素手冊":"暫無資料"},"LEX04O":{"商品名稱":"Lexotan 1.5MG Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LHR01I":{"商品名稱":"LH-RH tanabe inj 0.1mg\/1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LHR02I":{"商品名稱":"LHRH Ferring 0.1mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"請注意本品為冷藏冰箱藥。","抗生素手冊":"暫無資料"},"LIC01O":{"商品名稱":"Licodin 100mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"安全性和療效尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LID01E":{"商品名稱":"Lidopat Patch 5%","腎功能不良劑量調整":"建議使用較小的治療面積於操勞過度的病人，或者腎功能受損的病人","小兒建議劑量":"Apply to affected area up to 3-4 times daily as needed; maximum dose: 4.5 mg\/kg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LID01I":{"商品名稱":"Lidophrine 20ml Vial","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"\"小於 10 歲之孩童，每一次診療很少使用超過半瓶量之 Lidocaine HCl 注射劑<br>液\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LID01O":{"商品名稱":"Lidin 300mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 800-1200mg q24h \r<br>[10-50]: 50-75%\r<br>[<10 ]: 25-50%\r<br>HEMO: Dose after dialysis","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LID02E":{"商品名稱":"Lidocaine Soln 4% 30ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Apply to affected area up to 3-4 times daily as needed; maximum dose: 4.5 mg\/kg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LID03E":{"商品名稱":"Lidocaine Soln 4% 1ml(小單位檔)","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Apply to affected area up to 3-4 times daily as needed; maximum dose: 4.5 mg\/kg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LID03I":{"商品名稱":"Lidocaine HCl IV 2%\/5ml Amp","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling. However, accumulation of metabolites may be increased in renal dysfunction. Not dialyzable (0% to 5%) by hemo- or peritoneal dialysis; supplemental dose is not necessary","小兒建議劑量":"Children, IV loading by 0.5-1 mg\/kg, may be repeated as needed, total dose should not exceed 3-5 mg\/kg; maintenance infusion, 10-50 mcg\/kg\/min. [3]","提示內容":"心室性不整律之急性治療；注意處方可能誤開為Xylocaine  2% 20ml","抗生素手冊":"暫無資料"},"LID04I":{"商品名稱":"Lidocaine Anesthesia 2% 20mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Loading dose: 1 mg\/kg\/dose bolus of 0.5-1 mg\/kg\/dose\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LID05I":{"商品名稱":"Lidocaine Anesthesia 2% 1mL","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIG01O":{"商品名稱":"Ligilin 300mg Cap","腎功能不良劑量調整":"[>50 ml\/min]: 800-1200mg q24h \r<br>[10-50]: 50-75%\r<br>[<10 ]: 25-50%\r<br>HEMO: Dose after dialysis","小兒建議劑量":"兒童之安全性尚未建立,可能會引起骨骼變弱\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIN01O":{"商品名稱":"Linicor F.C.T. 500\/20mg#","腎功能不良劑量調整":"尚未進行過緩釋劑型niacin 製劑用於腎臟或肝臟功能不全患者的研究。腎功能不全患者使用緩釋劑型niacin 製劑時也應特別小心。嚴重腎功能不全（Clcr＜30 ml\/min ）的患者，將劑量調高至每天20mg 以上者應小心考慮, 若需要調高劑量，使用時應多加注意.","小兒建議劑量":"以目前不建議緩釋劑型niacin\/lovastatin複方綻劑給予小兒科病患使用。","提示內容":"QPM或QN使用   \r<br>持續釋放劑型，磨粉可能導致藥物短時間大量釋出","抗生素手冊":"暫無資料"},"LIN03O":{"商品名稱":"Lindacin 150mg Cap","腎功能不良劑量調整":"中度肝、腎疾病時，無需修改劑量表\r<br>","小兒建議劑量":"一月齡以上兒童 8-25 mg\/kg\/d，分3或4次投藥\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 450 mg q6h<br>小兒: 10 mg per kg q8h"},"LIN04O":{"商品名稱":"Linetero 600mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"出生至十一歲10mg\/kg靜脈注射或口服每八小時一次 ,12歲以上600mg靜脈注射或口服每十二小時一次\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 600 mg q12h須空腹"},"LIP01O":{"商品名稱":"LipDOWN 300mg Cap#","腎功能不良劑量調整":"Gemfibrozil is not recommended in patients with severe renal impairment. \r<br>GFR >50 mL\/min: No dosage adjustment necessary.\r<br>GFR 10~50 :  75% of dose.\r<br>GFR <10 : 50% of dose.\r<br>H\/D: Supplemental dose not necessary.","小兒建議劑量":"用於兒童患者的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIP02E":{"商品名稱":"Liprido 125gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIP03E":{"商品名稱":"Lipro cream 1000Gm bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"處置用藥，美容門診零購\r<br>Emla Cream 5% 5gm Tube之大包裝","抗生素手冊":"暫無資料"},"LIP08I":{"商品名稱":"Lipofundin MCT\/LCT 10% 250ml","腎功能不良劑量調整":"仿單未提及。","小兒建議劑量":"兒童: 每天每公斤體重注射0.5-3 g脂肪量，相當於每天每公斤體重5-30 ml之LipofundinR MCT\/LCT 10%。\r<br>新生兒、嬰兒及幼兒: 建議脂肪量不超過每天每公斤體重3-4 g。\r<br>注射速率: 脂肪乳劑應以慢速輸注為原則，尤其輸注之最初15分鐘之滴速不宜超過最大輸注速率的一半。\r<br>最大輸注速率: \r<br>兒童: < 0.13 g脂肪\/Kg\/hr\r<br>新生兒、嬰兒及幼兒: <0.17 g脂肪\/Kg\/hr","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIP10I":{"商品名稱":"Lipiodol Ultra-Fluide 10mL Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIP13O":{"商品名稱":"Lipitor FC 20mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"處方若開立Lipitor 20 mg 4 顆 before contras\r<br>→預防顯影劑引起之腎病變 ----micromedex","抗生素手冊":"暫無資料"},"LIP14O":{"商品名稱":"Lipanthyl Supra 160mg Tab#","腎功能不良劑量調整":"仿單》依腎功能調減劑量\r<br>Uptodate》Clcr<30ml: Use contraindicated.\r<br>KDOQI》\r<br>GFR>90: 201mgQD\r<br>GFR 90~60:134mg QD\r<br>GFR 59~15: 67mg QD\r<br>GFR<15: Avoid","小兒建議劑量":"Fenofibrate 對兒童和小於 18 歲的青少年之安全性和有效性尚未確立。因缺乏 相關數據,因此,fenofibrate 不建議使用在小於 18 歲的兒童患者。\r<br>","提示內容":"160mg QD(開立其他頻次須注意)","抗生素手冊":"暫無資料"},"LIP15I":{"商品名稱":"Lipo-Dox Liposome 20mg\/10ml Vial#","腎功能不良劑量調整":"若是腎功能損害病人因doxorubicin是由肝臟代謝，經由膽汁排除，故不必調整劑量。\r<br>","小兒建議劑量":"18歲以下兒童之有效性尚未建立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIP17I":{"商品名稱":"LIPOFUNDIN MCT\/LCT 20% 100ml","腎功能不良劑量調整":"仿單未提及。","小兒建議劑量":"兒童: 每天每公斤體重注射0.5-3 g脂肪量，相當於每天每公斤體重2.5-15 ml之LipofundinR MCT\/LCT 20%。\r<br>新生兒、嬰兒及幼兒: 建議脂肪量不超過每天每公斤體重3-4 g。\r<br>注射速率: 脂肪乳劑應以慢速輸注為原則，尤其輸注之最初15分鐘之滴速不宜超過最大輸注速率的一半。\r<br>最大輸注速率: \r<br>兒童: < 0.13 g脂肪\/Kg\/hr\r<br>新生兒、嬰兒及幼兒: <0.17 g脂肪\/Kg\/hr","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIQ01E":{"商品名稱":"Liq. Paraffine 30ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIV01O":{"商品名稱":"Livial 28tab\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LIV02O":{"商品名稱":"Livalo 2mg Tab#","腎功能不良劑量調整":"*輕、中度腎功能不全(腎絲球濾過率30 ~ 80 mL\/min\/1.73 m2)及正接受血液透析的末期腎臟病：起始劑量為每日一次1mg，最高劑量為每日一次2mg \r<br>*未曾研究LIVALO 使用於嚴重腎功能不全(腎絲球濾過率< 30 mL\/min\/1.73 m2)但尚未接受血液透析的患者。此類患者不可使用\r<br>LIVALO。","小兒建議劑量":"10歲以上兒童家族性高膽固醇血症:\r<br>每日1次口服LIVALO 1mg。劑量隨症狀作適當增減，低密度膽固醇值（LDL-C）降幅不足時，可調升劑量，每日最高服用劑量為2mg。","提示內容":"2 mg QD(Max. dose: 4 mg QD) ；\r<br>ClCr 15-59 ml\/min以及透析病人: 1 mg QD (Max. dose: 2 mg QD)\r<br>併用Erythromycin, 劑量<1 mg QD","抗生素手冊":"暫無資料"},"LIX01O":{"商品名稱":"Lixiana FC 30mg Tab#","腎功能不良劑量調整":"[CrCL  50 - 80ml\/min]：LixianaR 60mg QD。\r<br>[CrCL：15 - 50]：30mg QD。\r<br>[(ESRD)(CrCL < 15)或 H\/D ]：不建議使用。","小兒建議劑量":"在未滿18歲的兒童及青少年身上，目前尚未確立LixianaR的安全性與療效。目前仍無相關資料。","提示內容":"處方中若NOAC(Rivaroxaban、Apixaban、DABIGATRAN、Edoxaban)與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>60 mg QD 用於 :\r<br>1. 預防非瓣膜性心房顫動預防中風及全身性栓塞\r<br>2. 治療DVT及PE(接受5日抗凝血劑注射後)\r<br>30 mg QD 用於：\r<br>1.ClCr<50 ml\/min\r<br>2.體重<60 kg\r<br>3.併用cyclosporine, dronedarone, erythromycin, ketoclnazole\r<br>ClCr<15 ml\/min 不建議使用","抗生素手冊":"暫無資料"},"LIX02O":{"商品名稱":"LIXIANA FC 60mg Tab#","腎功能不良劑量調整":"[CrCL  50 - 80ml\/min]：LixianaR 60mg QD。\r<br>[CrCL：15 - 50]：30mg QD。\r<br>[(ESRD)(CrCL < 15)或 H\/D ]：不建議使用。","小兒建議劑量":"在未滿18歲的兒童及青少年身上，目前尚未確立LixianaR的安全性與療效。目前仍無相關資料。","提示內容":"處方中若NOAC(Rivaroxaban、Apixaban、DABIGATRAN、Edoxaban)與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>60 mg QD 用於 :\r<br>1. 預防非瓣膜性心房顫動預防中風及全身性栓塞\r<br>2. 治療DVT及PE(接受5日抗凝血劑注射後)\r<br>\r<br>30 mg QD 用於：\r<br>1.ClCr<50 ml\/min\r<br>2.體重<60 kg\r<br>3. 併用cyclosporine, dronedarone, erythromycin, ketoclnazole\r<br>\r<br>ClCr<15 ml\/min 不建議使用","抗生素手冊":"暫無資料"},"LOD02O":{"商品名稱":"Loditon 500mg Tab","腎功能不良劑量調整":"腎功能損傷之老年人不宜使用本品\r<br>eGFR介於30-45 applicable","小兒建議劑量":"孩童:不建議使用本品","提示內容":"max. dose:  3000 mg\/day \r<br>腎絲球體過濾率（eGFR）介於30-45 ml\/min\/1.73 m2應減量使用\r<br>腎功能不全患者，腎絲球體過濾率（eGFR）小於30 ml\/min\/1.73 m2禁用)","抗生素手冊":"暫無資料"},"LOM02E":{"商品名稱":"Lomexin 200mg Vag Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LON02O":{"商品名稱":"Lonine 200mg Cap","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"用於兒童之安全性及有效性皆尚未確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LON04O":{"商品名稱":"LONSURF 20MG TAB","腎功能不良劑量調整":"重度腎功能不全CLcr = 15 到 29ml\/min):\r<br>建議初始劑量為口服每劑 20 毫克\/平方公尺(劑量以 trifluridine 之含量表示)，每日兩次，早晚餐後服用。","小兒建議劑量":"朗斯弗在兒科病患的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LON05O":{"商品名稱":"Lonsurf 15mg Tab","腎功能不良劑量調整":"重度腎功能不全CLcr = 15 到 29ml\/min):\r<br>建議初始劑量為口服每劑 20 毫克\/平方公尺(劑量以 trifluridine 之含量表示)，每日兩次，早晚餐後服用。","小兒建議劑量":"朗斯弗在兒科病患的安全性及有效性尚未確立。","提示內容":"轉移性大腸直腸癌之成人患者使用\r<br>每日兩次，早晚餐後一小時內服用。\r<br>細胞毒性藥物，應遵照適當的特殊處理及處置程序。(禁用於孕婦, 碰觸錠劑前要戴手套, 事後洗手)","抗生素手冊":"暫無資料"},"LON06O":{"商品名稱":"Lonfilis FC 5mg Tab","腎功能不良劑量調整":"輕微及中度腎功能損害的病患不需調整劑量。\r<br>[Clcr: 31-50ml\/min]: Initial dose 5 mg once daily - Max. dose 10 mg not to be given more frequently than every 48 hours.\r<br>[< 30 or hemodialysis]: Maximum dose 5 mg. 對嚴重腎功能損害病患不建議每天給予一次","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LOP02O":{"商品名稱":"Loperam 2mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":".急性腹瀉:小孩初次量為每公斤0.08 mg，然後0.04 mg 每天2-3次. 慢性腹瀉:小孩每天1顆膠囊分兩次服用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LOR02O":{"商品名稱":"Lorviqua 25mg Tab","腎功能不良劑量調整":"重度腎功能不全 (CLcr:15~ <30 mL\/min):\r<br>75 mg QD","小兒建議劑量":"Lorviqua用於小兒的安全性及療效性尚未確立。","提示內容":"1.開立時需一次購買一瓶之數量30 tab，不拆零調劑\r<br>2.在開始服用本藥前，須停用強效CYP3A 誘導劑至少3 個血漿半衰期。\r<br>3.避免與強效CYP3A 抑制劑併用。若無法避免併用，將起始劑量自100mg QD降至75mg QD。\r<br>4.女性：治療期間及最後一次給藥後至少6個月內使用有效的非荷爾蒙避孕措施(因為本藥 會導致荷爾蒙避孕藥失效)。\r<br>5.男性：治療期間及最後一次給藥後至少3個月內使用有效的避孕措施","抗生素手冊":"暫無資料"},"LOR03O":{"商品名稱":"Lorazepam 1mg Tab #4","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童使用Lorazepam安全性尚未建立，不推薦使用於12歲以下的兒童\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LOX01O":{"商品名稱":"Loxol SR 75mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"長效劑型, 劑量為1 tab QD","抗生素手冊":"暫無資料"},"LUC01O":{"商品名稱":"Luckyhepa Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LUC02I":{"商品名稱":"Lucentis 10mg\/mL Syringe","腎功能不良劑量調整":"腎功能不全患者無須調整劑量。","小兒建議劑量":"由於缺乏安全性及療效的數據，故不建議兒童及小於18 歲之青少年使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LUC03I":{"商品名稱":"Lucentis (恩慈) 10mg\/mL Syringe","腎功能不良劑量調整":"腎功能不全患者無須調整劑量。","小兒建議劑量":"由於缺乏安全性及療效的數據，故不建議兒童及小於18 歲之青少年使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LUG01S":{"商品名稱":"Lugol 1-ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LUG02S":{"商品名稱":"Lugol solution 25ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LUM01E":{"商品名稱":"Lumigan Eye Drops 0.03% 30amp\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於小兒病人的安全性和功效性尚未確立。","提示內容":"1.本品以盒為單位開立\r<br>2.青光眼用藥\r<br>3.每晚一滴，投藥次數不可超過每日一次 (證據顯示較為頻繁地投藥，將減低降眼壓效果)","抗生素手冊":"暫無資料"},"LUM03I":{"商品名稱":"Lumicef 210mg\/1.5ml Syringe#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未有使用於18歲以下孩童之安全性及有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LYA01I":{"商品名稱":"Lyacety 500mg Vial","腎功能不良劑量調整":"Renal Impairment\r<br>CrCl <10 mL\/minute: Avoid use. \r<br>Dialyzable (50% to 100%)","小兒建議劑量":"針劑無小兒建議劑量，本品適應症只針對成人、老年人。","提示內容":"不得使用於12 歲以下兒童。\r<br>18 歲以下兒童不可用於病毒性引起之發燒(如水痘或流感)\r<br>→因可能會引起雷氏症候群(Reye's Syndrome)。","抗生素手冊":"暫無資料"},"LYN01O":{"商品名稱":"Lynparza 150mg Tab","腎功能不良劑量調整":"Clcr >50ml\/min :不需調整劑量\r<br>Clcr 30~50ml\/min :200mg BID\r<br>Clcr <30ml\/min :未有資料","小兒建議劑量":"尚未確立Lynparza用於兒童病人的安全性及療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LYO01I":{"商品名稱":"Lyo-Povigent (part I & II) 4ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"LYR01O":{"商品名稱":"Lyrica 75mg Cap#","腎功能不良劑量調整":"Clcr>60: 150-600 mg\/day devided in 2-3 doses.\r<br>30>Clcr>60: 75-300 mg\/day devided in 2-3 doses.\r<br>15>Clcr>30: 25-150 mg\/day devided in 1-2 doses.\r<br>Clcr<15: 25-75 mg QD.","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAB01I":{"商品名稱":"Mabthera 500mg\/50ml Vial#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"孩童\r<br>尚未建立MabThera對小兒科病人的安全性和有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAB02I":{"商品名稱":"Mabthera 100mg\/10ml Vial#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling (has not been studied","小兒建議劑量":"孩童\r<br>尚未建立MabThera對小兒科病人的安全性和有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAB03I":{"商品名稱":"Mabthera (恩慈)100mg\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAB04I":{"商品名稱":"Mabthera (恩慈)500mg\/50ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAB05I":{"商品名稱":"MABTHERA SC 1400mg\/11.7ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立本品對小兒科患者的安全性及有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAC02O":{"商品名稱":"Macalol 0.25mcg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAD01O":{"商品名稱":"Madopar 250mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 250-500 mg bid, 2nd dose:  up to 8g q24h\r<br>[10-50]:  50-100%\r<br>[<10 ]:  50%\r<br>HEMO: Dose after dialysis","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAD03O":{"商品名稱":"Madopar HBS 125mg Cap","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAD04O":{"商品名稱":"MADOPAR 250 TABLETS","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAG03I":{"商品名稱":"Mag. Sulfate 10%\/20ml Amp","腎功能不良劑量調整":"嚴重腎功能不全不能使用\r<br>","小兒建議劑量":"使用之安全性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAG04I":{"商品名稱":"Magnevist 20ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAG05O":{"商品名稱":"Magnesium Oxide Tab (Kingdom)","腎功能不良劑量調整":"嚴重腎功能不全不能使用\r<br>","小兒建議劑量":"3-6yr: 1\/4-1\/2# QD-BID; \r<br>6-12yr: 1\/2-1# QD-BID; \r<br>≧12yr: 1-2# QD-BID; \r<br>< 3yr:請洽醫師診治，不宜自行使用。\r<br>---------------------------------------------------------\r<br>< 6 months:    1\/4# TID;\r<br>6 months-2yr: 1\/3# QID; \r<br>2-8yr:               1\/2# QID;\r<br>> 8yr:                 1# QID","提示內容":"簡易換算: < 6個月: 1\/4# TID; 6個月-2歲: 1\/3# QID; 2-8歲: 1\/2# QID\r<br>> 8歲: 1# QID","抗生素手冊":"暫無資料"},"MAL01O":{"商品名稱":"Malarone 250\/100 mg Tab","腎功能不良劑量調整":"嚴重腎功能不良者(Clcr < 30 ml\/min)不應使用。","小兒建議劑量":"預防:自抵達高風險區前1-2天開始服用，每日一次，服用至離開高風險區7日。\r<br>>40 kg: 1 Tab\r<br>30 ~ 40kg:  3\/4 tab\r<br>20 ~ 30kg: 1\/2 tab\r<br>10 ~ 20kg:  1\/4 tab\r<br>8 ~10kg: 3\/16 tab\r<br>5 ~8 kg: 1\/8 tab\r<br>5公斤以下孩童不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAN01I":{"商品名稱":"Maniton inj 20% 100ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"：靜脈輸注，每公斤體重0.5g～2gm以15～25%溶液12 歲以下孩童禁用。\r<br>","提示內容":"結晶處理方式(週報2018\/01\/05 發行)\r<br>發現結晶請置於40~50°C 水浴加溫，可些許振搖，至結晶溶解後降至體溫後進行施打，且施打時使用過濾器防止肉眼未見的晶體存在，避免搖晃瓶身，若於管路中產生結晶則不建議繼續使用","抗生素手冊":"暫無資料"},"MAR01I":{"商品名稱":"Marcaine 100mg\/20ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAR02I":{"商品名稱":"Marcaine Spinal Heavy","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAR03I":{"商品名稱":"Marcaine Spinal 0.5%\/4ml Amp(麻開)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAV02O":{"商品名稱":"Mavenclad 10mg Tab","腎功能不良劑量調整":"輕度腎功能不良者不需調整劑量。\r<br>中度及重度腎功能不良病患，其安全性及療效尚未確立，因此禁用於這些病人。","小兒建議劑量":"未滿18歲病人使用之安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MAX03I":{"商品名稱":"Maxtam 500mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MCE01E":{"商品名稱":"M. C. Skin Lotion 60ml","腎功能不良劑量調整":"仿單無說明。","小兒建議劑量":"仿單無說明。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEB03O":{"商品名稱":"Meberine 135mg Tab (Y.C.)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEC01O":{"商品名稱":"Meclizine 25mg Tab","腎功能不良劑量調整":"嚴重肝腎代謝疾病者不可使用\r<br>","小兒建議劑量":"12歲以上是用成人劑量,12歲以下請洽醫生勿自行使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEC02O":{"商品名稱":"Mecater 25mcg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"<6yr: 0.25ml\/kg bid-tid; >6yr: 5ml QD-bid; \r<br>成人: 10ml QD-BID\r<br>----------------------------------------------------------\r<br>0.025 to 0.05 milligram twice daily (5-10ml)\r<br>----------------------------------------------------------\r<br>簡易換算: <6 y\/o: (BW\/4)c\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MED02O":{"商品名稱":"Medicon-A Cap","腎功能不良劑量調整":"無\r<br>","小兒建議劑量":"暫無資料","提示內容":"Medicon-A其中Dextromethorphan HBr含量為 20mg\r<br>Dextromethorphan每日最大劑量為120mg\/day","抗生素手冊":"暫無資料"},"MED02S":{"商品名稱":"Medicon Syrup 60ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"1~7yr: 1~1.5ml TID; 8~14yr: 2~3ml TID;\r<br>成人: 4~6ml TID。\r<br>----------------------------------------------------------\r<br>1-3 months: 0.5-1mg Q6-8H;\r<br>3-6 months: 1-2mg Q6-8H;\r<br>7-12 months: 2-4mg Q6-8H;\r<br>≧ 2-6yr: 2.5-7.5mg Q4-8H;\r<br>7-12yr: 5-10mg Q4H or 15mg Q6-8H;\r<br>>12yr: 10-30mg Q4-8H\r<br>----------------------------------------------------------\r<br>0.5 c.c.\/kg\/day: 分成3-4次。","提示內容":"1-7歲: 1~1.5ml TID; 8-14歲: 2~3ml TID\r<br>簡易算法: 0.5 c.c.\/kg\/day: 分成3-4次。","抗生素手冊":"暫無資料"},"MED04O":{"商品名稱":"Mednin 4mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEG04S":{"商品名稱":"Megest Oral Susp 40mg\/ml;120ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"使用之安全性尚未建立\r<br>","提示內容":"成人160~400mg\/day，max. 800mg\/day","抗生素手冊":"暫無資料"},"MEK01O":{"商品名稱":"Mekinist 2mg Tab","腎功能不良劑量調整":"無需針對輕度或中度腎功能不全患者調整劑量。","小兒建議劑量":"暫無資料","提示內容":"使用前需確認帶有BRAF V600突變\r<br>引進是作為個案肺腺癌治療之用，\r<br>應於餐前至少1小時或餐後至少2小時，空腹服用\r<br>不可咀嚼或咬碎錠劑。服藥後生嘔吐情形，不應重新服用該劑藥物，而應在下一劑排定的時間再服藥\r<br>儲存於冰箱冷藏室(2°C ~ 8°C)。藥瓶請保持緊閉。開封後，藥品可在30°C 以下儲存30 天","抗生素手冊":"暫無資料"},"MEL02O":{"商品名稱":"Meletin 100mg Cap","腎功能不良劑量調整":"No dosage adjustment necessary","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEL03O":{"商品名稱":"Meloxin 7.5mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"使用之安全性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEN01I":{"商品名稱":"Menocik 100mg Vial","腎功能不良劑量調整":"Max 2000mg\/day","小兒建議劑量":"8歲以上之孩童：\r<br>初劑量為4毫克／公斤，以後每隔12小時2毫克／公斤。","提示內容":"1. 200mg then100mg Q12H Max. dose 400mg\/day\r<br>2.需稀釋成100至1000ml使用，但不得與含鈣之溶液稀釋使用。配製成溶液後可在室溫保存24小時。\r<br>3. 8歲以上之孩童：4mg\/kg then 2mg Q12H","抗生素手冊":"100 mg q12h drip 1hr<br>lipophillic"},"MEN01O":{"商品名稱":"Menisone 4mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"本品會出現小兒發育抑制現象要十分注意觀察\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEN06E":{"商品名稱":"Menphencala Lotion 100ml","腎功能不良劑量調整":"仿單無記載","小兒建議劑量":"2歲以下兒童之使用須詢問醫師或藥師。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEP01I":{"商品名稱":"Mepivastesin 3% Inj 1.7ml\/Cart","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEP01O":{"商品名稱":"Meptin-Mini 25mcg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEP01S":{"商品名稱":"Meptin Liquid 5mcg\/ml;60ml","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"<6yr: 0.25ml\/kg bid-tid; >6yr: 5ml QD-bid; \r<br>成人: 10ml QD-BID\r<br>----------------------------------------------------------\r<br>0.025 to 0.05 mg twice daily (5-10ml)\r<br>----------------------------------------------------------\r<br>簡易換算: <6 y\/o: (BW\/4)c.c. bid.\r<br>                  >6 y\/o: 5c.c. bid","提示內容":"<6歲: 0.25ml\/kg BID-TID; >6歲: 5ml QD-BID","抗生素手冊":"暫無資料"},"MEP02I":{"商品名稱":"Mepem 250mg Vial#","腎功能不良劑量調整":"(Adults) 500mg~1g IV q8h.Meningitis: 2 gram IV q8h.(以下劑量腦膜炎可加50~100%)\r<br>[Clcr 26-50ml\/min]: 1g~500mg q12h.  \r<br>[10-25]: 500~250 mg q12h.  \r<br>[<10]: 500mg q24h.\r<br>HEMO\/PD: 500 mg q24h","小兒建議劑量":"PNA <14 days: 20 mg\/kg\/dose every 12 hours PNA >=14 days: 20 mg\/kg\/dose every 8 hours\r<br>","提示內容":"0.5-1g Q8H, 腦膜炎 2g Q8H(*熱病)\r<br>依張進祿《臨床使用抗生素手冊》的說明與s-lactams 共通過敏反應( cross-hypersensitivity reaction)幾乎不會發生\r<br>Mepem與Depakine併用會降低Depakine的血中濃度","抗生素手冊":"建議量: 500 mg to 1 gm q8h<br>Ccr less than 50: q12h<br>Ccr less than 25: 半劑量 q12h<br>Ccr less than 10, HD or PD: 半劑量 qd"},"MEP02S":{"商品名稱":"Meptin Liquid 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"<6yr: 0.25ml\/kg bid-tid; >6yr: 5ml QD-bid; \r<br>成人: 10ml QD-BID\r<br>----------------------------------------------------------\r<br>0.025 to 0.05 milligram twice daily (5-10ml)\r<br>----------------------------------------------------------\r<br>簡易換算: <6 y\/o: (BW\/4)c.c. bid.\r<br>                  >6 y\/o: 5c.c. bid","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEP03I":{"商品名稱":"Mepron 40mg Vial","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"不同的疾病有不同的劑量\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MER01I":{"商品名稱":"Merional 75 IU Vial","腎功能不良劑量調整":"不需調整","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MER01O":{"商品名稱":"Mercaptopurine 50mg Tab","腎功能不良劑量調整":"製造商未標示需劑量調整。但另有臨床建議為\r<br>CrCl <50 mL\/minute\/1.73 m2或 H\/D 或 CAPD或 CRRT: Administer every 48 hours","小兒建議劑量":"通常初劑量(1)成人及小孩均為2.5mg \/kg\/day， 一次服用。(2)或成人100-200mg QD，五歲大小孩50mg QD。如果連續用藥四週未見改善，可增加劑量到5mg\/kg\/day. \r<br>維持劑量: 症狀改善後，改成2.5mg\/kg\/day。","提示內容":"1.2.5-5mg\/kg\/day(成人100~200mg\/day)\r<br>2.不可用於慢性淋巴性白血病(chronic lymphoid leukemia)、何杰金氏病(Hodgkin’s disease)及惡性淋巴瘤(malignant lymphoma)。\r<br>3.注意與Allopurinol, azothioprine, mesalazine, olsalazine, sulphasalazine及warfarin之交互作用\r<br>4.與Allopurinol併用本品劑量需調整至常用劑量的1\/3-1\/4","抗生素手冊":"暫無資料"},"MER02O":{"商品名稱":"Mero 100mg Cap","腎功能不良劑量調整":"CrCl <80 mL\/min：一天不超過200mg。","小兒建議劑量":"8歲以上小孩：開始時4mg\/kg，然後每12小時2mg\/kg。","提示內容":"暫無資料","抗生素手冊":"建議量: 100 mg q12h"},"MES01E":{"商品名稱":"Mesa Inhal Soln 600mg\/3ml","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied)\r<br>\r<br>http:\/\/www.uptodate.com\/contents\/search?search=mesna&submit=Go","小兒建議劑量":"only off-lable use dosage, check with uptodate.\r<br>\r<br>http:\/\/www.uptodate.com\/contents\/search?search=mesna&submit=Go","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MES01O":{"商品名稱":"Mestinon 60mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"Myasthenia gravis:<br><br>\r<br>\r<br>Oral: Children: 7 mg\/kg\/24 hours divided into 5-6 doses. Most clinicians reserve sustained release dosage form for bedtime dose only.\r<br>\r<br>I.M., slow I.V. push: Children: 0.05-0.15 mg\/kg\/dose<br><br>\r<br>Reversal of nondepolarizing muscle relaxants: I.V.: Children: Dosing range: 0.1-0.25 mg\/kg\/dose (full recovery usually occurs <=15 minutes, but >=30 minutes may be required).<br><br>\r<br>\r<br>Note: Atropine sulfate (0.6-1.2 mg) I.V. immediately prior to pyridostigmine to minimize side effects:\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MES02O":{"商品名稱":"Mesyrel 50mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"十八歲以下之小孩其使用之效果與安全性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET01I":{"商品名稱":"Methergin 0.2mg\/1ml Amp","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"無相關適應症\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET02I":{"商品名稱":"Methycobal 500mcg\/1ml Amp#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"可依患者年齡或症狀調整\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET05I":{"商品名稱":"Methotrexat 500mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET05O":{"商品名稱":"Methotrexate 2.5mg Tab","腎功能不良劑量調整":"\"No dosage adjustment provided in the manufacturer’s labeling.\r<br>其它建議 Aronoff, 2007:Adults:\r<br>Clcr 10-50: Administer 50% of dose\r<br>Clcr <10 : Avoid use\r<br>H\/D: Administer 50% of dose\r<br>CRRT: Administer 50% of dose [uptodate]\"\r<br>","小兒建議劑量":"暫無資料","提示內容":"*免疫疾病(乾癬或RA)治療:  \r<br>2.5-5 mg every 12 hr for 3 doses given weekly\r<br>中文商品名由滅殺除癌正名為滅殺除炎","抗生素手冊":"暫無資料"},"MET06I":{"商品名稱":"Metronidazole 500mg\/100ml","腎功能不良劑量調整":"usual dose:500 mg po\/IV q6-8h\r\r<br>[Clcr <10 ml\/min]:  500mg q12h.  \r\r<br>HEMO: 500mg q8-12h (usually q12h)\r\r<br>CRRT: Dose as for normal renal function.","小兒建議劑量":"小於12歲的兒童: 以 22.5mg\/kg\/day，每日投與1次，以每分鐘5ml的速率慢速靜輸注。","提示內容":"暫無資料","抗生素手冊":"Max: 4 gm per day<br>Ccr less than 10, HD or Child C: 50%"},"MET06O":{"商品名稱":"Methyldopa F.C. 250mg Tab","腎功能不良劑量調整":"There are no dosage adjustments provided in manufacturer’s labeling; however, the following adjustments have been recommended (Aronoff, 2007):\r<br>CrCl >50:  Q8H給藥.\r<br>CrCl 10~50 : Q8~12H給藥.\r<br>CrCl <10 : Q12~ 24H給藥.","小兒建議劑量":"Oral: Initial: 10 mg\/kg\/day in 2 to 4 divided doses; increase every 2 days as needed to maximum dose of 65 mg\/kg\/day. Do not exceed 3 g daily","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET07I":{"商品名稱":"Methotrexate 500mg\/20ml Vial","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer’s labeling.\r<br>其它建議 Aronoff, 2007:Adults:\r<br>Clcr 10-50: Administer 50% of dose\r<br>Clcr <10 : Avoid use\r<br>H\/D: Administer 50% of dose\r<br>CRRT: Administer 50% of dose [uptodate]","小兒建議劑量":"另有兒童劑量，詳見protocol","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET07O":{"商品名稱":"MethyCOBAL(B12) 500mcg Cap#","腎功能不良劑量調整":"不用調整","小兒建議劑量":"可依患者年齡或症狀調整","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET15I":{"商品名稱":"Methylergonovine 0.2mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET17E":{"商品名稱":"Methocel 2% 30gm Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET17O":{"商品名稱":"Metalcaptase 300mg Tab","腎功能不良劑量調整":"\"No dosage adjustment provided in manufacturer’s labeling; however, the manufacturer labeling does suggest a cautious approach to dosing as this drug undergoes mainly renal elimination.<br>Alternate recommendations:<br>CrCl <50 mL\/minute: Avoid use (Aronoff, 2","小兒建議劑量":"\"Rheumatoid arthritis: \r<br>Note: The optimal duration of therapy has not been determined; in patients experiencing a remission for >=6 months, the daily dosage may be decreased in a stepwise fashion in 3-month intervals:<br>Children: Initial: 3 mg\/kg\/day (<=250 mg\/\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET18E":{"商品名稱":"Metsone Cream 0.1% 5g","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET18O":{"商品名稱":"Metrozole 250mg Tab","腎功能不良劑量調整":"usual dose:500 mg po\/IV q6-8h\r<br>[Clcr <10 ml\/min]:  500mg q12h.  \r<br>HEMO: 500mg q8-12h (usually q12h)\r<br>CRRT: Dose as for normal renal function.","小兒建議劑量":"安全性和有效性尚未確立","提示內容":"暫無資料","抗生素手冊":"Max: 4 gm per day<br>Ccr less than 10, HD or Child C: 50%"},"MET19O":{"商品名稱":"Methydur SR 22mg Cap #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"六歲以下不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MET20O":{"商品名稱":"METHYDUR SR 33MG CAP #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"六歲以下不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEV05O":{"商品名稱":"Mevalotin 40mg Tab#","腎功能不良劑量調整":"Significant impairment: Initial dose: 10 mg\/da\r<br>","小兒建議劑量":"\"Heterozygous familial hypercholesterolemia (HeFH): Oral: Children:\r<br><br><br>\r<br>8-13 years: 20 mg\/day<br><br>\r<br>14-18 years: 40 mg\/day\r<br><br><br>\r<br>Dosage adjustment for pravastatin with concomitant medications (clarithromycin, cyclosporine): Refer to adult dosing.\r<br>\r<br>Note: Doses should be individualized according to the baseline LDL-cholesterol levels, the recommended goal of therapy, and patient response; adjustments should be made at intervals of 4 weeks or more; doses may need adjusted based on concomitant medications\"\r<br>","提示內容":"QPM或QN使用","抗生素手冊":"暫無資料"},"MEX01O":{"商品名稱":"Mexitil 100mg Cap","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Children: Range: 1.4-5 mg\/kg\/dose (mean: 3.3 mg\/kg\/dose) given every 8 hours\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MEZ01O":{"商品名稱":"Mezavant XL 1200mg Tab#","腎功能不良劑量調整":"仿單無明確建議調整劑量。建議在開始使用本品治療前及治療過程中要定期評估病患的腎功能。已知腎功能障礙或有腎臟病史的患者使用本品時要特別小心謹慎.","小兒建議劑量":"不建議給予18 歲以下兒童，因為缺乏安全性與有效性的資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIA02I":{"商品名稱":"Miacalcic 50iu\/1ml Amp#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MID01I":{"商品名稱":"Midatin 5mg\/1ml Amp #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"0.08-0.2mg\/kg在麻醉誘導前30-60分鐘給予\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MID01O":{"商品名稱":"Midorine 2.5mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"12歲以上是用成人劑量(早晚各一錠),12歲以下由醫生按照體重決定使用劑量\r<br>","提示內容":"(週報2018\/04\/13 發行)\r<br> 一般建議要避免睡前4~6 小時內服用Midodrine以避免仰臥性高血壓 (Supine Hypertension)之發生","抗生素手冊":"暫無資料"},"MID02I":{"商品名稱":"MIDATIN 15MG\/3ML AMP #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"0.08-0.2mg\/kg在麻醉誘導前30-60分鐘給予\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIN04O":{"商品名稱":"Minocin 100mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIN06I":{"商品名稱":"Minirin 4mcg\/1ml Amp","腎功能不良劑量調整":"CrCl <50 mL\/minute: Use is contraindicated according to the manufacturer; however, has been used in acute and chronic renal failure patients experiencing uremic bleeding or for prevention of surgical bleeding\r<br>","小兒建議劑量":"一歲以上兒童每日1-2次，每次0.4-1mcg(0.1-0.25ml), 小於一歲之兒童每日1-2次，每次0.2-0.4mcg(0.05-0.1ml)\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIN08O":{"商品名稱":"MINIRIN MELT 60MCG TAB#","腎功能不良劑量調整":"Clcr<50ml\/min:\r<br>中度到嚴重的腎功能不全病人為禁忌使用。","小兒建議劑量":"原發性夜尿症(限用於6歲以上病患): 初始劑量為睡前120mcg，可增加至240mcg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIO01E":{"商品名稱":"Miostat Intraocular 0.01%\/1.5mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"幼兒使用本晶之安全性及有效性尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIR01I":{"商品名稱":"Mircera 0.05mg\/0.3ml Syringe#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Mircera在兒童病患中的安全性與療效尚未獲得確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIR01O":{"商品名稱":"Mirtapine Oral-Dis 30mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; clearance is decreased 30% in moderate (Clcr 11-39 mL\/minute\/1.73 m2) impairment and is decreased 50% in severe (Clcr <10 mL\/minute\/1.73 m2) impairment. Use with caution","小兒建議劑量":"孩童與18歲以下青少年之安全性與有效性尚未建立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIR02O":{"商品名稱":"MIRAPEX 1MG Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIR03E":{"商品名稱":"Mirena Intrauterine System","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童不宜使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIR03I":{"商品名稱":"MIRCERA 0.1mg\/0.3ml Syringe#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Mircera在兒童病患中的安全性與療效尚未獲得確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIR03O":{"商品名稱":"Mirobect 50mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 50-100mg q24h \r<br>[10-50]: 25-50mg q24h\r<br>[<10 ]: 25mg q24h\r<br>HEMO:  25-50mg after dialysis","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIR04O":{"商品名稱":"Mirapex PR 0.375mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未評估MIRAPEX PR錠劑在兒童病患使用的藥物動力學狀況、安全性與療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIS01S":{"商品名稱":"Mistabron","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIT03I":{"商品名稱":"Mitomycin-C 10mg Vial#","腎功能不良劑量調整":"肝腎功能不良者小心使用\r<br>","小兒建議劑量":"安全性和有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIT04I":{"商品名稱":"Mitonco 10mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MIY01O":{"商品名稱":"Miyarisan BM 1gm pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3-6yr: 1\/4包 TID; 6-12yr: 1\/2包 TID; \r<br>≧ 12yr: 1包 TID; < 3yr: 請洽醫師診治不宜自行服用。\r<br>----------------------------------------------------------------\r<br>< 3yr:   1\/4pk TID-QID;\r<br>3-6yr:   1\/3pk TID-QID;\r<br>6-12yr: 1\/2pk TID-QID;\r<br>> 12yr:  1pk TID-QID","提示內容":"< 3歲: 1\/4包 TID-QID; 3-6歲: 1\/3包 TID-QID; 6-12歲: 1\/2包 TID-QID; \r<br>> 12歲: 1包 TID-QID","抗生素手冊":"暫無資料"},"MMR02I":{"商品名稱":"MMR II (公費) Vaccine","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"0.5mL by SC inj in region of the deltoid muscle.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MMR04I":{"商品名稱":"MMR II (自費) Vaccine","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"0.5mL by SC inj in region of the deltoid muscle.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MMR05I":{"商品名稱":"MMR II (員工) Vaccine","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOC01O":{"商品名稱":"Mocalm 0.5\/10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於小孩、青少年和青年人時，應評估服用抗憂鬱劑之自殺等風險與效益。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOD01O":{"商品名稱":"Moduretic Tab","腎功能不良劑量調整":"Hyperkalemia with GFR<30, especially in DM. Metabolic acidosis.\r<br>[Clcr >50 ml\/min]: 1~2 tab daily. Max.: 4 tab\r<br>[10-50ml\/min]: 50% \r<br>[<10 ml\/min]: Avoid\r<br>HEMO:Avoid","小兒建議劑量":"Oral: Initial: 1\/2 to 1 tablet\/day\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOD02O":{"商品名稱":"Modipanol F.C 1mg Tab #3","腎功能不良劑量調整":"腎功能不良之病人，其服用劑量減半。\r<br>","小兒建議劑量":"小孩使用安全性尚未評估。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOL01O":{"商品名稱":"Molnupiravir 200mg Cap (公費)","腎功能不良劑量調整":"無。","小兒建議劑量":"不建議用於18歲以下病人。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOL02O":{"商品名稱":"Molnupiravir 200mg Bot (無健保非本國)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MON01O":{"商品名稱":"Monopril 10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MON04O":{"商品名稱":"Monurol Granular Powder#","腎功能不良劑量調整":"嚴重腎機能不全(Clcr<10)的病人，進行洗腎者，5歲以下兒童，不建議使用。","小兒建議劑量":"未滿   12  歲兒童之效益與安全性資訊尚未建立。","提示內容":"1. 尿道感染(非併發性下泌尿道感染) 1次1包空腹使用(建議睡前)\r<br>2. 泌尿道外科治療之感染預防：術前 3hr 用1包, 術後 24hr再用第二包\r<br>3.嚴重腎機能不全(ClCr<10)的病人，進行洗腎者，則無法達到尿中的治療濃度\r<br>補充 uptodate用法：Complicated UTI (off-label): Males: Oral: 3 g every 2 to 3 days for 3 doses\r<br>補充 uptodate用法：Prostatitis (off-label): Males: Oral: 3 g every 3 days for a total of 21 days","抗生素手冊":"暫無資料"},"MOP01O":{"商品名稱":"Mopride 5mg Tab","腎功能不良劑量調整":"小心使用,若發生副作用時可以減少用量\r<br>","小兒建議劑量":"安全性尚未確認\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOR01I":{"商品名稱":"Morphine 10mg\/1ml Amp #1","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Children >6 months and < 50 kg:\r<br>IM, IV: 0.1-0.2 mg\/kg every 3-4 hours as needed, slow IV over 4-5 mins.\r<br>Neonates (Use preservative-free formulation): \r<br>IM, IV, SubQ: Initial: 0.05 mg\/kg every 4-8 hours slow IV over 4-5 mins; titrate carefully to effect; max dose: 0.1 mg\/kg\/dose.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOR03I":{"商品名稱":"Moriamin-SN 200ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOR06O":{"商品名稱":"Morphine Sulphate 15mg Tab #1","腎功能不良劑量調整":"CrCl 10 to 50 : Children and Adults: 75% of normal dose.\r<br>CrCl <10: Children and Adults: 50% of normal dose.\r<br>HD: Children: 50% of normal dose.Adults: 不用調整\r<br>PD: Children: 50% of normal dose.\r<br>CRRT: Children and Adults: 75% of normal dose, titrate.","小兒建議劑量":"These are guidelines and do not represent the doses that may be required in all patients. Doses and dosage intervals should be titrated to pain relief\/prevention. 可用，每人需不同劑量來調整用量。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MOS01I":{"商品名稱":"Mosflow 400mg\/250ml Bot","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"並未有小兒族群使用 moxifloxacin 藥物動力學的研究\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 400 mg qd<br>留意 DDI 誘發 TdP "},"MOS01O":{"商品名稱":"Mosflow 400mg Tab","腎功能不良劑量調整":"不用調整","小兒建議劑量":"並未有小兒族群使用 moxifloxacin 藥物動力學的研究","提示內容":"暫無資料","抗生素手冊":"建議量: 400 mg qd<br>留意 DDI 誘發 TdP "},"MUA01O":{"商品名稱":"Muaction SR 100mg Tab #4","腎功能不良劑量調整":"[>50 ml\/min]: 50-100mg orally q4-6 hours (not > 400 mg\/day)\r<br>Elderly : 50-100 mg q4-6 hours not > 300 mg\/day\r<br>[<30 ]: 50-100 mg q12 hours (maximum: 200 mg\/day.)\r<br>HEMO:Insufficient data\r<br>Extended release: Should not be used in patients with Clcr <30 mL\/min","小兒建議劑量":"不適合14歲以下的兒童使用\r<br>","提示內容":"建議劑量:1-2 tab BID, Max dose: 400 mg daily\r<br>持續釋放劑型不建議磨粉","抗生素手冊":"暫無資料"},"MUL01I":{"商品名稱":"MultiHance 20ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MUL01O":{"商品名稱":"Multaq 400mg FC Tab#","腎功能不良劑量調整":"腎功能不全的病人不需調整劑量\r<br>","小兒建議劑量":"暫無資料","提示內容":"注意 QT prolong藥品交互作用，不得使用於有心衰竭住院診斷史病人。\r<br>Dronedarone併用Digoxin 需將Digoxin 劑量減半","抗生素手冊":"暫無資料"},"MUN01E":{"商品名稱":"Mundisal Gel 10gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小孩 本藥品含有43%(v\/v)酒精，應限於必須使用的情況下使用。(請參考注意事項與警語。)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MUS02O":{"商品名稱":"Musolax FC 150mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MUS04S":{"商品名稱":"Musco Soln 360mg\/120ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"< 2yr: 2.5ml BID; \r<br>2~5yr:2.5ml TID; \r<br>5~10yr: 5ml TID;\r<br>?> 10yr & 成人: 10ml TID。\r<br>------------------------------------------------------------------\r<br>MUCOLYTIC\r<br>0.5~0.7ml\/kg\/day分2-3次給予\r<br>(1.5~2mg\/kg\/d in 2 divided doses)\r<br>","提示內容":"成人及>10歲兒童: 10 mL tid \r<br>< 2歲: 2.5ml BID; 2~5歲: 2.5ml TID; 5~10歲: 5ml TID  \r<br>(1.5~2mg\/kg\/d in 2 divided doses)","抗生素手冊":"暫無資料"},"MVA01I":{"商品名稱":"MVASI 100mg\/4ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前尚未建立 MVASI 用在小孩及青少年的安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MVA02I":{"商品名稱":"MVASI (恩慈) 100mg\/4ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前尚未建立 MVASI 用在小孩及青少年的安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MVC01I":{"商品名稱":"MVC Flu Quad (公費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未曾接種過流感疫苗的9歲以下兒童須接種兩劑，兩劑之間至少間隔四週。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MXL01O":{"商品名稱":"MXL 60mg Cap #1","腎功能不良劑量調整":"CrCl 10 to 50 : 兒童及成人:  75% of normal dose.\r<br>CrCl <10 : 兒童及成人: 50% of normal dose.\r<br>HD: 兒童: 50% of normal dose.成人:不需調整\r<br>PD:  50% of normal dose.\r<br>CRRT: 75% of normal dose, titrate","小兒建議劑量":"滿一歲以上的小孩\r<br>尚未廣泛評估有關小孩使用MXL膠囊的情況。因癌症引起的嚴重性及難處理的疼痛，建議起始的劑量是每日每公斤體重給予0.4-1.6 mg的morphine。劑量的調整應比照成人劑量調整方式。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYA01O":{"商品名稱":"Myambutol (EMB) 400mg Tab#","腎功能不良劑量調整":"TB治療指引: Ethambutol不須改變劑量，但頻率改每週3次。病人如接受血液透析，透析當天的建議於透析後吃。\r<br>\r<br>熱病:\r<br>15-25mg\/kg q24h (MAX: 2500mg\/day)\r<br>[10~50ml\/min ]: Normal dose q24-36h\r<br>[<10 ]: Normal dose q48h.\r<br>HEMO:  Normal dose after dialysis.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYC01I":{"商品名稱":"Mycamine 50mg Vial#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 100 mg to 150 mg qd<br>小兒: 2 to 3 mg per kg qd"},"MYC01S":{"商品名稱":"Mycostatin Susp 2400000 Units\/24ml","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling [4]","小兒建議劑量":"嬰兒及孩童:通常治療劑量為每日四次，每次1-2ml，含於口中而吞下，臨床治癒後須至少續用48小時，以防復發。新生兒之預防劑量為每日1ml，一次用滴管入口中。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYC02O":{"商品名稱":"Mycobutin 150mg Cap","腎功能不良劑量調整":"TB治療指引: \r<br>正常劑量: 5mg\/kg劑量(最高劑量300mg)\r<br>輕中度腎功能不全者，不需調整劑量。\r<br>嚴重腎功能不全(當Clcr<30時)，rifabutin須減半劑量。","小兒建議劑量":"\"Prophylaxis for recurrence of Mycobacterium avium complex (MAC) in HIV-exposed\/-infected patients (unlabeled use; CDC, 2009): Oral: Infants and Children: 5 mg\/kg (maximum dose: 300 mg) once daily as an optional add-on to primary therapy of clarithromycin and ethambutol<br><br>\r<br>\r<br>Prophylaxis for first episode of MAC in HIV-exposed\/-infected patients (unlabeled use; CDC, 2009): Oral: Children >=6 years: 300 mg once daily<br><br>\r<br>\r<br>Treatment of active TB (as alternative to rifampin) in HIV-exposed\/-infected patients (unlabeled use; CDC, 2009): Oral: Infants and Children: 10-20 mg\/kg (maximum dose: 300 mg) once daily or intermittently 2-3 times weekly<br><br>\r<br>\r<br>Treatment of severe MAC in HIV-exposed\/-infected patients (unlabeled use; CDC, 2009): Oral: Infants and Children: 10-20 mg\/kg (maximum dose: 300 mg) once daily, in addition to primary therapy of clarithromycin and ethambutol\r<br>\r<br><br><br>Adolescents: Refer to adult dosing\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYC03E":{"商品名稱":"My Comb Cream 6gm","腎功能不良劑量調整":"仿單未載明。","小兒建議劑量":"仿單未載明。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYC04O":{"商品名稱":"Mycros 0.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"於小兒科其安全性和有效性尚未建立，故不建議用於小孩。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYC05O":{"商品名稱":"Mycocep 250mg Cap","腎功能不良劑量調整":"腎功能不良的人避免給予每天兩次每次高於一克的劑量\r<br>","小兒建議劑量":"BSA 1.25 m2 to 1.5 m2: 750 mg twice daily BSA >1.5 m2: 1000 mg twice daily","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYD01E":{"商品名稱":"Mydriacyl Eye Drop 1% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYD04O":{"商品名稱":"Mydocalm 150mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYF01O":{"商品名稱":"Myfortic 180mg Tab","腎功能不良劑量調整":"嚴重腎功能不良須小心使用\r<br>","小兒建議劑量":"安全性及療效尚未確認\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"MYK01O":{"商品名稱":"Mykrox 0.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAD01O":{"商品名稱":"Nadis 40mg Tab","腎功能不良劑量調整":"Acute renal failure: Doses up to 1-3 g daily may be necessary to initiate desired response; avoid use in oliguric states.\r<br>Not removed by hemo- or peritoneal dialysis; supplemental dose is not necessary.","小兒建議劑量":"兒童- 利尿劑 2mg\/kg\/dose，然後每6-8小時，再給1-2mg\/kg，調整劑量直到反達到為止。但每日最高不可超過40mg。有腎病綜合症兒童 可能需要達到 5mg\/kg\/dose。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAL01I":{"商品名稱":"Naloxone 0.4mg\/1ml Amp","腎功能不良劑量調整":"尚無良好的臨床試驗資料來評估使用在腎功能不良者的安全性及有效性\r<br>","小兒建議劑量":"安全性及療效尚未確認\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAL02I":{"商品名稱":"Naldebain ER 150mg\/2ml Vial","腎功能不良劑量調整":"腎功能不全患者不需調整劑量。","小兒建議劑量":"兒童患者使用NALDEBAIN之安全性及療效目前尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAP04O":{"商品名稱":"Naposin 250mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15未透析者:禁用","小兒建議劑量":".幼年型關節炎：每日總量 10 mg\/kg 分二\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAR01I":{"商品名稱":"Narcan 0.4mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAS02E":{"商品名稱":"Nasonex Nasal Spray 140d Bot","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"二歲以上每天每邊各噴一次\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAT01E":{"商品名稱":"Natesto Nasal Gel 5.5mg\/d;60d","腎功能不良劑量調整":"腎臟和肝臟功能障礙：未曾在腎臟或肝臟功能不全患者中進行研究。","小兒建議劑量":"由於尚未確立在< 18 歲兒童中的安全性和療效，因此不適用於此一病患族群","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAT03O":{"商品名稱":"Natrilix SR 1.5mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; use with caution.\r<br>","小兒建議劑量":"暫無資料","提示內容":"注意服用thiazide類可能有低血鉀, 高尿酸血症的發生","抗生素手冊":"暫無資料"},"NAV02I":{"商品名稱":"Navelbine 10mg\/1ml Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAV04O":{"商品名稱":"Navelbine 20mg Soft Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NAV05O":{"商品名稱":"NAVELBINE 30mg Soft Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEB01I":{"商品名稱":"Nebido 1000mg\/4ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEB01O":{"商品名稱":"Nebilet 5mg Tab","腎功能不良劑量調整":"Clcr< 30 ml\/min : 2.5mg once daily；if initial response is inadequate, may increase cautiously。(from Uptodate)\r<br>\r<br>\r<br>Hepatic impairment : \r<br>Mild impairment: no need to adjust。\r<br>\r<br>Moderate impairment :  2.5mg once daily；if initial response is inadequate,","小兒建議劑量":"使用於18歲以下病人的療效及安全性資料尚未建立。","提示內容":"成人建議每日固定時間服用一錠耐比洛(5毫克)。\r<br>嚴重低血壓, 嚴重心搏過慢及第二或第三期的心臟傳導阻斷為使用禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)","抗生素手冊":"暫無資料"},"NEO01E":{"商品名稱":"Neomycin Oint 0.5%;28gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"一天 2-4 次，適量塗於患部。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEO02E":{"商品名稱":"Neostigmin Eye Drop 0.01%;10ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"一次 2～3 滴，一日四次點眼。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEO02O":{"商品名稱":"Neomycin 250mg Cap","腎功能不良劑量調整":"Use with caution in patients with renal impairment; dosage modification or discontinuation required\r<br>","小兒建議劑量":"Oral: 50-100 mg\/kg\/day divided every 6-8 hours\r<br>","提示內容":"暫無資料","抗生素手冊":"500 mg bid<br>abs: poor"},"NEO04O":{"商品名稱":"Neo-Thyreostat 10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEO05O":{"商品名稱":"Neoral 25mg Cap#","腎功能不良劑量調整":"\"Nephrotic syndrome: \r<br>Canadian labeling: Initial: 2.5 mg\/kg daily<br>\r<br>Serum creatinine levels >30% above pretreatment levels: Take another sample within 2 weeks; if the level remains >30% above pretreatment levels, decrease dosage of cyclosporine (modified","小兒建議劑量":"新體睦使用於孩童的經驗仍相當有限。無論如何、從一歲就開始接受生體睦標準劑量治療的孩童並沒有出現特別的問題。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEO05S":{"商品名稱":"Neoral Solution 100mg\/ml;50ml#","腎功能不良劑量調整":"\"Nephrotic syndrome: Canadian labeling: Initial: 2.5 mg\/kg daily<br>Serum creatinine levels >30% above pretreatment levels: Take another sample within 2 weeks; if the level remains >30% above pretreatment levels, decrease dosage of cyclosporine (modified) by","小兒建議劑量":"Oral: Cyclosporine (non-modified):\r<br>    Initial: 14-18 mg\/kg\/dose administered 4-12 hours prior to organ transplantation; lower initial doses of 10-14 mg\/kg\/day have been used for renal transplants\r<br>    Maintenance, postoperative: 5-15 mg\/kg\/day divided every 12-24 hours; maintenance dose is usually tapered to 3-10 mg\/kg\/day\r<br>    When using non-modified formulation, cyclosporine levels may increase in liver transplant patients when the T-tube is closed; may need to decrease dose","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEO06O":{"商品名稱":"Neoral 100mg Cap#","腎功能不良劑量調整":"\"Nephrotic syndrome: Canadian labeling: Initial: 2.5 mg\/kg daily<br>Serum creatinine levels >30% above pretreatment levels: Take another sample within 2 weeks; if the level remains >30% above pretreatment levels, decrease dosage of cyclosporine (modified) by","小兒建議劑量":"新體睦使用於孩童的經驗仍相當有限。無論如何、從一歲就開始接受生體睦標準劑量治療的孩童並沒有出現特別的問題。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEP01I":{"商品名稱":"Nephrosteril 7% 250ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NER01O":{"商品名稱":"Nerlynx 40mg Tab","腎功能不良劑量調整":"重度腎功能不全或需腎臟透析的病人並不建議使用NERLYNX。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NES02I":{"商品名稱":"NESP Inj Plastic 20mcg\/0.5ml Syringe#","腎功能不良劑量調整":"Renal Impairment No dosage adjustment necessary.","小兒建議劑量":"Anemia associated with chronic kidney disease (CKD): Individualize dosing and use the lowest dose necessary to reduce the need for RBC transfusions.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEU01E":{"商品名稱":"Neupro Transdermal 4mg\/24h\/Patch#","腎功能不良劑量調整":" Mild-to-severe impairment (CrCl >=15 mL\/minute) including dialysis patients: No dosage adjustment necessary\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEU01I":{"商品名稱":"Neulasta 6mg\/0.6ml Syringe","腎功能不良劑量調整":"Renal Impairment No dosage adjustment necessary.","小兒建議劑量":"Prevention of chemotherapy-induced neutropenia (solid tumors): Children and Adolescents (off-label use): SubQ: 100 mcg\/kg (maximum dose: 6 mg) once per chemotherapy cycle, beginning 24 to 72 hours after completion of chemotherapy.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEU01O":{"商品名稱":"Neuquinon 10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEU02E":{"商品名稱":"NEUPRO Transdermal 6mg\/24h\/Patch#","腎功能不良劑量調整":"對輕度到中度肝功能不全的患者和輕度到重度腎功能不全(包括需要進行透析治療的患者)的患者，都不必調整劑量","小兒建議劑量":"由於缺乏有關安全性和療效的資料，不推薦將Neupro用於兒童和青少年。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEU03I":{"商品名稱":"NeuraCeq 300MBq (8.1mCi) 3ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Neuraceq 不適用於兒科患者。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEU03O":{"商品名稱":"Neurontin 100mg Cap#","腎功能不良劑量調整":"[Clcr >50 ml\/min]:300mg q8h. Usual maintenance dose: 300-600mg q8h. Max. dosage\/day: 1800 mg \r<br>[30-49 ]: 300-900mg\/day \r<br>[15-29 ]: 150-600mg\/day.\r<br>[<15]: 150-300 mg\/day. (300mg QOD or QD)\r<br>HD : 300mg loading, then 200-300mg after HD","小兒建議劑量":"\"3-12歲兒童患者：<br>Gabapentin的起始劑量是10-15 mg\/kg\/天，分成三等分服用(每天三次)，可以用三天的時間逐步調高劑量，以達到有效劑量。對於5歲及5歲以上的兒童患者，gabapentin的有效劑量是25-35 mg\/kg\/天，分成三等分服用(每天三次)，對於3歲至未滿5歲兒童者，gabapentin的有效劑量是40 mg\/kg\/天，分成三等分服用(每天三次)。長期的臨床試驗顯示，當劑量高達50 mg\/kg\/天時，患者的耐受性仍然良好。劑量與劑量之間的最大間隔不應超過12小時。<br>使用gabapentin治療時，不需要監測gabapentin的血漿濃度。此外，gabapentin可以和其他抗癲癇藥品合併使用，無須顧慮gabapentin或其他抗癲癇藥物的血中濃度會改變。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEU04O":{"商品名稱":"NEURONTIN 300mg Cap","腎功能不良劑量調整":"[Clcr >50 ml\/min]:300mg q8h. Usual maintenance dose: 300-600mg q8h. Max. dosage\/day: 1800 mg \r<br>[30-49 ]: 300-900mg\/day \r<br>[15-29 ]: 150-600mg\/day.\r<br>[<15]: 150-300 mg\/day. (300mg QOD or QD)\r<br>HD : 300mg loading, then 200-300mg after HD","小兒建議劑量":"3-12歲兒童: 起始劑量 10-15mg\/kg\/天，分3等分服用。\r<br>常見有效劑量:(都分3等分服用)\r<br>>5歲: 25-35mg\/kg\/天; \r<br>3~5歲: 40mg\/kg\/天。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEX01O":{"商品名稱":"Nexium 40mg Tab#","腎功能不良劑量調整":"\"腎功能不良之患者，並不須調整劑量。對腎臟功能嚴重不足之患者，<br>因經驗有限，治療此類病人仍需特別謹慎。\"\r<br>","小兒建議劑量":"使用於 18 歲以下患者的安全性及有效性尚未建立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NEX02O":{"商品名稱":"Nexavar 200mg Tab#","腎功能不良劑量調整":"\"未接受透析治療的病患，不需調整<br>劑量。\"\r<br>","小兒建議劑量":"安全性與有效性尚未建立\r<br>","提示內容":"400 mg BID (飯前1小時服用)","抗生素手冊":"暫無資料"},"NIC04O":{"商品名稱":"Nicorette 2mg Chewing Gum","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未滿18歲禁止使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIC05O":{"商品名稱":"NICORETTE 4MG CHEWING GUM","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未滿18歲禁止使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIF01O":{"商品名稱":"Nifedipine SRFC 30mg Tab","腎功能不良劑量調整":"腎機能障礙及肺高血壓患者應慎重投與。There are no dosage adjustments provided in manufacturer’s labeling (has not been studied); the pharmacokinetics of nifedipine are not significantly influenced by the degree of renal impairment","小兒建議劑量":"兒童安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIG01O":{"商品名稱":"Nigoline 10mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIL02O":{"商品名稱":"Nilasen 24mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; use with caution.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIM01I":{"商品名稱":"Nimotop 0.02%\/50ml Vial#","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIM01O":{"商品名稱":"Nimotop 30mg Tab","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIM02I":{"商品名稱":"Nimenrix 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"1歲以下不建議施打。\r<br>\r<br>1歲以上，於出發前10天，給予單一劑量0.5ml IM，必要時每3~5年可追加施打一劑，","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIM03I":{"商品名稱":"Nimbex 10mg\/5ml Amp","腎功能不良劑量調整":" Because slower times to onset of complete neuromuscular block were observed in renal dysfunction patients, extending the interval between the administration of cisatracurium and intubation attempt may be required to achieve adequate intubation conditions","小兒建議劑量":"\"1. 快速靜脈注射使用： 1個月至12歲兒童的劑量：氣管內插管─與成人一樣，本品注射劑的建議起始劑量為0.15mg\/kg，注射時間為5～10秒。此劑量在注射120秒後可產生理想的插管狀態。<br>\r<br>\r<br>2. 靜脈點滴的使用: 成人及1個月至12歲兒童的劑量：點滴輸注本品注射劑可維持神經肌肉阻斷的作用。在自發性恢復出現後，若想要繼續維持在89%～99%的T1抑制作用時，建議可給予一個3μg\/kg\/min(0.18mg\/kg\/hr)的點滴起始速率。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIN01O":{"商品名稱":"Ninlaro 3mg Cap","腎功能不良劑量調整":"重度腎功能不良者(Clcr <30 ml\/min)或ESRD需要血液透析患者，起始劑量應調降至3mg。\r<br>\r<br>中度(總膽紅素高於正常值1.5-3倍)或重度肝功能不良者(總膽紅素高於正常值3倍)，起始劑量應調降至3mg。","小兒建議劑量":"尚未確立用於兒科病人的安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIN02E":{"商品名稱":"Nincort Oral Gel 6gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIN02O":{"商品名稱":"NINLARO 4MG CAP","腎功能不良劑量調整":"重度腎功能不良者(Clcr <30 ml\/min)或ESRD需要血液透析患者，起始劑量應調降至3mg。\r<br>\r<br>中度(總膽紅素高於正常值1.5-3倍)或重度肝功能不良者(總膽紅素高於正常值3倍)，起始劑量應調降至3mg。","小兒建議劑量":"尚未確立用於兒科病人的安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NIT01E":{"商品名稱":"Nitroderm TTS 5","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"1 patch QD for 12-14 hr\r<br>用於冠動疾病引起心絞痛之預防與治療\r<br>不適用於心絞痛急性發作PRN用, 開立Q12H需做建議","抗生素手冊":"暫無資料"},"NIV01I":{"商品名稱":"Nivestim 300mcg\/0.5ml Syringe","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer's labeling.\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOG01O":{"商品名稱":"Nogout 100mg Tab#","腎功能不良劑量調整":"一般常用的劑量為每日 50 mg，最大劑量為每日 100 mg，\r<br>CCr <20 mL\/min 時，因缺乏效果宜避免使用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOL01O":{"商品名稱":"Nolvadex 10mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"安全性和療效尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NON01O":{"商品名稱":"Noncough 20\/90\/20mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOO01I":{"商品名稱":"Nootropil 1gm\/5ml Amp#","腎功能不良劑量調整":"正常: 1.2~2.4g. 初劑量可達4.8g, 分2~4次服用\r<br>Clcr 79~50: 2\/3 劑量，分2~3次服用 (1g bid)\r<br>Clcr 49~30:  1\/3劑量，2次服用 (500mg bid)\r<br>Clcr <30 : 1\/6劑量，每日1次 (500mg qd)\r<br>Clcr <20 : 禁用","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOO02I":{"商品名稱":"Noopol 1gm\/5ml Amp#","腎功能不良劑量調整":"正常: 1.2~2.4g. 初劑量可達4.8g, 分2~4次服用\r<br>Clcr 79~50: 2\/3 劑量，分2~3次服用 (1g bid)\r<br>Clcr 49~30:  1\/3劑量，2次服用 (500mg bid)\r<br>Clcr <30 : 1\/6劑量，每日1次 (500mg qd)\r<br>Clcr <20 : 禁用","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR01I":{"商品名稱":"Norepinephrine 4mg\/4ml Amp","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling.(uptodate)","小兒建議劑量":"兒童使用Levophed的安全性與治療性尚未建立。","提示內容":"將4ml amp本品溶液加入1000ml D5W或D5S稀釋後使用。\r<br>起始速率 2-3 mL IV infusion, 維持速率: 0.5-1 mL","抗生素手冊":"暫無資料"},"NOR01O":{"商品名稱":"Norina 5mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"Adolescents: Refer to adult dosing","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR04I":{"商品名稱":"Normal Saline 20ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR06I":{"商品名稱":"Normal Saline 1000ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR07O":{"商品名稱":"Norvasc 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR08O":{"商品名稱":"Normacol Plus Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"本品勿於就寢前服用或服用完立即呈橫臥姿勢，特別是老年人。處方開立睡前服用需確認","抗生素手冊":"暫無資料"},"NOR13I":{"商品名稱":"刪除Normal Saline 500ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR17I":{"商品名稱":"Normal Saline 100ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR23I":{"商品名稱":"刪除Normal Saline 250ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR26I":{"商品名稱":"Isotonic NaCl 500ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR28E":{"商品名稱":"N.S. Irrigation 500ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOR29E":{"商品名稱":"N.S. Irrigation 1000ml 塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOT02O":{"商品名稱":"Notholic FC 50mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV01I":{"商品名稱":"Novamin 5mg\/1ml Amp","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"Note: Injection solution mesylate formulation has Canadian availability (not available in U.S.).<br>\r<br>Use is contraindicated in children <9 kg or <2 years.<br><br>Antiemetic:<br><br>\r<br>Oral, rectal (therapy >1 day usually not required):<br><br>\r<br>9-13 kg: 2.5 mg 1-2 times\/day as needed (maximum: 7.5 mg\/day)\r<br><br><br>>13-18 kg: 2.5 mg 2-3 times\/day as needed (maximum: 10 mg\/day)<br><br>\r<br>>18-39 kg: 2.5 mg 3 times\/day or 5 mg 2 times\/day as needed (maximum: 15 mg\/day)<br><br>\r<br>I.M. (as edisylate): 0.13 mg\/kg\/dose; convert to oral therapy as soon as possible<br><br>\r<br>I.M. (as mesylate): 0.14 mg\/kg\/dose; convert to oral therapy at equivalent or greater dose (if necessary) as soon as possible<br><br>\r<br>Antipsychotic: Children 2-12 years:<br><br>\r<br>Oral, rectal: 2.5 mg 2-3 times\/day; do not give more than 10 mg the first day; increase dosage as needed to maximum daily dose of 20 mg for 2-5 years and 25 mg for 6-12 years\r<br>I.M. (as edisylate): 0.13 mg\/kg\/dose; convert to oral therapy as soon as possible\r<br><br><br>I.M. (as mesylate): 0.14 mg\/kg\/dose; convert to oral therapy at equivalent or greater dose (if necessary) as soon as possible\"\r<br>","提示內容":"仿單建議限以SC或IM給藥, 否則易引起EPS的副作用","抗生素手冊":"暫無資料"},"NOV02I":{"商品名稱":"NOVOMIX 50 Penfill 300iu\/3ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV02O":{"商品名稱":"Novonorm 1mg Tab","腎功能不良劑量調整":"eGFR< 30: 起始劑量減為 隨餐0.5 mg","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV03I":{"商品名稱":"NovoMix 30 Penfill 300iu\/3ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV04I":{"商品名稱":"NovoRapid Penfill 300iu\/3ml","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; insulin requirements may be reduced due to changes in insulin clearance or metabolism; monitor blood glucose closely.\r<br>","小兒建議劑量":"\"- Diabetes mellitus, type 1: Children >=2 years and Adolescents: Refer to adult dosing.\r<br><br>- Diabetic ketoacidosis (DKA), mild-to-moderate (unlabeled use): Children and Adolescents: \r<br>Treatment should continue until reversal of acid-base derangement\/ketonemia. Serum glucose is not a direct indicator of these abnormalities, and may decrease more rapidly than correction of the metabolic abnormalities. Also refer to institution-specific protocols where appropriate.<br>\r<br>\r<br>SubQ (Note: Use of I.V. regular insulin is preferred; only use the SubQ route if I.V. infusion access is unavailable): 0.3 units\/kg followed in 1 hour by 0.1 units\/kg given every hour or 0.15-0.2 units\/kg every 2 hours; continue until acidosis clears, then decrease to 0.05 units\/kg given every hour until maintenance SubQ replacement dosing can be initiated (Kitabchi, 2004; Wolfsdorf, 2007)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV07I":{"商品名稱":"NovoRapid FLEXPEN 300iu\/3ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Diabetes mellitus, type 1: Children >=2 years and Adolescents: Refer to adult dosing.\r<br><br>- Diabetic ketoacidosis (DKA), mild-to-moderate (unlabeled use): Children and Adolescents: \r<br>Treatment should continue until reversal of acid-base derangement\/ketonemia. Serum glucose is not a direct indicator of these abnormalities, and may decrease more rapidly than correction of the metabolic abnormalities. Also refer to institution-specific protocols where appropriate.<br>\r<br>\r<br>SubQ (Note: Use of I.V. regular insulin is preferred; only use the SubQ route if I.V. infusion access is unavailable): 0.3 units\/kg followed in 1 hour by 0.1 units\/kg given every hour or 0.15-0.2 units\/kg every 2 hours; continue until acidosis clears, then decrease to 0.05 units\/kg given every hour until maintenance SubQ replacement dosing can be initiated (Kitabchi, 2004; Wolfsdorf, 2007)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV08I":{"商品名稱":"NovoMix 30 FlexPen 300iu\/3ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV09I":{"商品名稱":"NOVOMIX 50 FlexPen 300iu\/3ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV10I":{"商品名稱":"NovoMix 30 1 iu (FlexPen 小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV11I":{"商品名稱":"NOVOMIX 50 1 iu (FlexPen 小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV12I":{"商品名稱":"NovoRapid 1 iu (FLEXPEN 小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NOV13I":{"商品名稱":"NovoRapid  1 iu (Penfill 小單位檔)","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; insulin requirements may be reduced due to changes in insulin clearance or metabolism; monitor blood glucose closely.\r<br>","小兒建議劑量":"\"- Diabetes mellitus, type 1: Children >=2 years and Adolescents: Refer to adult dosing.<br>\r<br>- Diabetic ketoacidosis (DKA), mild-to-moderate (unlabeled use): Children and Adolescents: \r<br>Treatment should continue until reversal of acid-base derangement\/ketonemia. Serum glucose is not a direct indicator of these abnormalities, and may decrease more rapidly than correction of the metabolic abnormalities. Also refer to institution-specific protocols where appropriate.<br>SubQ (Note: Use of I.V. regular insulin is preferred; only use the SubQ route if I.V. infusion access is unavailable): 0.3 units\/kg followed in 1 hour by 0.1 units\/kg given every hour or 0.15-0.2 units\/kg every 2 hours; continue until acidosis clears, then decrease to 0.05 units\/kg given every hour until maintenance SubQ replacement dosing can be initiated (Kitabchi, 2004; Wolfsdorf, 2007)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NTG01I":{"商品名稱":"NTG Premixed 50mg\/250ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"依(Hosp Pharm 2014；49(2):136-163)之建議使用時不需避光。藥品會受PVC管路吸附，但因使用不會吸附的管路產生作用的劑量於病人間的差別很大。故仿單說明未限制PVC管路之使用，劑量需依病人的臨床反應調整","抗生素手冊":"暫無資料"},"NTG01O":{"商品名稱":"NTG (Nitrostat) 0.6mg Tab","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NTG02O":{"商品名稱":"NTG (Nitrostat) 25tab\/Bot","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NUB01O":{"商品名稱":"Nubeqa 300mg Tab","腎功能不良劑量調整":"對重度(腎絲球過濾率估計值[eGFR] 15至29 mL\/min\/1.73 m2)腎功能不全且未接受透析治療的病人，建議起始劑量為每日服用兩次300mg darolutamide。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NUC02I":{"商品名稱":"Nucala 100mg\/1ml Pen","腎功能不良劑量調整":"目前尚未在臨床試驗中探討過腎功能不全對mepolizumab之藥物動力學的影響。","小兒建議劑量":"12歲以下不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NUS01O":{"商品名稱":"Nuspas 0.125mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling, use with caution.","小兒建議劑量":"2~12歲兒童：一次1\/2~1錠，每4小時或需要時一次，每日不超過6錠。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NUT01I":{"商品名稱":"Nutriflex Peri 40\/80;1000ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NUT02I":{"商品名稱":"Nutrineal PD4 With 1.1% Amino Acid#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NUT04I":{"商品名稱":"NUTRIFLEX SPECIAL 70\/240 1000ml Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NUV01I":{"商品名稱":"COVID-19 Vaccine Novavax (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"NYS01O":{"商品名稱":"Nystatin 500000u Cap","腎功能不良劑量調整":"仿單沒有顯示\r<br>","小兒建議劑量":"Infants: 200,000-400,000 units 4 times\/day or 100,000 units to each side of mouth 4 times\/day\r<br>","提示內容":"常用漱口劑量為400000~600000Unit, qid\r<br> (即21# Nystatin泡在500 ml D5W內, 每次以20-30 ml 漱口吞服)","抗生素手冊":"PK: poorly abs"},"OBI01I":{"商品名稱":"OBI-822\/OBI-821 37.5\/150mcg Vial\/Set","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OFE01O":{"商品名稱":"Ofev Soft 150mg Cap#","腎功能不良劑量調整":"CrCl ?30 mL\/minute: No initial dosage adjustment necessary.\r<br>CrCl <30 mL\/minute and end-stage renal disease (ESRD): There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied).","小兒建議劑量":"尚未建立兒童病患使用本藥物時的安全性與有效性。","提示內容":"1.本品適應症為「特發性肺纖維化」，「與全身性硬化症有關之間質性肺病\r<br>2.建議最大日劑量300毫克\r<br>3.需監測肝功能","抗生素手冊":"暫無資料"},"OFL01E":{"商品名稱":"Ofloxin Otic Soln 3mg\/ml;5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OGI01I":{"商品名稱":"Ogivri 440mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用本品的安全性及效果","提示內容":"Herceptin 的生物相似性藥品","抗生素手冊":"暫無資料"},"OGI02I":{"商品名稱":"Ogivri 1mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用本品的安全性及效果","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OGI03I":{"商品名稱":"Ogivri (恩慈) 440mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用本品的安全性及效果","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OGI04I":{"商品名稱":"Ogivri (恩慈) 1mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立小兒科病人使用本品的安全性及效果","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OLA01O":{"商品名稱":"Olan OD 5mg Tab","腎功能不良劑量調整":"此類病患應考慮給予較低的起始劑量 (5 毫克 )。","小兒建議劑量":"因為缺乏安全性和療效的資料，不建議孩童十八歲以下青少年服用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OLM03O":{"商品名稱":"Olmetec FC 40mg Tab","腎功能不良劑量調整":"腎功能不全病患血漿中的濃度會高於腎功能正常的病患。重複投藥後，嚴重腎功能損傷病患(Clcr<20)的AUC會提高3倍。在血液透析病患的藥物動力學尚未被研究。","小兒建議劑量":"在18歲以下病患的藥物動力學尚未建立。","提示內容":"注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"OLU01O":{"商品名稱":"Olumiant 4mg Tab","腎功能不良劑量調整":"30ml\/min <= Clcr <= 60ml\/min: 2mg QD;\r<br>Clcr < 30ml\/min: avoid.","小兒建議劑量":"無相關資料。","提示內容":"1.緩解因新型冠狀病毒引起併發症。與 dexamethasone，或 dexamethasone + remdesivir 合併用於需使用高流量氧氣或非侵襲性呼吸器但未插管，同時發炎指數上升 (CRP ? 7.5 mg\/dL)之病患。 \r<br>2.劑量：每天 4mg 口服使用 14 天或至出院","抗生素手冊":"暫無資料"},"OME02O":{"商品名稱":"Omezol 20mg Cap#","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"\"GERD or other acid-related disorders: Oral: Children 1-16 years:\r<br>5 kg to <10 kg: 5 mg once daily<br><br>\r<br>10 kg to <20 kg: 10 mg once daily\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OMN01I":{"商品名稱":"Omnipaque 300mg\/100ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OMN02I":{"商品名稱":"Omnipaque 35000mg\/100mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OMN03I":{"商品名稱":"Omnipaque 17500mg\/50mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ONC01I":{"商品名稱":"OncoTICE(2-8x10^8 CFU) Vial (BCG)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ONC02I":{"商品名稱":"Oncoginase 10000IU Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ONG01O":{"商品名稱":"ONGLYZA FC 5MG TAB#","腎功能不良劑量調整":"對中度或重度腎功能不全的患者或需要接受血液透析的末期腎病(ESRD)患者（[CrCl]<50 mL\/min），ONGLYZA劑量為每日一次2.5毫克。ONGLYZA 應在血液透析後給藥。[1]","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"一般劑量: 5 mg QD\r<br>ClCr<50 ml\/min 劑量需調整為 2.5 mg QD","抗生素手冊":"暫無資料"},"ONG02O":{"商品名稱":"Onglyza FC 2.5mg Tab","腎功能不良劑量調整":"對中度或重度腎功能不全的患者或需要接受血液透析的末期腎病(ESRD)患者（[CrCl]<50 mL\/min），ONGLYZA劑量為每日一次2.5毫克。ONGLYZA 應在血液透析後給藥。[1]","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ONI01I":{"商品名稱":"Onivyde 43mg\/10ml Vial#","腎功能不良劑量調整":"不建議使用於重度腎功能不全及洗腎病患。","小兒建議劑量":"尚未建立使用於兒童患者的安全性及有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPD01I":{"商品名稱":"OPDIVO 100mg\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對小孩無使用經驗，尚未確立其安全性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPD02I":{"商品名稱":"OPDIVO 20mg\/2ml Vial","腎功能不良劑量調整":"起始劑量不需依腎功能調整。但治療期間，若\r<br>Scr大於正常值1.5-6倍(或原本值的1.5倍)：暫停使用、\r<br>Scr大於正常值6倍：永久停用","小兒建議劑量":"對小孩無使用經驗，尚未確立其安全性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPD03I":{"商品名稱":"OPDIVO (恩慈) 20mg\/2ml Vial","腎功能不良劑量調整":"起始劑量不需依腎功能調整。但治療期間，若\r<br>Scr大於正常值1.5-6倍(或原本值的1.5倍)：暫停使用、\r<br>Scr大於正常值6倍：永久停用","小兒建議劑量":"對小孩無使用經驗，尚未確立其安全性","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPD04I":{"商品名稱":"OPDIVO (恩慈) 100mg\/10ml Vial","腎功能不良劑量調整":"起始劑量不需依腎功能調整。但治療期間，若\r<br>Scr大於正常值1.5-6倍(或原本值的1.5倍)：暫停使用、\r<br>Scr大於正常值6倍：永久停用","小兒建議劑量":"對小孩無使用經驗，尚未確立其安全性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPD05I":{"商品名稱":"Opdivo 120mg\/12mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPI01E":{"商品名稱":"Opiodur Patch 12mcg\/h#2","腎功能不良劑量調整":"少於10%的fentanyl會以原型自腎臟排出。不同於morphine，DUROGESICR沒有活性代謝物會由腎臟排出。腎功能受損之病患給予DUROGESICR應注意是否有fentanyl中毒之情況，必要時應降低劑量。\r<br>","小兒建議劑量":"DUROGESICR僅能使用於對類鴉片藥物有耐受性的病童(年齡為2-16歲)，該病童須正接受至少相當於每日30 mg的口服嗎啡劑量。欲將病童自口服或靜脈注射類鴉片藥物轉換成DUROGESICR時，請參考等止痛劑量換算和依每日口服嗎啡劑量推算而得的DUROGESICR推薦劑量。未研究兩歲以下兒童使用DUROGESICR的情形。DUROGESICR只能用於對類鴉片藥物有耐受性的兩歲以上兒童。為避免兒童意外攝入，要小心選擇DUROGESICR的使用部位，並密切監測貼片的黏著性。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPS01O":{"商品名稱":"Opsumit 10mg Tab#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; however, pharmacokinetic changes were not considered clinically relevant. Canadian labeling does not recommend use in dialysis patients (has not been studied).","小兒建議劑量":"兒童：安全性與有效性尚未被建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPT01E":{"商品名稱":"Optive Fusion Eye Drops 30amp\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPT01I":{"商品名稱":"Optiray 320# 50ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OPT03I":{"商品名稱":"Optiray 350# 100ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ORA02O":{"商品名稱":"Oraphine 60mg Cap","腎功能不良劑量調整":"重度腎功能不建議使用","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ORE01I":{"商品名稱":"ORENCIA  IV Inj 250MG#","腎功能不良劑量調整":"腎、肝功能不全病患\r<br>Orencia尚未對於這些病患族群進行研究，因此無建議使用劑量。","小兒建議劑量":"**Orencia未於6歲以下的兒童進行任何研究。小兒病患：\r<br>Juvenile idiopathic arthritis (6-17 yrs): \r<br>< 75 kg, 10 mg\/kg; ? 75 kg, following the adult dosing regimen; max. 1000 mg.","提示內容":"<60kg: 500mg, 60-100kg: 750mg\r<br> >100kg:1000mg (大約10mg\/kg), \r<br>應在第一次輸注後的第2及4週後給藥，此後每4週給藥一次。","抗生素手冊":"暫無資料"},"ORE02I":{"商品名稱":"Orencia SC Inj 125mg Syringe","腎功能不良劑量調整":"腎、肝功能不全病患\r<br>Orencia尚未對於這些病患族群進行研究，因此無建議使用劑量。","小兒建議劑量":"本藥品恩瑞舒針筒裝皮下注射劑125毫克未核准用於6歲以上、中重度活動性幼年型慢性關節炎兒童。","提示內容":"Orencia 125mg 使用SC QW","抗生素手冊":"暫無資料"},"ORF01O":{"商品名稱":"ORFARIN 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"處方中若NOAC與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>GI bleeding為warfarin使用禁忌","抗生素手冊":"暫無資料"},"ORF02O":{"商品名稱":"Orfarin 3mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"處方中若NOAC與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>GI bleeding為warfarin使用禁忌","抗生素手冊":"暫無資料"},"OSE01S":{"商品名稱":"Oseltamivir Susp 6mg\/mL;60mL (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3kg=1.5mL BID 5days\r<br>4kg=2.0mL BID 5days\r<br>5kg=2.5mL BID 5days\r<br>6kg=3.0mL BID 5days\r<br>7kg=3.5mL BID 5days\r<br>8kg=4.0mL BID 5days\r<br>9kg=4.5mL BID 5days\r<br>10-15kg=5.0mL BID 5days\r<br>16-23kg=7.5mL BID 5days\r<br>23-40kg=10.0mL BID 5days","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OTO01E":{"商品名稱":"Otozambon Ear Drops 8ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小孩: 一次滴於耳孔內2-3滴，一日3-4次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OTR01I":{"商品名稱":"Otril 3mg\/3ml Vial","腎功能不良劑量調整":"於嚴重腎衰竭病患之資料顯示，靜脈給予單一劑量後之藥物動力學參數大致和正常人相似。腎功能不全：無特殊劑量指示。\r<br>\r<br>","小兒建議劑量":"~抗腫瘤化學療法引起的噁心及嘔吐: 同成人劑量\r<br>~兒童之預防及治療抗腫瘤放射線療法引起的噁心及嘔吐之用法用量 : 目前尚無足夠的資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OXA01I":{"商品名稱":"Oxalip 50mg\/10ml Vial#","腎功能不良劑量調整":"U.S. labeling:\r<br>CrCl >30 mL\/min: No dosage adjustment necessary.\r<br>CrCl <30 mL\/min: Reduce dose from 85 to 65 mg\/m2.\r<br>\r<br>Canadian labeling: CrCl <30 mL\/min: Use is contraindicated.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OXA03I":{"商品名稱":"Oxacillin Powder for Injection  1gm Vial","腎功能不良劑量調整":"腎功能不全的病人通常無需調整劑量。","小兒建議劑量":"輕到中度之上呼吸道感染：局部皮膚及軟組織感染：\r<br>< 40 kg : 50 mg\/kg\/d，divided to Q6H\r<br>>40 kg : 250-500 mg Q4-6H\r<br>更嚴重的感染：如下呼吸道或散佈性的感染 \r<br>< 40 kg : 100 mg\/kg\/d，divided to Q4-6H\r<br>> 40 kg : >1g Q4-6H\r<br>注意：由吸收及排出的資料顯示，對早產兒及新生兒給予25 mg\/kg\/day 已足可達到治療濃度。\r<br>------------------------------------------------------------------------\r<br>簡易換算:50-200 mg\/kg\/d dividedin 2-4 doses。","提示內容":"小兒劑量：\r<br>50-200mg\/kg\/d divided in 2-4 doses.","抗生素手冊":"建議量: 1 to 2 gm q4h<br>主要經肝臟排泄"},"OXB01O":{"商品名稱":"Oxbu ER 5mg Tab#","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"Children >=6 years: Extended release: 5 mg once daily; adjust dose in 5 mg increments; maximum: 20 mg once daily\r<br>","提示內容":"Oxbu是緩釋錠, 若需切半或磨粉, 可處方同成份同劑量的Ditropan","抗生素手冊":"暫無資料"},"OXO01I":{"商品名稱":"Oxocin 10iu\/1ml Amp","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"無兒童劑量","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OXY01I":{"商品名稱":"Oxytocin 10iu\/1ml Amp","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OXY01O":{"商品名稱":"OxyNorm IR 5mg Cap #2","腎功能不良劑量調整":"CrCl less than 60 mL\/min: Initiate therapy and adjust doses conservatively; if a dose less than 9 mg is necessary, use an alternative analgesic.","小兒建議劑量":"目前尚未以未滿18歲的兒童病患為對象，探討奧諾美的安全性與療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OXY02O":{"商品名稱":"Oxycontin CR 10mg Tab#2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未滿11歲的病人無法確立該年齡層使用產品的安全性","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OXY03O":{"商品名稱":"OXYCONTIN CR 20MG TAB#2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未滿11歲的病人無法確立該年齡層使用產品的安全性","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OZA01O":{"商品名稱":"Ozapex OD 5mg Tab","腎功能不良劑量調整":"此類病患應考慮給予較低的起始劑量 (5 毫克 )。","小兒建議劑量":"因為缺乏安全性和療效的資料，不建議孩童十八歲以下青少年服用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OZE01I":{"商品名稱":"Ozempic 2mg\/1.5ml Pen","腎功能不良劑量調整":"Semaglutide因資料有限，不建議用於ESRD病患。","小兒建議劑量":"尚未有18歲以下孩童使用之安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OZE02I":{"商品名稱":"OZEMPIC 4MG\/3ML PEN","腎功能不良劑量調整":"Semaglutide因資料有限，不建議用於ESRD病患。","小兒建議劑量":"尚未有18歲以下孩童使用之安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"OZU01I":{"商品名稱":"Ozurdex Intravitreal Implant 0.7mg","腎功能不良劑量調整":"目前尚未針對腎功能異常患者進行OZURDEXR試驗，然而對於此族群不需有特殊考量。","小兒建議劑量":"OZURDEX尚未建立小兒族群的安全性與療效。","提示內容":"成分0.7 mg dexamethasone\r<br>玻璃體內植入物注射器\r<br>每個注射器只能用於治療一隻眼睛","抗生素手冊":"暫無資料"},"OZU02I":{"商品名稱":"Ozurdex(恩慈) Intravitreal Implant 0.7mg","腎功能不良劑量調整":"目前尚未針對腎功能異常患者進行OZURDEX試驗，然而對於此族群不需有特殊考量。","小兒建議劑量":"OZURDEX尚未建立小兒族群的安全性與療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAD01I":{"商品名稱":"Padcev 30mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAD01O":{"商品名稱":"Padalin 100mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAD02I":{"商品名稱":"Padcev (恩慈) 30mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAI02O":{"商品名稱":"Painkyl 200 mcg #2","腎功能不良劑量調整":"目前所存資訊不足以針對 PAINKYL 於腎或肝功能損害病患中之使用作出建議。吩坦尼主要經由人類 CYP3A4 異構酵素系統代謝，而其非活性代謝物主要經由尿液排除；因吩坦尼經由肝臟代謝且經由腎臟排除，應更謹慎用於罹患嚴重腎臟或肝臟疾病之病患。","小兒建議劑量":"未滿 18 歲小兒科病患的安全性與療效資料目前尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAN01E":{"商品名稱":"Panoxyl 5 Acne Gel 5% 6gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAN01I":{"商品名稱":"PANACAL 30mg\/1ml Amp","腎功能不良劑量調整":"腎功能不全者應延長給藥間隔（interval）；\r<br>輕度（GFR＞50 mL\/min）：間隔6小時；\r<br>中度（GFR 10-50 mL\/min）：間隔6-12小時；\r<br>重度（GFR＜10 mL\/min）：間隔12-18小時。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAN01O":{"商品名稱":"Pantoloc 40mg Tab#","腎功能不良劑量調整":"No dosage adjustment necessary; pantoprazole is not removed by hemodialysis","小兒建議劑量":"\r<br>因使用於孩童、經驗有限，因此Pantoloc iv 40mg不建議使用於18歲以下之病人","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAN02I":{"商品名稱":"Pantoloc I.V. 40mg Vial","腎功能不良劑量調整":"腎功能不全病人不需調整劑量。\r<br>患有嚴重肝功能不全的病人每日劑量須降至\r<br>Pantoprazole 20mg， 並且在治療期間， 定期監\r<br>測肝酵素， 若肝酵素指數升高， 應停止使用\r<br>Pantoloc i.v.。","小兒建議劑量":"Dosage not established","提示內容":"高劑量Pantoloc 持續輸注治療: \r<br>起始劑量80 mg輸注30 min; then 8 mg\/hr for 72 hrs\r<br>\r<br>-->處方常見 1 vial Q6H 使用3天","抗生素手冊":"暫無資料"},"PAN04O":{"商品名稱":"Panamax 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Max. dose: 4 g\/day (8 tab\/day)","抗生素手冊":"暫無資料"},"PAR01I":{"商品名稱":"Paren-Aid No.3 400ml Bot","腎功能不良劑量調整":"仿單未提及","小兒建議劑量":"小孩依體重定義之。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAR04I":{"商品名稱":"Paraplatin 150mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAR06I":{"商品名稱":"Paren-Aid No.3 200ml 0.5Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAR06O":{"商品名稱":"Parilac  2.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAR07O":{"商品名稱":"Parkryl 5mg Tab (M.S.)","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"ADHD (unlabeled use): Children and Adolescents: Oral: 5-15 mg\/day (Jankovic, 1993)\r<br><br>\r<br>Discontinuation of therapy: Refer to adult dosing.\r<br>\r<br><br><br>MAO inhibitor recommendations: Refer to adult dosing","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAR08E":{"商品名稱":"Parmason Gargle Solution","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAR08O":{"商品名稱":"Pariet 20mg Tab#","腎功能不良劑量調整":"不需劑量調整","小兒建議劑量":"不建議使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAR09O":{"商品名稱":"Parotin FC 75mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"Oral: Children ?12 years: Refer to adult dosing.\r<br>Children: 3-6 mg\/kg\/day in 3 divided doses","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAT01I":{"商品名稱":"Patent Blue V 2ml\/AMP","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAX01O":{"商品名稱":"Paxlovid 150\/100mg Tab\/Set (公費)","腎功能不良劑量調整":"eGFR介於30~60ml\/min：150mg (1#) Nirmatrelvir + 100mg (1#) Ritonavir PO BID * 5 days\r<br>eGFR小於30ml\/min：不建議使用。","小兒建議劑量":"12歲以下或40公斤以下不建議使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PAX02O":{"商品名稱":"Paxlovid 150\/100mg Box (無健保非本國)","腎功能不良劑量調整":"eGFR介於30~60ml\/min：150mg (1#) Nirmatrelvir + 100mg (1#) Ritonavir PO BID * 5 days\r<br>eGFR小於30ml\/min：不建議使用。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PCA001":{"商品名稱":"PCA (Morphine 80mg+ NS 76ml) (一級)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PCA002":{"商品名稱":"PCA (Fentanyl 1.6mg+ NS 48ml) (二級)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PCA003":{"商品名稱":"PCA (Fentanyl 2.5mg+ NS 75ml) (二級)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PCA005":{"商品名稱":"PCA (Fentanyl 2mg+ NS 60ml) (二級)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PEC03S":{"商品名稱":"Pecolin Suspension 120ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"2-5yr: 7.5ml QID; \r<br>> 6yr: 15ml QID; \r<br>成人: 30ml QID\r<br>-----------------------------------------------\r<br>< 1yr:  3c.c. TID; \r<br>1-3yr:  5c.c. TID; \r<br>3-6yr: 7.5c.c.TID; \r<br>> 6yr: 10c.c. TID","提示內容":"藥委會通過零購品項開檔使用。(成分為Kaolin+Pectin, 暫時緩解輕微或中度急性腹瀉) \r<br>(1)避免與其他藥品同時服用(2)急性腹瀉不得超過使用48小時。建議開封安定性:14天。","抗生素手冊":"暫無資料"},"PEG03I":{"商品名稱":"PEGASYS 180mcg\/0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Children  >=3 years: \r<br>SubQ: Combination therapy with ribavirin: 60 mcg\/m2 once weekly; Note: Children who reach their 18th birthday during treatment should remain on the pediatric regimen. Treatment duration is 48 weeks for genotype 1, 24 weeks for genotypes 2 and 3. Discontinue combination therapy in patients with HCV (genotype 1) at 12 weeks if HCV-RNA does not decrease by at least 2 log (compared to pretreatment) or if detectable HCV-RNA present at 24 weeks\r<br>","提示內容":"1.為慢性B肝及C肝治療用藥，每周一次皮下注射","抗生素手冊":"暫無資料"},"PEN01O":{"商品名稱":"Pentop S.R 400mg Tab#","腎功能不良劑量調整":"Pentoxyfyllin一般劑量為400mg TID\r<br>Clcr 30~50 : 400mg bid\r<br>Clcr 10~30: 400mg qd~bid \r<br>Clcr <10: 400mg qd~qod\r<br>HEMO:   None","小兒建議劑量":"18歲以下兒童安全性尚未建立(仿單)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PEN02O":{"商品名稱":"Pentasa Sachet 2g Pack","腎功能不良劑量調整":"有腎功能不全的病人，不建議使用本品。","小兒建議劑量":"兒童：初始劑量由每日每公斤體重給予\r<br>             20mg－30mg，分次給予。","提示內容":"1.不可咀嚼。直接將小包內顆粒劑倒在舌頭上用水或果汁吞服。\r<br>2.發作期治療劑量：每日最高4 g，一次或分次給予。平穩期維持劑量：每日2 g，一次或分次給予。一般體重小於40 kg之兒童建議使用劑量為成人劑量的一半；體重大於40 kg之兒童建議使用劑量與成人使用劑量相同。","抗生素手冊":"暫無資料"},"PEN03O":{"商品名稱":"Pentixol FC 3mg Tab","腎功能不良劑量調整":"腎功能受損者，可以一般劑量投與。","小兒建議劑量":"因缺乏臨床經驗，不建議使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PEN05I":{"商品名稱":"Penicillin G 3000000U Vial","腎功能不良劑量調整":"Penicillin G: 1~ 4 mu q4-6h. \r<br>[30-50 ml\/min]:  q6h\r<br>[10-30]:  q8h \r<br>[<10 and HEMO]:  q12h.","小兒建議劑量":"\"Susceptible infections: I.M., I.V.:<br><br>\r<br>\r<br>Infants>=1 month and Children: 100,000-400,000 units\/kg\/day in divided doses every 4-6 hours (maximum dose: 24 million units\/day)\r<br>\r<br><br><br>Community-acquired pneumonia (CAP) (IDSA\/PIDS, 2011): I.V.: Infants and Children >3 months: Note: May consider addition of vancomycin or clindamycin to empiric therapy if community-acquired MRSA suspected. In children >=5 years, a macrolide antibiotic should be added if atypical pneumonia cannot be ruled out.<br><br>\r<br>\r<br>Empiric treatment or S. pneumoniae (moderate-to-severe; MICs to penicillin <=2.0 mcg\/mL) (preferred): 200,000-250,000 units\/kg\/day divided every 4-6 hours<br><br>\r<br>\r<br>Group A Streptococcus (moderate-to-severe) (preferred): 100,000-250,000 units\/kg\/day divided every 4-6 hours<br><br>\r<br>\r<br>Meningitis (gonococcal): I.V.: 250,000 units\/kg\/day in 4 divided doses<br><br>\r<br>\r<br>Moderate infections: I.M., I.V.: 100,000-250,000 units\/kg\/day in 4 divided doses<br><br>\r<br>\r<br>Neurosyphilis: I.V.: 200,000-300,000 units\/kg\/day divided every 4-6 hours for 10-14 days (maximum dose: 24 million units\/day)<br><br>\r<br>\r<br>Severe infections: I.M., I.V.: 250,000-400,000 units\/kg\/day in divided doses every 4-6 hours (maximum dose: 24 million units\/day)\r<br>\r<br><br><br>Syphilis (congenital): I.V.:<br><br>\r<br>\r<br>Infants: 50,000 units\/kg every 12 hours for first 7 days of life, then every 8 hours for a total of 10 days (CDC, 2010)<br><br>Children: 50,000 units\/kg every 4-6 hours for 10 days (CDC, 2010)\"\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 1 vial q4h<br>Ccr less than 30: q8h<br>Ccr less than 10, HD or PD: q12h"},"PEN08I":{"商品名稱":"Penicillin Skin Test Soln 10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PEN09I":{"商品名稱":"Pentaxim Vaccine(公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"針對2個月大以上之嬰幼兒，白喉、破傷風、百日咳、小兒痲痺及b型流行性感冒嗜血桿菌之主動免疫<br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PEP01O":{"商品名稱":"Peptidin Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PER01E":{"商品名稱":"Permethrin Cream 5% 30g Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6-12歲: 單次使用半條(15g)\r<br>\r<br>1-5歲: 單次使用0.25條(7.5g)\r<br>\r<br>2個月-1歲: 單次使用0.125條(3.75g)","提示內容":"1.僅供外用於成人、2 個月及以上的兒童和老年人。\r<br>2.用量≧12 歲 30克-60克；6-12 歲15g；1-5 歲  7.5g； 2 個月 – 1 歲 3.75g。7-14日可評估再次給藥治療\r<br>3.不應塗抹在破損的皮膚、粘膜或眼睛附近。清洗身體後(如洗完熱水澡)不應立即使用，待皮膚冷卻乾燥後再行塗抹。使用本品時只要輕輕擦拭皮膚即可。使用後8-12小時應徹底清洗全身。\r<br>4.老人 塗抹在全身包括頸部、面部、耳朵和頭皮，但要避開靠近眼睛的區域。特別注意手指和腳趾之間、指甲下、手腕、腋窩、外生殖器、乳房和臀部的區域是否有塗抹。\r<br>5. 2 歲以上的兒童和成人塗抹在全身但頭和臉不用塗抹。特別注意手指和腳趾之間、指甲下、手腕、腋窩、外生殖器、乳房和臀部的區域是否有塗抹。\r<br>6. 2 歲以下兒童塗抹在全身包括頸部、面部、耳朵和頭皮。但要避開可以舔掉本品的嘴巴周圍和眼睛周圍的區域。特別注意手指和腳趾之間、指甲下、手腕、腋窩、手掌和腳底、外生殖器和臀部的區域是否有塗抹。","抗生素手冊":"暫無資料"},"PER01I":{"商品名稱":"Perjeta 420mg\/14ml Vial","腎功能不良劑量調整":"Clcr ?30 mL\/minute: No dosage adjustment necessary.\r<br>Clcr <30 mL\/minute: No dosage adjustment provided in the manufacturer’s labeling (has not been studied)","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PER02E":{"商品名稱":"Periocline Periodontal Oint","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PER02I":{"商品名稱":"Persantin 10mg Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PER03E":{"商品名稱":"Permetriin Gel 5% 30g Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6-12歲: 單次使用半條(15g)\r<br>\r<br>1-5歲: 單次使用0.25條(7.5g)\r<br>\r<br>2個月-1歲: 單次使用0.125條(3.75g)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PER03I":{"商品名稱":"Perjeta (恩慈) 420mg\/14ml Vial","腎功能不良劑量調整":"Clcr >30 mL\/minute: No dosage adjustment necessary.\r\r<br>Clcr <30 mL\/minute: No dosage adjustment provided in the manufacturer’s labeling (has not been studied)","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PER03O":{"商品名稱":"Persantin 75mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling\r<br>","小兒建議劑量":"\r<br>\r<br>一般兒童劑量: 目前尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PER05I":{"商品名稱":"Perdipine 10mg\/10ml Amp","腎功能不良劑量調整":"老年\/ 孕婦\/ 肝腎功能不良者： 依據病人血壓及臨床情況， 起始劑量為1-5 mg \/ h ， 持續輸注30 分鐘後， 視實際治療效果， 劑量可以0.5 mg \/ h 逐漸調高或降低， 但最大不超過15 mg \/ h 。\r<br>","小兒建議劑量":"本藥之靜脈輸注應僅使用於小兒患者於重症加護或手術後危急生命之高血壓。\r<br>起始劑量： 在危急情況下，建議起始劑量為0.5-5 mcg\/kg\/min。\r<br>建議維持劑量： 1-4 mcg \/ kg \/min。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PG201I":{"商品名稱":"PG2 Inj 500mg Vial","腎功能不良劑量調整":"仿單沒有寫\r<br>","小兒建議劑量":"仿單沒有寫\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHA03I":{"商品名稱":"Pharmorubicin 10mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHA04I":{"商品名稱":"PHARMORUBICIN 50mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHE01I":{"商品名稱":"Phenobital 100mg\/1ml Amp#4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"Sedation: Oral: Children: 2 mg\/kg 3 times\/day<br><br>\r<br>Preoperative sedation: Oral, I.M., I.V.: Children: 1-3 mg\/kg 1-1.5 hours before procedure<br><br>\r<br>\r<br>Anticonvulsant\/status epilepticus (loading dose): I.V.: Infants and Children: 15-20 mg\/kg (maximum: 1000 mg\/dose, maximum rate <=30 mg\/minute in children <60 kg); may repeat dose after 15 minutes as needed (maximum total dose: 40 mg\/kg)<br><br>\r<br>\r<br>Anticonvulsant maintenance dose: Oral, I.V.:\r<br>\r<br><br><br>Infants: 5-8 mg\/kg\/day in 1-2 divided doses<br><br>\r<br>\r<br>Children:<br><br>\r<br>1-5 years: 6-8 mg\/kg\/day in 1-2 divided doses<br><br>\r<br>5-12 years: 4-6 mg\/kg\/day in 1-2 divided doses\r<br><br><br>>12 years: 1-3 mg\/kg\/day in divided doses or 50-100 mg 2-3 times\/day\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHE01O":{"商品名稱":"Phenobarbital 30mg Tab (Johnson)#4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"Sedation: Oral: Children: 2 mg\/kg 3 times\/day<br><br>Preoperative sedation: Oral, I.M., I.V.: Children: 1-3 mg\/kg 1-1.5 hours before procedure<br><br>Anticonvulsant\/status epilepticus (loading dose): I.V.: Infants and Children: 15-20 mg\/kg (maximum: 1000 mg\/dose, maximum rate <=30 mg\/minute in children <60 kg); may repeat dose after 15 minutes as needed (maximum total dose: 40 mg\/kg)<br><br>Anticonvulsant maintenance dose: Oral, I.V.:<br><br>Infants: 5-8 mg\/kg\/day in 1-2 divided doses<br><br>Children:<br><br>1-5 years: 6-8 mg\/kg\/day in 1-2 divided doses<br><br>5-12 years: 4-6 mg\/kg\/day in 1-2 divided doses<br><br>>12 years: 1-3 mg\/kg\/day in divided doses or 50-100 mg 2-3 times\/day\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHE02I":{"商品名稱":"Phesgo SC 600\/600mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHE03E":{"商品名稱":"Phenylephrine Eye Drops 10% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHE09O":{"商品名稱":"Phenobarbital 30mg Tab U.L #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHI01E":{"商品名稱":"Phisohex 0.5% 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PHY01I":{"商品名稱":"Phytonadione(Vit K1) 10mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"neonate:0.5~2mg max:10mg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIC03O":{"商品名稱":"Picetam 400mg Cap#","腎功能不良劑量調整":"正常: 800mg TID口服, Max. 4.8g\/day\r<br>Clcr 79~50: 2\/3 劑量，每日分2~3次服用\r<br>Clcr 49~30:  1\/3劑量，每日分2次服用\r<br>Clcr <30 : 1\/6劑量，每日1次\r<br>Clcr <20 : 禁用","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIL03E":{"商品名稱":"PILOCARPINE Oph Soln 2% 15ml Bot","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling [4]","小兒建議劑量":"同成人使用劑量","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIL04O":{"商品名稱":"Pilian 4mg Tab","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer’s labeling\r<br>","小兒建議劑量":"2-6yr: 2mg BID-TID, max 12mg\/day\r<br>          (about 0.25 mg\/kg\/day)\r<br>7-14yr: 4mg BID-TID, max 16mg\/day; \r<br>","提示內容":"藥委會通過零購品項開檔使用\r<br>成人每日3~4次，每次一錠。2~6歲每次1\/4錠，7~14歲每次1\/2錠，一天3~4次。\r<br>促進食欲(off-label use):1錠 BID-QID。(0.5mg\/kg\/day)\r<br>婦產科袁九重主任會使用此藥促進癌症病人食慾","抗生素手冊":"暫無資料"},"PIN01O":{"商品名稱":"Pinsaun 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIQ03O":{"商品名稱":"Piqray 150mg FC Tab","腎功能不良劑量調整":"CrCl <30 mL\/minute: There are no dosage adjustments provided in the manufacturer's labeling","小兒建議劑量":"PIQRAY 用於兒童病人的安全性和療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIQ04O":{"商品名稱":"Piqray 50mg FC Tab","腎功能不良劑量調整":"CrCl <30 mL\/minute: There are no dosage adjustments provided in the manufacturer's labeling","小兒建議劑量":"PIQRAY 用於兒童病人的安全性和療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIQ05O":{"商品名稱":"PIQRAY 200MG FC TAB","腎功能不良劑量調整":"CrCl <30 mL\/minute: There are no dosage adjustments provided in the manufacturer's labeling","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIR01O":{"商品名稱":"Pirespa 200mg Tab","腎功能不良劑量調整":"本藥不建議使用於末期腎病的需透析患者。","小兒建議劑量":"對於出生體重不足的嬰兒、新生兒、乳幼兒及小兒的投與安全性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PIT02I":{"商品名稱":"Pitressin 20u\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"治療效益大於危險性才可使用，應按比例減低劑量\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PKM01O":{"商品名稱":"Pk-Merz 100mg Tab","腎功能不良劑量調整":"Day1 200mg than, \r<br>Clcr 30~50: 100mg qd\r<br>Clcr 15~30: 100mg qod\r<br>Clcr <15: 100mg 1W2D\r<br>HEMO: 100mg 1W2D","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PLA02O":{"商品名稱":"Plaquenil 200mg Tab","腎功能不良劑量調整":"對嚴重肝腎功能不全的病人，應監測其血漿中 Hydroxychloroquine的濃度並依之調整劑量。(仿單)","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PLA03O":{"商品名稱":"Plavix 75mg Tab#","腎功能不良劑量調整":"No dosage adjustment necessary?\r<br>","小兒建議劑量":" 保栓通不建議用於兒童或18歲以下的青少年。\r<br>","提示內容":"急性冠心症(ACS):\r<br> loading dose 300 mg- 600mg ST","抗生素手冊":"暫無資料"},"PLE01I":{"商品名稱":"Plegridy (恩慈) 63mcg\/0.5ml Pen","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未有18歲以下孩童的安全性及有效性的資料。","提示內容":"初始治療，第一個劑量為63mcg SC，兩週後的第二個劑量為94mcg、之後每兩週使用125mcg的維持劑量","抗生素手冊":"暫無資料"},"PLE01O":{"商品名稱":"Plendil 5mg Tab","腎功能不良劑量調整":"No dosage adjustment necessary\r<br>","小兒建議劑量":"用於孩童治療之經驗有限。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PLE02E":{"商品名稱":"Plegisol Solution 1000ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PLE02I":{"商品名稱":"PLEGRIDY (恩慈) 94MCG\/0.5ML PEN","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未有18歲以下孩童的安全性及有效性的資料。","提示內容":"初始治療，第一個劑量為63mcg SC，兩週後的第二個劑量為94mcg、之後每兩週使用125mcg的維持劑量","抗生素手冊":"暫無資料"},"PLE02O":{"商品名稱":"Pletaal 100MG TAB#","腎功能不良劑量調整":"透析的病患尚未被研究，但因Cilostazol 有高蛋白結合率（95-98%），可能不易以透析有效地排除。當嚴重腎功能障害（creatinine clearance 約 < 25 ml\/min）病患使用 Pletaal 時，應特別小心。","小兒建議劑量":"對兒科病患的安全性和有效性尚未確立","提示內容":"1 tab BID, 飯前半小時使用","抗生素手冊":"暫無資料"},"PLE03I":{"商品名稱":"PLEGRIDY 125MCG\/0.5ML PEN","腎功能不良劑量調整":"依據輕度、中度、重度腎功能不全以及末期腎病患者的臨床資料，腎功能不全患者不須調整劑量","小兒建議劑量":"Plegridy 對 0 至 18 歲兒童及青少年患者的多發性硬化症的安全性以及療效尚未確立。無可用資料。","提示內容":"初始治療，第一個劑量為63mcg SC，兩週後的第二個劑量為94mcg、之後每兩週使用125mcg的維持劑量\r<br>1. 每14天(每2週) 皮下注射1劑\r<br>2. 貯存2-8°C。冰箱取出後可於室溫(最高25°C) 保存最多30天，但必須避免光照。(多次從冰箱取出至室溫的總和時間不超過30天)","抗生素手冊":"暫無資料"},"PNE03I":{"商品名稱":"Pneumovax 23 (中央公費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PNE04I":{"商品名稱":"Pneumovax 23 (北市公費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PNE05I":{"商品名稱":"Pneumovax 23 (自費) 0.5mL Syringe","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"\"4. 6週至6個月大的嬰兒：基礎劑之接種時程包含三劑，每劑0.5毫升，兩劑之間至少間隔1個月 (見藥效學性質) 。建議於接種最後一劑基礎劑至少6個月後追加1劑，此追加劑最好在年齡12至15個月時施打。 <br>5.先前未曾接種疫苗之較大嬰兒與兒童：<br>7-11個月大的嬰兒：基礎劑之接種時程包含二劑，每劑0.5毫升，兩劑之間至少間隔1個月。第三劑建議於出生後的第二年施打，第二劑與第三劑之間至少間隔2個月。<br>12-23個月大的幼兒：基礎劑之接種時程包含二劑，每劑0.5毫升，兩劑之間至少間隔2個月。於此接種時程之後再追加一劑的必要性尚未確立。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POL03O":{"商品名稱":"Polaramine 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POL06O":{"商品名稱":"Polupi 50mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"Children 10-14years Initially 200-300mg daily, 5-9years Initially 100-200mg daily. To be taken in 2-4divided doses. Maintenance: 50-100mg daily in 1-2divided doses.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POM01O":{"商品名稱":"Pomalyst 3mg Cap#","腎功能不良劑量調整":"在進行血液透析治療的日子，應於透析治療結束後再服用POMALYST","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POM02O":{"商品名稱":"POMALYST 4mg Cap","腎功能不良劑量調整":"在進行血液透析治療的日子，應於透析治療結束後再服用POMALYST","小兒建議劑量":"暫無資料","提示內容":"急用個案藥品到貨。(本院另有低劑量的Pomalyst 3mg cap)。核准用於多發性骨髓瘤(multiple myeloma, MM)\r<br>由於會對胎兒造成危害， 所以無論是男女在服藥期間及完成後的一個月內都必須避孕並禁止捐血捐精\r<br>若出現血管水腫、脫皮、大或任何其他嚴重皮膚反應，應停止治療\r<br>若患者發生呼吸急促、胸痛、手臂或腿部腫脹等症狀，即應就醫\r<br>治療前8週應每週監測全血球計數，之後每月監測一次。\r<br>每月監測一次肝功能\r<br>起始劑量為每28天療程之第1-21天使用，每日一次，每天口服4 mg，直到疾病惡化為止。須併用dexamethasone及建議劑量：在每個28天療程的第1天、第8天、第15天和第22天，每日一次口服40 mg。(本院品項為 Dorison 4mg tab)\r<br>不得壓碎、咀嚼或打開膠囊\r<br>劑量調整詳見仿單","抗生素手冊":"暫無資料"},"POM03O":{"商品名稱":"Pomalyst 1mg cap","腎功能不良劑量調整":"在進行血液透析治療的日子，應於透析治療結束後再服用POMALYST","小兒建議劑量":"暫無資料","提示內容":"(本院另有Pomalyst 4mg cap與Pomalyst 3mg cap)。核准用於多發性骨髓瘤(multiple myeloma, MM)\r<br>由於會對胎兒造成危害， 所以無論是男女在服藥期間及完成後的一個月內都必須避孕並禁止捐血捐精\r<br>若出現血管水腫、脫皮、大或任何其他嚴重皮膚反應，應停止治療\r<br>若患者發生呼吸急促、胸痛、手臂或腿部腫脹等症狀，即應就醫\r<br>治療前8週應每週監測全血球計數，之後每月監測一次。\r<br>每月監測一次肝功能\r<br>起始劑量為每28天療程之第1-21天使用，每日一次，每天口服4 mg，直到疾病惡化為止。須併用dexamethasone及建議劑量：在每個28天療程的第1天、第8天、第15天和第22天，每日一次口服40 mg。(本院品項為 Dorison 4mg tab)\r<br>不得壓碎、咀嚼或打開膠囊\r<br>劑量調整詳見仿單","抗生素手冊":"暫無資料"},"POS01I":{"商品名稱":"Posintin 10mg\/2ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POS04E":{"商品名稱":"Posuline 100\/2.5mg Supp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POS04O":{"商品名稱":"Posanol 100mg Tab","腎功能不良劑量調整":"無須因腎功能不全調整劑量。","小兒建議劑量":"用於未滿13 歲青少年及兒童的安全性和療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"須餐後因高脂食物增加吸收<br>建議量: 400 mg q12h<br>DDI: TdP"},"POT01I":{"商品名稱":"Pot Chloride 15%;40meq\/20ml Amp","腎功能不良劑量調整":"依血鉀調整劑量\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>Children Max: 3 mEq\/kg or 40 mEq\/mL daily.","提示內容":"KCL稀釋濃度建議：\r<br>周邊靜脈輸注濃度<10 mEq\/100 mL，輸注速率<10 mEq\/hr\r<br>中央靜脈輸注(CVP line)濃度為20-40 mEq\/100 mL，輸注速率<40 mEq\/hr","抗生素手冊":"暫無資料"},"POT03M":{"商品名稱":"Pot Iodine 25gm Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POT04I":{"商品名稱":"Pot Phosphate 20ml Amp","腎功能不良劑量調整":"依血鉀調整劑量\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POT04M":{"商品名稱":"Pot. Iodine 1gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POT06I":{"商品名稱":"Pot Phosphate 10ml\/0.5Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"POU01O":{"商品名稱":"Poulican Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PPN001":{"商品名稱":"PPN3-A 40\/80 1ML (1018 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PPN002":{"商品名稱":"PPN3-B (Glycerol) 1ML (518 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PPN003":{"商品名稱":"PPN3-C 46\/103\/41 1ML (1466 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PPN004":{"商品名稱":"PPN3-D 1mL (1018mL\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRA01O":{"商品名稱":"Pradaxa 110 mg Cap#","腎功能不良劑量調整":"請至少每年進行一次腎功能評估。\r<br>Clcr 30~50: 110mg BID，\r<br>Clcr<30者，尚無資料支持使用。 \r<br>(或Clcr 15~30: 75mg bid)\r<br>Clcr <15: 禁用\r<br>HEMO：禁用","小兒建議劑量":"目前尚無 18 歲以下病患使用 PRADAXA 的經驗，因此不建議孩童使用 PRADAXA。\r<br>","提示內容":"110-150 mg BID\r<br>需整粒吞服, 膠囊不可打開使用(會增加生體可用率, 提高出血風險)\r<br>\r<br>處方中若NOAC與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>\r<br>ClCr< 30 ml\/min禁用此藥","抗生素手冊":"暫無資料"},"PRA02O":{"商品名稱":"PRADAXA 150 mg Cap#","腎功能不良劑量調整":"請至少每年進行一次腎功能評估。\r<br>Clcr 30~50: 110mg BID，\r<br>Clcr<30者，尚無資料支持使用。 \r<br>(或Clcr 15~30: 75mg bid)\r<br>Clcr <15: 禁用\r<br>HEMO：禁用","小兒建議劑量":"尚未針對18歲以下病患進行Pradaxa的研究，因此不建議兒童接受Pradaxa治療","提示內容":"110-150 mg BID\r<br>需整粒吞服, 膠囊不可打開使用(會增加生體可用率, 提高出血風險)\r<br>\r<br>處方中若NOAC與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>\r<br>ClCr< 30 ml\/min禁用此藥","抗生素手冊":"暫無資料"},"PRA03I":{"商品名稱":"Praluent 75mg\/mL Pen","腎功能不良劑量調整":"輕度或中度肝功能不全患者不需調整劑量。無重度肝功能不全患者之資料。","小兒建議劑量":"Praluent使用於兒童及小於18歲之青少年的安全性及療效尚未建立。無可提供之資料。","提示內容":"75 mg 每兩週一次SC","抗生素手冊":"暫無資料"},"PRA04I":{"商品名稱":"Praxbind 2.5g\/50ml 2vial\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE01I":{"商品名稱":"Precedex 200mcg\/2ml Vial#","腎功能不良劑量調整":"No specific guidelines available; however, dexmedetomidine pharmacokinetics were not different in patients with severe renal impairment compared to those with normal renal function\r<br>","小兒建議劑量":"仿單:不建議用於小於18歲的兒童                                                                                                                               uptodate:Children (limited data): Loading d\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE02E":{"商品名稱":"Premarin Vag Cream 14gm Tube","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer’s labeling (has not been studied). Use with caution; may increase risk of fluid retention.\r<br>","小兒建議劑量":"不可使用於孩童。未曾對小兒族群進行臨床試驗。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE02I":{"商品名稱":"Prevenar 13 (自費) Conj Vaccine","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"肌肉注射。\r<br>開始施打年齡，決定劑量數:\r<br>6個月大以內嬰兒-共4劑，前3劑至少間隔1個月，第4劑第於12-15個月大施打。\r<br>7~11個月大-共3劑，前2劑至少間隔1個月，第3劑於滿1歲後施打。\r<br>12-23個月大幼兒- 共2劑，每次間隔至少2個月\r<br>2-5歲-接受單一劑量即可。\r<br>50歲以上成人-單一劑量。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE02O":{"商品名稱":"Premarin 0.625MG TAB","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"小兒科的使用 <br>雖然雌激素療法用來誘導發育遲緩者進入青春期，但其安全與效力尚未建立。用於未進入<br>青春期的女孩會產生乳房過早發育與陰道角膜變化，且可能引起陰道出血。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE04E":{"商品名稱":"Premare Vag Cream 14gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE05E":{"商品名稱":"Pred Forte Oph Susp 1% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE06I":{"商品名稱":"Premixed Dopamine 400mg\/250ml Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE07I":{"商品名稱":"Prevenar 13 (兒童公費) Conj Vaccine","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"肌肉注射。\r<br>開始施打年齡，決定劑量數:\r<br>6個月大以內嬰兒-共4劑，前3劑至少間隔1個月，第4劑第於12-15個月大施打。\r<br>7~11個月大-共3劑，前2劑至少間隔1個月，第3劑於滿1歲後施打。\r<br>12-23個月大幼兒- 共2劑，每次間隔至少2個月\r<br>2-5歲-接受單一劑量即可。\r<br>50歲以上成人-單一劑量。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE08O":{"商品名稱":"Prednisolone 5mg Tab VPP","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRE10I":{"商品名稱":"Prevenar 13 (長者公費) Conj Vaccine","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI01I":{"商品名稱":"Primperan 10mg\/2ml Amp","腎功能不良劑量調整":"[Clcr >50 ml\/min]: 10-15 mg\/dose orally up to 4 times\/day\r<br>[10-50 ml\/min]: 50%\r<br>[<10 ml\/min]: 25%\r<br>HEMO: Dose as for Clcr<10","小兒建議劑量":"5mg成人劑量的一半\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI01O":{"商品名稱":"Primperan 5mg Tab","腎功能不良劑量調整":"腎功能不良者慎重給藥\r<br>","小兒建議劑量":"依症狀或年齡適宜增減\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI02I":{"商品名稱":"Primovist 10mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI02O":{"商品名稱":"Priligy FC 30mg Tab","腎功能不良劑量調整":"建議用於輕度至中度腎功能不全的病人，應謹慎使用。重度腎功能不全病人不建議使用Priligy.","小兒建議劑量":"Priligy不能使用於18歲以下的兒童及青少年。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI03I":{"商品名稱":"Prismasol B0 Solution 5L","腎功能不良劑量調整":"仿單未記載。請依監測離子濃度調整用量。因為本產品不含鉀，應特別注意低血鉀病患。","小兒建議劑量":"適用之補充液量取決於治療的程度及為了達到液體平衡目標所需要的量而定。\r<br>一般血液過濾及血液透析過濾中補充液的使用流速為: 小孩: 15-20 ml\/kg\/hr. \r<br>一般連性血液透析治療中透析液的使用流速為- 小孩: 15-20 ml\/kg\/hr","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI03O":{"商品名稱":"Primolut-Nor 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI04I":{"商品名稱":"Primacor 10mg\/10ml Amp","腎功能不良劑量調整":"CRCL -  mL\/min\/1.73 m2 \r<br>[CRCL > 50]: LD: 50 mcg\/kg slowly over 10 minutes, then start maintenance: 0.375 to 0.75 mcg\/kg\/min\r<br>[50]: 0.43 mcg\/kg\/min\r<br>[40]: 0.38 mcg\/kg\/min\r<br>[30]: 0.33 mcg\/kg\/min\r<br>[20]: 0.28 mcg\/kg\/min\r<br>[10]: 0.23 mcg\/kg\/min\r<br>[5]: 0.2 mcg\/k","小兒建議劑量":"安全性和有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI05I":{"商品名稱":"Privigen 5gm\/50ml Bot","腎功能不良劑量調整":"Dosing: Renal Impairment\r<br>IV: Use with caution due to risk of immune globulin-induced renal dysfunction; the rate of infusion and concentration of solution should be minimized. Discontinue if renal function deteriorates during treatment.","小兒建議劑量":"雖可用數據有限，仍預期相同警語、注意事項及危險因子適用於小兒族群。於上市後經驗中觀察到高劑量IVIg使用在兒童上，特別是川崎氏症，相較於其它使用在兒童上的IVIg在溶血反應有關的通報比率上有增加。","提示內容":"【需記錄產品的名稱與批號】免疫球蛋白製劑【IVIG_5g】\r<br>一定不可與生理食鹽水混合，然而，用生理食鹽水潤洗輸注管是允許的。(1080118新增)\r<br>初始輸注速率為0.5mg\/kg bw\/min), 耐受良好可逐漸增加。","抗生素手冊":"暫無資料"},"PRI06I":{"商品名稱":"Priorix 0.5ml Vial (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRI09I":{"商品名稱":"Prismasol K4 Solution 5L","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO01I":{"商品名稱":"Prolia inj 60mg\/1ml Syri#","腎功能不良劑量調整":"對腎功能受損的患者，並不須調整劑量。","小兒建議劑量":"Prolia並不建議用於年齡小於4歲的小兒病人，因為其骨骼生長快速，且Prolia可能會對齒列及長骨生長具有不良影響。Prolia在小兒病人中的安全性及有效性尚未確立。\r<br>","提示內容":"停經後婦女骨質疏鬆症:每6個月注射一次 60mg (皮下注射)","抗生素手冊":"暫無資料"},"PRO02E":{"商品名稱":"Proparacaine Oph 5mg\/ml 15ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO02I":{"商品名稱":"Promeran 10mg\/2ml Amp","腎功能不良劑量調整":"[Clcr >50 ml\/min]: 10-15 mg\/dose orally up to 4 times\/day\r<br>[10-50 ml\/min]: 50%\r<br>[<10 ml\/min]: 25%\r<br>HEMO: Dose as for Clcr<10","小兒建議劑量":"兒童按年齡、體重、症狀每日1 次，每次0.5ml 至2m1，行肌肉或靜脈注射。","提示內容":"ClCr<40 ml\/min 劑量需減半\r<br>可能有EPS方面副作用, 老年人或Parkinson病人需慎用。\r<br>預防化療引起之嘔吐, 與diphenhydramine併用可降低EPS的風險","抗生素手冊":"暫無資料"},"PRO05I":{"商品名稱":"Protamine 50mg\/5ml Amp","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"跟大人劑量一樣\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO09I":{"商品名稱":"PROGESTERONE 25mg\/1ml (ASTAR)","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO10O":{"商品名稱":"Procil 50mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"Hyperthyroidism: Oral: Children: Initial: 5-7 mg\/kg\/day or 150-200 mg\/m2\/day in divided doses every 8 hours or\r<br>6-10 years: 50-150 mg\/day; >10 years: 150-300 mg\/day","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO11I":{"商品名稱":"PROPOFOL-LIPURO 500mg\/50ml Vial#4","腎功能不良劑量調整":"Dosing: Renal Impairment No dosage adjustment necessary.\r<br>Dosing: Hepatic Impairment No dosage adjustment necessary.","小兒建議劑量":"*Propofol-Lipuro 1% (10 mg\/ml) 不可使用於年齡小於1個月的兒童之麻醉誘導或維持。\r<br>*年齡小於16歲之病患，不可使用於加護單位之鎮靜。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO11O":{"商品名稱":"Provera 10mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Oral: 5-10 mg\/day for 5-10 days\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO12I":{"商品名稱":"Progeston Depot 125mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO12O":{"商品名稱":"Prozac 20mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO13I":{"商品名稱":"Propofol-Lipuro 200mg\/20ml Amp#4","腎功能不良劑量調整":"Dosing: Renal Impairment No dosage adjustment necessary.\r<br>Dosing: Hepatic Impairment No dosage adjustment necessary.","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO14I":{"商品名稱":"Promostan 20mcg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO15O":{"商品名稱":"Procal 667mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"本品需在餐前或餐中服用","抗生素手冊":"暫無資料"},"PRO17O":{"商品名稱":"Prograf (Fk506) 1mg Cap","腎功能不良劑量調整":"定期監測血中濃度，調整投與量\r<br>","小兒建議劑量":"安全性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO18O":{"商品名稱":"PROGRAF (Fk506) 5mg Cap","腎功能不良劑量調整":"定期監測血中濃度，調整投與量\r<br>","小兒建議劑量":"安全性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO19E":{"商品名稱":"Prostin E2 3mg Vag Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO20O":{"商品名稱":"Propranolol 10mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"Proliferating infantile hemangioma (Hemangeol): Infants ?2 kg: Oral: Note: Initiate treatment at age 5 weeks to 5 months; doses should be administered at least 9 hours apart. Refer to product labeling for detailed weight-based dosing tabulation.<br><br>\r<br>\r<br>Week 1: 0.15 mL\/kg (~0.6 mg\/kg) twice daily<br><br>\r<br>Week 2: 0.3 mL\/kg (~1.1 mg\/kg) twice daily<br><br>\r<br>Week 3 (maintenance): 0.4 mL\/kg (~1.7 mg\/kg) twice daily; maintain this dose for 6 months. Readjust dose periodically as the child's weight increases. Treatment may be reinitiated if hemangiomas recur.<br><br>\r<br>Hypertension (unlabeled use): Oral: Initial: 0.5-1 mg\/kg\/day in divided doses every 6-12 hours; increase gradually every 5-7 days; maximum: 16 mg\/kg\/24 hours<br><br>\r<br>\r<br>Migraine headache prophylaxis (unlabeled use): Oral: Initial: 2-4 mg\/kg\/day or<br><br>\r<br><=35 kg: 10-20 mg 3 times\/day<br><br>\r<br>>35 kg: 20-40 mg 3 times\/day\r<br><br><br>Tachyarrhythmias (unlabeled use):<br><br>\r<br>\r<br>Oral: Initial: 0.5-1 mg\/kg\/day in divided doses every 6-8 hours; titrate dosage upward every 3-7 days; usual dose: 2-6 mg\/kg\/day; higher doses may be needed; do not exceed 16 mg\/kg\/day or 60 mg\/day\r<br>\r<br><br><br>I.V.: 0.01-0.1 mg\/kg\/dose slow IVP over 10 minutes; maximum dose: 1 mg for infants; 3 mg for children<br><br>\r<br>Thyroid storm (unlabeled use): Oral: Children: 0.5 mg\/kg\/dose every 4-8 hours; titrate to effective dose (Eyal, 2008)<br><br>\r<br>\r<br>Thyrotoxicosis (unlabeled use): Oral:\r<br>\r<br><br><br>Children: 10-40 mg every 6 hours; titrate to effective dose (Eyal, 2008)\r<br>\r<br><br><br>Adolescents: Refer to adult dosing.<br><br>\r<br>\r<br>Hypercyanotic spells (TOF) (unlabeled use):<br><br>\r<br>\r<br>Oral: Palliation: Initial: 1 mg\/kg\/day every 6 hours; if ineffective, may increase dose after 1 week by 1 mg\/kg\/day to a maximum of 5 mg\/kg\/day, if patient becomes refractory, may increase slowly to a maximum of 10-15 mg\/kg\/day. Allow 24 hours between dosing changes.\r<br>\r<br><br><br>I.V.: 0.01-0.2 mg\/kg\/dose infused over 10 minutes; maximum dose: 5 mg\"\r<br>","提示內容":"注意氣喘或有呼吸道阻塞性疾病, 心搏過緩, 心臟傳導阻斷, 心臟衰竭為禁忌。\r<br>可能會惡化Prinzmetal angina(血管痙攣而干擾冠狀動脈血管血流之心絞痛)","抗生素手冊":"暫無資料"},"PRO21O":{"商品名稱":"Propecia F.C. Tab. 1mg","腎功能不良劑量調整":"No adjustment is necessary\r<br>","小兒建議劑量":"不得用於女性或兒童\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO22I":{"商品名稱":"Isoproternol 0.2mg\/1ml Amp","腎功能不良劑量調整":"Dosing: Renal Impairment No dosage adjustment provided in manufacturer’s labeling.(Uptodate)","小兒建議劑量":"Bradyarrhythmias, AV nodal block, or refractory torsade de pointes: Continuous IV infusion: Usual range: 0.05-2 mcg\/kg\/minute; titrate to patient response.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO25O":{"商品名稱":"Progor 180mg Cap","腎功能不良劑量調整":"肝腎疾患者須注意監控\r<br>","小兒建議劑量":"幼兒使用本品之安全性及有效性尚未建立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO27E":{"商品名稱":"Protopic Oint 0.03% 10gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Apply 0.03% ointment thinly and rub in bid, continue for one week after signs or symptoms clear.用於>2 years old\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO28O":{"商品名稱":"Prograf (Fk506) 0.5mg Cap","腎功能不良劑量調整":"定期監測血中濃度，調整投與量\r<br>","小兒建議劑量":"安全性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO29O":{"商品名稱":"Protase 280mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO30O":{"商品名稱":"Provigil 200mg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PRO31O":{"商品名稱":"Promeran FC 3.84mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PUL01E":{"商品名稱":"Pulmicort Turbuhale 200mcg\/d;100d","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"注意病人是否可以用力深吸氣","抗生素手冊":"暫無資料"},"PUL03E":{"商品名稱":"Pulmicort Respules Neb Susp 1mg\/2ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PUL04E":{"商品名稱":"Pulmicort Nasal Aqua 64mcg\/d;120d","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PYR03I":{"商品名稱":"Pyridoxal Phosphate Inj. 20mg\/2ml Kyorin","腎功能不良劑量調整":"仿單未提及","小兒建議劑量":"Treatment of isoniazid-induced seizures and\/or coma (unlabeled use): I.V.: Children:\r<br>\r<br>Acute ingestion of known amount: Initial: A total dose of pyridoxine equal to the amount of isoniazid ingested (maximum dose: 70 mg\/kg, up to 5 g);","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PYR04I":{"商品名稱":"Pyridoxal Phosphate 10mg\/2ml Amp Taiyu","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Treatment of isoniazid-induced seizures and\/or coma (unlabeled use): I.V.: Children:\r<br>\r<br>Acute ingestion of known amount: Initial: A total dose of pyridoxine equal to the amount of isoniazid ingested (maximum dose: 70 mg\/kg, up to 5 g);","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"PYR05O":{"商品名稱":"Pyrazinamide 500mg Tab","腎功能不良劑量調整":"TB治療指引: 當Clcr<30時，pyrazinamide不須改變劑量，但頻率改每週3次。病人如接受血透析，透析當天的藥建議於透析後吃。\r<br>\r<br>熱病:\r<br>Usual dosage: 25-30 mg\/kg q24h(Max. 2.5g \/day)\r<br>[Clcr<10]: 12-25mg\/kg q24h\r<br>HEMO: 25-30mg\/kg after dialysis","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"QTE01O":{"商品名稱":"Qtern 5\/10mg Tab#","腎功能不良劑量調整":"QTERN 禁用於 (eGFR 低於 45 mL\/min\/1.73 m2 )的病人[1]\r<br>---【複方錠】-------------------------------------\r<br>．Saxagliptin：(< 50)：2.5 mg qd\r<br>．Dapagliflozin：(<45)：避免使用; (<30)：禁止使用。","小兒建議劑量":"尚未確立 QTERN 在 18 歲以下兒童病人的安全性和療效。","提示內容":"1.禁用於 eGFR < 45 mL\/min\/1.73 m2\r<br>2.勿併用 強效CYP 450 3A4\/5 抑制劑 (如 ketoconazole、atazanavir、clarithromycin、indinavir、itraconazole、nefazodone、nelfinavir、ritonavir、saquinavir 和 telithromycin)\r<br>3.留意生殖泌尿道感染。\r<br>4.留意血管內容量減少的狀況，並監測治療後是否低血壓的症狀和徵象","抗生素手冊":"暫無資料"},"QTI01S":{"商品名稱":"Qting Oral Soln 25mg\/ml;120ml Bot","腎功能不良劑量調整":"腎臟及肝臟功能不全的病人， 經口服之 quetiapine 的廓清率約減少 25%。Quetiapine\r<br>廣泛地經由肝臟進行代謝，因此已知肝功能不全的病人服用 Quetiapine 時，應該小心使用。\r<br>腎臟及肝臟功能不全的病人剛開始服用 Quetiapine 的劑量，應為每日 25 mg。劑量應每日增加 25-50 m","小兒建議劑量":"Quetiapine 不適用於 18 歲以下的兒童及青少年。\r","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"QUE01O":{"商品名稱":"Questran 9gm Pack#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"QUI05O":{"商品名稱":"Quinidine 200mg Tab","腎功能不良劑量調整":"(Aronoff, 2007): Oral:\r<br>CrCl ?10 : No dosage adjustment necessary.\r<br>CrCl <10: Administer 75% of normal dose.\r<br>HD: Dose following hemodialysis.\r<br>PD: Supplemental dose is not necessary.\r<br>CRRT: No dosage adjustment required; monitor serum concentrations.","小兒建議劑量":"小孩：一天5 次，每次 6mg\/Kg。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RAD01I":{"商品名稱":"Radicut 30mg\/20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未有使用於小兒之安全性及有效性。","提示內容":"1.為專案進口用於肌萎縮性側索硬化症(amyotrophic lateral sclerosis; ALS; 俗稱漸凍人)\r<br>2. 以適量生理鹽水稀釋，每天一次靜脈輸注60分鐘以上。給藥時間和停藥時間合併為一個治療週期，28天，並重複此週期。第一個週期連續投與14天，停藥14天。從第2週期起，於每個週期的前14天投與10天，然後停藥14天。\r<br>3.注意腎、肝功能變化與彌散性血管內凝血 (DIC)之發生\r<br>4.與從腎排除之抗生素有交互作用","抗生素手冊":"暫無資料"},"RAD01O":{"商品名稱":"Radi-K 595mg Tab","腎功能不良劑量調整":"依血鉀調整劑量。正常血鉀值 Serum potassium: 3.5-5.2 mEq\/L","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RAK01O":{"商品名稱":"Rakinson 1mg Tab","腎功能不良劑量調整":"腎功能受損之病患：使用於腎功能受損之病患時，無需調整藥物劑量。","小兒建議劑量":"小兒族群：由於缺乏使用的安全性與療效資料，因此不建議小孩與青少年使用Rasagiline。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RAN02O":{"商品名稱":"Rancad ER 500mg Tab","腎功能不良劑量調整":"針對中重度腎功能不全病人，需要持續定期監控腎功能。若發現腎衰竭，則需要停止服用Ranolazine。\r<br>","小兒建議劑量":"無兒童病人使用本品的安全性及療效資料。\r<br>","提示內容":"1.500mg bid  Max. dose 1000mg bid\r<br>2.整粒吞服，不可壓碎或剝開\r<br>3.CYP3A中度抑制劑(如diltiazem、verapamil 及erythromycin)Max. dose 500mg bid\r<br>4.禁止與CYP3A 強效抑制劑併用、禁用於肝硬化病人\r<br>5.CrCL<60mL\/min請注意腎功能變化，CrCL<30mL\/min有造成急性腎衰竭之疑慮\r<br>6.注意QT interval 延長","抗生素手冊":"暫無資料"},"RAP01I":{"商品名稱":"Rapifen 1mg\/2ml Amp#2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RAP01O":{"商品名稱":"Rapamune 1mg Tab","腎功能不良劑量調整":"No dosage adjustment required. Bioavailability and half-life increase with Clcr <30 mL\/minute. Use in severe renal impairment is contraindicated in the Canadian labeling\r<br>","小兒建議劑量":"改口服液劑\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RAP02I":{"商品名稱":"Rapifen 0.5mg\/1ml#2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RAP04I":{"商品名稱":"Rapiacta 300mg (自費)Bag","腎功能不良劑量調整":"一般情況 (可能會惡化的情況)\r<br>當Clcr <50: 300mg (600mg)\r<br>Clcr 30~50: 100mg (200mg)\r<br>Clcr 10~30:  50mg (100mg)","小兒建議劑量":"小兒：通常Peramivir 以1 天1 次10mg\/kg 投與，單次點滴靜脈注射15 分鐘以上，可依狀連續多日反覆投與。最高投與劑量，每次最多不得超過600mg。但新生兒之安全性尚未確立","提示內容":"成人通常投與Peramivir 300mg，單次點滴靜脈注射15 分鐘以上。\r<br>*因併發症等可能有惡化之虞的病患，1 天1 次600mg，單次點滴靜脈注射15 分鐘以上\r<br>可依症狀連續多日反覆投與\r<br>\r<br>ClCr 30-50 mL\/min: 100-200 mg QD；\r<br>ClCr 10-30 mL\/min: 50-100 mg QD\r<br>\r<br>兒童劑量：10mg\/kg QD","抗生素手冊":"暫無資料"},"RAS01O":{"商品名稱":"Rasitol 40mg Tab","腎功能不良劑量調整":"renal failure, chronic: initial, 80 to 120 mg ORALLY daily; MAX 1500 mg ORALLY daily.\r<br>","小兒建議劑量":"\"一般兒童劑量：利尿劑－口服，初劑量每公斤體重2 mg作單劑量服用，然後每6～8小時，依每公斤體重增加1～2 mg，調整劑量直到反應達到為止。但每日最高劑量不可超過40mg。<br>〔注意〕對有腎病綜合症之兒童，可能需要高達每公斤體重5 mg劑量。\"\r<br>","提示內容":"注意病人是否有低血鉀的症狀","抗生素手冊":"暫無資料"},"REB02I":{"商品名稱":"Rebif 132 mcg","腎功能不良劑量調整":"Dosing: Renal Impairment There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied).","小兒建議劑量":"尚未有使用在16歲以下兒童資料，不宜使用於16歲以下兒童","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REC03I":{"商品名稱":"Recormon 2000iu Syringe#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"在使用於慢性腎衰竭所引起的貧血時，容可曼不可用於嬰兒(即 2 歲以下的幼兒)                                           兒童及青少年: <br>針對兒童及青少年所進行之臨床研究的結果顯示，平均而言，患者越年輕，所須使用<br>的容可曼劑量就越高。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REG01O":{"商品名稱":"Regpara 25mg Tab","腎功能不良劑量調整":"不須調整劑量。","小兒建議劑量":"無相關資料。","提示內容":"一種擬鈣製劑 (calcimimetic), 可降低PTH(parathyroid hormone)及血鈣。治療透析患者的次發性副甲狀腺機能亢進\r<br>整粒吞服,不可分割  起始: 25mg QD, 一週內檢測血鈣及血磷, 一到四週後檢測PTH。給予12小時後再測iPTH值 (intact-PTH)\r<br>使用藥品期間可能會發生低血鈣，若有發生皮膚感覺異常、肌痛、抽筋、抽搐等情形，請告知醫師。","抗生素手冊":"暫無資料"},"REG03I":{"商品名稱":"Regular Insulin 1iu\/0.01ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REG04O":{"商品名稱":"Regrow SR 60mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不適用於12歲以下的兒童\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REL01E":{"商品名稱":"Relenza Rotadisks(公費)","腎功能不良劑量調整":"成人:連續5天，每天2次，每次吸入2劑(2×5mg), 每天總吸入劑量為20mg. \r<br>\r<br>兒童、老年人、腎功能不良、肝功能損害: 不預調整劑量","小兒建議劑量":"成人:連續5天，每天2次，每次吸入2劑(2×5mg), 每天總吸入劑量為20mg. \r<br>\r<br>兒童、老年人、腎功能不良、肝功能損害: 不預調整劑量","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REL01I":{"商品名稱":"Relefact LH-RH 0.1mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"為LH-RH tanabe inj 0.1mg\/1ml同級品替代藥\r<br>腦下垂體ＬＨ分泌機能檢查劑","抗生素手冊":"暫無資料"},"REL02I":{"商品名稱":"Relaxin 500mg\/25ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REL02O":{"商品名稱":"Relazide Tab","腎功能不良劑量調整":"重症的腎障害病患應慎重投藥。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REL03E":{"商品名稱":"Relvar Ellipta 92\/22mcg (Inhalation)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"RELVAR ELLIPTA 並不適用於兒童。用於兒童病患的安全性與療效尚未確立。","提示內容":"1 puff QD\r<br>本品為乾粉吸入劑型請注意病人是否可經口深吸氣(可能無法從氣切管吸入)","抗生素手冊":"暫無資料"},"REL03I":{"商品名稱":"Relaxin 20mg\/1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對嬰兒及小兒投與方法為靜脈內注射時1mg\/kg，不能行靜脈注射時，以2-3mg\/kg行肌肉內注射。\r<br>肌肉內注射需注意:\r<br>1 注意要避剛注入神經行走部位\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REL03O":{"商品名稱":"Relinide 1mg Tab#","腎功能不良劑量調整":"CrCl ?40 mL\/minute: No dosage adjustment necessary. \r<br>CrCl 20 to 40 mL\/minute: Initial: 0.5 mg with meals; titrate carefully.\r<br>eGFR< 30: 起始劑量減為 隨餐0.5 mg","小兒建議劑量":"repaglinide 不建議給18 歲以下之孩童使用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REL04E":{"商品名稱":"RELVAR ELLIPTA 184\/22MCG (Inhalation)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"RELVAR ELLIPTA 並不適用於兒童。用於兒童病患的安全性與療效尚未確立。","提示內容":"1 puff QD\r<br>本品為乾粉吸入劑型請注意病人是否可經口深吸氣(可能無法從氣切管吸入)","抗生素手冊":"暫無資料"},"REM01I":{"商品名稱":"Remodulin 20mg\/20ml Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REM01S":{"商品名稱":"Remaltin Oral Soln 50mg\/ml; 240ml\/Bot","腎功能不良劑量調整":"大於12歲及成人:\r<br>CrCl ?60:  300~1,200 mg TID\r<br>CrCl 30~59 : 200~700 mg BID\r<br>CrCl 15~29: 200~ 700 mg QD\r<br>CrCl 15: 100~ 300 mg QD\r<br>CrCl <15:  [50~150 mg\/day] for CrCl 7.5 mL\/minute)\r<br>ESRD on H\/D: Dose based on CrCl + a single supplemental dose of 125~350 mg","小兒建議劑量":"Seizures, partial onset:\r<br>3~4歲: Oral (excluding Gralise) Initial: 10 ~15 mg\/kg\/day 分3次服用; 每3天可調整劑量;常用劑量: 40 mg\/kg\/day 分3次服用;\r<br>5~11歲s: 起始劑量同上。常用劑量: 25~ 35 mg\/kg\/day分3次服用; 最高劑量可到 50mg\/kg\/day","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REM02I":{"商品名稱":"Remdesivir (Veklury) 100mg Vial (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3.5公斤至40公斤第一天5mg\/kg IV 30-120min，第二天起2.5mg\/kg IV 30-120min。","提示內容":"1.使用期間每日監測肝、腎功能，ALT?5倍正常範圍上限勿開始使用\r<br>2.劑量 3.5-40kg兒童第1天5mg\/kg，然後從第2天起2.5mg。>40kg 第1天200mg，然後從第2天起100mg\r<br>3..先以注射用水(19ml)配製再用N\/S稀釋成250ml以30-120mins輸注給藥。\r<br>4..未使用ECMO或機械呼吸器的病人則為最長5天，如果未獲改善，則可延長至最長10天。已裝上ECMO或機械呼吸器，建議總治療時間為最長10天(疾管署公費不適用此適應症)。\r<br>5..配製之後，投藥前的總存放時間在室溫下不可超過4小時，在冷藏溫度(2°C至8°C)下不可超過24小時。稀釋後在室溫(20°C至25°C)下可維持安定4小時，在2°C至8°C的冰箱中可維持24小時","抗生素手冊":"暫無資料"},"REM02O":{"商品名稱":"Remeron Sol-Tab 30mg","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; clearance is decreased 30% in moderate (Clcr 11-39 mL\/minute\/1.73 m2) impairment and is decreased 50% in severe (Clcr <10 mL\/minute\/1.73 m2) impairment. Use with caution","小兒建議劑量":"孩童使用 Remeron 之安全性與有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REM03I":{"商品名稱":"Remsima 100mg Vial","腎功能不良劑量調整":"尚未針對這些病人族群，研究過Remsima。無法就劑量方面給予相關建議","小兒建議劑量":"1、克隆氏症(6至17歲)、潰瘍性結腸炎(6至17歲)：先以靜脈輸注方式給予5 mg\/kg的劑量，然後在第1次輸注後的第2週及第6週再靜脈輸注5 mg\/kg的劑量，然後每8週輸注1次。目前可得的資料不支持讓治療一開始10週或8週內反應不佳的兒童病人，繼續接受infliximab的治療\r<br><br><br>2、僵直性脊椎炎、幼年類風濕性關節炎：<br>尚未建立使用infliximab治療年紀未滿18歲的兒童與青少年安全性與療效。","提示內容":"為Remicade的生物相似性藥品\r<br>1.配製後溶液應以0.9%NaCl稀釋至250 mL。靜脈輸注需超過2小時，並在3小時內使用完畢。\r<br>2.國內核准用於(1)6歲以上的克隆氏症(Crohn’s disease)(2)6歲以上的潰瘍性結腸炎(Ulcerative colitis)(3)類風濕性關節炎(Rheumatoid arthritis) (4)僵直性脊椎炎(Ankylosing Spondylitis)","抗生素手冊":"暫無資料"},"REM04I":{"商品名稱":"Remifentanil inj 2mg Vial #2","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前未有1歲以下的新生兒及嬰兒使用的數據。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REM05I":{"商品名稱":"Veklury 100mg Vial  (無健保非本國)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3.5公斤至40公斤第一天5mg\/kg IV 30-120min，第二天起2.5mg\/kg IV 30-120min。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REP01I":{"商品名稱":"Repatha 140mg\/1mL Pen","腎功能不良劑量調整":"輕度至中度腎功能不全患者不需要調整劑量，關於重度腎功能不全患者則未有研究。","小兒建議劑量":"目前尚未確立年齡未滿 18 歲兒童使用 Repatha 治療原發性高膽固醇血症及混合型血脂異常的\r<br>安全性及療效。目前尚無資料。\r","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REP01O":{"商品名稱":"Repaglinide 1mg Tab#","腎功能不良劑量調整":"CrCl ?40 mL\/minute: No dosage adjustment necessary. \r<br>CrCl 20 to 40 mL\/minute: Initial: 0.5 mg with meals; titrate carefully.\r<br>eGFR< 30: 起始劑量減為 隨餐0.5 mg","小兒建議劑量":"repaglinide 不建議給18 歲以下之孩童使用","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REP02I":{"商品名稱":"Repatha (恩慈) 140mg\/1mL Pen","腎功能不良劑量調整":"輕度至中度腎功能不全患者不需要調整劑量，關於重度腎功能不全患者則未有研究。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REP03I":{"商品名稱":"REPATHA (罕病) 140mg\/1mL Pen","腎功能不良劑量調整":"輕度至中度腎功能不全患者不需要調整劑量，關於重度腎功能不全患者則未有研究。","小兒建議劑量":"暫無資料","提示內容":"本院Repatha有Evolocumab(Repatha) 140mg\/1mL Pen與Evolocumab(罕病)(REPATHA) 140mg\/1mL Pen小心發藥\r<br>中文商品名：\"安進\"瑞百安注射液\r<br>藥委會通過個案藥品開檔使用\r<br>適應症：同合子家族性高膽固醇血症(HoFH)","抗生素手冊":"暫無資料"},"REQ02O":{"商品名稱":"REQUIP PD 2MG Tab","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REQ03O":{"商品名稱":"Requip FC 0.25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前並無18歲以下之患者使用ropinirole的安全性與有效性資料，因此不建議用於此年齡群的病患。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RES01E":{"商品名稱":"Restasis Oph Emul 0.05% 30amp\/Box","腎功能不良劑量調整":"仿單未說明","小兒建議劑量":"用於16歲以下兒童病人的安全性及療效尚未明確建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RES06I":{"商品名稱":"Resovist 1.4ml Syringe","腎功能不良劑量調整":"No dosage adjustment is necessary.\r<br>","小兒建議劑量":"No clinical experience is available with patients under 18 years of age.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RET01O":{"商品名稱":"Retsevmo 80mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REV02O":{"商品名稱":"Revatio 20mg Tab#","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"小兒不建議使用\r<br>","提示內容":"不可並用Nitrate","抗生素手冊":"暫無資料"},"REV03O":{"商品名稱":"Revlimid 5mg Cap#","腎功能不良劑量調整":"正常or Clcr>60 : 25mg QD\r<br>[ 30~60 ] : 10mg QD\r<br>[ <30且未透析] : 15mg Q48H\r<br>[ <30 有透析] : 5mg QD，透析當日請於透析後給藥。","小兒建議劑量":"目前尚無針對18歲以下患者的藥物動力學數據","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REV04O":{"商品名稱":"REVLIMID 25mg Cap#","腎功能不良劑量調整":"正常or Clcr>60 : 25mg QD\r<br>[ 30~60 ] : 10mg QD\r<br>[ <30且未透析] : 15mg Q48H\r<br>[ <30 有透析] : 5mg QD，透析當日請於透析後給藥","小兒建議劑量":"目前尚無針對18歲以下患者的藥物動力學數據。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REV05O":{"商品名稱":"Revlimid 10mg Cap#","腎功能不良劑量調整":"正常or Clcr>60 : 25mg QD\r<br>[ 30~60 ] : 10mg QD\r<br>[ <30且未透析] : 15mg Q48H\r<br>[ <30 有透析] : 5mg QD，透析當日請於透析後給藥\r<br>","小兒建議劑量":"目前尚無針對18歲以下患者的藥物動力學數據。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REV06O":{"商品名稱":"Revolade FC 25mg Tab","腎功能不良劑量調整":"There are no dosage adjustments necessary腎功能受損的病患無須調整劑量。\r<br>嚴重腎功能不全之患者在使用REVOLADE時應小心使用並且可以考慮增加劑量。","小兒建議劑量":"兒童族群\r<br>由於尚未有足夠的安全性及療效資料，REVOLADE不建議使用於兒童與18歲以下的青少年","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REV07O":{"商品名稱":"REVLIMID 15MG CAP","腎功能不良劑量調整":"正常or Clcr>60 : 25mg QD\r<br>[ 30~60 ] : 10mg QD\r<br>[ <30且未透析] : 15mg Q48H\r<br>[ <30 有透析] : 5mg QD，透析當日請於透析後給藥。","小兒建議劑量":"目前尚無針對18歲以下患者的藥物動力學數據","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"REX01O":{"商品名稱":"Rexulti 2mg Tab","腎功能不良劑量調整":"在中度、重度或末期腎功能不全( 肌酸酐廓清率CLcr <60 ml\/min) 的病人中，思覺失調症病人的每日最大建議劑量為3 mg\r<br>","小兒建議劑量":"安全性及有效性目前尚未確立\r<br>","提示內容":"1. 1- 4mg\/day Max. dose 4mg\/day\r<br>2. child pugh score≧7 Max. dose 3mg\/day\r<br>3. CrCL<60mL\/min Max. dose 3mg\/day","抗生素手冊":"暫無資料"},"RHE01I":{"商品名稱":"Rheomacrodex 10% 500ml Bag","腎功能不良劑量調整":"Use with extreme caution.\r<br>","小兒建議劑量":"\"Volume expansion\/shock: I.V.:<br>Infants: Infuse 5 mL\/kg as rapidly as necessary; maximum daily dose: 20 mL\/kg\/day for first 24 hours, 10 mL\/kg\/day thereafter; therapy should not be continued beyond 5 days<br>Children and Adolescents <50 kg: Infuse 10 mL\/kg as \"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RHO01I":{"商品名稱":"Rho(D) Immune Globulin(HyperRHO S\/D) 1ml","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling.\r<br>","小兒建議劑量":"新生兒勿用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RHY01O":{"商品名稱":"Rhynorm 150mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIB03O":{"商品名稱":"Ribarin 200mg Cap#","腎功能不良劑量調整":"[Clcr <50 ml\/min ]:  not be treated with ribavirin.  \r<br>HEMO : Avoid.\r<br>=====\r<br>CrCl >50 :不需調劑量\r<br>CrCl 30 ~50 : 200~400mg QD\r<br>CrCl <30 : 200 mg  QD.\r<br>ESRD requiring hemodialysis: 200 mg QD","小兒建議劑量":"\"Chronic hepatitis C monoinfection (in combination with pegylated or nonpegylated interferon alfa-2b):<br><br>\r<br>Children >=3 years: Oral capsule or solution (Rebetol, Ribasphere): Note: Oral solution should be used in children <47 kg, or those unable to swallow capsules. Children who start treatment prior to age 18 years should continue on pediatric dosing regimen through therapy completion. Recommended therapy duration (manufacturer labeling): Genotypes 2,3: 24 weeks; all other genotypes: 48 weeks<br><br>\r<br>\r<br>Oral capsule, oral solution dosing recommendations:<br><br><47 kg: 15 mg\/kg\/day in 2 divided doses (morning and evening) as oral solution<br><br>\r<br>\r<br>47-59 kg: 800 mg daily (400 mg in morning and evening)<br><br>\r<br>\r<br>60-73 kg: 1000 mg daily (400 mg in morning and 600 mg in the evening)\r<br>\r<br>>73 kg: 1200 mg daily (600 mg in morning and evening)<br><br>\r<br>\r<br>Alternative recommendations: American Association for the Study of Liver Diseases (AASLD) guidelines: Children 2-17 years with chronic hepatitis C infection (Ghany, 2009): Treatment of choice: Ribavirin 15 mg\/kg daily (in combination with SubQ peginterferon alfa-2b) once weekly for 48 weeks<br><br>\r<br>\r<br>Chronic hepatitis C monoinfection (in combination with peginterferon alfa-2a):<br><br>\r<br>\r<br>Children >=5 years: Oral tablet (Copegus): Note: Assess child’s ability to swallow tablet; children who start treatment prior to age 18 years should continue on pediatric dosing regimen through therapy completion. Recommended therapy duration (manufacturer labeling): Genotypes 2,3: 24 weeks; all other genotypes: 48 weeks\r<br>\r<br><br><br>23-33 kg: 400 mg daily (200 mg in the morning and evening)<br><br>\r<br>34-46 kg: 600 mg daily (200 mg in the morning and 400 mg in the evening)<br><br>\r<br>47-59 kg: 800 mg daily (400 mg in the morning and evening)\r<br>60-74 kg: 1000 mg daily (400 mg in the morning and 600 mg in the evening)\r<br><br>>=75 kg: 1200 mg daily (600 mg in the morning and evening)<br><br>\r<br>\r<br>RSV infection: Infants and Children: Aerosol inhalation: Use with ViratekR small particle aerosol generator (SPAG-2): A concentration of 20 mg\/mL (6 g reconstituted with 300 mL of sterile water without preservatives) administered for 12-18 hours\/day for 3 days, up to 7 days in length.\r<br>\r<br><br><br>Dosing: Geriatric Refer to adult dosing.<br>\r<br>Dosing: Renal Impairment CHC infection: Oral:\"\r<br>","提示內容":"為Robatrol 200mg Cap#替代藥品開檔使用\r<br>不論男女，應在治療期間和之後 6 個月內作有效避孕，以免致畸胎的危險","抗生素手冊":"暫無資料"},"RIF08O":{"商品名稱":"RIFAMPICIN 300MG CAP#","腎功能不良劑量調整":"TB治療指引\/仿單: rifampicin不須改變劑量。 \r<br>\r<br>熱病:\r<br>usually dosage: 600mg\/day \r<br>[<50 ]: 300-600mg q24h\r<br>HEMO: no adjstment; CAPD: Dose for CCl<10","小兒建議劑量":"1.5 歲以下的兒童－劑量尚未確立。\r<br>2.5 歲及5 歲以上的兒童：\r<br>*結核病：與其他抑制結核菌劑併用－口服，每公斤體重10-20mg，每天一次。\r<br>*奈瑟氏腦膜炎球菌帶原者(無症狀)－上述劑量連續4天服用。\r<br>「注意」：每日最大劑量不可超過600mg。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIF09O":{"商品名稱":"RIFAMPIN 450mg Cap#","腎功能不良劑量調整":"TB治療指引\/仿單: rifampicin不須改變劑量。 \r<br>\r<br>熱病:\r<br>usually dosage: 600mg\/day \r<br>[<50 ]: 300-600mg q24h\r<br>HEMO: no adjstment; CAPD: Dose for CCl<10","小兒建議劑量":"1.5 歲以下的兒童－劑量尚未確立。\r<br>2.5 歲及5 歲以上的兒童：\r<br>*結核病：與其他抑制結核菌劑併用－口服，每公斤體重10-20mg，每天一次。\r<br>*奈瑟氏腦膜炎球菌帶原者(無症狀)－上述劑量連續4天服用。\r<br>「注意」：每日最大劑量不可超過600mg。","提示內容":"藥委會通過原Rifampicin 150mg Cap缺貨之替代不同劑量品項開檔使用。\r<br>(請注意與150mg及300mg的LASA)","抗生素手冊":"暫無資料"},"RIL01O":{"商品名稱":"Rilutek 50mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIN01E":{"商品名稱":"Rinderon-V Cream 0.06% 5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIN02E":{"商品名稱":"Rinderon-A Eye Sol 0.1% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"藥於耳內。中耳炎、耳膜穿孔等患者,若以點耳、耳浴的方式使用本藥時恐會造成不可逆性的重聽,","抗生素手冊":"暫無資料"},"RIN03O":{"商品名稱":"Rinvoq ER 15mg Tab","腎功能不良劑量調整":"輕度或中度腎功能不全的病人不需調整劑量。重度腎功能不全病人的建議劑量是 15mg 每日一次。","小兒建議劑量":"使用於體重不足40 公斤青少年及0 至未滿12 歲兒童的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIN12I":{"商品名稱":"Ringer Injection 500ml Bot","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIN13I":{"商品名稱":"Rinderon 4mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIP01O":{"商品名稱":"RIPAM 2MG TAB #4","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; use with caution.\r<br>","小兒建議劑量":"\"為避免開始治療的不良反應，必須慢慢增加每日劑量至適合各個病人之維持劑量。<br>嬰兒和10歲以下孩童(或體重30 kg以下)的起始劑量為每日0.01-0.03 mg\/kg，10 歲以上孩童(或體重超過30 kg)的建議起始劑量為每日1-2 mg。<br>維持劑量在嬰兒和10歲以下孩童(或體重30 kg以下)為每日0.05-0.1 mg\/kg，10-16歲孩童(或體重超過30 kg)為每日1.5-3 mg<br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIP02O":{"商品名稱":"Ripam 0.5mg Tab #4","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; use with caution.\r<br>","小兒建議劑量":"小孩─起始劑量每天每公斤0.01～0.03mg，每3天增加0.25～0.5mg，一般的劑量範圍(0.1～0.2mg\/kg\/天)。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIS02O":{"商品名稱":"RISPERDAL 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前處方15歲以下兒童精神分裂資料不足\r<br>目前缺乏雙極性躁狂發作的兒童及未滿18歲青少年使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIS04S":{"商品名稱":"Risperdal Oral Soln 30mg\/30ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前處方15歲以下兒童精神分裂資料不足\r<br>目前缺乏雙極性躁狂發作的兒童及未滿18歲青少年使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIS06I":{"商品名稱":"Risperdal CONSTA 37.5mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"目前處方15歲以下兒童精神分裂資料不足\r<br>目前缺乏雙極性躁狂發作的兒童及未滿18歲青少年使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIT01O":{"商品名稱":"Ritalin 10mg Tab #3","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童(6歲及6歲以上)：錠劑 - 起始劑量為每天一或二次，每次5毫克(如：在早餐或午餐時服用)，每星期增加5-10毫克，每日劑量應分次投與。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIT02O":{"商品名稱":"RITALIN LA 20MG CAP #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未滿6 歲或60 歲以上病患，因療效及安全性尚未確立，不應使用。\r<br>6歲以上:每天一次，在早上投與，建議起始劑量為10 毫克。劑量調整可依照所觀察到的耐受性及治療效果，每週增加10 毫克，直至每日最大劑量40 毫克。與速效劑型合用時，所有不同劑型的methylphenidate hydrochloride 總量不可超過每日60 毫克。","提示內容":"≧6 歲MAX: 40mg\/day。若本品與速效劑型合用時，所有不同劑型的methylphenidate HCl總量不可超過60 mg\/day。\r<br>18-60歲MAX: 60mg\/day。若本品與速效劑型合用時，所有不同劑型的methylphenidate HCl總量不可超過60 mg\/day。\r<br>不可磨碎、咀嚼或切割藥粒。可將膠囊內的藥粒撒在少量的食物上後服用","抗生素手冊":"暫無資料"},"RIV01S":{"商品名稱":"Rivast Oral Soln 240mg\/120ml Bot","腎功能不良劑量調整":"原則上不需調整劑量。","小兒建議劑量":"尚無兒童的研究報告，因此不建議兒童使用。","提示內容":"(週報2018\/03\/23 發行)\r<br>病人中止服Rivastigmine數天後，若想重新服藥，應從最低1.6mg 開始調整，每隔兩週逐漸增加到中止藥物前有良好耐受性的劑量","抗生素手冊":"暫無資料"},"RIV03O":{"商品名稱":"Rivapress 250mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: :250-500mg q8h\r<br>[10-50]: Q8-12h\r<br>[<10 ]: Q12-24h\r<br>HEMO:Dose after dialysis","小兒建議劑量":"Oral: Initial: 10 mg\/kg\/day in 2-4 divided doses; increase every 2 days as needed to maximum dose of 65 mg\/kg\/day; do not exceed 3 g\/day\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIV04O":{"商品名稱":"RIVOtril 0.5mg Tab #4","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; use with caution.\r<br>","小兒建議劑量":"小孩─起始劑量每天每公斤0.01～0.03mg，每3天增加0.25～0.5mg，一般的劑量範圍(0.1～0.2mg\/kg\/天)。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIV05O":{"商品名稱":"RIVOTRIL 2mg Tab #4","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; use with caution.\r<br>","小兒建議劑量":"\"為避免開始治療的不良反應，必須慢慢增加每日劑量至適合各個病人之維持劑量。<br>嬰兒和10歲以下孩童(或體重30 kg以下)的起始劑量為每日0.01-0.03 mg\/kg，10 歲以上孩童(或體重超過30 kg)的建議起始劑量為每日1-2 mg。<br>維持劑量在嬰兒和10歲以下孩童(或體重30 kg以下)為每日0.05-0.1 mg\/kg，10-16歲孩童(或體重超過30 kg)為每日1.5-3 mg<br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIX01I":{"商品名稱":"Rixathon 100mg\/10ml Vial","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling (has not been studied","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIX02I":{"商品名稱":"RIXATHON 500MG\/50ML VIAL","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RIZ01O":{"商品名稱":"Rizatan 5mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; however, the AUC was 44% greater in patients on hemodialysis","小兒建議劑量":"對兒童的安全性及有效性尚未建立；因此Rizatriptan不建議使用在18歲以下的病患","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROA02O":{"商品名稱":"Roaccutane 20mg Cap#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Children 12-17 years: Oral: 0.5-1 mg\/kg\/day in 2 divided doses\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROB03O":{"商品名稱":"Robatrol 200mg Cap#","腎功能不良劑量調整":"[Clcr <50 ml\/min ]:  not be treated with ribavirin.  \r<br>HEMO : Avoid.\r<br>=====\r<br>CrCl >50 :不需調劑量\r<br>CrCl 30 ~50 : 200~400mg QD\r<br>CrCl <30 : 200 mg  QD.\r<br>ESRD requiring hemodialysis: 200 mg QD\r<br>","小兒建議劑量":"\"Chronic hepatitis C monoinfection (in combination with pegylated or nonpegylated interferon alfa-2b):<br><br>\r<br>Children >=3 years: Oral capsule or solution (Rebetol, Ribasphere): Note: Oral solution should be used in children <47 kg, or those unable to swallow capsules. Children who start treatment prior to age 18 years should continue on pediatric dosing regimen through therapy completion. Recommended therapy duration (manufacturer labeling): Genotypes 2,3: 24 weeks; all other genotypes: 48 weeks<br><br>\r<br>\r<br>Oral capsule, oral solution dosing recommendations:<br><br><47 kg: 15 mg\/kg\/day in 2 divided doses (morning and evening) as oral solution<br><br>\r<br>\r<br>47-59 kg: 800 mg daily (400 mg in morning and evening)<br><br>\r<br>\r<br>60-73 kg: 1000 mg daily (400 mg in morning and 600 mg in the evening)\r<br>\r<br>>73 kg: 1200 mg daily (600 mg in morning and evening)<br><br>\r<br>\r<br>Alternative recommendations: American Association for the Study of Liver Diseases (AASLD) guidelines: Children 2-17 years with chronic hepatitis C infection (Ghany, 2009): Treatment of choice: Ribavirin 15 mg\/kg daily (in combination with SubQ peginterferon alfa-2b) once weekly for 48 weeks<br><br>\r<br>\r<br>Chronic hepatitis C monoinfection (in combination with peginterferon alfa-2a):<br><br>\r<br>\r<br>Children >=5 years: Oral tablet (Copegus): Note: Assess child’s ability to swallow tablet; children who start treatment prior to age 18 years should continue on pediatric dosing regimen through therapy completion. Recommended therapy duration (manufacturer labeling): Genotypes 2,3: 24 weeks; all other genotypes: 48 weeks\r<br>\r<br><br><br>23-33 kg: 400 mg daily (200 mg in the morning and evening)<br><br>\r<br>34-46 kg: 600 mg daily (200 mg in the morning and 400 mg in the evening)<br><br>\r<br>47-59 kg: 800 mg daily (400 mg in the morning and evening)\r<br>60-74 kg: 1000 mg daily (400 mg in the morning and 600 mg in the evening)\r<br><br>>=75 kg: 1200 mg daily (600 mg in the morning and evening)<br><br>\r<br>\r<br>RSV infection: Infants and Children: Aerosol inhalation: Use with ViratekR small particle aerosol generator (SPAG-2): A concentration of 20 mg\/mL (6 g reconstituted with 300 mL of sterile water without preservatives) administered for 12-18 hours\/day for 3 days, up to 7 days in length.\r<br>\r<br><br><br>Dosing: Geriatric Refer to adult dosing.<br>\r<br>Dosing: Renal Impairment CHC infection: Oral:\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROC01I":{"商品名稱":"Rocuronium Kabi 100mg\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROC01O":{"商品名稱":"Rocaltrol 0.25mcg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROC02I":{"商品名稱":"Rocephin 500mg Vial#","腎功能不良劑量調整":"No adjustments are necessary, however, blood levels are recommended in dialysis patients. Adults with both renal and hepatic failure should not receive more than 2 gm\/day \r<br>Hemodialysis: No specific recommendations. 1g, dose after HD\r<br>PD: 750mg q12h.","小兒建議劑量":"≦ 14day: 20-50mg\/kg QD, max dose: 50mg\/kg\/d;\r<br>15day-12yr: 20-80mg\/kg QD;\r<br>≧ 12yr or > 50kg: 1-2g QD。\r<br>---------------------------------------------------\r<br> Meningitis:\r<br>(75xBW)mg QD\r<br>(50xBW)mg Q12H","提示內容":"暫無資料","抗生素手冊":"3rd cephas 呼吸道菌首選<br>常用量: 2 g qd<br>Max: 2 g q12h"},"ROC03I":{"商品名稱":"Rocurin 50mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROL01I":{"商品名稱":"Rolikan 7% 20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"(週報2018\/03\/23 發行)\r<br>目前院內對於將進行心導管的病人，可將20-80 ml(依據腎功能的好壞來決定) Rolikan 加在500ml 的點滴中，一天內給予共1000ml 的輸液來預防顯影劑造成的腎病變。","抗生素手冊":"暫無資料"},"ROL02I":{"商品名稱":"ROLIKAN Inj 250ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROM01I":{"商品名稱":"Romiplate 250mcg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立18歲以下兒童使用的安全性及療效。","提示內容":"血小板缺乏紫斑症治療用藥(與本院的Revolade 25mg tab (Eltrombopag) 均為Thrombopoietin- Receptor Agonists (TPO-RAs), 兩藥的給藥途徑不同)\r<br>起始劑量為1ug\/kg，一周一次皮下注射。後續劑量可以起始劑量，再依血小板的計數做調整。\r<br>全瓶有375μg，加入0.72ml無菌注射用水後，需使用含有0.01ml刻度之針頭抽取所需劑量。不可使用氯化鈉溶液。調配後的藥品須避光，放於室溫或冷藏可達24小時。","抗生素手冊":"暫無資料"},"ROP01I":{"商品名稱":"Ropica Inj 200mg\/20ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"請參見仿單「1-12歲兒童病人之Ropivacaine推薦劑量(限單一注射)。尾部脊椎硬膜外給藥及週邊神經阻斷用。\r<br>本藥不建議用於低於1歲以下兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROS01I":{"商品名稱":"Rosis 20mg\/2ml Amp","腎功能不良劑量調整":"Acute renal failure: Doses up to 1-3 g daily may be necessary to initiate desired response; avoid use in oliguric states.\r<br>\r<br>Not removed by hemo- or peritoneal dialysis; supplemental dose is not necessary.","小兒建議劑量":"抗高血鈣劑:20-50mg，必要每4小時重覆至預期反應達到為止。利尿劑: 每公斤體重1mg作單劑量注射，再每隔2小時另增加 1mg\/kg。Max: 6mg\/kg.","提示內容":"持續靜脈輸注:\r<br> IV bolus 40-100 mg over 1-2 mins, then 10-40 mg\/hour \r<br>→因此可能遇到960 mg\/day 之處方\r<br>\r<br>Bumetanide 1 mg = furosemide 40 mg\r<br>注意病人是否有低血鉀的症狀","抗生素手冊":"暫無資料"},"ROT02S":{"商品名稱":"Rotarix 1.5mL Vial (自費口服藥)","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer's labeling.\r<br>","小兒建議劑量":"對第一劑接種RotarixTM的嬰兒，強烈建議應使用RotarixTM完成 2 劑的接種程序。\r<br>\r<br>完整疫苗接種程序共須接種兩劑，最好在出生後六至十六週接種，並且必須在出生後二十四週\r<br>內完成。兩劑間隔不得少於四週。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROT03S":{"商品名稱":"RotaTeq 2ml Tube (自費口服藥)","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"僅供口服使用。切勿注射投予。\r<br>RotaTeq的接種系列共包含三劑現成可用的口服液劑，第一劑開始於6至12週齡時投予，然後再以4至10\r<br>週的間隔時間投予後續的劑次。第3劑不可於32週齡之後投予.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROZ01O":{"商品名稱":"Rozerem 8mg Tab","腎功能不良劑量調整":"腎功能不須調整劑量。中度肝功能不全的患者應謹慎服用Rozerem．","小兒建議劑量":"腎功能不須調整劑量。中度肝功能不全的患者應謹慎服用Rozerem．","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ROZ02O":{"商品名稱":"Rozlytrek 200mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"小兒病人的Rozlytrek建議劑量為口服300 mg\/m2體表面積(BSA) ，每天一次","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RUN01O":{"商品名稱":"Runesda-S 3mg Tab#4","腎功能不良劑量調整":"輕度或中度肝功能不良者不需調整劑量。重度肝功能不良者起始劑量為1mg，最高不可超過2mg。","小兒建議劑量":"未有使用於未滿18歲孩童之安全性及有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RYB01I":{"商品名稱":"Rybrevant 350mg\/7ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RYB01O":{"商品名稱":"Rybelsus 3mg Tab","腎功能不良劑量調整":"輕微、中度或重度腎功能不全的病人不需調整劑量，semaglutide 用於重度腎功能不全病人的經驗有限。semaglutide 不建議用於末期腎病的病人","小兒建議劑量":"瑞倍適用於18 歲以下兒童和青少年的安全性及療效尚未確立，目前沒有相關資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RYB02O":{"商品名稱":"RYBELSUS 7MG TAB","腎功能不良劑量調整":"輕微、中度或重度腎功能不全的病人不需調整劑量，semaglutide 用於重度腎功能不全病人的經驗有限。semaglutide 不建議用於末期腎病的病人","小兒建議劑量":"瑞倍適用於18 歲以下兒童和青少年的安全性及療效尚未確立，目前沒有相關資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RYB03O":{"商品名稱":"RYBELSUS 14MG TAB","腎功能不良劑量調整":"輕微、中度或重度腎功能不全的病人不需調整劑量，semaglutide 用於重度腎功能不全病人的經驗有限。semaglutide 不建議用於末期腎病的病人","小兒建議劑量":"瑞倍適用於18 歲以下兒童和青少年的安全性及療效尚未確立，目前沒有相關資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RYD01O":{"商品名稱":"Rydapt 25mg Soft Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未建立18歲以下孩童的安全性及療效性。","提示內容":"1.新確診為FLT3 突變陽性的急性骨髓性白血病(AML) 成人病患之標準前導(daunorubicin 併用cytarabine) 與鞏固性化療( 高劑量cytarabine) 時合併使用\r<br>2.50 mg每日口服二次，間隔 12 小時，於前導和鞏固化療週期的第8至21天給予\r<br>3.接受骨髓移植時，應於接受調理療法(conditioning regimen)的48小時前停用","抗生素手冊":"暫無資料"},"RYT01O":{"商品名稱":"Rytmonorm 150mg Tab","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RYZ01I":{"商品名稱":"Ryzodeg Flextouch 300U\/3ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"RYZ02I":{"商品名稱":"Ryzodeg Flextouch 1U (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAB01I":{"商品名稱":"SABS 500mg\/100ml Bot","腎功能不良劑量調整":"usual dose:500 mg po\/IV q6-8h\r<br>[Clcr <10 ml\/min]:  500mg q12h.  \r<br>HEMO: 500mg q8-12h (usually q12h)\r<br>CRRT: Dose as for normal renal function.","小兒建議劑量":"尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAI01I":{"商品名稱":"Saizen 12mg Cart","腎功能不良劑量調整":"對於慢性腎功能不足的病人，開始治療前腎功能必須在正常值的百分之五十以下。為了確定生長障礙，在開始治療前應觀察其生長為期一年左右。在這段觀察期間內應建立腎功能不足的保守治療(包括控制酸血症、副甲狀腺機能亢進及營養狀態)，並在生長激素治療期間並應維持此保守治療?","小兒建議劑量":"皮下注射，注射部位應常更換以免皮下脂肪組織萎縮。\r<br>兒童因生長激素分泌不足所導致之生長障礙：通常建議劑量為每天0.025-0.035 mg\/kg 體重，或每天0.7-1.0 mg\/m2 體表面積。\r<br>各項治療詳見仿單資訊","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAI02I":{"商品名稱":"Saizen (恩慈) 12mg Cart","腎功能不良劑量調整":"對於慢性腎功能不足的病人，開始治療前腎功能必須在正常值的百分之五十以下。為了確定生長障礙，在開始治療前應觀察其生長為期一年左右。在這段觀察期間內應建立腎功能不足的保守治療(包括控制酸血症、副甲狀腺機能亢進及營養狀態)，並在生長激素治療期間並應維持此保守治療?","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL01I":{"商品名稱":"Saline Inj 0.9% 250ML (PP袋)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL01O":{"商品名稱":"Salazine 500mg Tab","腎功能不良劑量調整":"There are no dosage adjustments provided in manufacturer's labeling; use with extreme caution","小兒建議劑量":"發炎性腸道疾病\r<br>(發作期)-小孩:每天每公斤體重 40-60mg，分成 3-6 次服用。\r<br>(預防復發):每天每公斤體重 20-30mg，分成 3-6 次服用。\r<br>RA-小孩:目前無足夠之資料可建議幼年型慢性關節炎(Juvenile chronic arthritis)之劑量。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL02I":{"商品名稱":"Saline Inj 0.9% 100ML (PP袋)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL02O":{"商品名稱":"Saltolin 2mg Tab","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer's labeling; use with caution. No dosage adjustment required in patients on hemodialysis, peritoneal dialysis, or CRRT (Aronoff 2007).","小兒建議劑量":"兒童須減量服用，通常成人量1\/2～1\/4","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL03E":{"商品名稱":"Saldolin Inh Soln 5mg\/2.5ml","腎功能不良劑量調整":" Use with caution in patients with renal impairment. No dosage adjustment required (including patients on hemodialysis, peritoneal dialysis, or CRRT; Aronoff, 2007)","小兒建議劑量":"成人及兒童 : 以液體吸入方式給藥的適當初劑量為2.5mg，必要時增加至5mg, 一日得重覆四次。\r<br>18個月以下嬰兒的臨床藥效性尚未確知，由於可能鋰引起血氧過少現象，因此宜備妥氧氣的補充。\r<br>Infants and Children: Limited data in ages <2 years:\r<br>Intermittent: 0.15 mg\/kg (minimum dose: 2.5 mg) every 20 minutes for 3 doses then 0.15-0.3 mg\/kg not to exceed 10 mg every 1-4 hours","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL03I":{"商品名稱":"Saline Inj 0.9% 500ML (PP袋)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL03O":{"商品名稱":"Salazopyrin 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"40~60mg\/kg \/day ，分成3～6次\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL04I":{"商品名稱":"Saline Inj 0.9% 1L (PP袋)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL05I":{"商品名稱":"Saline Inj 0.45% 500ML (PP袋)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAL05O":{"商品名稱":"Salagen 5mg Tab#","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"同成人使用劑量\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAM01O":{"商品名稱":"Samsca 15mg Tab","腎功能不良劑量調整":"Clcr ?10 mL\/minute: 不用調整劑量\r<br>Clcr <10 mL\/minute:雖然沒有相關文獻指出但不建議用\r<br>","小兒建議劑量":"暫無資料","提示內容":"一般病人用藥療程不可>30天\r<br>有潛在性肝臟疾病的病人應避免服用","抗生素手冊":"暫無資料"},"SAN01O":{"商品名稱":"Sanyl 50mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAN02I":{"商品名稱":"Sandimmun 50mg\/1ml Amp#","腎功能不良劑量調整":"如果超過一次血清肌酸酐值持續增加至高於底線30%時就必須減少25-50%劑量的新體睦。對於腎功能不正常底線的病患應該從每日每公斤體重2.5毫克的劑量開始治療並且必須要非常小心的監測。\r<br>","小兒建議劑量":"生體睦使用於孩童的經驗仍相當有限。無論如何、從一歲就開始接受生體睦標準劑量治療的孩童並沒有出現特別的問題。\r<br>","提示內容":"建議用non-PVC容器或non-PVC tubing","抗生素手冊":"暫無資料"},"SAN04I":{"商品名稱":"Sandostatin 0.1mg\/1ml Amp","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAN05I":{"商品名稱":"Sandostatin LAR 20mg Vial#","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SAX02I":{"商品名稱":"Saxenda 18mg\/3ml Pen","腎功能不良劑量調整":"輕度或中度腎功能不全病人 (肌酸酐清除率 ?30 ml\/min) 不需調整劑量。不建議將善纖達用於重度腎功能不全病人(肌酸酐清除率 <30 ml\/min)，包括末期腎病病人","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SCA01I":{"商品名稱":"Scandonest 2% Special 1.8ml\/Cart","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SCA01O":{"商品名稱":"Scanol 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SCR01S":{"商品名稱":"Scrat Suspension 10ml Pack","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling. Aluminum salt is minimally absorbed; however, may accumulate in renal impairment; use with caution in patients with chronic renal failure.","小兒建議劑量":"Doses of 40-80 mg\/kg\/day divided every 6 hours have been used","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SEC04S":{"商品名稱":"Secorine Syrup 120ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童: 5ml TID，依年齡增減; 成人: 10ml TID。\r<br>\r<br>Chlorpheniramine not recommended in children less than 6 yrs of age. Allergic rhinitis & Common cold: (6-\r<br>11 yrs) 2 mg ORALLY every 4-6 hrs; maximum dose: 12 mg\/day.\r<br>-----------------------------------------------\r<br>簡易換算: 1ml\/kg\/day, 分成3到4次。","提示內容":"兒童: 5ml TID\r<br>簡易算法: 1 c.c.\/kg\/day: 分成3或4次。","抗生素手冊":"暫無資料"},"SEC05S":{"商品名稱":"Secorine Syrup 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童: 5ml TID，依年齡增減; 成人: 10ml TID。\r<br>\r<br>Chlorpheniramine not recommended in children less than 6 yrs of age. Allergic rhinitis & Common cold: (6-\r<br>11 yrs) 2 mg ORALLY every 4-6 hrs; maximum dose: 12 mg\/day.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SEG02O":{"商品名稱":"Seginine 5mg Tab","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"\"ADHD (unlabeled use): Children and Adolescents: Oral: 5-15 mg\/day (Jankovic, 1993)\r<br><br>\r<br>Discontinuation of therapy: Refer to adult dosing.\r<br>\r<br><br><br>MAO inhibitor recommendations: Refer to adult dosing\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SEN02O":{"商品名稱":"Sennoside Tab","腎功能不良劑量調整":"仿單沒有寫\r<br>","小兒建議劑量":"6歲以上未滿12歲一次1~1\/2顆,三歲以上未滿六歲一次1\/4~1\/2顆,三歲以下禁止使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SEN03O":{"商品名稱":"Senin F.C Tab 40mg#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SEP02I":{"商品名稱":"Septrin For Infusion#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER01E":{"商品名稱":"Serodine Aqu 10% 120ml","腎功能不良劑量調整":"仿單未載","小兒建議劑量":"有全身性吸收之可能性，因此反覆使用新生兒可能出現甲狀腺功能低下，孕婦及其胎兒及授乳婦有造成甲狀腺腫及甲狀腺功能低下","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER01S":{"商品名稱":"Seridol Oral Soln 30mg\/30ml","腎功能不良劑量調整":"腎功能不全病人排除活性抗精神病藥物成分的能力較正常成年人差。\r<br>起始及後續劑量須減半，且腎臟或肝臟功能不全病人的劑量增加速度須較緩慢。Risperidone 用於此類病人須小心。\r<br>Oral: CrCl <30 mL\/minute: Starting dose of 0.5 mg twice daily","小兒建議劑量":"目前處方15歲以下兒童精神分裂資料不足\r<br>目前缺乏雙極性躁狂發作的兒童及未滿18歲青少年使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER02O":{"商品名稱":"Seroxat 20mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER03I":{"商品名稱":"Servicillin 500mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER03O":{"商品名稱":"Seroquel 25mg Tab#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"Bipolar disorder: Children >=10 years and Adolescents <=17 years: Oral: Mania (monotherapy):<br><br>\r<br>Immediate release: Initial: 25 mg twice daily on day 1; increase to 50 mg twice daily on day 2, then increase by 100 mg daily (administered twice daily) each day until 200 mg twice day is reached on day 5. May further increase up to 600 mg daily in increments of <=100 mg daily. Usual dosage range: 400-600 mg daily; maximum: 600 mg daily. Note: Total daily doses may also be divided into 3 doses per day, based on response and tolerability.\r<br>Extended release: Initial: 50 mg once daily on day 1; increase to 100 mg once daily on day 2, further increase by 100 mg once daily until 400 mg once daily is reached on day 5. Usual dosage range: 400-600 mg once daily; maximum dose: 600 mg once daily.<br><br>\r<br>Schizophrenia: Adolescents 13 to <=17 years: Oral:<br><br>\r<br>Immediate release: Initial: 25 mg twice daily on day 1; increase to 50 mg twice daily on day 2, further increase by 100 mg daily each day (divided twice daily) until 400 mg twice daily is reached on day 5. May further increase up to 800 mg daily in increments of <=100 mg daily. Usual dosage range: 400-800 mg daily; maximum dose: 800 mg daily. Note: Total daily doses may also be divided into 3 doses per day, based on response and tolerability.<br><br>\r<br>\r<br>Extended release: Initial: 50 mg once daily on day 1; increase to 100 mg once daily on day 2, further increase by 100 mg once daily until 400 mg once daily is reached on day 5. Usual dosage range: 400-800 mg once daily; maximum dose: 800 mg once daily\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER05O":{"商品名稱":"SEROQUEL XR 200mg Tab#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"\"Bipolar disorder: Children >=10 years and Adolescents <=17 years: Oral: Mania (monotherapy):<br><br>\r<br>\r<br>Immediate release: Initial: 25 mg twice daily on day 1; increase to 50 mg twice daily on day 2, then increase by 100 mg daily (administered twice daily) each day until 200 mg twice day is reached on day 5. May further increase up to 600 mg daily in increments of <=100 mg daily. Usual dosage range: 400-600 mg daily; maximum: 600 mg daily. Note: Total daily doses may also be divided into 3 doses per day, based on response and tolerability.<br><br>\r<br>Extended release: Initial: 50 mg once daily on day 1; increase to 100 mg once daily on day 2, further increase by 100 mg once daily until 400 mg once daily is reached on day 5. Usual dosage range: 400-600 mg once daily; maximum dose: 600 mg once daily.<br><br>\r<br>Schizophrenia: Adolescents 13 to <=17 years: Oral:<br><br>Immediate release: Initial: 25 mg twice daily on day 1; increase to 50 mg twice daily on day 2, further increase by 100 mg daily each day (divided twice daily) until 400 mg twice daily is reached on day 5. May further increase up to 800 mg daily in increments of <=100 mg daily. Usual dosage range: 400-800 mg daily; maximum dose: 800 mg daily. Note: Total daily doses may also be divided into 3 doses per day, based on response and tolerability.<br><br>\r<br>Extended release: Initial: 50 mg once daily on day 1; increase to 100 mg once daily on day 2, further increase by 100 mg once daily until 400 mg once daily is reached on day 5. Usual dosage range: 400-800 mg once daily; maximum dose: 800 mg once daily\"\r<br>","提示內容":"若有磨粉需要, 請改開非緩釋劑型的Utapine","抗生素手冊":"暫無資料"},"SER06O":{"商品名稱":"Sermion 10mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER09E":{"商品名稱":"Seretide 50 Evohaler 120d","腎功能不良劑量調整":"不需要調整劑量\r<br>","小兒建議劑量":"成人及12歲以上青少年:\r<br>每日兩次，每次吸2單位劑量(seretide evohaler50, 125, 250)\r<br>\r<br>四歲以上之兒童:\r<br>每日兩次，每次吸2單位劑量\r<br>(seretide evohaler50)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER09O":{"商品名稱":"Seroquel XR 50mg Tab#","腎功能不良劑量調整":"No dosage adjustment necessary [uptodate]\r<br>Seroquel XR用於腎功能不全病人的臨床經驗有限","小兒建議劑量":"兒童使用\r<br>Seroquel XR不適用於兒童以及18歲以下的青少年。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SER12E":{"商品名稱":"SERETIDE 250 EVOHALER 120D","腎功能不良劑量調整":"不須調整劑量","小兒建議劑量":"成人及12歲以上青少年:\r<br>每日兩次，每次吸2單位劑量(seretide evohaler50, 125, 250)\r<br>\r<br>四歲以上之兒童:\r<br>每日兩次，每次吸2單位劑量\r<br>(seretide evohaler50)","提示內容":"2 puff BID\r<br>僅建議用於常規性治療，不用於急性發作","抗生素手冊":"暫無資料"},"SET01O":{"商品名稱":"Setine 20mg Tab#","腎功能不良劑量調整":"[Clcr>50 ml\/min]: 20-60 mg q24h\r<br>[10-50 ml\/min]: 50-75%\r<br>[<10 ml\/min]: 50% \r<br>HEMO:  None","小兒建議劑量":"ocial anxiety disorder (unlabeled use): Children and Adolescents 8-17 years: Oral: Initial: 10 mg once daily; titrate at intervals of at least 7 days in increments of 10 mg daily; maximum daily dose: 50 mg daily; trials have typically continued for a 16-week treatment course (Wagner, 2004)\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SET02I":{"商品名稱":"Setron 3mg\/3mL Amp","腎功能不良劑量調整":"於嚴重腎衰竭病患之資料顯示，靜脈給予單一劑量後之藥物動力學參數大致和正常人相似。腎功能不全：無特殊劑量指示。\r<br>\r<br>","小兒建議劑量":"~抗腫瘤化學療法引起的噁心及嘔吐: 同成人劑量\r<br>~兒童之預防及治療抗腫瘤放射線療法引起的噁心及嘔吐之用法用量 : 目前尚無足夠的資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SET02O":{"商品名稱":"Setron FC 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SEV01I":{"商品名稱":"Sevatrim 5ml Amp#","腎功能不良劑量調整":"Clcr>25: 標準劑量\r<br>Clcr 15~25: 以標準劑量為最大劑量，給3天後劑量減半\r<br>Clcr<15: 不給藥(除非有血液透析裝備，若透析病患可給標準劑量的一半。","小兒建議劑量":"12歲以下兒童:\r<br>建議劑量為每24小時使用約6mg trimethoprim及30mg sulfamethoxazole\/kg體重，分2次相等劑量給。\r<br>可依下列劑量為給藥準則:\r<br>6星期-6個月大: 1.25ml\/次，每天2次。\r<br>6個月-6歲    大: 2.5 ml\/次，每天2次。\r<br>6~12歲大        :  5.0 ml\/次，每天2次。\r<br>嚴重感染時，小兒劑量可以增加50%","提示內容":"ClCr <15 mL\/min且未做血液透析病人禁用\r<br>\r<br>只能經由靜脈途徑給藥，且給藥前必須依下列稀釋配製：\r<br>a. 一安瓿之注射液（5ml），加至125ml 輸注溶液中。\r<br>b. 二安瓿之注射液（10ml），加至250ml 輸注溶液中。\r<br>c. 三安瓿之注射液（15ml），加至500ml 輸注溶液中。\r<br>使用前直接稀釋。","抗生素手冊":"iv drip over than 1hr<br>5 mg TMP per kg q6 to 8h<br>Ccr less than 30: qd<br>Ccr less than 15 or HD or PD: qod"},"SEV01O":{"商品名稱":"SEVINA 28tab\/Piece","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SEV03O":{"商品名稱":"SEVIKAR 5\/40mg Tab","腎功能不良劑量調整":"目前並無針對Sevikar研究設計用於腎功能不全病患。單方Amlodipine可從一般起始劑量開始服用，而Olmesartan對於中腎功能不全(Clcr<40)建議不需調整起始劑量。","小兒建議劑量":"Sevikar對兒科病人的安全性和效果尚未確立。","提示內容":"複方成分, 注意處方是否有重複使用同類藥品\r<br>注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"SHI02I":{"商品名稱":"SHINCORT 40mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6~12 y\/o 40mg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SHI03I":{"商品名稱":"Shingrix 0.5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SHI04I":{"商品名稱":"Shingrix (專科) 0.5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIB01O":{"商品名稱":"Sibelium 5mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIG01O":{"商品名稱":"SIGMART 5mg Tab","腎功能不良劑量調整":"\"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein >3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SII01I":{"商品名稱":"SII-ONCO-BCG 40mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIL01E":{"商品名稱":"Silver Nitrate 10% 1-ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIL01O":{"商品名稱":"Silmitasertib (CX-4945) (恩慈) 200mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIL03E":{"商品名稱":"Siliverzine Cream 1% 20Gm","腎功能不良劑量調整":"仿單無載明","小兒建議劑量":"同成人使用方式。新生兒及早產兒、G6PD缺乏症，不推薦使用本劑。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIL05E":{"商品名稱":"Silver Nitrate 20% 25ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIL06E":{"商品名稱":"SILIVERZINE Cream 1% 500Gm","腎功能不良劑量調整":"仿單無載明","小兒建議劑量":"同成人使用方式。新生兒及早產兒、G6PD缺乏症，不推薦使用本劑。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIL06M":{"商品名稱":"Silver Nitrate 1 gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIL07O":{"商品名稱":"Silence 1mg Tab #4","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童使用Lorazepam安全性尚未建立，不推薦使用於12歲以下的兒童\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIM01E":{"商品名稱":"Simbrinza Eye Drops Susp 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不建議讓兒童或青少年使用SIMBRINZA 點眼液。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIM01I":{"商品名稱":"Simdax 12.5mg\/5ml Vial","腎功能不良劑量調整":"對於輕度至中度腎功能不全病患必須小心使用。Simdax不可使用於重度腎功能不全病人\r<br>","小兒建議劑量":"Simdax不可使用於兒童和18歲以下青少年\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIM01S":{"商品名稱":"Simethicone oral susp. 30% 300ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"3歲以下: 請洽醫師診治。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIM02I":{"商品名稱":"Simponi 50mg\/0.5ml#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling (has not been studied).\r<br>","小兒建議劑量":"對18歲以下之兒童病患使用欣普尼SIMPONI的安全性及有效性目前尚未確立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN01E":{"商品名稱":"Sindecon Nasal Spray 5mg\/10ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"成人及6歲以上: 每天1-3次，每次兩鼻孔各噴一下\r<br>6歲以下: 請勿使用\r<br>\r<br>\r<br>","提示內容":"交感神經興奮劑中之局部血管收縮劑\r<br>使用前請先震搖10秒，第一次使用時請先對空按壓6到7次。\r<br>成人及6歲以上 每天1-3次, 每次兩鼻孔各噴一下\r<br>6歲以下 請勿使用\r<br>藥委會通過處置用藥轉為一般常備藥品。25℃以下儲存","抗生素手冊":"暫無資料"},"SIN01I":{"商品名稱":"Sintrix 500mg Vial#","腎功能不良劑量調整":"腎臟功能不好的病人，不需要降低劑量。唯有腎衰竭末期前的病人(Creatinine Clearance < 10ml\/分)，則其劑量不得超過2 公克。","小兒建議劑量":"新生兒(<14天)：20-50mg\/kg QD, MAX 50mg\/kg\r<br>嬰兒小孩(14天至12歲)：20-80mg\/kg QD\r<br>小孩體重大於50kg就必須使用成人的一般劑量。\r<br>-----------------------------------------------------------------------\r<br>Neonates:\r<br>Postnatal age : < 7 days: 50 mg\/kg QD\r<br>postnatal : > 7 days: < 2000g: 50 mg\/kg QD\r<br>                                    > 2000g: 50-75 mg\/kg QD\r<br>Infants and children: 50-75 mg\/kg\/d Q12-24H\r<br>-----------------------------------------------------------------------\r<br>Meningitis: (75xBW) mg QD\r<br>(50xBW) mg Q12H","提示內容":"暫無資料","抗生素手冊":"3rd cephas 呼吸道菌首選<br>常用量: 2 g qd<br>Max: 2 g q12h"},"SIN01M":{"商品名稱":"Sindine Soln 10% 1-Gal","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN02M":{"商品名稱":"Sindine Surgical Scrub 1-Gal","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN03E":{"商品名稱":"Sindine Oint 450gm Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN03O":{"商品名稱":"Sinequan 25mg Cap","腎功能不良劑量調整":"神寧健應謹慎使用於肝臟或腎臟功能不全的病人。\r<br>","小兒建議劑量":"\"針對18歲以下之兒童使用神寧健治療鬱症或其它精神疾患的安全性與療效尚未<br>充分確立。因此神寧健不可用於治療此年齡群的鬱症或其它精神疾患。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN06E":{"商品名稱":"Sinomin Oph Solu 4% 15ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN06O":{"商品名稱":"Sintec 20mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN10E":{"商品名稱":"Sinpharderm Keratolytic Cream 40% 10gm","腎功能不良劑量調整":"仿單未載明","小兒建議劑量":"仿單未載明","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN10O":{"商品名稱":"Singulair 10mg Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"?6歲～14歲兒童患者的劑量為每日睡前服用一粒5mg咀嚼錠。在此年齡層內的患者不需調整劑量。6歲以下兒童患者使用本品的安全性及療效資料則尚未建立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN11E":{"商品名稱":"Sindine Soln 10% 200ml Bot","腎功能不良劑量調整":"沒有特別寫\r<br>","小兒建議劑量":"視情況減量使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN12E":{"商品名稱":"Sindine Soln 10% 500ml Bot","腎功能不良劑量調整":"沒有特別寫\r<br>","小兒建議劑量":"視情況減量使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN13E":{"商品名稱":"Sindine AlC 10% 200ml Bot","腎功能不良劑量調整":"沒有特別寫\r<br>","小兒建議劑量":"視情況減量使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN14E":{"商品名稱":"Sindine AlC 10% 500ml Bot","腎功能不良劑量調整":"沒有特別寫\r<br>","小兒建議劑量":"視情況減量使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN15E":{"商品名稱":"Sintropic Oph Soln 0.5% 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN15O":{"商品名稱":"Singulair Chewable 4mg Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":">15y\/o: 每日服用一粒10mg tab\r<br>6~14歲: 每日服用一粒5mg\r<br>2-5歲: 每日服用一粒4mg\r<br>6個月~2歲: 每日服用一包4mg顆粒劑。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN16O":{"商品名稱":"Singulair 5mg Chewable Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":">15y\/o: 每日服用一粒10mg tab\r<br>6~14歲: 每日服用一粒5mg\r<br>2-5歲: 每日服用一粒4mg\r<br>6個月~2歲: 每日服用一包4mg顆粒劑。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN17O":{"商品名稱":"SINGULAIR ORAL GRANULES 4MG Pack","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":">15y\/o: 每日服用一粒10mg tab\r<br>6~14歲: 每日服用一粒5mg\r<br>2-5歲: 每日服用一粒4mg\r<br>6個月~2歲: 每日服用一包4mg顆粒劑。\r<br>顆粒劑可直接口服，或與滿滿一茶匙冷開水或母乳或乳品，開封後必須立即服完小包內全部劑量(15分鐘內)","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIN20O":{"商品名稱":"Sinmaron OD 30mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling; clearance is decreased 30% in moderate (Clcr 11-39 mL\/minute\/1.73 m2) impairment and is decreased 50% in severe (Clcr <10 mL\/minute\/1.73 m2) impairment. Use with caution","小兒建議劑量":"孩童與18歲以下青少年之安全性與有效性尚未建立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIR01E":{"商品名稱":"Siruta Inhal Soln 600mg\/3ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIR01O":{"商品名稱":"Sirdalud 2mg Tab","腎功能不良劑量調整":"Clcr<25mi\/min 2mg qd\r<br>","小兒建議劑量":"\"不適用於<br>孩童病患\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SIV01I":{"商品名稱":"Sivkort Susp 10mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SKI01E":{"商品名稱":"Skinoren Cream 20% 30gm","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Apply bid. In the event of excessive skin irritation, reduce amount of cream\/application or reduce application to once a day until irritation ceases or interrupt treatment temporarily for a few days.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SMA01O":{"商品名稱":"Smartgen 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"對小孩無使用經驗，尚未確立其安全性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SME01O":{"商品名稱":"Smecta Powder For Oral Susp 3gm","腎功能不良劑量調整":"Dioctahedral smectite不會被胃腸道吸收，不會進入血液循環，由糞便排出\r<br>","小兒建議劑量":"2歲以上兒童: 每日2-3 袋，分3次服用。嚴重急性腹瀉患者其首日初劑量可增加。\r<br>--------------------------------------------------------------------\r<br>嬰兒及2歲以下兒童應避免使用本品。","提示內容":"仿單已刪除2歲以下嬰兒及兒童急性腹瀉的適應症，以符合此年齡層以口服脫水補充液(ORS)作為首選治療之建議。\r<br>\r<br>過去用法: < 1歲: 1\/3包 TID; 1-3歲: 1\/2包 TID; > 3歲: 1包 TID","抗生素手冊":"暫無資料"},"SMO01I":{"商品名稱":"SMOFlipid Emulsion 20% 250ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Children: It is recommended not to exceed 15 mL\/kg body weight\/day.\r<br>The daily dose should be increased gradually during the 1st week of administration.\r<br>The infusion rate should not exceed 0.15 g fat\/kg body weight\/hr.\r<br>\r<br>Neonates and Infants: Initial Dose: 0.5-1 g fat\/kg body weight\/day followed by a successive increase by 0.5-1 g fat\/kg body weight\/day up to 3 g fat\/kg body weight\/day","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SMO02E":{"商品名稱":"Smokfree Tdds 10(20.8mg)","腎功能不良劑量調整":"\"無<br>temporarily discontinue therapy if 24-hour urine protein >=3 g or for other toxicities when clinically indicated.\"\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SMO02I":{"商品名稱":"Smofkabiven Peripheral 1.45L\/Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SMO03E":{"商品名稱":"SMOKFREE TDDS 15(31.2mg)","腎功能不良劑量調整":"無\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SMO03I":{"商品名稱":"SMOFKABIVEN CENTRAL 1477ml\/Bag","腎功能不良劑量調整":"查無資料","小兒建議劑量":"不建議使用於兒童","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SMO04I":{"商品名稱":"SmofKabiven Emulsion 493ml Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD01E":{"商品名稱":"Sod. Chloride 5% 10mL Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD01I":{"商品名稱":"Sod. Bicarbonate 7%\/20ml Amp (Bicarbona)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD02I":{"商品名稱":"Sod. Chloride 0.45% 20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD02O":{"商品名稱":"Sodium Iodide(I - 131) 100uCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD03I":{"商品名稱":"Sod. Acetate 80meq\/20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD03O":{"商品名稱":"Sodium Iodide(I - 131) 3mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD04I":{"商品名稱":"Sod.Chloride 0.45% 500ml 軟袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD05O":{"商品名稱":"Sodium Bicarbonate 600mg Tab","腎功能不良劑量調整":"避免長期使用\r<br>","小兒建議劑量":"6-12 years 600 mg daily. \r<br>3-6 years 300 mg daily.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD06O":{"商品名稱":"Sodium Iodide(I - 131) 30mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD07O":{"商品名稱":"Sodium Iodide(I - 131) 4mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD08O":{"商品名稱":"Sodium Iodide(I - 131) 5mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD09O":{"商品名稱":"Sodium Iodide(I - 131) 6mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD10O":{"商品名稱":"Sodium Iodide(I - 131) 7mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD11I":{"商品名稱":"Sod. Chloride 23.5% 200ml玻璃瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD11O":{"商品名稱":"Sodium Iodide(I - 131) 8mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD12I":{"商品名稱":"Sodium Chloride 3% 500ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"(週報2018\/02\/23 發行)以霧化吸入給藥可供化痰使用。","抗生素手冊":"暫無資料"},"SOD12O":{"商品名稱":"Sodium Iodide(I - 131) 9mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD13O":{"商品名稱":"Sodium Iodide(I - 131) 10mCi Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD15I":{"商品名稱":"Sod. Chloride 0.9% 1.5L PVC袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD16I":{"商品名稱":"Sodi-bicarbo 500gm Pack","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOD17I":{"商品名稱":"Sodium Chloride 3% 500mL Bag YF","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOL01O":{"商品名稱":"Solaxin 200mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling.\r<br>","小兒建議劑量":"孩童每天3～4次。每次125～500mg。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOL02I":{"商品名稱":"Solu-Cortef 100mg Vial","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling; use with caution.\r<br>","小兒建議劑量":"嬰兒及兒童的劑量可能需減少，但應視病情的嚴重程度和病人反應決定劑量，而非由年齡或體重決定之，每天劑量不應低於25mg，最大劑量為15mg\/kg。\r<br>--------------------------------------------------------\r<br>1-5mg\/kg\/day (max 15mg\/kg\/d) divided in 3-4 doses.","提示內容":"簡易換算: 1-5mg\/kg\/d divided in 3-4 doses.\r<br>(max: 15mg\/kg\/d)","抗生素手冊":"暫無資料"},"SOL03I":{"商品名稱":"SOLU-MEDROL 500mg Vial","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"不同的疾病有不同的劑量\r<br>","提示內容":"調製後溶液原安定性標示為48小時修正為室溫須於3小時內使用，若冷藏須於24小時內使用","抗生素手冊":"暫無資料"},"SOL04I":{"商品名稱":"Solu-Medrol 40mg Vial","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"不同的疾病有不同的劑量\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOL06I":{"商品名稱":"Soliqua 300iu\/150ug 3ml Pen","腎功能不良劑量調整":"嚴重腎功能不足或末期腎病不建議使用。","小兒建議劑量":"無使用於兒童之相關資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOL06O":{"商品名稱":"Solantin 25mg Tab","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling\r<br>","小兒建議劑量":"\"\r一般兒童劑量: 目前尚未建立。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOL07I":{"商品名稱":"Soliris (恩慈) 300mg\/30ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"舒立瑞治療PNH兒科病人的安全性及有效性尚未確立。","提示內容":"1.使用前需以0.9%NaCl、0.45%NaCl、D5W或林格氏注射液稀釋至濃度5mg\/ml，輸注時間成年病人>35分鐘不可>2小時，兒科病人應以1-4小時\r<br>2.應安排病人接種腦膜炎球菌疫苗2週後，再施打。併監測病人是否有腦膜炎球菌感染的早期病徵\r<br>3.不可用於治療Shiga toxin E. coli相關的溶血性尿毒症候群的病人","抗生素手冊":"暫無資料"},"SOL07O":{"商品名稱":"Soliky 200mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR<45:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~45: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者，禁止","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOL08I":{"商品名稱":"Soliris 300mg\/30ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOL08O":{"商品名稱":"Solian 200mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOM01O":{"商品名稱":"Somn Well XR 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SON01I":{"商品名稱":"Sonazoid 16ul\/2ml vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SOR01S":{"商品名稱":"Sortuss Liquid 60mL Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SPA04O":{"商品名稱":"Spasmotin 0.125mg Tab","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling, use with caution.\r<br>","小兒建議劑量":"2~12歲兒童：一次1\/2~1錠，每4小時或需要時一次，每日不超過6錠。\r<br>","提示內容":"為Buwecon替代用藥\r<br>2~12歲兒童：一次1\/2~1錠，每4小時或需要時一次，每日不超過6錠。\r<br>成人及大於12歲兒童：一次1~2錠，每4小時或需要時一次，每日不超過12錠。","抗生素手冊":"暫無資料"},"SPE02E":{"商品名稱":"Spersin Ointment 10Gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SPI02O":{"商品名稱":"Spironolactone 25mg Tab","腎功能不良劑量調整":"[Clcr >50 ml\/min]: :25mg tid-qid \r<br>[10-50 ml\/min]: Q12-24h.需監測血鉀\r<br>[<10 ml\/min ]: Avoid.\r<br>HEMO: Not applicable","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SPI04E":{"商品名稱":"Spiriva Respimat 2.5mcg (Inhalation)","腎功能不良劑量調整":"腎功能不全患者無須調整劑量，需嚴密監控病情\r<br>","小兒建議劑量":"安全性和療效尚未確立\r<br>","提示內容":"2 puffs QD\r<br>住院病人可能會用到 3 puffs QD (使用呼吸器病人)","抗生素手冊":"暫無資料"},"SPI05E":{"商品名稱":"Spiolto Respimat 2.5\/2.5mcg (Inhalation)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童患者(18歲以下)通常不會使用SPIOLTO RESPIMAT。","提示內容":"適用於慢性阻塞性肺疾(包括慢性支氣管炎及肺氣腫)之長期維持治療。\r<br>為複方的 LABA\/LAMA，本院屬LABA\/LAMA尚有Anoro和Ultibro\r<br>請注意本院三個Respimat (Spiriva，Striverdi，Spiolto)英文名及外觀相近，中文名也只差一字，調劑時請小心。","抗生素手冊":"暫無資料"},"SPO01O":{"商品名稱":"Sporanox 100mg Cap#","腎功能不良劑量調整":"Oral: 100-400mg po qd or divided doses - bid. (Doses >200 mg\/day are given in 2 divided doses.)\r<br>Clcr <10 mL\/minute: 50% of normal dose.\r<br>CRRT\/HEMO: 200 mg q12 h for 4 doses, then 200 mg q 24 h.","小兒建議劑量":"適撲諾SPORANOX膠囊用於小兒科的臨床資料有限\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 200 mg qd to q12h<br>DDI: QTc prolongation<br>禁忌: HF"},"SPR01E":{"商品名稱":"Spravato Nasal Spray 28mg Bot #3","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SPR01O":{"商品名稱":"SPRYCEL F.C. TAB 50MG#","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer’s labeling. However, <4% of dasatinib and metabolites are renally excreted [4]","小兒建議劑量":"SPRYCEL用於18歲以下患者的安全性與療效尚未確立。","提示內容":"慢性期慢性骨髓性白血病: 100 mg QD\r<br>急性期或加速期慢性骨髓性白血病: 140 mg QD","抗生素手冊":"暫無資料"},"SPR02O":{"商品名稱":"Sprycel F.C. Tab 20mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"10kg至未滿20kg：40mg\/日\r<br>20kg至未滿30kg：60mg\/日\r<br>30kg至未滿45kg：70mg\/日\r<br>45kg以上：100mg\/日\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STA01I":{"商品名稱":"Stazolin 1gm Vial","腎功能不良劑量調整":"熱病: usual dose: 1-2g Q6H-Q8H\r<br>[Clcr 50-90]: q8h\r<br>[10-50]: q12h (same dose for CRRT)\r<br>[<10]: q24-48h. \r<br>[HEMO]: extra 0.5-1g AD\r<br>[CAPD]:0.5g q12h","小兒建議劑量":"小兒按體重1 天20-50mg\/kg。嚴重時，可至1 天100mg\/kg，分次投與。\r<br>Neonates: ≦ 7days: 40mg\/kg\/day Q12H, \r<br>> 7 days: ≦ 2000g: 40mg\/kg\/day Q12H, \r<br>> 2000g: 60mg\/kg\/day Q8H;\r<br>Infants and children: 50-100mg\/kg\/day Q8H, max dose 6g\/d\r<br>--------------------------------------------------------------------\r<br>簡易換算 : 20-100 mg\/kg\/d divided in 2-3 doses。","提示內容":"簡易換算: 20-100mg\/kg\/d in divided 2-3 doses. \r<br>max dose 6g\/d","抗生素手冊":"建議量:  2 g q8h才能達到PD<br>Ccr less than 30: 2 gm q12h<br>Ccr less than 10 or HD PD: 1 gm qd"},"STA02I":{"商品名稱":"Standardized Mite Extract 10ml Vial","腎功能不良劑量調整":"仿單無資料","小兒建議劑量":"兒童和老人對過敏原注射劑的耐受性顯然良好，故對兒童與老年病人族群並無特殊建議事項","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STA03I":{"商品名稱":"Stamaril 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6個月以下不應施打。\r<br>\r<br>6~9個月因產生副作用的可能性較高或尚未明確，應盡可能避免施打。\r<br>\r<br>9個月以上:旅行前至少10天皮下施打一劑 0.5 ml。必要時每10年可再施打一劑。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STA05O":{"商品名稱":"Stable 25mg Tab","腎功能不良劑量調整":"\"- CrCl 10-50 mL\/minute: Administer every 8 hours.<br>- CrCl <10 mL\/minute: Administer every 8-16 hours in fast acetylators and every 12-24 hours in slow acetylators.<br>- Hemodialysis effects: Supplemental dose is not necessary.<br>- Peritoneal dialysis effects:","小兒建議劑量":"\"- Hypertension: Oral: Initial: 0.75-1 mg\/kg\/day in 2-4 divided doses; increase over 3-4 weeks to maximum of 7.5 mg\/kg\/day in 2-4 divided doses; maximum daily dose: 200 mg\/day<br>- Acute hypertension: I.M., I.V.: 0.1-0.2 mg\/kg\/dose (not to exceed 20 mg) every 4-6 hours as needed, up to 1.7-3.5 mg\/kg\/day in 4-6 divided doses\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STE03E":{"商品名稱":"Steridal Solution 0.5% 500ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STI01I":{"商品名稱":"Stin 1gm Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STI02O":{"商品名稱":"Stivarga FC 40mg Tab","腎功能不良劑量調整":"輕度腎功能不全的病患不建議調整劑量。中度腎功能不全(CLcr 30 - 59)的病患，其藥動學資料非常少。未曾對重度腎功能受損或腎病末期的病患進行癌瑞格的試驗","小兒建議劑量":"目前尚未建立低於18歲小兒病患之癌瑞格的安全性及療效","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STI04O":{"商品名稱":"Stilnox 10mg Tab #4","腎功能不良劑量調整":"no\r<br>","小兒建議劑量":"不可使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STR01E":{"商品名稱":"Striverdi Respimat 2.5mcg (Inhalation)","腎功能不良劑量調整":"可依建議劑量使用。\r<br>No dosage adjustment inecessary.","小兒建議劑量":"COPD通常不會發生於兒童。Steriverdi Respimat用於兒童族群的安全性及有效性尚未確立。","提示內容":"2 puff QD\r<br>不可用於氣喘病人","抗生素手冊":"暫無資料"},"STR01O":{"商品名稱":"Strocain Tab","腎功能不良劑量調整":"需依腎功能調整劑量\r<br>","小兒建議劑量":"對小孩的用藥安全尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STR01S":{"商品名稱":"Strolin Liquid 0.5mg\/ml;60ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"<1yr:   2.5ml bid; \r<br>1-6yr:  2.5~5ml tid; \r<br>6-14yr: 5 ml tid; \r<br>>14yr:  5-10ml tid","提示內容":"<1歲: 2.5ml BID; 1-6歲: 2.5~5ml TID; 6-14歲: 5ml TID; >14歲: 5-10ml TID","抗生素手冊":"暫無資料"},"STR02O":{"商品名稱":"Strattera 25mg Hard Cap","腎功能不良劑量調整":"不需劑量調整","小兒建議劑量":"6歲以下兒童或體重<70Kg：起始劑量0.5 mg\/kg\/天(至少3天)，然後增加至1.2 mg\/kg\/天。可以一次服用，或分一半早晚服用。最高劑量1.4mg\/kg或100mg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STR03O":{"商品名稱":"STRATTERA 40mg Hard Cap","腎功能不良劑量調整":"不需劑量調整","小兒建議劑量":"6歲以下兒童或體重<70Kg：起始劑量0.5 mg\/kg\/天(至少3天)，然後增加至1.2 mg\/kg\/天。可以一次服用，或分一半早晚服用。最高劑量1.4mg\/kg或100mg","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"STR04O":{"商品名稱":"Stromectol 3mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於體重不足 15 公斤之兒童病患的安全性及有效性尚未確立。","提示內容":"本藥是脂溶性化合物，且高脂肪飲食會升高其藥物血中濃度。因此，應空腹服用。(美國CDC, 熱病等則建議與食物並服)\r<br>疥瘡- 單次口服劑量為每公斤體重約ivermectin 200微克。在初次投藥後8至15天內，針對嚴重形式的感染，如出現新的明確疥瘡病灶或寄生蟲學檢查仍為陽性反應，可考慮投予第二個劑量。不須因搔癢症狀或抓傷痕持續存在而投予第二個劑量。第二個劑量亦為每公斤約ivermectin 200微克。","抗生素手冊":"暫無資料"},"STR05I":{"商品名稱":"Stronger Neo Minophagen C Inj","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"用量依照年齡症狀適當的增減\r<br>","提示內容":"慢性肝病: 每日一次 40-60 mL , 可視情況增加至100 ml daily","抗生素手冊":"暫無資料"},"SUB01I":{"商品名稱":"Subacillin Inj 1.5gm Vial#","腎功能不良劑量調整":"CrCl >30 : No dosage adjustment necessary.\r<br>CrCl 15 to 29 : 1.5 to 3 g every 12 hours\r<br>CrCl 5 to 14 : 1.5 to 3 g every 24 hours","小兒建議劑量":"大部分孩童:150mg\/kg\/day，每6或8小時注射一次。\r<br>一周大的新生兒:75mg\/kg\/day，分次每12小時注射一次。\r<br>---------------------------------------\r<br>簡易換算 : (75xBW) mg Q6H\r<br>                   100-400 mg\/kg\/d divided in 4 doses。","提示內容":"暫無資料","抗生素手冊":"建議量:  1.5 gm to 3 gm q6h <br>Ccr less 30: 3 gm q12h<br>Ccr less 10 or HD: 3 gm qd"},"SUL01I":{"商品名稱":"Sulbactam 500 mg Vial","腎功能不良劑量調整":"Clcr 15 ~30  :至多每日可用Sulbactam 2000 mg\r<br>Clcr <15 :最多為每日Sulbactam 1000 mg。","小兒建議劑量":"兒童、幼童及嬰兒(見注意事項)：一般用量Sulbactam 50 mg\/kg\/day 為適當劑量，按6~8 或12 小時間隔均分使用，兒童每日至多80 mg\/kg。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUL01O":{"商品名稱":"Sulmatyl FC 50mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUL01S":{"商品名稱":"Sulfacotrim Susp 60ml Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6wk-5mo:   1~2.5 ml BID; \r<br>6mo-5yr:   2.5~ 5ml BID; \r<br>6-12yr:      5~10ml BID\r<br>-------------------------------------------------------------\r<br>(Dosage recommendations are based on the trimethoprim (TMP) component):\r<br>> 2 mo & Adults: \r<br>Mild-moderate infections: 6-12 mg TMP (0.75~0.5ml)\/kg\/d in 2 divided doses;\r<br>Serious infection\/Pneumocystis: 15-20 mg; TMP (1.875~2.5ml)\/kg\/d in 3~4 divided doses","提示內容":"< 6個月: 1-2.5 ml BID; 6個月-5歲: 2.5-5 ml BID; 5-12歲: 5-10 ml BID","抗生素手冊":"4 mg TMP per kg q12h<br>預防UTI: 2 mg TMP per kg qd"},"SUL02O":{"商品名稱":"Sulindec 200mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUL04O":{"商品名稱":"Sulpin 200mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUN01I":{"商品名稱":"Suntose 5%+0.45% 500ml PP袋","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUP02E":{"商品名稱":"Suprane 240ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUP03E":{"商品名稱":"Suprane 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUR01E":{"商品名稱":"Survanta Intratracheal Susp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUT01E":{"商品名稱":"Sutrol Vag Gel 0.75% 25gm Tube","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Intravaginal: One applicatorful (~5 g gel contains ~37.5 mg of metronidazole) intravaginally once daily at bedtime for 5 days\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUT01O":{"商品名稱":"Sutent 12.5mg Cap#","腎功能不良劑量調整":"\"不須調整<br>起始劑量。後續則應依據安全性與耐受性的表現來調整劑量\"\r<br>","小兒建議劑量":"安全性和有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SUW01O":{"商品名稱":"Suwell Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"一天三次，或需要時服用。應嚼碎後吞服。\r<br>6歲以上未滿12歲: 每次1錠\r<br>3歲以上未滿6歲: 每次1\/2錠\r<br>3歲以下嬰幼兒: 請洽醫師診治，不宜自行使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYL01I":{"商品名稱":"Sylvant 100mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYL02I":{"商品名稱":"Sylvant (恩慈) 100mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYM01E":{"商品名稱":"Symbicort Turbuhaler 160\/4.5mcg 120d#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYM01O":{"商品名稱":"Symproic 0.2mg Tab","腎功能不良劑量調整":"腎功能不全的病人無需調整劑量。\r<br>本藥無法以血液透析之方式移除。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYM02E":{"商品名稱":"SYMBICORT RAPIHALER 160\/4.5mcg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYN01O":{"商品名稱":"Synbot 20mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 5-20mg q12-24h \r<br>[10-50]: 50-100%\r<br>[<10 ]:  25%\r<br>HEMO: Dose after dialysis","小兒建議劑量":"\"Hypertension<br>Children: initial 0.08mg\/kg qd, adjust dosage based on patient response\"\r<br>","提示內容":"注意病人是否有高血鉀的症狀\r<br>與Neprilysin inhibitor (如Entresto)不可併用，如需轉換需間隔至少36小時，否則有引發血管性水腫的風險。","抗生素手冊":"暫無資料"},"SYN02O":{"商品名稱":"Syntrend 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYN03I":{"商品名稱":"Synagis 50mg\/0.5mL Vial#","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"Prevention of RSV:?I.M.: Infants and Children <2 years: 15 mg\/kg of body weight, monthly throughout RSV season (first dose administered prior to commencement of RSV season).?Note:?The AAP recommends a maximum of 3 doses for patients born 32-34 6\/7 weeks without significant congenital heart disease or chronic lung disease; maximum of 5 doses for all others\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYN03O":{"商品名稱":"Syntrend 6.25mg Tab","腎功能不良劑量調整":"Dosing: Renal Impairment \r<br>No dosage adjustment necessary","小兒建議劑量":"孩童使用\r<br>對小於18歲的藥動學資料有限","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"SYS01E":{"商品名稱":"Systane Ultra Eye Drops 32amp\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAB01O":{"商品名稱":"Tabrecta 200mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAD01O":{"商品名稱":"Tadex 10mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAG02O":{"商品名稱":"Tagrisso 80mg Tab","腎功能不良劑量調整":"Clcr > 30 ml\/min 無須調整劑量，重度和末期腎病患則沒有建議劑量。","小兒建議劑量":"尚未確定安全性及有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAI01O":{"商品名稱":"Taigexyn 250mg Cap","腎功能不良劑量調整":"中度至重度腎功能不全患者及末期腎臟疾病(ESRD) 患者不建議使用本藥品輕度腎功能不全患者( 肌酸酐清除率【CLcr】60~90 mL\/min) 不須調整用藥劑量。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"仿單: 500 mg once  daily<br>SE: 肌腱炎、肌腱斷裂、周邊神經炎<br>DDI: TdP"},"TAI02I":{"商品名稱":"Taita No. 2 500ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAI03I":{"商品名稱":"Taita No.3 500ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAI05I":{"商品名稱":"Taita No.5 400ml","腎功能不良劑量調整":"無尿或腎衰竭等情形慎用\r<br>","小兒建議劑量":"小孩依體重定之。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAI06I":{"商品名稱":"Taigexyn 500mg\/250ml Bag","腎功能不良劑量調整":"中度至重度腎功能不全病人及末期腎臟疾病（ESRD）病人不建議使用本藥品。\r<br>輕度腎功能不全病人（肌酸酐清除率【CLcr】60~90 mL\/min）不須調整用藥劑量。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"仿單: 500 mg once  daily<br>SE: 肌腱炎、肌腱斷裂、周邊神經炎<br>DDI: TdP"},"TAK01I":{"商品名稱":"Takepron IV 30mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Takepron IV 使用於兒童患者的安全性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAK01O":{"商品名稱":"Takepron OD 30mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"安全性及有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAL01I":{"商品名稱":"Taltz 80mg\/1ml Pen","腎功能不良劑量調整":"There are no dosage adjustments provided in the manufacturer's labeling (has not been studied). (Uptodate)","小兒建議劑量":"兒童斑塊性乾癬\r<br>每4週(Q4W)以皮下注射方式給予\r<br>>50KG：160mg for 0 week, then 80mg Q4W.\r<br>25-50KG：80mg for 0 week, then 40mg Q4W.\r<br><25KG：40mg for 0 week, then 20mg Q4W.","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAL01S":{"商品名稱":"Talopram Oral Soln 150mg\/150ml Bot","腎功能不良劑量調整":"輕微或中度的腎功能受損患者，毋須調整劑量\r<br>但對於嚴重腎功能受損患者(CLCR小於30ml\/min.)須小心注意。","小兒建議劑量":"孩童及青少年（小於18歲者）：\r<br>不建議使用，因此族群的安全與療效性資料尚未研究，曾有兒童使用本藥時發生自殺意念或行為之報告。","提示內容":"1. 5-10mg\/day Max. dose 20mg\/day\r<br>2. 65 歲以上、肝功能有問題、使用 omeprazole 或cimetidine Max. dose 10mg\/day\r<br>3.注意QT interval 延長","抗生素手冊":"暫無資料"},"TAM02O":{"商品名稱":"Tamiflu 75mg Cap(自費)","腎功能不良劑量調整":"[仿單, 2017熱病].\r<br>CrCl >60 mL\/min: 不需調整, 75mg BID\r<br>CrCl >30 to 60: 30 mg BID\r<br>CrCl >10 to 30: 30 mg QD\r<br>CrCl<10 : 不建議使用，除非是洗腎後給予\r<br>例行性血液透析: 建議每次透析後投予一劑30mg\r<br>","小兒建議劑量":"流行性感冒的治療\r<br>1歲或以上兒童服用Tamiflu建議劑量\r<br>≦15公斤    : 30mg BID \r<br>>15-23公斤: 45mg BID\r<br>>23-40公斤: 60mg BID\r<br>>40公斤      : 75mg BID\r<br>[註:院內只有膠囊劑型，尚無懸浮液劑型]\r<br>\r<br>若為預防，則上述劑量改為 QD使用","提示內容":"用法為 1 tab BID for 5 days,\r<br>→注意開立天數可能有誤\r<br>\r<br>ClCr 30-60 mL\/min：30mg BID,\r<br>ClCr 10-30mL\/min：30mg QD\r<br>HD:洗腎後投與30mg\r<br>\r<br>小兒劑量：\r<br> <=15kg：30mg；> 15-23kg：45mg；> 23-40kg：60mg \r<br>(配製: 1 cap 加 15(10?)ml水, 配成5 mg\/ml溶液)","抗生素手冊":"暫無資料"},"TAM03O":{"商品名稱":"Tamiflu 75mg Cap(疾管署公費)","腎功能不良劑量調整":"[仿單, 2017熱病].\r<br>CrCl >60 mL\/min: 不需調整, 75mg BID\r<br>CrCl >30 to 60: 30 mg BID\r<br>CrCl >10 to 30: 30 mg QD\r<br>CrCl<10 : 不建議使用，除非是洗腎後給予\r<br>例行性血液透析: 建議每次透析後投予一劑30mg\r<br>","小兒建議劑量":"1歲或以上兒童服用Tamiflu建議劑量\r<br>≦15公斤    : 30mg BID \r<br>>15-23公斤: 45mg BID\r<br>>23-40公斤: 60mg BID\r<br>>40公斤      : 75mg BID\r<br>[註:院內只有膠囊劑型，尚無懸浮液劑型]\r<br>\r<br>若為預防，則上述劑量改為 QD使用","提示內容":"用法為 1 tab BID for 5 days,\r<br>→注意開立天數可能有誤\r<br>\r<br>ClCr 30-60 mL\/min：30mg BID,\r<br>ClCr 10-30mL\/min：30mg QD\r<br>HD:洗腎後投與30mg\r<br>\r<br>小兒劑量：\r<br> <=15kg：30mg；> 15-23kg：45mg；> 23-40kg：60mg \r<br>(配製: 1 cap 加 15(10?)ml水, 配成5 mg\/ml溶液)","抗生素手冊":"暫無資料"},"TAM04O":{"商品名稱":"Tambocor 100mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 50-100mg q12h \r<br>[10-50]: 50% \r<br>[<10 ]: 50%\r<br>HEMO: None\r<br>--------------------------\r<br>[35–50] Dose as in normal renal function.\r<br>[10–35] Oral: Initially 100 mg daily (or 50 mg bid\r<br>[<10] Oral: Initially 100 mg daily (or 50 mg bid)  ,\r<br>HEMO：","小兒建議劑量":"兒童使用本品之證據尚不足，不推薦12歲以下的小孩使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAM07O":{"商品名稱":"Tamlosin D 0.2mg Tab","腎功能不良劑量調整":"由於高齡者有時有腎功能低下的情形，對腎功能低下者由0.1 mg開始投與，經過充分的觀察才\r<br>能增量至0.2 mg。投與0.2 mg治療無法獲得所預期的效果時，請勿再增量，宜採行其他的適當\r<br>處置。","小兒建議劑量":"暫無資料","提示內容":"1.注意姿勢性低血壓\r<br>2.白內障或青光眼手術前需暫停","抗生素手冊":"暫無資料"},"TAN01O":{"商品名稱":"TANATRIL 5mg Tab","腎功能不良劑量調整":"CrCl<30 mL\/min 或 Scr>3 mg\/dL之嚴 重腎機能障礙的患者，應小心投與，考慮將常用劑量減半，或延長投予間隔。\r<br>","小兒建議劑量":"對於幼兒的安全性尚未確立\r<br>","提示內容":"注意病人是否有高血鉀的症狀\r<br>與Neprilysin inhibitor (如Entresto)不可併用，如需轉換需間隔至少36小時，否則有引發血管性水腫的風險。","抗生素手冊":"暫無資料"},"TAP01I":{"商品名稱":"Tapimycin 4.5gm Vial#","腎功能不良劑量調整":"Usual dose: 3.375-4.5g q6-8h\r<br>[CrCl  20~40ml\/min]:  2.25 g q6h  \r<br>[CrCl  < 20] : 2.25 g q8h  \r<br>HEMO: 2.25g q8-12h + 0.75g after dialysis \r<br>CAPD: 4.5g q12h, CRRT:4.5g q8h","小兒建議劑量":"沒有紀錄\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量:  4.5 gm q8h <br>Ccr less 20 or HD: 4.5 gm q12h"},"TAP01O":{"商品名稱":"Tapal 100mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAR01E":{"商品名稱":"Tarivid Otic Soln 3mg\/ml;5ml","腎功能不良劑量調整":"仿單沒有顯示\r<br>","小兒建議劑量":"\"Acute otitis media with tympanostomy tubes: Children >1 year to 12 years: Instill 5 drops (0.25 mL) into the affected ear(s) twice daily for 10 days<br><br>\r<br>\r<br>Chronic suppurative otitis media with perforated tympanic membranes: Adolescents ?12 years and Adults: Instill 10 drops (0.5 mL) into the affected ear(s) twice daily for 10-14 days\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAR02I":{"商品名稱":"Targocid 200mg Vial#","腎功能不良劑量調整":"治療前三日無需調整劑量，第四日起\r<br>Clcr:40-60 ml\/min:\r<br>每日投與減半之維持劑量，或起始劑量隔日投與或每日投與減半之起始劑量。\r<br>Clcr<40 ml\/min or H\/D:\r<br>每日投與1\/3維持劑量或以起始劑量每三日投與一次或每日投與1\/3起始劑量。","小兒建議劑量":"2個月至16歲兒童:\r<br>一般革蘭氏陽性菌感染:\r<br>loading dose: IV 10mg\/Kg Q12H for 3 dose.\r<br>maintain dose: IV or IM 6mg\/Kg QD\r<br>嚴重感染及嗜中性白血球低下病人:\r<br>loading dose: IV 10mg\/Kg Q12H for 3 dose.\r<br>maintain dose: IV or IM 10 mg\/Kg QD.\r<br>新生兒及兩個月以下幼兒:\r<br>第一天投與16mg\/Kg單劑靜脈注射，接續每日投與8mg\/Kg單劑靜脈注射。靜脈注射應以超過30分鐘輸注方式投與。\r<br>","提示內容":"起始劑量: 400 mg Q12H for 3 dose(2 days), then 400 mg QD; \r<br>腎功能不全起始劑量不需調整, 三日後依據腎功能調整劑量","抗生素手冊":"loading: 6 mg or 12 mg per kg q12h for 3 doses then qd<br>Ccr less than 50: qod<br>Ccr less than, HD or PD: 1w3d  "},"TAR03O":{"商品名稱":"TARCEVA FC 150mg Tab#","腎功能不良劑量調整":"Renal impairment at treatment initiation: No dosage adjustment provided in the manufacturer’s labeling (has not been studied), although <9% of a single dose is excreted in the urine.<br><br>Renal toxicity during treatment: Withhold treatment for grades3\/4rena","小兒建議劑量":"目前尚未建立TARCEVA對小兒病患的安全性及有效性。\r<br>","提示內容":"100-150mg QD (飯前1小時服用)","抗生素手冊":"暫無資料"},"TAR04O":{"商品名稱":"TARCEVA FC 150mg Tab(恩慈)","腎功能不良劑量調整":"Renal impairment at treatment initiation: No dosage adjustment provided in the manufacturer’s labeling (has not been studied), although <9% of a single dose is excreted in the urine.\r\r<br>Renal toxicity during treatment: Withhold treatment for grades3\/4rena","小兒建議劑量":"目前尚未建立TARCEVA對小兒病患的安全性及有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAR05O":{"商品名稱":"Tarceva FC 100mg Tab#","腎功能不良劑量調整":"Renal impairment at treatment initiation: No dosage adjustment provided in the manufacturer’s labeling (has not been studied), although <9% of a single dose is excreted in the urine.\r<br>Renal toxicity during treatment: Withhold treatment for grades3\/4rena","小兒建議劑量":"目前尚未建立TARCEVA對小兒病患的安全性及有效性。","提示內容":"100-150mg QD (飯前1小時服用)","抗生素手冊":"暫無資料"},"TAS01O":{"商品名稱":"TASIGNA 200 mg Cap#","腎功能不良劑量調整":"目前尚無針對腎功能不全患者進行的臨床試驗。但於臨床試驗中，已排除血清肌酸酐濃度高於正常範圍上限的1.5 倍之受試者。由於nilotinib 及其代謝物並非經由腎臟排出身體，故可預期腎功能不全患者不會降低nilotinib 的全身清除率","小兒建議劑量":"Tasigna 使用於孩童的安全性和療效尚未獲得證實。","提示內容":"150-200mg Q12H(用藥前2hrs及用藥後1 hr不可進食)","抗生素手冊":"暫無資料"},"TAS02O":{"商品名稱":"Tasigna 150 mg Cap#","腎功能不良劑量調整":"目前尚無針對腎功能不全患者進行的臨床試驗。但於臨床試驗中，已排除血清肌酸酐濃度高於正常範圍上限的1.5 倍之受試者。由於nilotinib 及其代謝物並非經由腎臟排出身體，故可預期腎功能不全患者不會降低nilotinib 的全身清除率","小兒建議劑量":"Tasigna 使用於孩童的安全性和療效尚未獲得證實。","提示內容":"150-200mg Q12H(用藥前2hrs及用藥後1 hr不可進食)","抗生素手冊":"暫無資料"},"TAT03I":{"商品名稱":"TATUMCEF 2GM VIAL","腎功能不良劑量調整":"成人劑量:1-2 g IV q8-12 hours. \r<br>[Clcr 31-50 ml\/min ]: 1 g q12h. \r<br>[16-30 ml\/min ]: 1 g q24h. \r<br>[6-15 ]: 500 mg q24h. \r<br>[<5 ~dialysis]: 500 mg q48h. \r<br>上述劑量於嚴重感染可增加50%  \r<br>HEMO: 1 g q48h, \r<br>CAPD: 1 g x 1, followed by 500mg q24h.","小兒建議劑量":"嬰兒及孩童(2 個月以上者)：每日每公斤體重30~100mg 分2 或3 次給藥。\r<br>對於免疫不全或纖維性囊性病變的感染孩童或是患有腦膜炎之孩童可給予每天每公斤體重150mg 之劑\r<br>量(最大劑量為每天6g)，分三次給藥。\r<br>新生兒(0~2 個月)：每日每公斤體重25~60mg 分2 次給藥。\r<br>Ceftazidime 在新生兒的血中半衰期可能為成人的3~4 倍。","提示內容":"暫無資料","抗生素手冊":"3ed cephas<br>經驗性應以ceftriaxone取代<br>經驗性 for GNB UTI<br>建議量:  2 gm q8h<br>Ccr less 50: 2 g q12h<br>Ccr less 30: 2 g qd<br>Ccr less 10 or HD: 1 g qd"},"TAX01I":{"商品名稱":"Taxol 30mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAX02I":{"商品名稱":"Taxotere 20mg Vial#","腎功能不良劑量調整":"Renal excretion is minimal (~6%), therefore, the need for dosage adjustments for renal dysfunction is unlikely (Janus, 2010; Li, 2007). Not removed by hemodialysis, may be administered before or after hemodialysis\r<br>","小兒建議劑量":"兒童使用本品之安全性及有效性尚未建立。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TAX03I":{"商品名稱":"Taxotere (恩慈) 20mg Vial","腎功能不良劑量調整":"Renal excretion is minimal (~6%), therefore, the need for dosage adjustments for renal dysfunction is unlikely (Janus, 2010; Li, 2007). Not removed by hemodialysis, may be administered before or after hemodialysis\r<br>","小兒建議劑量":"兒童使用本品之安全性及有效性尚未建立。","提示內容":"特殊藥品調配室調劑之藥品","抗生素手冊":"暫無資料"},"TAZ02I":{"商品名稱":"Tazocin 2.25gm Vial#","腎功能不良劑量調整":"Clcr>40mL\/min：3.375-4.5g Q6H；Clcr 20-40mL\/min：2.25-3.375g Q6H；Clcr<20mL\/min：2.25g Q6H-Q8H；HD：2.25g Q8H-Q12H；CAPD：2.25g Q8H-Q12H","小兒建議劑量":"沒有紀錄\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量:  4.5 gm q8h <br>Ccr less 20 or HD: 4.5 gm q12h"},"TEA01E":{"商品名稱":"Tears Naturale 15ml Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"Ophthalmic:<br>Infants, Children, and Adolescents:<br>Ocular dryness\/irritation: 1-2 drops into eye(s) as needed to relieve symptoms<br>Dry eye associated with ocular inflammation (eg, blepharitis, conjunctivitis, keratitis): 1-2 drops into eye(s) at least twice day\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC01I":{"商品名稱":"Techne MDP kit(1-20mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC01O":{"商品名稱":"Tecfidera 120mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"在10至18歲兒童及青少年患者，Tecfidera的安全性及有效性尚未確立。","提示內容":"多發性硬化症用藥【120mg】\r<br>應與食物一起服用 (可減少發生潮紅或胃腸道不良反應之發生)\r<br>微錠外的腸溶衣可防止刺激腸道，膠囊或其內容不要壓碎、溶解或咀嚼。","抗生素手冊":"暫無資料"},"TEC02I":{"商品名稱":"Techne DTPA kit(1-10mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC02O":{"商品名稱":"TECFIDERA 240MG CAP#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"在10至18歲兒童及青少年患者，Tecfidera的安全性及有效性尚未確立。","提示內容":"多發性硬化症用藥【240mg】\r<br>應與食物一起服用 (可減少發生潮紅或胃腸道不良反應之發生)\r<br>微錠外的腸溶衣可防止刺激腸道，膠囊或其內容不要壓碎、溶解或咀嚼。","抗生素手冊":"暫無資料"},"TEC03I":{"商品名稱":"Tc-99m MAA(1-5mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC04I":{"商品名稱":"Tc-99m Sod Pertech(1-5mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC05I":{"商品名稱":"Tc-99m Sod Pertech(6-30mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC06I":{"商品名稱":"Techne Pyophosphate Kit","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC07I":{"商品名稱":"Techne Phytate Kit(1-6mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC08I":{"商品名稱":"Tc-99m DMSA kit(1-10mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC09I":{"商品名稱":"Tc-99m Neurolite Kit(30mCi\/dose)(ECD)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC10I":{"商品名稱":"Tecentriq (恩慈) 1200mg\/20ml Vial","腎功能不良劑量調整":"No dosage adjustment is necessary (the effect on atezolizumab pharmacokinetics in patients with estimated glomerular filtration rate 15 to 29 mL\/minute has not been studied and is unknown)","小兒建議劑量":"未?確定在兒童患者中TECENTRIQ的安全性和有效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC11I":{"商品名稱":"TECENTRIQ 1200MG\/20ML VIAL","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC12I":{"商品名稱":"Tecentriq 840mg\/14ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC13I":{"商品名稱":"Tecentriq(恩慈) 840mg\/14ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC14I":{"商品名稱":"Tc-99m PYP (25mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC15I":{"商品名稱":"Tc-99m MIBI cardiac set (8mCi+25mCi)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC16I":{"商品名稱":"Tc-99m MIBI (25mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC17I":{"商品名稱":"Techne Pyrophosphate Kit (昶洋)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC18I":{"商品名稱":"Techne Phytate Kit (10mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEC19I":{"商品名稱":"Techne DTPA Kit (20mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEG01O":{"商品名稱":"Tegretol 200mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEI01I":{"商品名稱":"Teicod 200mg Vial","腎功能不良劑量調整":"治療前三日無需調整劑量，第四日起\r<br>Clcr:40-60 ml\/min:\r<br>每日投與減半之維持劑量，或起始劑量隔日投與或每日投與減半之起始劑量。\r<br>Clcr<40 ml\/min or H\/D:Teicoplanin不會經由血液透析移除。每日投與1\/3維持劑量或以起始劑量每三日投與一次或每日投與1\/3起始劑量。","小兒建議劑量":"2個月至16歲兒童:\r<br>一般革蘭氏陽性菌感染:\r<br>loading dose: IV 10mg\/Kg Q12H for 3 dose.\r<br>maintain dose: IV or IM 6mg\/Kg QD\r<br>嚴重感染及嗜中性白血球低下病人:\r<br>loading dose: IV 10mg\/Kg Q12H for 3 dose.\r<br>maintain dose: IV or IM 10 mg\/Kg QD.","提示內容":"暫無資料","抗生素手冊":"loading: 6 mg or 12 mg per kg q12h for 3 doses then qd<br>Ccr less than 50: qod<br>Ccr less than, HD or PD: 1w3d  "},"TEL01I":{"商品名稱":"Telebrix-35 50ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEM01O":{"商品名稱":"Temgesic Sublingual 0.2mg Tab #3","腎功能不良劑量調整":"Injection, sublingual, transdermal: No dosage adjustment provided in manufacturer’s labeling (has not been adequately studied); use with caution","小兒建議劑量":"12 歲以下兒童：丁基原啡因舌下錠0.2 公絲依下列劑量適用於12 歲以下之兒童：\r<br>16.0- 25.0 公斤體重：0.1 公絲 ( 1\/2 錠 )\r<br>25.0- 37.5 公斤體重：0.1 公絲 – 0.2 公絲 \r<br>( 1\/2 錠至1 錠 )\r<br>37.5- 50.0 公斤體重：0.2 公絲 – 0.3 公絲 \r<br>( 1 錠至 1-1\/2 錠)\r<br>推薦之劑量應於每隔 6 – 8 小時再服用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEM02O":{"商品名稱":"TEMODAL 100mg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"在三歲以下的嬰幼兒並沒有使用 TEMODAL 的臨床治療經驗\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEM03O":{"商品名稱":"Temodal 20mg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"在三歲以下的嬰幼兒並沒有使用 TEMODAL 的臨床治療經驗\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEN03O":{"商品名稱":"Tenolol 100mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 50-100mg q24h \r<br>[10-50]: 25-50mg q24h\r<br>[<10 ]: 25mg q24h\r<br>HEMO:  25-50mg after dialysis","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEN04I":{"商品名稱":"Tencam 20mg Vial","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR<45:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~45: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁用?","小兒建議劑量":"暫無資料","提示內容":"常用劑量為20-40 mg\/day, 若頻次劑量超過需注意","抗生素手冊":"暫無資料"},"TES03I":{"商品名稱":"Testosterone Cypionate 200mg\/1ml Amp","腎功能不良劑量調整":"慎重投藥或禁用之\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TES05I":{"商品名稱":"Testodiol Depot Inj 1ml Amp","腎功能不良劑量調整":"仿單未說明","小兒建議劑量":"仿單未提及","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TET01E":{"商品名稱":"Tetracycline Oph Oint 1% 5gm (GCPC)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TET02O":{"商品名稱":"Tetracycline HCl 250mg Cap","腎功能不良劑量調整":"Usual Dosing (Adults) :Systemic infection: 250-500mg po q6h\r<br>[>50 ml\/min]: usual dose q8-12h\r<br>[10-50]: usual dose q12-24h.\r<br>[<10]: q24h (recommend avoid use)  \r<br>Hemo: Usual dose q24h (recommend avoid use). Supplemental dose not needed.","小兒建議劑量":"嬰兒和8 歲以下的孩童不宜使用，除非其他抗菌劑無效或有禁忌時才考慮使用。\r<br>Children > 8 yrs, 25-50 mg\/kg\/day in q6h doses; \r<br>max. 3 g\/day.","提示內容":"暫無資料","抗生素手冊":"建議量: 500 mg q6h<br>renal dysfunction: 建議選用doxy"},"TET06E":{"商品名稱":"Tetracycline Oph Oint 1% 5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TET06I":{"商品名稱":"Tetraxim 0.5ml Syringe (公費)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TET08I":{"商品名稱":"Tetana 0.5ml amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TET09I":{"商品名稱":"Tetanus Toxoid Adsorbed 0.5ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TEZ01I":{"商品名稱":"Tezspire 210mg\/1.91mL Pen","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"THA01I":{"商品名稱":"Thallous chloride Tl-201 1uCi (2.5mCi\/d)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"THA01O":{"商品名稱":"Thado 50mg Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"使用本藥的前一個月直到停藥後的一個月期間，都必須採用至少兩種之避孕措施\r<br>服藥期間不可捐血。","抗生素手冊":"暫無資料"},"THA02I":{"商品名稱":"Thallous chloride Tl-201 1uCi (2mCi\/d)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"THO01O":{"商品名稱":"Thoin SR 125mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"1tab q12h\r<br>","提示內容":"病人心搏過慢時，心臟科會處方Xanthium 200mg 1cap QD-BID,\r<br>且可能同時併用口服β2作用劑\r<br>→可衛教病人此藥可增加心跳","抗生素手冊":"暫無資料"},"THR01O":{"商品名稱":"Through Tab","腎功能不良劑量調整":"無建議調整劑量","小兒建議劑量":"12歲以上適用成人劑量; 6~12歲: 一次1\/2~1錠; 3~6歲: 一次1\/4~1\/2錠; <3歲之嬰幼兒，請洽醫師診治，不宜自行使用。最初應使用最小劑量。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"THY01I":{"商品名稱":"Thymoglobuline 25mg Vial#","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"THY02I":{"商品名稱":"Thyrogen 1.1mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TIG01I":{"商品名稱":"Tigelin 50mg Vial","腎功能不良劑量調整":"嚴重肝功能不全的病人(Child Pugh C)，則TYGACIL的首次劑量仍為100 mg，但建議將維持劑量調降為25 mg，每12小時給藥一次，同時治療期間必須留意病人反應及追蹤療效。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"mino衍生<br>age over than 8 years old"},"TIM03E":{"商品名稱":"Timoptol XE 0.5% 2.5ml Bot#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未對兒童進行試驗\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TIN02O":{"商品名稱":"Tinten 500mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TIS01E":{"商品名稱":"Tisseel Solution for sealant 2ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TIS02E":{"商品名稱":"Tisseel Solution for sealant 4ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOB02E":{"商品名稱":"Tobrex Oph Soln 3mg\/ml; 5ml","腎功能不良劑量調整":"仿單未說明","小兒建議劑量":"臨床試驗實Tobramycin可用於孩童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOF02O":{"商品名稱":"Tofranil 25mg Tab","腎功能不良劑量調整":" No dosage adjustment provided in manufacturer's labeling; use with caution.\r<br>","小兒建議劑量":"\"- 小兒科：起始治療為每日10 mg。超過10天，5~8歲的兒童增至20 mg，9~14歲增至20~50mg，超過14歲增至50~80mg。\r<br><br>- 夜間遺尿(只用於超過5歲的兒童)：\r<br><br>5~8歲兒童的起始劑量：20~30mg\r<br><br>9~12歲兒童的起始劑量：25~50mg<br>\r<br>較大兒童：25~75mg<br>使用Tofranil一星期未有充分反應的病人要用較高的劑量。錠劑需在晚餐之後以單一劑量給予，但對於入睡不久及尿床的小孩，要在晚餐前(4p.m.)給予部分劑量。一旦達到預期的反應，需繼續治療(持續1~3個月)，逐步將劑量降至維持劑量。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TON01O":{"商品名稱":"Tonsaric 100mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 300mg q24h \r<br>[20-50]: 100-300mg q24h.\r<br>[10-20]: 100-200mg q24h.\r<br>[<10]: 100mg q24-48h. \r<br>HEMO:  100mg q24-48h，Dose after dialysis","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TON02O":{"商品名稱":"Tonec 100mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOP02E":{"商品名稱":"Topsym Cream 10gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"Pruritus and inflammation: Refer to adult dosing.<br>Plaque-type psoriasis: Children >=12 years: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOP06O":{"商品名稱":"Topamax 50mg Tab","腎功能不良劑量調整":"不同適應症劑量不一, for seizure, Max. dose:200mg q12h\r<br>[Clcr <70 ml\/min ]: 50% \r<br>[<10 ml\/min]: 25% \r<br>HEMO: Dose for normal renal function after dialysis","小兒建議劑量":">2 y\/o, 0.5~1mg\/kg qn\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOP07E":{"商品名稱":"Topsym Lotion 5mg\/10ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"Pruritus and inflammation: Refer to adult dosing.<br>Plaque-type psoriasis: Children >=12 years: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOR01E":{"商品名稱":"Toricam Gel 40gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOR03O":{"商品名稱":"Torsix 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOT01E":{"商品名稱":"Totifen Oph Soln 1.25mg\/5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOU01I":{"商品名稱":"Toujeo SoloStar 450iu\/1.5ml#","腎功能不良劑量調整":"腎功能不全對Toujeo藥物動力學的影響尚無相關研究。","小兒建議劑量":"兒童病患使用Toujeo的安全性及效果尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TOU02I":{"商品名稱":"Toujeo SoloStar 1 iu (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN107":{"商品名稱":"TPN7 (Pediatric) 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN108":{"商品名稱":"TPN8 (Pediatric) 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN109":{"商品名稱":"TPN9 (Nephrotic-2) 1ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN121":{"商品名稱":"TPN1-A 48\/100 1ML (818 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN122":{"商品名稱":"TPN1-B 63\/100 1ML (1318 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN123":{"商品名稱":"TPN2-A 70\/240 1ML (1018 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN124":{"商品名稱":"TPN2-B 72\/150 1ML (1218 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN125":{"商品名稱":"TPN4-A 18\/100 1ML (668 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN126":{"商品名稱":"TPN2-C 75\/187\/56 1ML (1492 ML\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPN127":{"商品名稱":"TPN9-A 1 mL (1018 mL\/Bag)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TPO01O":{"商品名稱":"Tpoxx 200mg Cap (公費)","腎功能不良劑量調整":"不需調整。","小兒建議劑量":"13 to 25 kg: 200mg BID w\/ meal × 14days\r<br>25 to 40 kg: 400mg BID w\/ meal × 14days","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRA01O":{"商品名稱":"Trajenta FC 5mg Tab#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"TRAJENTA 用於兒童病患時的安全性與有效性，尚未獲得確立。","提示內容":"5 mg QD, 腎功能不全無須調整劑量","抗生素手冊":"暫無資料"},"TRA02I":{"商品名稱":"Trandate 25mg\/5ml Amp","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"安全性及有效性尚未確立\r<br>","提示內容":"非選擇性Beta-blocker\r<br>→禁用於心臟衰竭或第二或第三期的心臟傳導阻斷病人\r<br>\r<br>不應使用於氣喘或有呼吸道阻塞性疾病的病患\r<br>→惡化呼吸道問題。","抗生素手冊":"暫無資料"},"TRA02O":{"商品名稱":"Trandate 200mg Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"安全性及有效性尚未確立\r<br>","提示內容":"非選擇性Beta-blocker\r<br>→禁用於心臟衰竭或第二或第三期的心臟傳導阻斷病人\r<br>\r<br>不應使用於氣喘或有呼吸道阻塞性疾病的病患\r<br>→惡化呼吸道問題。","抗生素手冊":"暫無資料"},"TRA03O":{"商品名稱":"Transamin 250mg Cap","腎功能不良劑量調整":"[Clcr 20~50] Oral：25mg\/kg 12 hourly.\r<br>[Clcr 10~20] Oral：25mg\/kg 24 hourly.\r<br>[Clcr <10] 　Oral：12.5mg\/kg 24hourly\r<br>HEMO: Avoid\r<br>【renal_drug_handbook】","小兒建議劑量":"Tranexamic acid通常成人1日750?2000mg分3?4次經口投與。\r<br>依照年齡、症狀之輕重適當增減用量。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRA04I":{"商品名稱":"Tramal 100mg\/2ml Amp #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRA05I":{"商品名稱":"Trace Element 10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRA07I":{"商品名稱":"Tramtor 100mg\/2ml Amp #4","腎功能不良劑量調整":"[Clcr >50 ml\/min]: 50-100mg orally q4-6 hours (not > 400 mg\/day)\r<br>Elderly : 50-100 mg q4-6h, not > 300 mg\/day\r<br>[<30 ml\/min ]: 50-100 mg q12 hours (Max.: 200 mg\/day.)\r<br>HEMO:Insufficient data","小兒建議劑量":"暫無資料","提示內容":"一般成人:Max dose為 400 mg\/day\r<br>>75歲老人:Max dose為 300 mg\/day\r<br>ClCr<30 ml\/min:Max dose為 200 mg\/day","抗生素手冊":"暫無資料"},"TRA08I":{"商品名稱":"Tractocile 37.5mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未有資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRA10O":{"商品名稱":"Trand 250mg Cap","腎功能不良劑量調整":"Clcr 20~50 Oral: 25mg\/kg 12 hourly.\r<br>Clcr 10~20 Oral: 25mgmg\/kg 24 hourly.\r<br>Clcr <10 Oral: 12.5mg\/kg 24hourly\r<br>HEMO: Avoid\r<br>【renal_drug_handbook】","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRA11O":{"商品名稱":"Traceton FC Tab#4","腎功能不良劑量調整":"腎功能不全病人使用本品之情形未有研究。Clcr< 30 mL\/min的病人，建議增加本品的給藥間隔，每12小時不要超過兩錠","小兒建議劑量":"尚未確定幼童（未滿十六歲兒童）使用本品的安全性及有效性","提示內容":"1-2 tab Q6H","抗生素手冊":"暫無資料"},"TRA13O":{"商品名稱":"TRACLEER-CHD 125mg Tab#","腎功能不良劑量調整":"Renal Impairment No dosage adjustment necessary.","小兒建議劑量":"3歲及3歲以上兒童健議劑量\r<br>體重 10-20kg : 起始劑量31.25mg qd, 第5週起維持劑量 31.25mg BID\r<br>20~40 kg:  31.25mg BID ---> 62.5mg BID\r<br>>40kg    : 62.5mg BID---> 125mg BID","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRA14O":{"商品名稱":"TRAJENTA DUO 2.5\/850MG TAB#","腎功能不良劑量調整":"Metformin：\r<br>(eGFR <30 )：不可使用。\r<br>(eGFR 30-45 )：不建議使用\/減量使用。\r<br>--【複方錠】---------------------\r<br>Linagliptin：不需調整劑量。","小兒建議劑量":"TRAJENTA DUO在未滿18歲兒童病人使用的安全性及有效性，尚未獲得確立。","提示內容":"1.不可用於eGFR<30 mL\/min\/1.73 m 的病人\r<br>2 不建議eGFR介於30-45 mL\/min\/1.73 m 的病人使用\r<br>3.投予含碘顯影劑時，應在檢查前後至少48小時停止使用，待腎功能經評估確定已恢復正常後，才能再服用","抗生素手冊":"暫無資料"},"TRE01E":{"商品名稱":"Tretinoin Cream 0.1% 5gm\/Tube","腎功能不良劑量調整":"仿單未載明","小兒建議劑量":"須置於小孩接觸不到之處。\r<br>Acne vulgaris: \r<br>Children ?10 years (Atralin only) or Children ?12 years and Adolescents可使用，由低劑量低濃度開始","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRE01I":{"商品名稱":"Tren 500mg\/5ml Amp","腎功能不良劑量調整":"Clcr 20~50 IV: 10mg\/kg 12 hourly.\r<br>Clcr 10~20 IV: 10mg\/kg 24 hourly.\r<br>Clcr <10 IV: 5mg\/kg 24hourly\r<br>【renal_drug_handbook】","小兒建議劑量":"仿單未載。\r<br>Dental extraction in hemophiliacs: Adults & children,\r<br>Pre-op: IV 10 mg\/kg before tooth extraction, then 10 mg\/kg IV or 25 mg\/kg\/dose po tid-qid post operation for 2~8 days [uptodate]","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRE02E":{"商品名稱":"Trelegy Ellipta 92\/55\/22mcg Inh; 30d","腎功能不良劑量調整":"腎功能不全病人不須調整劑量","小兒建議劑量":"Trelegy用於兒童病人的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRE03E":{"商品名稱":"TRELEGY ELLIPTA 184\/55\/22 MCG INH; 30D","腎功能不良劑量調整":"不須調整劑量","小兒建議劑量":"兒童病人[17歲(含)以下]的安全性與療效尚未確立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRE03I":{"商品名稱":"Tresiba Flextouch 300U\/3ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"1歲以下孩童尚未有安全性及療效性資料。\r<br>\r<br>1歲以上以皮下注射給藥，於一天中同一時間注射一次。Tresiba單次注射的劑量範圍為1-80單位。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRE04I":{"商品名稱":"Tresiba Flextouch 1 U (小單位檔)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"1歲以下孩童尚未有安全性及療效性資料。\r<br>\r<br>1歲以上以皮下注射給藥，於一天中同一時間注射一次。Tresiba單次注射的劑量範圍為1-80單位。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRI01E":{"商品名稱":"Trichloroacetic Acid 50% 25ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRI07O":{"商品名稱":"Tritace 2.5mg Tab","腎功能不良劑量調整":"[Clcr >50 ml\/min]: 2.5mg q24h, 2nd dose: 5-10mg q24h\r<br>[10-50ml\/min]:  25-50% \r<br>[<10 ml\/min]:25%\r<br>或([GFR< 40 g一天一次開始。","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"注意病人是否有高血鉀的症狀\r<br>與Neprilysin inhibitor (如Entresto)不可併用，如需轉換需間隔至少36小時，否則有引發血管性水腫的風險。","抗生素手冊":"暫無資料"},"TRI08O":{"商品名稱":"Trileptal 300mg Tab","腎功能不良劑量調整":"Clcr <30 mL\/minute: Therapy should be initiated at 1\/2 usual starting dose (300mg qd)\r<br>[>50 ml\/min]: 300-600mg bid\r<br>[10-50ml\/min]: 75%\r<br>[<10 ml\/min]: 50%\r<br>HEMO:    Dose for Clcr<10, give after dialysis\r<br>","小兒建議劑量":"2. 小孩：initially，8-10mg\/kg\/day in 2 divided dose，Max 60mg\/kg\/day。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRI09O":{"商品名稱":"TRITACE 10mg Tab","腎功能不良劑量調整":"Clcr >50 ml\/min]: 2.5mg q24h, 2nd dose: 5-10mg q24h\r<br>[10-50ml\/min]:  25-50% \r<br>[<10 ml\/min]:25%\r<br>或([GFR< 40 g一天一次開始。","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"注意病人是否有高血鉀的症狀\r<br>與Neprilysin inhibitor (如Entresto)不可併用，如需轉換需間隔至少36小時，否則有引發血管性水腫的風險。","抗生素手冊":"暫無資料"},"TRI10E":{"商品名稱":"Trichloroacetic Acid 50%;1-ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRI12E":{"商品名稱":"Trimbow 100\/6\/12.5mcg Inh.;120d","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不適用於兒童族群\r<br>","提示內容":"1. 2 puff bid  Max. dose 2 puff bid\r<br>2.未開封：保存於2°C-8°C 開封後：可保存於25°C以下（最長可存放4個月）。","抗生素手冊":"暫無資料"},"TRI12I":{"商品名稱":"Triamcinolone 10mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":">6y\/o 30~200mcg IM qd~once a week\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRI13E":{"商品名稱":"Trisonin Nasal Spray 55mcg\/d;120d Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"110mcg\/day = 1 dose per nostril QD but if go severe, try on 220mcg\/day not exceed 3 months.\r<br>\r<br>NOT FOR CHILD BEFORE 6 YO (INCLUDE).","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRI13I":{"商品名稱":"TRIAMCINOLONE 40MG\/1ML AMP","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"(六歲以上)肌肉注射每次每公斤體重用30mcg ～ 200mcg(即μg)，每日一次至每週注射一次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRO01E":{"商品名稱":"TROPINE EYE DROPS 0.3% 5ML BOT","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRO01I":{"商品名稱":"Tc-99m Trodat-1 Vial (1-28mCi\/dose)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRO01O":{"商品名稱":"Trolovol 300mg Tab","腎功能不良劑量調整":"\"No dosage adjustment provided in manufacturer’s labeling; however, the manufacturer labeling does suggest a cautious approach to dosing as this drug undergoes mainly renal elimination.<br>Alternate recommendations:<br>CrCl <50 mL\/minute: Avoid use (Aronoff, 2","小兒建議劑量":"\"Rheumatoid arthritis: \r<br>Note: The optimal duration of therapy has not been determined; in patients experiencing a remission for >=6 months, the daily dosage may be decreased in a stepwise fashion in 3-month intervals:<br>Children: Initial: 3 mg\/kg\/day (<=250 mg\/\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRO02E":{"商品名稱":"Tropine Eye Drop 0.125% 5ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRO02I":{"商品名稱":"Trodelvy 180mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRO02O":{"商品名稱":"Trokendi XR 50mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"癲癇單一療法：25mg QN × 1 week，之後以+25~50mg\/week的速率提升到最大劑量。\r<br>11公斤以下最大劑量250mg\/day。\r<br>12-22公斤以下最大劑量300mg\/day。\r<br>23-38公斤以下最大劑量350mg\/day。\r<br>39公斤以上最大劑量400mg\/day。\r<br>癲癇輔助療法：1~3mg\/kg QN × 1week，之後以+1~3mg\/kg\/week的速率提升到5~9mg\/kg。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRO03I":{"商品名稱":"Trodelvy (恩慈) 180mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRU01E":{"商品名稱":"Trusopt Oph Soln 2% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRU01I":{"商品名稱":"Trulicity 1.5mg\/0.5ml Pen#","腎功能不良劑量調整":"多數通報的案例有噁心、嘔吐、腹瀉或脫水的情況。因這些反應可能會使腎功能惡化，故於腎功能不全的病患身上開始使用易週糖R或是增加劑量時須謹慎。","小兒建議劑量":"不建議用於小於18歲的孩童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRU02I":{"商品名稱":"TRUXIMA 500MG\/50ML VIAL","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRU03I":{"商品名稱":"Truxima 100mg\/10ml Vial","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling (has not been studied","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TRY02O":{"商品名稱":"Tryptanol 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TS101O":{"商品名稱":"TS-1 20 mg Cap","腎功能不良劑量調整":"因肝、腎功能不全患者使用TS-1 之藥動學尚未評估，故不建議使用。","小兒建議劑量":"仿單無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TUB01I":{"商品名稱":"Tuberculin PPD RT23 SSI Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TUB02I":{"商品名稱":"Tuberculin(公費) PPD RT23 SSI Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TWY01O":{"商品名稱":"Twynsta Tablets 80\/5 mg","腎功能不良劑量調整":"對於輕度或中度腎功能受損的病患，起始治療無須進行劑量調整。對於重度腎功能受損的病患，須緩慢調整劑量","小兒建議劑量":"TWYNSTA 用於兒童病患時的安全性與有效性尚未獲確立。","提示內容":"複方成分, 注意處方是否有重複使用同類藥品\r<br>注意病人是否有高血鉀的症狀","抗生素手冊":"暫無資料"},"TYG01I":{"商品名稱":"Tygacil 50mg Vial#","腎功能不良劑量調整":"嚴重肝功能不全的病人(Child Pugh C)，則TYGACIL的首次劑量仍為100 mg，但建議將維持劑量調降為25 mg，每12小時給藥一次，同時治療期間必須留意病人反應及追蹤療效。","小兒建議劑量":"暫無資料","提示內容":"嚴重肝功能不全(Child Pugh C): \r<br>首次劑量 100 mg，維持劑量為25 mg Q12H\r<br>與四環素類抗生素具有相似的化學結構，可能會有過敏反應。","抗生素手冊":"mino衍生<br>age over than 8 years old"},"TYK01O":{"商品名稱":"Tykerb 250mg Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"TYKERB對小兒病患的安全性與療效尚未獲得確立\r<br>","提示內容":"1250mg QD (5 Tabs), 飯前一小時服用","抗生素手冊":"暫無資料"},"TYP01I":{"商品名稱":"Typhim Vi 0.5ml Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"未滿2歲嬰幼兒應避免使用。\r<br>\r<br>2歲以上給予single dose 0.5ml IM or SC，必要時每3年可追加一劑。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"TYS01I":{"商品名稱":"Tysabri For Infusion 300mg\/15ml Vial#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling (has not been studied)","小兒建議劑量":"目前沒有TYSABRIR治療18歲以下多發性硬化症的安全性與療效資料，TYSABRIR的適應症並不包括18歲以下的病患。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UCA01O":{"商品名稱":"U-Ca 0.25mcg Soft Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"Macalol缺貨，替代藥品開檔","抗生素手冊":"暫無資料"},"UCI01O":{"商品名稱":"U-Citra Granules 5gm\/Pack","腎功能不良劑量調整":"仿單及資料庫並無資料，應依患者血鉀情況調整劑量。","小兒建議劑量":"仿單及資料庫並無資料。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UFU01O":{"商品名稱":"Ufur Cap#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"安全性和療效尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ULB01O":{"商品名稱":"Ulban A 900mg Gran#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ULC01I":{"商品名稱":"Ulcertin 20mg\/2ml Amp#","腎功能不良劑量調整":"[3]↓ dose or ↑ interval to q36-48h \r<br>(to limit potential CNS adverse effects).\r<br>[Clcr>50 ml\/min]: 20-40 mg qhs\r<br>[10~50]:  10~50%\r<br>[<10 ]: 10%\r<br>HEMO: Dose after dialysis","小兒建議劑量":"Should not be given to children\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ULE01S":{"商品名稱":"Ulexin Susp 25mg\/ml;60ml Bot","腎功能不良劑量調整":"腎功能有顯著損傷的患者，劑量應比一般建議劑量低。End stage renal disease (ESRD) on intermittent hemodialysis(Aronoff 2007): Oral: 250 to 500 mg every 12 to 24 hours; moderately dialyzable (20% to 50%); give dose after dialysis session.","小兒建議劑量":"兒童 25-50mg\/kg\/d (1-2ml\/kg\/d) divided in 2-4 doses，嚴重感染時劑量可加倍。\r<br>--------------------------------------\r<br>簡易換算: (BW\/2)c.c. q6h","提示內容":"一般: 25-50mg\/kg\/d Q6-8H\r<br>嚴重感染: 50-100mg\/kg\/d Q6-8H\r<br>中耳炎: 75-100mg\/kg\/d Q6H; max. dose 4g\/d","抗生素手冊":"10 mg to 20 mg per kg q6h"},"ULI01O":{"商品名稱":"Ulicin 250mg Tab#","腎功能不良劑量調整":"腎功能不全患者肌酐酸廓清率低於30ml\/min，clarithromycin之劑量須減半，例如，250mg每天一次，或較嚴重的病患以250mg每天二次。這些病患不得連續使用超過14天。","小兒建議劑量":"Usual dosage range: \r<br>Infants ?6 months, Children, and Adolescents: Oral: 7.5 mg\/kg every 12 hours (maximum: 500 mg\/dose) for 10 days (UpTodate)","提示內容":"1.注意QT延長交互作用\r<br>2.為強力 CYP3A4 抑制劑注意交互作用(如 Domperidone、lovastatin或simvastatin、colchicine、ranolazine 等)\r<br>3.為P-glycoprotein(Pgp)抑制劑注意交互作用(如 Digoxin)","抗生素手冊":"暫無資料"},"ULT01O":{"商品名稱":"Ultracet Tab#4","腎功能不良劑量調整":"Clcr <30 mL\/minute: Maximum of 2 tablets q12 h. Treatment should not > 5 days.","小兒建議劑量":"安全性和療效尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ULT02E":{"商品名稱":"Ultibro Breezhaler 50\/110mcg\/cap; 30Cap#","腎功能不良劑量調整":"腎功能不全\r<br>輕度至中度腎功能不全病人可使用建議劑量之Ultibro Breezhaler。重度腎功能不全或末期腎疾病需洗腎的病人，僅在預期的效益大於潛在危險時，才可使用。","小兒建議劑量":"兒童\r<br>Ultibro Breezhaler 對於兒童族群（18 歲以下）的COPD 適應症無相關的使用經驗。Ultibro Breezhaler 使用於兒童的安全性和療效尚未確立，且無資料。","提示內容":"1 cap QD\r<br>不可用於氣喘病人\r<br>本品為吸入膠囊劑型請注意病人是否可經口深吸氣(可能無法從氣切管吸入)","抗生素手冊":"暫無資料"},"ULT02I":{"商品名稱":"Ultravist 370#100ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ULT03I":{"商品名稱":"Ultravist 370#200ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ULT04E":{"商品名稱":"Ultane 250ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ULT05E":{"商品名稱":"Ultane 1ml","腎功能不良劑量調整":"scr>1.5必須要小心評估\r<br>","小兒建議劑量":"目前沒有明顯證據\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UNA01I":{"商品名稱":"Unasyn 1.5gm Vial#","腎功能不良劑量調整":"[CRCL >30]: 1.5-3.0 grams q6-8h\r<br>[15-30]: 1.5-3.0 grams q12h\r<br>[5-14 ]: 1.5-3.0 grams q24 hours\r<br>HEMO: 1.5 - 3.0 grams q24 hours , dose after dialysis\r<br>PD: 1.5 - 3.0 grams q24 hours","小兒建議劑量":"150mg (sulbactam 50mg\/ampicillin 100mg)\/kg\/d Q6-8H;\r<br>一週大的新生兒(特別是早產兒): 75mg(sulbactam\r<br>25mg\/ampicillin 50mg)\/kg\/d Q12H\r<br>-------------------------------------------------------------\r<br>簡易換算 : (75xBW)mg Q6H 100-400mg\/kg\/d:\r<br>divided into 4 doses.","提示內容":"暫無資料","抗生素手冊":"建議量:  1.5 gm to 3 gm q6h <br>Ccr less 30: 3 gm q12h<br>Ccr less 10 or HD: 3 gm qd"},"UNA01O":{"商品名稱":"Unasyn 375mg Tab#","腎功能不良劑量調整":"根據廠商提供資料(OP_122)：依腎功能調整給藥間隔\r<br>Clcr15~29 mL\/min Q12H\r<br>Clcr5~14 mL\/min   Q24H\r<br>Clcr 5mL\/min          Q48H","小兒建議劑量":"此藥用於早產兒或新生兒的安全性尚未建立\r<br>根據廠商提供資料\r<br>＜30kg兒童 25~50mg\/kg\/day divided in 2 doses\r<br>＞30kg兒童 依據成人劑量","提示內容":"1 tab Q8H ; ClCr15~29 mL\/min Q12H,\r<br>ClCr5~14 mL\/min Q24H, ClCr<5mL\/min Q48H","抗生素手冊":"暫無資料"},"UPL01I":{"商品名稱":"Uplizna 100mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UPT04O":{"商品名稱":"Uptravi 200mcg Tab","腎功能不良劑量調整":"輕度或中度腎功能不全的病患無需調整劑量。重度腎功能不全(估計腎絲球過濾率[eGFR] < 30 mL\/min\/1.73 m2)的病患無需調整起始劑量；為這些病患調整劑量時應謹慎。","小兒建議劑量":"Uptravi在0歲至未滿18歲兒童的安全性與療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UPT05O":{"商品名稱":"UPTRAVI 600MCG TAB","腎功能不良劑量調整":"輕度或中度腎功能不全的病患無需調整劑量。重度腎功能不全(估計腎絲球過濾率[eGFR] < 30 mL\/min\/1.73 m2)的病患無需調整起始劑量；為這些病患調整劑量時應謹慎。","小兒建議劑量":"Uptravi在0歲至未滿18歲兒童的安全性與療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UPT06O":{"商品名稱":"UPTRAVI 800MCG TAB","腎功能不良劑量調整":"輕度或中度腎功能不全的病患無需調整劑量。重度腎功能不全(估計腎絲球過濾率[eGFR] < 30 mL\/min\/1.73 m2)的病患無需調整起始劑量；為這些病患調整劑量時應謹慎。","小兒建議劑量":"Uptravi在0歲至未滿18歲兒童的安全性與療效尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URE03E":{"商品名稱":"Urea Cream 100mg\/gm;20gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URE04E":{"商品名稱":"Ureson Cream 16gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URI01O":{"商品名稱":"Urief 4mg Tab","腎功能不良劑量調整":"中度腎功能障礙者(CCr30~50ml\/min)服用本品可能會造成血中濃度上升,建議以低劑量(1次2mg,一天兩次)作為治療的開始劑量,輕度腎功能障礙者(CCr50~80ml\/min)無須調整\r<br>\r<br>Clcr<30ml\/min禁用","小兒建議劑量":"本品不建議用於兒童","提示內容":"1.CCr <30 mL\/min禁用\r<br>2.注意姿勢性低血壓\r<br>3.白內障或青光眼手術前需暫停","抗生素手冊":"暫無資料"},"URI02O":{"商品名稱":"URIEF FC 8MG TAB","腎功能不良劑量調整":"CCr 30-50 mL\/min 2mg BID PC","小兒建議劑量":"本品不建議用於兒童","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO01I":{"商品名稱":"Urografin 76%","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO01O":{"商品名稱":"Urosin FC 100mg Tab","腎功能不良劑量調整":"[>50 ml\/min]: 50-100mg q24h \r<br>[10-50]: 25-50mg q24h\r<br>[<10 ]: 25mg q24h\r<br>HEMO:  25-50mg after dialysis\r<br>\r<br>對嚴重腎臟機能失常的病人應依情況調整劑量。一般而言病人其\r<br>Clcr 15-35mL\/min\/l.73 ㎡ :50mg QD；\r<br>Clcr <15mL\/min\/1.73㎡ :50mg QOD。\r<br>","小兒建議劑量":"仿單-兒童：本藥物尚無用於兒童之經驗，故不宜使用\r<br>Uptodate-Hypertension: Oral: Children: 0.5-1 mg\/kg\/dose given daily; range of 0.5-1.5 mg\/kg\/day; maximum dose: 2 mg\/kg\/day up to 100 mg\/day","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO02O":{"商品名稱":"UroSAN 100mg Cap","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling (has not been studied","小兒建議劑量":"在16 歲以下孩童使用的安全性和有效性尚未建立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO03O":{"商品名稱":"Urodine 100mg Tab","腎功能不良劑量調整":"Use is contraindicated in renal impairment.","小兒建議劑量":"Urinary analgesic:Oral: Children: 12 mg\/kg\/day in 3 divided doses administered after meals for 2 days","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO05I":{"商品名稱":"Uromitexan 400mg\/4ml Amp","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Mesna dose depends on dose of antineoplastic agent used\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO05O":{"商品名稱":"Uroprin 100mg Tab (Pyridium)","腎功能不良劑量調整":"Use is contraindicated in renal impairment.\r<br>","小兒建議劑量":"Urinary analgesic:Oral: Children: 12 mg\/kg\/day in 3 divided doses administered after meals for 2 days\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO07I":{"商品名稱":"Urokinase 60000IU Vial YCH","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO07O":{"商品名稱":"Urotrol 15mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URO08I":{"商品名稱":"UROKINASE(Green Cross) 60000IU VIAL","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"URS01O":{"商品名稱":"Urso 100mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"USO01E":{"商品名稱":"U Soft Cream 40% 10gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"USO01I":{"商品名稱":"U-Sodin 5mg\/2ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UTA01O":{"商品名稱":"Utapine 200mg Tab","腎功能不良劑量調整":"腎及肝功能不全病人，經口服之Quetiapine的清除率約減少25%。腎及肝功能不全者剛開始服用本品的劑量，應為每日25mg，可每日增加25-50mg，至有效劑量為止。","小兒建議劑量":"本品未核准使用於兒童及青少年。不適用於18歲以下的兒童或青少年。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UTR01O":{"商品名稱":"Utrogestan 100mg Cap","腎功能不良劑量調整":"不需調整劑量。但是，嚴重腎功能族群的研究尚未建立故不可使用\r<br>","小兒建議劑量":"對兒童的安全性及有效性尚未建立\r<br>","提示內容":"可用於陰道內投藥, 作為不孕症或是習慣性流產的治療\r<br>(一般劑量為 100mg BID )","抗生素手冊":"暫無資料"},"UTR02O":{"商品名稱":"Utraphen FC 37.5\/325mg Tab#4","腎功能不良劑量調整":"腎功能不全病人使用本品之情形未有研究。Clcr< 30 mL\/min的病人，建議增加本品的給藥間隔，每12小時不要超過兩錠","小兒建議劑量":"尚未確定幼童（未滿十六歲兒童）使用本品的安全性及有效性","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UWA01O":{"商品名稱":"Uwarin 2.5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"UWA02O":{"商品名稱":"UWARIN 5MG TAB","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAB01I":{"商品名稱":"Vabysmo 6mg\/0.05mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAB02I":{"商品名稱":"Vabysmo (恩慈) 6mg\/0.05mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAG01I":{"商品名稱":"Vagostin 0.5mg\/1ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAL01O":{"商品名稱":"Valium 2mg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAL02O":{"商品名稱":"Valium 5mg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAL03O":{"商品名稱":"Valdoxan FC 25mg Tab","腎功能不良劑量調整":"對於有憂鬱症且合併有嚴重或中度腎功能不全的病人使用ValdoxanR 之臨床資料有限，因此對腎功能不全患者開立處方時應謹慎","小兒建議劑量":"ValdoxanR 用於治療18歲以下兒童之療效與安全性資料尚未確立，目前無相關資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAL04O":{"商品名稱":"Valcyte 450mg Tab","腎功能不良劑量調整":"CMV retinitis: Induction: 900mg bid x 21 days (take with food).\r<br>Maint: 900mg qd (take with food).\r<br>[40-59 ]: Induction: 450mg bid. Maint: 450mg qd.\r<br>[25-39 ]: Induction: 450mg po qd. Maint: 450 mg q48h.\r<br>[10-24 ]: Induction: 450mg po q2 days. Maint: 450m","小兒建議劑量":"安全及療效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAL05O":{"商品名稱":"Valtrex 500mg Tab","腎功能不良劑量調整":"Clcr=15-30\r<br>帶狀皰疹：1000mg BID\r<br>\r<br>Clcr<15\r<br>帶狀皰疹：1000mg QD\r<br>單純皰疹治療：500mg QD\r<br>免疫健全單純皰疹預防：250mg QD\r<br>免疫不全單純皰疹預防：500mg QD","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAN03I":{"商品名稱":"Vancomycin 1g Vial#","腎功能不良劑量調整":"依CLcr調整劑量。Vancomycin hydrochloride每日劑量（mg），約為腎絲球濾過率（ml\/min）的15倍。","小兒建議劑量":"通常靜脈投與量，每6小時注射10 mg\/kg體重。每次劑量注射的時間，至少須60分鐘以上。","提示內容":"1g Q12H\r<br>腎功能不全初劑量應為15 mg\/kg才能達治療濃度, 後續劑量依ClCr調整\r<br>由於1Vial稀釋液至少200ml\r<br>→故每日需 NS或D5W 250 ml\/bag Q12H (每次輸注2小時)\r<br>\r<br>* C. difficile引起之假膜性結腸炎:\r<br>口服vancomycin 125 mg Q6H for 10-14 days, \r<br>嚴重複雜性感染可用500 mg QID + metronidazole 500 mg IV Q8H","抗生素手冊":"暫無資料"},"VAN04I":{"商品名稱":"Vanco 1g Vial","腎功能不良劑量調整":"依CLcr調整劑量。Vancomycin hydrochloride每日劑量（mg），約為腎絲球濾過率（ml\/min）的15倍。","小兒建議劑量":"通常靜脈投與量，每6小時注射10 mg\/kg體重。每次劑量注射的時間，至少須60分鐘以上。","提示內容":"1g Q12H\r<br>腎功能不全初劑量應為15 mg\/kg才能達治療濃度, 後續劑量依ClCr調整\r<br>由於1Vial稀釋液至少200ml\r<br>→故每日需 NS或D5W 250 ml\/bag Q12H (每次輸注2小時)\r<br>\r<br>* C. difficile引起之假膜性結腸炎:\r<br>口服vancomycin 125 mg Q6H for 10-14 days, \r<br>嚴重複雜性感染可用500 mg QID + metronidazole 500 mg IV Q8H","抗生素手冊":"建議量: 1 gm or 15 mg per kg q12h<br>使用超過二周須監測血中濃度"},"VAN04O":{"商品名稱":"Vancover 125mg Cap","腎功能不良劑量調整":"Oral: There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.","小兒建議劑量":"兒童 - 每日劑量 40 mg\/kg，分三至四次口服，治療七至十天。一日總量應不超過 2 g。","提示內容":"暫無資料","抗生素手冊":"建議量: 125 mg or 500 mg q6h for 10 days"},"VAQ01I":{"商品名稱":"VAQTA 25U\/0.5ml Vial","腎功能不良劑量調整":"仿單未提及","小兒建議劑量":"肌肉注射用的無菌懸浮液。嬰幼兒\/青少年: 年齡介於12個月~18歲者，在接種日接種單劑量0.5ml(約25 U)，6~18個月後接種追加劑量0.5ml(約25 U)。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAQ02I":{"商品名稱":"VAQTA 50U\/1ml Vial (Adult)","腎功能不良劑量調整":"仿單未提及","小兒建議劑量":"肌肉注射用的無菌懸浮液。嬰幼兒\/青少年: 年齡介於12個月~18歲者，在接種日接種單劑量0.5ml(約25 U)，6~18個月後接種追加劑量0.5ml(約25 U)。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAR01I":{"商品名稱":"Varivax (公費) 0.5ml Vial","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer's labeling","小兒建議劑量":"疫苗配製成0.5ml即為單一免疫劑量。\r<br>限皮下注射。\r<br>12個月以上~12歲之幼兒: 建議使用單一劑量。\r<br>13歲(含)以上: 建議投予兩劑並應間隔6-10週。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAR02I":{"商品名稱":"Varilrix (自費) 0.5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"12個月大至12歲的孩童只需皮下注射一劑0.5ml。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAR04I":{"商品名稱":"Varivax (自費) 0.5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"12個月大至12歲的孩童只需皮下注射一劑0.5ml。","提示內容":"伏痘敏活性水痘疫苗\r<br>注射本疫苗後三個月內應避免懷孕。","抗生素手冊":"暫無資料"},"VAR05I":{"商品名稱":"Varilrix 0.5ml Vial (員工)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"12個月大至12歲的孩童只需皮下注射一劑0.5ml。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAR06I":{"商品名稱":"Varivax (員工) 0.5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAS01M":{"商品名稱":"Vaselin 1-Lb","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAX06I":{"商品名稱":"Vaxigrip Tetra (自費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童\r<br>年齡介於6個月-17歲的兒童：0.5毫升一劑。\r<br>年齡小於 9 歲且先前未曾接種過流感疫苗的兒童，應至少間隔4 週後再接種第2 劑疫苗0.5毫升。\r<br>年齡小於六個月的兒童：VaxigripTetra的安全性及療效資料尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAX07I":{"商品名稱":"Vaxigrip Tetra (公費) 0.5mL Syringe","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"兒童\r<br>年齡介於6個月-17歲的兒童：0.5毫升一劑。\r<br>年齡小於 9 歲且先前未曾接種過流感疫苗的兒童，應至少間隔4 週後再接種第2 劑疫苗0.5毫升。\r<br>年齡小於六個月的兒童：VaxigripTetra的安全性及療效資料尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VAX09I":{"商品名稱":"Vaxneuvance 15 (自費) Conj Vaccine","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VB103O":{"商品名稱":"Vitamin B1 100mg Tab (Johnson)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEC01I":{"商品名稱":"Vectibix 100mg\/5ml Vial#","腎功能不良劑量調整":" There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied).","小兒建議劑量":"尚無兒童族群使用Vectibix治療大腸直腸癌的相關經驗。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEL01I":{"商品名稱":"Velcade 3.5mg Vial#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEM01O":{"商品名稱":"Vemlidy 25mg tab#","腎功能不良劑量調整":"對輕度、中度或重度腎功能不全的患者，並不須調整VEMLIDY的劑量。 \r<br>VEMLIDY不建議用於末期腎病(Clcr<15ml\/min)患者","小兒建議劑量":"18歲以下之兒童病患的安全性及有效性尚未確立。","提示內容":"治療代償性(compensated)成人慢性B型肝炎\r<br>零採個案藥品，貨到開檔使用。\r<br>不建議用於末期腎病（估計肌酸酐廓清率低於15毫升\/分鐘）患者","抗生素手冊":"暫無資料"},"VEN01E":{"商品名稱":"Ventolin For Nebules 5mg\/2.5ml#","腎功能不良劑量調整":" Use with caution in patients with renal impairment. No dosage adjustment required (including patients on hemodialysis, peritoneal dialysis, or CRRT; Aronoff, 2007)","小兒建議劑量":"成人及兒童 : 以液體吸入方式給藥的適當初劑量為2.5mg，必要時增加至5mg, 一日得重覆四次。\r<br>18個月以下嬰兒的臨床藥效性尚未確知，由於可能鋰引起血氧過少現象，因此宜備妥氧氣的補充。\r<br>Infants and Children: Limited data in ages <2 years:\r<br>Intermittent: 0.15 mg\/kg (minimum dose: 2.5 mg) every 20 minutes for 3 doses then 0.15-0.3 mg\/kg not to exceed 10 mg every 1-4 hours","提示內容":"成分與Combivent重複, 需注意","抗生素手冊":"暫無資料"},"VEN02E":{"商品名稱":"Ventolin Inhaler 200d","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"\"Bronchospasm:<br><br>\r<br>Metered-dose inhaler (90 mcg\/puff): NIH Guidelines, 2007: Quick relief:<br><br>\r<br>\r<br>Children <=4 years: 2 puffs every 4-6 hours as needed<br><br>\r<br>\r<br>Children 5-11 years: 2 puffs every 4-6 hours as needed<br><br>\r<br>\r<br>Children >=12 years: 2 puffs every 4-6 hours as needed<br><br>\r<br>\r<br>Metered-dose inhaler (100 mcg\/puff): Airomir [Canadian product]:<br><br>\r<br>\r<br>Children 6-11 years:<br><br>\r<br>\r<br>Acute treatment: 1 puff; additional puffs may be necessary if inadequate relief; however, patients should be advised to promptly consult health care provider or seek medical attention if no relief from acute treatment<br><br>\r<br>\r<br>Maintenance: 1 puff; may increase to maximum of 1 puff 4 times daily<br><br>\r<br>\r<br>Children ?12 years: Refer to adult dosing.\r<br><br><br>Nebulization solution:<br><br>\r<br>\r<br>Manufacturer's recommendations:<br><br>\r<br>\r<br>Children 2-12 years (AccuNeb): 0.63-1.25 mg 3-4 times daily as needed<br><br>\r<br>\r<br>Children >=12 years: 2.5 mg 3-4 times daily as needed<br><br>\r<br>\r<br>NIH Guidelines, 2007: Quick relief:<br><br>\r<br>\r<br>Children <=4 years: 0.63-2.5 mg every 4-6 hours as needed<br><br>\r<br>\r<br>Children >=5 years: 1.25-5 mg every 4-8 hours as needed\r<br><br><br>\r<br>Children >=12 years: Refer to adult dosing.<br><br>\r<br>\r<br>Oral: Note: Oral is not the preferred route for treatment of asthma; inhalation via nebulization or MDI is preferred (NIH guidelines, 2007).<br><br>\r<br>\r<br>Regular release:<br><br>\r<br>\r<br>Children 2-6 years: 0.1-0.2 mg\/kg\/dose 3 times daily (maximum: 12 mg daily)<br><br>\r<br>\r<br>Children 6-12 years: 2 mg\/dose 3-4 times daily (maximum: 24 mg daily)<br><br>\r<br>\r<br>Children >12 years: 2-4 mg\/dose 3-4 times daily (maximum: 32 mg daily)<br><br>\r<br>Extended release:<br><br>\r<br>\r<br>Children 6-12 years: 4 mg every 12 hours (maximum: 24 mg daily)\r<br><br><br>\r<br>Children >12 years: 8 mg every 12 hours (maximum: 32 mg daily)<br><br>\r<br>\r<br>Exacerbation of asthma (acute, severe) (NIH Guidelines, 2007):<br><br>Metered-dose inhaler (90 mcg\/puff):<br><br>\r<br>\r<br>Children <12 years: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed<br><br>\r<br>\r<br>Children >=12 years: 4-8 puffs every 20 minutes for up to 4 hours, then every 1-4 hours as needed<br><br>\r<br>\r<br>Nebulization solution:<br><br>\r<br>\r<br>Children <12 years: 0.15 mg\/kg (minimum: 2.5 mg) every 20 minutes for 3 doses, then 0.15-0.3 mg\/kg (maximum: 10 mg) every 1-4 hours as needed, or 0.5 mg\/kg\/hour by continuous nebulization<br><br>\r<br>\r<br>Children >=12 years: 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed, or 10-15 mg\/hour by continuous nebulization<br><br>Exercise-induced bronchospasm (prevention):<br><br>\r<br>Metered-dose inhaler (90 mcg\/puff):<br><br>\r<br>\r<br>Children <=4 years: 1-2 puffs 5 minutes prior to exercise (NIH Guidelines, 2007)\r<br><br><br>\r<br>Children >4 years: 2 puffs 5-30 minutes prior to exercise<br><br>\r<br>Metered-dose inhaler (100 mcg\/puff): Airomir [Canadian product]:<br><br>Children 6-11 years: 1 puff 30 minutes prior to exercise<br><br>Children >=12 years: Refer to adult dosing\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEN02O":{"商品名稱":"Ventolin 2mg Tab","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"\"Bronchospasm:\r<br><br><br>Metered-dose inhaler (90 mcg\/puff): NIH Guidelines, 2007: Quick relief:<br><br>\r<br>\r<br>Children <=4 years: 2 puffs every 4-6 hours as needed<br><br>\r<br>Children 5-11 years: 2 puffs every 4-6 hours as needed<br><br>\r<br>\r<br>Children >=12 years: 2 puffs every 4-6 hours as needed\r<br>Metered-dose inhaler (100 mcg\/puff): Airomir [Canadian product]:<br><br>\r<br>\r<br>Children 6-11 years:<br><br>\r<br>Acute treatment: 1 puff; additional puffs may be necessary if inadequate relief; however, patients should be advised to promptly consult health care provider or seek medical attention if no relief from acute treatment\r<br>\r<br>Maintenance: 1 puff; may increase to maximum of 1 puff 4 times daily<br><br>\r<br>\r<br>Children >=12 years: Refer to adult dosing.<br><br>\r<br>Nebulization solution:<br><br>\r<br>Manufacturer's recommendations:<br><br>\r<br>\r<br>Children 2-12 years (AccuNeb): 0.63-1.25 mg 3-4 times daily as needed<br><br>\r<br>\r<br>Children >=12 years: 2.5 mg 3-4 times daily as needed<br><br>NIH Guidelines, 2007: Quick relief:\r<br>\r<br><br><br>Children <=4 years: 0.63-2.5 mg every 4-6 hours as needed<br><br>\r<br>\r<br>Children >=5 years: 1.25-5 mg every 4-8 hours as needed\r<br>\r<br>Children >=12 years: Refer to adult dosing.<br><br>\r<br>Oral: Note: Oral is not the preferred route for treatment of asthma; inhalation via nebulization or MDI is preferred (NIH guidelines, 2007).<br><br>\r<br>\r<br>Regular release:<br><br>\r<br>\r<br>Children 2-6 years: 0.1-0.2 mg\/kg\/dose 3 times daily (maximum: 12 mg daily)\r<br>\r<br><br><br>Children 6-12 years: 2 mg\/dose 3-4 times daily (maximum: 24 mg daily)<br><br>\r<br>\r<br>Children >12 years: 2-4 mg\/dose 3-4 times daily (maximum: 32 mg daily)\r<br>\r<br><br><br>Extended release:<br><br>\r<br>\r<br>Children 6-12 years: 4 mg every 12 hours (maximum: 24 mg daily)<br><br>\r<br>\r<br>Children >12 years: 8 mg every 12 hours (maximum: 32 mg daily)<br><br>\r<br>\r<br>Exacerbation of asthma (acute, severe) (NIH Guidelines, 2007):<br><br>Metered-dose inhaler (90 mcg\/puff):<br><br>\r<br>\r<br>Children <12 years: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed<br><br>\r<br>\r<br>Children >=12 years: 4-8 puffs every 20 minutes for up to 4 hours, then every 1-4 hours as needed<br><br>\r<br>\r<br>Nebulization solution:\r<br>\r<br>Children <12 years: 0.15 mg\/kg (minimum: 2.5 mg) every 20 minutes for 3 doses, then 0.15-0.3 mg\/kg (maximum: 10 mg) every 1-4 hours as needed, or 0.5 mg\/kg\/hour by continuous nebulization<br><br>\r<br>\r<br>Children >=12 years: 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed, or 10-15 mg\/hour by continuous nebulization<br><br>Exercise-induced bronchospasm (prevention):<br><br>\r<br>\r<br>Metered-dose inhaler (90 mcg\/puff):<br><br>\r<br>\r<br>Children <=4 years: 1-2 puffs 5 minutes prior to exercise (NIH Guidelines, 2007)<br><br>\r<br>\r<br>Children >4 years: 2 puffs 5-30 minutes prior to exercise<br><br>\r<br>\r<br>Metered-dose inhaler (100 mcg\/puff): Airomir [Canadian product]:<br><br>\r<br>\r<br>Children 6-11 years: 1 puff 30 minutes prior to exercise<br><br>\r<br>\r<br>Children >=12 years: Refer to adult dosing\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEN04E":{"商品名稱":"Ventavis 20mcg\/2ml Nebuliser Soln#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"使用於兒童及青少年（18 歲以下）的經驗有限。因此本品不建議使用於兒科病患。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEN04O":{"商品名稱":"Venina 28Tab\/Piece","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEN05O":{"商品名稱":"Venclexta 100mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"尚未確立用於兒童病人的安全性及療效。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEP01I":{"商品名稱":"Vepesid (VP-16) 100mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VEP01O":{"商品名稱":"Vepesid (VP-16) 50mg Cap","腎功能不良劑量調整":"Clcr>50: 100%劑量\r<br>Clcr15~50: 75%劑量\r<br>Clcr<15 : no data","小兒建議劑量":"用於小兒科患者的安全性及有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VER01I":{"商品名稱":"Verpamil 5mg\/2ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VER01O":{"商品名稱":"Verzenio 150mg Tab","腎功能不良劑量調整":"輕度或中度肝功能不全(Child-Pugh A 或B)不需調整劑量。\r<br>\r<br>重度肝功能不全(Child-Pugh C)應降低用藥頻率。","小兒建議劑量":"用於孩童病人的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VER02I":{"商品名稱":"Verorab Vaccine 0.5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"同成人。","提示內容":"值班期間若有遇到開立疫苗，請告知藥庫，謝謝。\r<br>暴露前的疫苗接種：D0、D7、D21或D28       \r<br>暴露後的疫苗接種：D0、D3、D7、D14、D28或2doseD0、D7、D21\r<br>疫苗僅可肌肉注射，出生後12個月內通常施打於大腿的前外側，滿12個月後兒童及成人則施打於三角肌部位，不可接種於臀部。","抗生素手冊":"暫無資料"},"VER02O":{"商品名稱":"Verzenio (恩慈) 150mg Tab","腎功能不良劑量調整":"輕度或中度肝功能不全(Child-Pugh A 或B)不需調整劑量。\r<br>\r<br>重度肝功能不全(Child-Pugh C)應降低用藥頻率。","小兒建議劑量":"用於孩童病人的安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VER03O":{"商品名稱":"Verquvo FC 5mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VER04O":{"商品名稱":"VERQUVO FC 10MG TAB","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VES01O":{"商品名稱":"Vesanoid 10mg Cap#","腎功能不良劑量調整":"No dosage adjustment provided in the manufacturer’s labeling (has not been studied). (uptodate)","小兒建議劑量":"45 or 25 mg\/m2\/day in 2 equally divided doses 依不同症狀給予不同劑量及天數選擇。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VES02O":{"商品名稱":"Vesicare FC 5mg Tab#","腎功能不良劑量調整":"Clcr >30: 不需調整\r<br>Clcr<30 (重度腎功能障礙者): 謹慎給藥，每天不得多於5mg","小兒建議劑量":"兒童服藥的有效性及安全性尚未確立﹒因此，兒童不可使用本品﹒","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VFE01I":{"商品名稱":"Vfend 200mg Vial","腎功能不良劑量調整":"CCr   建議劑量\r<br>< 50 (mL\/min):  After initial LD, change to oral therapy when possible; monitor Scr","小兒建議劑量":"nfants & Children < 12 yrs: loading, 9 mg\/kg q12h × 2 doses; then 8-9 mg\/kg q12h; max. 350 mg\/dose.(Red book, 2012) \r<br>Infants & Children < 12 yrs: max. 350 mg q12h","提示內容":"暫無資料","抗生素手冊":"for Aspergilllosis<br>可穿透BBB<br>loading: 6 mg per kg for 2 doses than 4 mg per kg q12h<br>PK: urine less than 2%<br>DDI: QTc prolongation"},"VFE01O":{"商品名稱":"Vfend 200mg Tab","腎功能不良劑量調整":"【腎】口服voriconazole的藥動學不會受腎功能障礙影響。因此有輕微至嚴重腎功能障礙的患者無須調整劑量。\r<br>【肝】嚴重肝功能障礙患者必須小心監測藥物毒性。","小兒建議劑量":"用於兒童(2至<12歲)與年齡較小的青少年(12至14歲且<50公斤)\r<br>每日兩次9毫克\/公斤 (最高劑量為每日兩次350毫克)","提示內容":"暫無資料","抗生素手冊":"須空腹因高脂食物<br>體重超過40公斤: loading: 400 mg for 2 doses than 200 mg q12h<br>wt less than 40 kg: 劑量減半<br>DDI: QTc prolongation"},"VGE01I":{"商品名稱":"V-Genta 80mg\/2ml Vial","腎功能不良劑量調整":"需定期監測腎功能、藥物濃度。\r<br>Conventional dosing: 約2 mg\/kg\/dose Q8-12 h; \r<br>Clcr >\/=60 mL\/minute:  q8h\r<br>Clcr 40-60 : q12h\r<br>Clcr 20-40 :  q24h\r<br>Clcr<20 : Loading dose, then TDM\r<br>Hemo: 洗腎後給 1\/2 normal dose\r<br>Once-daily Dose請查詢文獻","小兒建議劑量":"\"一般兒童劑量:<br>肌肉注射或靜脈輸注，相當於Gentamicin之量:<br>早產兒或出生一星期以下之足月新生兒--每公斤體重2.5mg，每12小時一次。<br>較大新生兒及嬰兒--每公斤體重2.5mg，每8小時一次。<br>兒童-每公斤體重2~2.5mg，每8小時一次。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 1.7 mg per kg q8h<br>renal dysfunction: 使用一周後建議監測血中濃度<br>使用二周後必須監測血中濃度"},"VGS01I":{"商品名稱":"VG Solution 500ml bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIA03O":{"商品名稱":"Viagra 100mg Tab","腎功能不良劑量調整":"\"CrCl >=30 mL\/minute:<br><br>\r<br>Revatio: No dosage adjustment necessary.<br><br>Viagra: No dosage adjustment recommended.<br><br>CrCl <30 mL\/minute:\r<br><br><br>Revatio: No dosage adjustment necessary.<br><br>Viagra: Starting dose of 25 mg should be considered\"\r<br>","小兒建議劑量":"小兒不建議使用\r<br>","提示內容":"不可與Nitrate類並用","抗生素手冊":"暫無資料"},"VIA04O":{"商品名稱":"Viagra ODT 50mg Tab","腎功能不良劑量調整":"就重度腎功能不全(肌酸酐廓清率< 30毫升\/分鐘)的患者而言，由於sildenafil的廓清率會下降，因此應考慮使用25毫克的劑量。視藥效與耐受性而定，可在必要時將劑量逐步提高至50毫克，最高至100毫克。","小兒建議劑量":"VIAGRA並不適用於18歲以下的兒童。","提示內容":"不可與Nitrate類並用","抗生素手冊":"暫無資料"},"VIA05O":{"商品名稱":"Viartril-S 1500mg Pack; 30Pack\/Box","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIC01I":{"商品名稱":"Victoza 18mg\/3ml Pen#","腎功能不良劑量調整":"在上市後的報告中，有急性腎衰竭與慢性腎衰竭惡化而有時需要透析的案例[見警語及注意事項(5.5)與不良反應(6.2)],對於這些患者族群須謹慎使用 Victoza 。對於脫水的患者亦需謹慎使用 Victoza 。","小兒建議劑量":"針對兒童患者，Victoza的安全性與效力尚未確立。Victoza不建議使用於兒童患者。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VID01E":{"商品名稱":"Vidisic Gel 10gm Tube","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VID01I":{"商品名稱":"Vidaza 100mg Vial#","腎功能不良劑量調整":"如果在原因不明下，血清重碳酸鹽濃度下降至小於 20 mEq\/L，應將下一個療程的劑量減少 50%。同樣地，如果在原因不明下，血中尿素氮(BUN)或血清肌酸酐升高，應等到數值恢復到正常值或基準線時才開始下一療程，而且下一療程的劑量要減少 50%。","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIG01E":{"商品名稱":"Vigamox Oph Soln 0.5% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"用於一歲以下嬰兒的安全性及效果尚未確立，不建議使用在兒科患者。","提示內容":"(成分為Moxifloxacin, 屬FQ, 本院同類品有Cravit (Levofloxacin) oph soln)\r<br>應停戴隱形眼鏡。\r<br>出現過敏症狀立刻停藥。","抗生素手冊":"暫無資料"},"VIM01E":{"商品名稱":"Vimax Foaming Solution","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"長期使用於廣泛部位會造成全身性的吸收，產生腎上腺皮質機能亢進現象。尤其是使用在嬰兒、孩童、及封閉包紮情況。建議孩童每周複診。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIM01I":{"商品名稱":"Vimpat IV 200mg\/20ml Vial","腎功能不良劑量調整":"輕度及中度腎功能不全(Clcr>30 ml\/min):無須調整劑量。\r<br>重度及末期腎病:每日劑量不得超過300mg\/day。\r<br>","小兒建議劑量":"不建議使用於4歲以下之兒童和青少年，因為未有安全性及有效性的數據。","提示內容":"Preferably infuse over a period of 30 to 60 minutes; may infuse over 15 minutes if needed.(Micromedex)\r<br>可以N\/S、D5、LR稀釋注射。稀釋後於25度以下有24小時的物理相容性與化學安定性。\r<br>Clcr<=30 ml\/min :最大劑量不得超過300mg\/day。\r<br>需要接受血液透析的病人，在血液透析結束後可直接補充劑量，直到至每日每次劑量的50%。","抗生素手冊":"暫無資料"},"VIM01O":{"商品名稱":"Vimpat 100mg Tab","腎功能不良劑量調整":"對有重度腎功能不全(CLCR?30 毫升\/分鐘）和終末期腎病患者，建議最大劑量不得超過300 毫克\/天。\r<br>需要接受血液透析的患者，在血液透析結束後可直接補充劑量，直到至每日每次劑量的 50%。","小兒建議劑量":"暫無資料","提示內容":"劑量的增減要緩慢\r<br>增強slow inactivation of VGSCs，使得過度被刺激的神經細胞膜穩定\r<br>注意PR prolongation，而已知患有2級或3級房室阻斷的病人，則是禁用此藥","抗生素手冊":"暫無資料"},"VIN01I":{"商品名稱":"Vinblastine 10mg\/10ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不可超過12.5mg\/m2\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIN01O":{"商品名稱":"Vinobin 20mg Softgel Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIN05I":{"商品名稱":"Vincristine Sulphate 1mg\/1ml Vial#","腎功能不良劑量調整":"Renal Impairment No dosage adjustment necessary [4]","小兒建議劑量":"小孩：\r<br>一般劑量1.5-2.0mg\/m2，每星期給予一次。最大劑量2mg。\r<br>小孩體重10kg或更少，或身體表面積少於1m2，初次劑量應為0.05mg\/kg，一星期投與一次。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIN07I":{"商品名稱":"Vinorel 10mg\/1ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIO02O":{"商品名稱":"Vioment Tab","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"兒童: 1-3 tab TID; 成人: 3-10 tab TID。\r<br>劑量不必太精確，因為不吸收。\r<br>----------------------------------------------------------\r<br>< 1yr: 1\/4# TID-QID;\r<br>1-3yr: 1\/3# TID-QID;\r<br>3-6yr: 1\/2# TID-QID;\r<br>> 6yr:    1# TID-QID","提示內容":"< 1歲: 1\/4# TID-QID; 1-3歲: 1\/3# TID-QID\r<br> 3-6歲: 1\/2# TID-QID; > 6歲: 1# TID-QID","抗生素手冊":"暫無資料"},"VIR01O":{"商品名稱":"Viread 300mg Tab#","腎功能不良劑量調整":"[Clcr > 50 ml\/min]: Usual dosage.\r<br>[30-49]: 300 mg q48 h\r<br>[10-29]: 300 mg 1W2D\r<br>Clcr <10 而未洗腎者:不建議使用\r<br>HEMO: 300 mg q 7 days","小兒建議劑量":"對未滿 18 歲的患者的安全性和有效性目前尚未確立。","提示內容":"ClCr 30-49: 300mg Q48H\r<br>ClCr 10-29: 300mg 1W2D\r<br>ClCr <10:不建議使用\r<br>HD: 300mg QW","抗生素手冊":"暫無資料"},"VIR02E":{"商品名稱":"Virless Cream 5% 5gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"取出適量塗抹於患部，每三小時一次，一天6次，連續7天。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIS01E":{"商品名稱":"Viscone Eye Drops 0.1% 5ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Inflammatory disorder of the eye: ophthalmic suspension (2 years and older): Instill 1 drop into the conjunctival sac 2 to 4 times daily.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIS01I":{"商品名稱":"Visudyne 15mg Vial#","腎功能不良劑量調整":"No dosage adjustment\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIS01O":{"商品名稱":"Vistaril 25mg Cap","腎功能不良劑量調整":"[>50 ml\/min]: 50-100mg qid\r<br>[< 50]:  50%\r<br>HEMO: Dose for Ccr<10","小兒建議劑量":"\"Note: Adjust dose based on patient response.\r<br>- Antiemetic: I.M.: 1.1 mg\/kg\/dose\r<br>- Preoperative sedation:<br>Oral: 0.6 mg\/kg\/dose\r<br><br>I.M.: 1.1 mg\/kg\/dose\r<br><br>- Pruritus, anxiety: Oral:<br>\r<br><6 years: 50 mg daily in divided doses\r<br><br>>=6 years: 50-100 mg daily in divided dose\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIS02I":{"商品名稱":"Visipaque 320mg\/mL Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIS02O":{"商品名稱":"Visanne 2mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"可於月經週期的任一天開始服藥。無論是否發生陰道出血，均必須連續服藥，持續不間斷。","抗生素手冊":"暫無資料"},"VIT01I":{"商品名稱":"Vitacicol 100mg\/2ml Amp (Vit. C)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIT04I":{"商品名稱":"Vitagen 5% 100ml 玻璃瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"- Treatment of hypoglycemia: Doses may be repeated in severe cases<br>\r<br>\r<br>I.V.:<br>\r<br>Infants <=6 months: 0.25-0.5 g\/kg\/dose (1-2 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>\r<br>Infants >6 months and Children: 0.5-1g\/kg\/dose (2-4 mL\/kg\/dose of 25% solution); maximum: 25 g\/dose<br>\r<br>Adolescents: Refer to adult dosing.\r<br>\r<br>Oral: Refer to adult dosing:<br>\r<br>-Treatment of hyperkalemia: I.V. (in combination with insulin):\r<br><br>Infants and Children: 0.5-1 g\/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed\r<br>Adolescents: Refer to adult dosing.\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIT05I":{"商品名稱":"VitaCAL 20ml Amp (Ca2+:5.44mEq)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"仿單無記載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIT06I":{"商品名稱":"Vitamin B1 Inj 100mg\/2ml amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"Parenteral nutrition, maintenance requirement: \r<br>Infants: 0.35 to 0.5 mg\/kg\/day; maximum daily dose: 1.2 mg\/day\r<br>Children: 1.2 mg\/day\r<br>\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIT07I":{"商品名稱":"Vitacicol Forte 5000mg\/20ml Amp","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VIT08I":{"商品名稱":"Vitamin C 5gm\/270ml Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VOL01I":{"商品名稱":"Voluven Soln 6% 500ml Bag","腎功能不良劑量調整":"Avoid use in patients with preexisting renal dysfunction. Use is contraindicated in oliguric\/anuric renal failure unrelated to hypovolemia or patients receiving dialysis. Discontinue use at the first sign of renal injury.\r<br>","小兒建議劑量":"\"Plasma volume expansion: I.V. infusion: Note: With severe dehydration, administer crystalloid first. Daily dose and rate of infusion dependent on amount of blood lost, on maintenance or restoration of hemodynamics, and on amount of hemodilution. Titrate to individual colloid needs, hemodynamics, and hydration status. Do not use in the critically ill including patients with sepsis, those with preexisting renal dysfunction or receiving dialysis, those with preexisting bleeding disorders or those with intracranial bleeding.<br>Children <=12 years and Adolescents: May administer up to 50 mL\/kg\/day (or up to 3500 mL per day in a 70 kg patient); may administer repetitively over several days.<br>Mean daily dose ± SD in pediatric clinical trials:<br>Children <2 years: 16 ± 9 mL\/kg<br>Children 2-12 years: 36 ± 11 mL\/kg\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VOL01O":{"商品名稱":"Volna-K F.C 25mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"Children and Adolescents <18 years:\r<br>Immediate release tablet: 2-3 mg\/kg\/day divided 2-4 times\/day; maximum daily dose: 200 mg\/day","提示內容":"max. 200mg daily","抗生素手冊":"暫無資料"},"VOL04O":{"商品名稱":"Voltaren SR 75mg Tab","腎功能不良劑量調整":"健保署NSAIDs開立建議:\r<br>eGFR:45~30:臨床上避免使用，若仍需使用，以短期為原則，且須追蹤腎功能變化。\r<br>30~15: 不建議使用NSAIDs，應改以其他止痛藥物或類固醇替代; 若評估利弊後仍須使用，則以短期且必要時服用為原則，並告知病人有惡化腎功能的可能性。\r<br><15且未透析者:禁","小兒建議劑量":"由於 Voltaren Retard (SR)劑量較高，因此不適用於兒童。\r<br>","提示內容":"max. 200mg daily","抗生素手冊":"暫無資料"},"VOR02E":{"商品名稱":"Voren-G Gel 1% 40gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"2歲以下兒童之使用須詢問醫生和藥師\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VOR03E":{"商品名稱":"Voren 12.5mg Supp","腎功能不良劑量調整":"禁忌:重症之腎障害患者\r<br>","小兒建議劑量":"<3yr: 0.5 supp; 3-5yr: 0.5-1 supp; \r<br>6-8yr: 1 supp; 9-11yr 1-2 supp; QD-BID。\r<br>---------------------------------------------------------------\r<br>簡易換算\r<br>6 kg=0.5 supp\r<br>Q6H PRN if BT >39℃","提示內容":"成人也可使用Voren栓劑退燒 \r<br>因Diclofenac 25mg 直腸給藥的生體可用率達100%\r<br>→此劑量( 12.5 mg) 是有效的","抗生素手冊":"暫無資料"},"VOS01O":{"商品名稱":"Vosevi 400\/100\/100mg Tab","腎功能不良劑量調整":"對任何程度腎功能不全（包括接受透析治療）的病人，並不須調整VOSEVI的劑量","小兒建議劑量":"VOSEVI對兒童病人的安全性及有效性尚未建立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"VOT01O":{"商品名稱":"Votrient FC 200mg Tab#","腎功能不良劑量調整":"無須依腎功能不全調整劑量。\r<br>temporarily discontinue therapy if 24-hour urine protein ?3 g or for other toxicities when clinically indicated.","小兒建議劑量":"目前無小兒安全性資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WAR02E":{"商品名稱":"Wart Del Cream 0.15% 5g","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WAT03I":{"商品名稱":"Water For Inj 1000ml Bag","腎功能不良劑量調整":"仿單無提及","小兒建議劑量":"仿單無提及","提示內容":"處方出現Water for injection要確認\r<br>目前一般用在呼吸治療科Ventilator 機器的加濕","抗生素手冊":"暫無資料"},"WAT04E":{"商品名稱":"Water For Irrigation 2L Bag","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WAT05I":{"商品名稱":"Water For Inj 20ml (信東)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WAT07E":{"商品名稱":"Water For Irrigation 1000ml Bot塑膠瓶","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WAT07I":{"商品名稱":"Water For Inj 500ml Bot NK (Sterille)","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WAT08I":{"商品名稱":"Water For Inj 500ml Bot TBC","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WEC01O":{"商品名稱":"Wecoli 25mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WEI02O":{"商品名稱":"Weisu 200mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WEL03O":{"商品名稱":"Wellbutrin XL 150mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WEM01S":{"商品名稱":"Wempty Susp 60mg\/60ml Bot","腎功能不良劑量調整":"Severe impairment (serum creatinine >0.6 mmol\/L or 6 mg\/dL): Reduce dosing frequency to 1-2 times daily with prolonged therapy. Dose reduction may also be necessary\r<br>","小兒建議劑量":"「12歲以下兒童」及「12歲以上體重小於35kg之青少年」：1次0.25mg\/kg，每日最多3次\r<br>(by衛署公告201411)\r<br>\r<br>TID-QID 飯前15-30分鐘服用, \r<br>1~3yr: 每次1.25~2.5ml ( <3歲 避免連續使用 >7day)\r<br>3~6yr:   每次2.5~5ml;\r<br>6~12yr: 每次5~10ml;\r<br>>12yr&成人: 每次 10ml。\r<br>--------------------------------------------------------------------\r<br>< 1yr:  1.25 c.c. AC TID;\r<br>1-3yr:  2.5  c.c. AC TID;\r<br>3-6yr:   5     c.c. AC TID;\r<br>6-12yr: 7.5  c.c. AC TID;\r<br>> 12 yr: 10  c.c. AC TID","提示內容":"12yr以下或體重<35kg青少年: 0.25mg\/kg TID AC(每日最大0.75mg\/kg)。\r<br>6~12歲: 每次5~10ml, 每日最多三次\r<br>3~6歲: 每次2.5~5ml\r<br>1~3歲: 每次1.25~2.5ml (三歲以下避免連續使用7日以上)","抗生素手冊":"暫無資料"},"WIL01M":{"商品名稱":"Wilcon Suspension 300ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"WIT01O":{"商品名稱":"Witgen 10mg Tab#","腎功能不良劑量調整":"[>50 ml\/min]: 5-20 mg\/day\r<br>[5-29]: 5mg bid\r<br>[HEMO ]:  Not recommended","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XAL01E":{"商品名稱":"Xalatan 0.005% 2.5ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"安全性及有效性尚未確立\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XAL01O":{"商品名稱":"Xalkori 250mg Cap#","腎功能不良劑量調整":"對輕度或中度腎功能不全(Clcr>30ml\/min)的患者，並不建議調整起始劑量。\r<br>重度(CLcr <30ml\/min)者:crizotinib dosage 250mg QD。至少治療4週後，依個別患者的安全性與耐受性，可將劑量調整成 200mg BID。","小兒建議劑量":"兒童的的安全性與療效目前尚未確立。目前並無任何資料可供參考","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XAL02E":{"商品名稱":"Xalacom Eye Drops","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"至今仍未建立兒童和青少年使用Xalacom的安全性及有效性資料。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XAM01E":{"商品名稱":"Xamiol Gel 30g","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XAN01O":{"商品名稱":"Xanax 0.25mg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XAN03O":{"商品名稱":"Xanthium 200mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"6歲以下禁用\r<br>","提示內容":"病人心搏過慢時，心臟科會處方Xanthium 200mg 1cap QD-BID,\r<br>且可能同時併用口服β2作用劑\r<br>→可衛教病人此藥可增加心跳","抗生素手冊":"暫無資料"},"XAN04O":{"商品名稱":"XANAX XR 0.5mg Tab #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XAR01O":{"商品名稱":"XARELTO FC 10MG TAB#","腎功能不良劑量調整":"CrCl: 30-50 ml\/min: 建議每天1次10mg~15mg. \r<br>CrCl < 15 ml\/min的病患禁止使用本品。\r<br>------------------------\r<br>[Clcr >50]：15mg~20mg QD\r<br>[Clcr 30~50]：15mg QD\r<br>[Clcr 15~30]：10mg QD\r<br>[Clcr <15]：禁用","小兒建議劑量":"小於18歲以下孩童及青少年的安全性與療效資料尚未建立","提示內容":"10 mg適應症:\r<br>1.非瓣膜性心房顫動預防中風及全身性栓塞: 15-20 mg QD \r<br>2.預防下肢重大骨科手術後之靜脈血栓栓塞症(VTE):10 mg QD, 至少10-14天, 建議用35天\r<br>\r<br>15及20mg適應症: \r<br>1.非瓣膜性心房顫動預防中風及全身性栓塞: 15-20 mg QD\r<br>2. 治療深部靜脈血栓(DVT)與肺栓塞(PE)及預防再發性DVT與PE:前三週15 mg BID，接著20 mg QD\r<br>    \r<br>ClCr < 15 mL\/min之患者禁止使用本品 (<30 mL\/min 避免使用)\r<br>處方中若NOAC與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>\r<br>Dosage in Renal Failure(資料來源：Micromedex R)\r<br>A) Nonvalvular Atrial Fibrillation----(1) CrCl 50 mL\/min or less: 15 mg orally once daily with evening meal (2) Acute renal failure: Consider dosage adjustment or discontinuation \r<br>B) Treatment of DVT or Pulmonary Embolism (PE) and Prevention of Recurrent DVT or PE----(1) CrCl <30 mL\/min: Avoid use \r<br>C) Postoperative Prophylaxis of DVT----(1) CrCl <30 mL\/min: Avoid use(2) Acute renal failure: Discontinue treatment\r<br>D) Chronic or Peripheral Artery Disease----(1) No dosage adjustment necessary","抗生素手冊":"暫無資料"},"XAR02O":{"商品名稱":"XARELTO FC 20mg Tab#","腎功能不良劑量調整":"[Clcr >50]：15mg~20mg QD\r<br>[Clcr 30~50]：15mg QD\r<br>[Clcr 15~30]：10mg QD\r<br>[Clcr <15]：禁用","小兒建議劑量":"小於18歲以下孩童及青少年的安全性與療效資料尚未建立","提示內容":"10 mg適應症:\r<br>1.非瓣膜性心房顫動預防中風及全身性栓塞: 15-20 mg QD \r<br>2.預防下肢重大骨科手術後之靜脈血栓栓塞症(VTE):10 mg QD, 至少10-14天, 建議用35天\r<br>\r<br>15及20mg適應症: \r<br>1.非瓣膜性心房顫動預防中風及全身性栓塞: 15-20 mg QD\r<br>2. 治療深部靜脈血栓(DVT)與肺栓塞(PE)及預防再發性DVT與PE: 前三週15 mg BID，接著20 mg QD\r<br> \r<br>ClCr < 15 mL\/min之患者禁止使用本品 (<30 mL\/min 避免使用)\r<br>處方中若NOAC與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>\r<br>Dosage in Renal Failure(資料來源：Micromedex R)\r<br>A) Nonvalvular Atrial Fibrillation----(1) CrCl 50 mL\/min or less: 15 mg orally once daily with evening meal (2) Acute renal failure: Consider dosage adjustment or discontinuation \r<br>B) Treatment of DVT or Pulmonary Embolism (PE) and Prevention of Recurrent DVT or PE----(1) CrCl <30 mL\/min: Avoid use \r<br>C) Postoperative Prophylaxis of DVT----(1) CrCl <30 mL\/min: Avoid use(2) Acute renal failure: Discontinue treatment\r<br>D) Chronic or Peripheral Artery Disease----(1) No dosage adjustment necessary","抗生素手冊":"暫無資料"},"XAR03O":{"商品名稱":"XARELTO FC 15mg Tab#","腎功能不良劑量調整":"[Clcr >50]：15mg~20mg QD\r<br>[Clcr 30~50]：15mg QD\r<br>[Clcr 15~30]：10mg QD\r<br>[Clcr <15]：禁用\r<br>","小兒建議劑量":"小於18歲以下孩童及青少年的安全性與療效資料尚未建立","提示內容":"10 mg適應症:\r<br>1.非瓣膜性心房顫動預防中風及全身性栓塞: 15-20 mg QD \r<br>2.預防下肢重大骨科手術後之靜脈血栓栓塞症(VTE):10 mg QD, 至少10-14天, 建議用35天\r<br>\r<br>15及20mg適應症: \r<br>1.非瓣膜性心房顫動預防中風及全身性栓塞: 15-20 mg QD\r<br>2. 治療深部靜脈血栓(DVT)與肺栓塞(PE)及預防再發性DVT與PE: 前三週15 mg BID，接著20 mg QD\r<br>\r<br>ClCr < 15 mL\/min之患者禁止使用本品 (<30 mL\/min 避免使用)\r<br>處方中若NOAC與wafarin同時出現, 可能是醫師要轉換藥物漏刪一筆, 需注意提醒\r<br>\r<br>Dosage in Renal Failure(資料來源：Micromedex R)\r<br>A) Nonvalvular Atrial Fibrillation----(1) CrCl 50 mL\/min or less: 15 mg orally once daily with evening meal (2) Acute renal failure: Consider dosage adjustment or discontinuation \r<br>B) Treatment of DVT or Pulmonary Embolism (PE) and Prevention of Recurrent DVT or PE----(1) CrCl <30 mL\/min: Avoid use \r<br>C) Postoperative Prophylaxis of DVT----(1) CrCl <30 mL\/min: Avoid use(2) Acute renal failure: Discontinue treatment\r<br>D) Chronic or Peripheral Artery Disease----(1) No dosage adjustment necessary","抗生素手冊":"暫無資料"},"XAR04O":{"商品名稱":"Xarelto FC 2.5mg Tab#","腎功能不良劑量調整":"避免使用在CrCl：介於15-30 mL\/min 的病人，CrCl < 15 mL\/min 之病人禁止使用本品","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XEL01O":{"商品名稱":"Xeloda 500mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XEL02O":{"商品名稱":"Xeljanz 5mg Tab","腎功能不良劑量調整":"中度與重度腎功能受損的患者，XELJANZ的劑量應降低至5毫克每日一次。在臨床試驗中，並未對Clcr(依Cockroft-Gault公式估算而得)<40ml\/min的類風濕性關節炎患者進行XELJANZ的評估。","小兒建議劑量":"兒童之使用: XELJANZ用於兒童病患的安全性及有效性尚未確立","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XEN01I":{"商品名稱":"Xenetix 350 Inj 100ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XEN01O":{"商品名稱":"Xenical 120mg Cap","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"Children >=12 years: Refer to adult dosing.\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XGE01I":{"商品名稱":"Xgeva 120mg\/1.7ml Vial","腎功能不良劑量調整":"Monitor patients with severe impairment (CrCl <30 mL\/minute or on dialysis) due to increased risk of hypocalcemia","小兒建議劑量":"XGEVA並不建議用於兒童病患。XGEVA在兒童病患中的安全性及有效性尚未確立","提示內容":"*腫瘤有蝕骨性骨轉移之病患: \r<br>120 mg 每4週皮下注射一次","抗生素手冊":"暫無資料"},"XIG01O":{"商品名稱":"Xigduo XR 10\/1000mg Tab#","腎功能不良劑量調整":"(eGFR > 45 )：No dosage adjustment necessary.\r<br>(eGFR < 45 )：No suggest.\r<br>(eGFR < 30 )：Use is contraindicated.\r<br>Hemodialysis：Use is contraindicated.\r<br>---【複方錠】-------------------------\r<br>","小兒建議劑量":"尚未確立未滿18歲的兒童患者使用的安全性和有效性。","提示內容":"口服降血醣劑【複方】Dapagliflozin(SGLT2)+Metformin\r<br>【持續錠】需整粒吞服，勿磨碎、嚼碎。錠中無活性成分有時以柔軟的含水塊狀物從糞便中排出。\r<br>留意生殖泌尿道感染。\r<br>留意血管內容量減少的狀況，並監測治療後是否低血壓的症狀和徵象。\r<br>eGFR <60 mL\/minute\/1.73 m2: Use is contraindicated.\r<br>投予含碘顯影劑時，應在檢查前後至少48小時停止使用，待腎功能經評估確定已恢復正常後，才能再服用","抗生素手冊":"暫無資料"},"XOF01I":{"商品名稱":"Xofigo 6ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XOF01O":{"商品名稱":"Xofluza 20mg Tab","腎功能不良劑量調整":"輕度或中度腎功能不全(CrCl ?30 mL\/min)的患者，不需要調整劑量。\r<br>目前尚無重度腎功能不全病患(CrCl <30 mL\/min)投與本藥後的藥物動力學資料。","小兒建議劑量":"5歲以下兒童之安全性及療效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XOL01I":{"商品名稱":"Xolair 150mg\/mL Syringe#","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"Asthma\/Chronic idiopathic urticaria:?\r<br>Adolescents >=12 years: SubQ: Refer to adult dosing\r<br>","提示內容":"150-300mg every 4 wks","抗生素手冊":"暫無資料"},"XOL02I":{"商品名稱":"Xolair (恩慈) 150mg\/mL Syringe","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"Asthma\/Chronic idiopathic urticaria:?\r<br>Adolescents >=12 years: SubQ: Refer to adult dosing\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XTA01O":{"商品名稱":"Xtandi 40mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"在治療成年男性去勢抗性的轉移性前列腺癌方面，enzalutamide 沒有相關之小兒族群的使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XTA02O":{"商品名稱":"Xtandi FC 40mg Tab","腎功能不良劑量調整":"輕度或中度腎功能不全病人無須調整劑量)。重度腎功能不全或末期腎病病人應小心使用。","小兒建議劑量":"沒有小兒族群相關的使用。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XY102I":{"商品名稱":"Xylocaine 1% 1-ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XY103I":{"商品名稱":"Xylocaine 1% 5ml Amp","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Loading dose: 1 mg\/kg\/dose bolus of 0.5-1 mg\/kg\/dose\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XY201I":{"商品名稱":"Xylocaine 2% 20ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Loading dose: 1 mg\/kg\/dose bolus of 0.5-1 mg\/kg\/dose\r<br>","提示內容":"僅限局部麻醉, 不可靜脈注射","抗生素手冊":"暫無資料"},"XY202I":{"商品名稱":"Xylocaine 2% 1-ml","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Loading dose: 1 mg\/kg\/dose bolus of 0.5-1 mg\/kg\/dose\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XY402E":{"商品名稱":"Xylocaine 4% 1-ml","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XYA01I":{"商品名稱":"Xylocaine IV 2%\/5ml Amp","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Loading dose: 1 mg\/kg\/dose bolus of 0.5-1 mg\/kg\/dose\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XYJ01E":{"商品名稱":"Xylocaine Jelly 2% 30gm","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"Children: Dose varies with age and weight; maximum dose: 4.5 mg\/kg\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XYL01I":{"商品名稱":"Xylestesin-A 2% 1.7ml\/Cart","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XYS02E":{"商品名稱":"Xylocaine Spray 10%","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"XYZ01O":{"商品名稱":"Xyzal 5mg Tab","腎功能不良劑量調整":"Clcr\r<br>正常 ?80 每日一錠\r<br>輕微 50 – 79 每日一錠\r<br>中度 30 – 49 隔日一錠\r<br>嚴重 <30 每三天一錠\r<br>透析及腎疾末期Clcr <10: 禁用","小兒建議劑量":"六歲至十二歲的孩童：建議每日劑量為 5 毫克(一錠)。六歲以下孩童尚不建議使用。\r<br>","提示內容":"腎功能不佳的劑量調整：\r<br>CLcr 30-49 ml\/min: 5 mg QOD\r<br>CLcr <30 ml\/min: 5mg Q3D\r<br>\r<br>透析病人: 禁用\r<br>\r<br>小兒劑量：\r<br>6-12 歲: 5 mg QD\r<br>6歲以下不建議使用","抗生素手冊":"暫無資料"},"YAZ01O":{"商品名稱":"Yaz 28tab\/Box","腎功能不良劑量調整":"有腎功能受損就不能使用\r<br>","小兒建議劑量":"青少年第一次月經來前請勿使用。\r<br>","提示內容":"於月經的第1天（第1天開始），或月經開始後的第1個星期日（星期日開始）服用。連續服用24天每天1錠淡粉紅色錠劑，然後接著4天每天1錠無作用的白色錠劑。","抗生素手冊":"暫無資料"},"YER02I":{"商品名稱":"Yervoy (恩慈) 50mg\/10mL Vial","腎功能不良劑量調整":"對腎功能不全的病患，並不須調整劑量。","小兒建議劑量":"YERVOY用於兒童患者的安全性與有效性尚未確立。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"YON01I":{"商品名稱":"Yondelis 1mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZAD01E":{"商品名稱":"Zaditen Eye Drops 1.25mg\/5ml Bot","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"\"成人，老人，兒童(3歲以上)：一次一滴，一天二次，<br>滴入雙眼之結膜囊。 <br>\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZAL01E":{"商品名稱":"Zalain Vag Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"塞劑用法為每週一次睡前使用, 注意處方可能開成QD","抗生素手冊":"暫無資料"},"ZAL02E":{"商品名稱":"ZALAIN CREAM 2% 15g\/Tube","腎功能不良劑量調整":"仿單無建議劑量","小兒建議劑量":"仿單無記載","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZAL03E":{"商品名稱":"Zalain Ext Gel 2% 30ml Bot","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZAN02O":{"商品名稱":"Zanidip 10mg Tab","腎功能不良劑量調整":"對輕至中度肝、腎功能不良之患者剛開始使用需特別謹慎，雖此類患者可容忍一般推薦劑量，但如增加至20mg仍需注意。\r<br>禁用於有嚴重肝腎功能不良者(GFR < 30 ml\/min)，包含正在進行透析患者。\r<br>","小兒建議劑量":"因未對18 歲以下之患者進行臨床試驗，故目前並不推薦孩童使用。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZAP01O":{"商品名稱":"Zapine 100mg Tab#","腎功能不良劑量調整":"嚴重腎疾病為禁忌症","小兒建議劑量":"Clozapine 對於兒童的安全性與藥效尚未被確定。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZAV02I":{"商品名稱":"Zavicefta 2.5g Vial","腎功能不良劑量調整":"CrCl (31-50 mL\/min): 1.25 gm IV Q8H \r<br>CrCl (16-30 mL\/min): 0.94 gm IV Q12H\r<br>CrCl (6-15 mL\/min): 0.94 gm IV Q24H\r<br>ESRD or H\/D : 0.94 gm IV Q48H \r<br>藥物需於H\/D後給予。","小兒建議劑量":"尚未確立未滿18歲兒童和青少年的安全性及療效性。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZAV03I":{"商品名稱":"Zavedos 5mg\/5ml Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZCO01O":{"商品名稱":"Zcough Soft 100mg Cap","腎功能不良劑量調整":"No dosage adjustment provided in manufacturer’s labeling","小兒建議劑量":"(10歲以上)每日三次，每次1~2粒膠囊。\r<br>10歲以下兒童尚未確立效能與安全性，若過量使用曾有致死報告","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZEJ01O":{"商品名稱":"Zejula 100mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZEP01I":{"商品名稱":"Zepzelca 4mg Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZEP02O":{"商品名稱":"Zeposia 0.23mg Cap","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZEP03O":{"商品名稱":"ZEPOSIA 0.46MG CAP","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZEP04O":{"商品名稱":"ZEPOSIA 0.92MG CAP","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZER01I":{"商品名稱":"Zerbaxa 1.5gm Vial","腎功能不良劑量調整":"Clcr 30-50：750mg-1.5g Q8H\r<br>Clcr 15-29：375mg-750mg Q8H\r<br>ESRD、HD：Loading dose 750-2250mg, maintain dose 150-450mg Q8H","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZIN03I":{"商品名稱":"Zinc Sulfate 29.7mg\/5ml Amp (Zinc:6.75mg","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZIN04E":{"商品名稱":"Zin Oint 20%\/28.4gm","腎功能不良劑量調整":"仿單未提及","小兒建議劑量":"仿單未提及\r<br>Protectant: Topical: Apply as required to affected areas several times daily [uptodat]","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZIN04I":{"商品名稱":"Zinforo 600mg Vial","腎功能不良劑量調整":"成人Clcr >50 ml\/min: 600mg Q12H~Q8H\r<br>(30~50 ): 400 mg IV Q12H\r<br>(15~30 ): 300 mg IV Q12H        \r<br>ESRD or H\/D : 200 mg IV Q12H","小兒建議劑量":"尚未確立用於兒童患者(出生到小於18歲)的安全性及療效","提示內容":"1.成人600mg Q12H 以5-60min輸注(金黃色葡萄球菌之複雜性皮膚或軟組織感染 600mg Q8H以120min輸注)\r<br>2.兒童劑量 輸注濃度不超過12mg\/ml 2yrs-12yrs 或< 33kg  12mg\/kg(max. 400mg) Q8H 以5-60min輸注；2months-2yrs 8mg\/kg Q8H 以5-60min輸注；出生-< 2months  6mg\/kg Q8H 以60min輸注\r<br>3.CrCL<50mL\/min需調整劑量請參閱仿單\r<br>4.可被血液透析，血液透析當日請血液透析後才給","抗生素手冊":"5th cephas 相當vanco + ceftri<br>高劑量: 600 mg q8h<br>Ccr less 30: 300 mg q8h<br>Ccr less 15 or HD: 200 mg q8h"},"ZIT01O":{"商品名稱":"Zithromax 250mg Tab#","腎功能不良劑量調整":"No adjustments required in renal failure.  Use caution in patients with Clcr <10 ml\/minute.   \r<br>Hemodialysis:  No adjustments required in renal failure.","小兒建議劑量":" Children 10 mg\/kg daily for 3 days.","提示內容":"*社區感染性肺炎\r<br>day 1: 500 mg QD\r<br>day 2-5: 250 mg QD\r<br> (或 500 mg QD for 3 days)\r<br>\r<br>250 mg TIW用於長期治療以預防COPD之惡化","抗生素手冊":"500 mg qd for 3 days<br>Legionnaires disease for 1 week"},"ZIT01S":{"商品名稱":"Zithromax Susp 40mg\/ml;15ml#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"<45kg 10mg\/kg\/d (0.25ml\/kg\/d); QD*3d\r<br>>45kg 12.5ml; QD*3d\r<br>-------------------------------------------\r<br>簡易換算 : 0.25ml\/kg\/d QD x 3day\r<br>","提示內容":"<45kg: 10mg\/kg\/d (0.25ml\/kg\/d) QD for 3 days","抗生素手冊":"須空腹<br>10 mg per kg qd for 3 days<br>loading: 10 mg per kg then 5 mg per kg for 4 days"},"ZOB01I":{"商品名稱":"Zobonic 4mg Vial#","腎功能不良劑量調整":"Hypercalcemia of malignancy (corrected serum calcium  12 mg\/dL): \r<br>[ >60 ml\/min ]:  4 mg (maximum) IV x 1. Wait at least 7 days before considering retreatment\r<br>[ 50-60 ]: 3.5 mg; [ 40-49 ]: 3.3 mg; \r<br>[30-39]: 3 mg ;[<30 ]: insufficient data\r<br>HEMO: Insuffi","小兒建議劑量":"不可使用","提示內容":"惡性腫瘤之高血鈣併發症: 單次投藥, 4 mg 稀釋後輸注>15 min。\r<br>ClCr<30ml\/min之病人不建議使用\r<br>\r<br>不可和鈣或其它含二價陽離子( ex. 乳酸林格氏液) 的靜脈輸注溶液混合\r<br>→使用獨立的靜脈導管給藥","抗生素手冊":"暫無資料"},"ZOD01I":{"商品名稱":"Zodonic 4mg\/5mL Vial","腎功能不良劑量調整":"Hypercalcemia of malignancy (corrected serum calcium  12 mg\/dL): \r<br>[ >60 ml\/min ]:  4 mg (maximum) IV x 1. Wait at least 7 days before considering retreatment\r<br>[ 50-60 ]: 3.5 mg; [ 40-49 ]: 3.3 mg; \r<br>[30-39]: 3 mg ;[<30 ]: insufficient data\r<br>HEMO: Insuffi","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOD01O":{"商品名稱":"Zodenox FC 10mg Tab #4","腎功能不良劑量調整":"no\r<br>","小兒建議劑量":"不可使用\r<br>","提示內容":"處方若要開立>1顆, 需會診精神科或神內\r<br>(且須將原本處方DC, 再重新開立)","抗生素手冊":"暫無資料"},"ZOL01I":{"商品名稱":"Zoladex Depot 3.6mg Syringe#","腎功能不良劑量調整":"腎臟功能不良之病患無需調整劑量。 \r<br>","小兒建議劑量":"Zoladex 3.6mg 不推薦使用於孩童。 \r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOL01O":{"商品名稱":"Zolpidem FC 10mg Tab CYH #4","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"不可使用\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOL02I":{"商品名稱":"ZOLADEX LA 10.8mg Syringe#","腎功能不良劑量調整":"腎功能不良(impairment)的病人無需調整劑量。 \r<br>","小兒建議劑量":"Zoladex LA 10.8mg 不推薦使用於孩童。\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOL02O":{"商品名稱":"Zoloft 50mg Tab","腎功能不良劑量調整":"無須調整劑量\r<br>","小兒建議劑量":"\"Obsessive-compulsive disorder (OCD):<br><br>\r<br>\r<br>Children 6-12 years: Oral: Initial: 25 mg once daily. Note: May increase daily dose, at intervals of not less than 1 week, to a maximum of 200 mg daily.<br><br>\r<br>Adolescents 13-17 years: Oral: Initial: 50 mg once daily. Note: May increase daily dose, at intervals of not less than 1 week, to a maximum of 200 mg daily.<br><br>\r<br>Depression (unlabeled use):<br><br>\r<br>\r<br>Children 6-12 years: Oral: Initial: 12.5-25 mg once daily; titrate dose upwards if clinically needed; may increase by 25-50 mg daily increments at intervals of at least 1 week; mean final dose in 21 children (8-18 years of age) was 100 ± 53 mg or 1.6 mg\/kg\/day (n=11); range: 25-200 mg daily; maximum dose: 200 mg daily (Dopheide, 2006; Tierney, 1995); avoid excessive dosing<br><br>\r<br>\r<br>Children 6-12 years: Oral: Initial: 25 mg once daily. Note: May increase daily dose, at intervals of not less than 1 week, to a maximum of 200 mg daily.<br><br>\r<br>Adolescents 13-17 years: Oral: Initial: 50 mg once daily. Note: May increase daily dose, at intervals of not less than 1 week, to a maximum of 200 mg daily.<br><br>\r<br>Depression (unlabeled use):<br><br>\r<br>\r<br>Children 6-12 years: Oral: Initial: 12.5-25 mg once daily; titrate dose upwards if clinically needed; may increase by 25-50 mg daily increments at intervals of at least 1 week; mean final dose in 21 children (8-18 years of age) was 100 ± 53 mg or 1.6 mg\/kg\/day (n=11); range: 25-200 mg daily; maximum dose: 200 mg daily (Dopheide, 2006; Tierney, 1995); avoid excessive dosing\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOM01I":{"商品名稱":"Zometa 4mg Vial#","腎功能不良劑量調整":"Hypercalcemia of malignancy (corrected serum calcium  12 mg\/dL): \r<br>[ >60 ml\/min ]:  4 mg (maximum) IV x 1. Wait at least 7 days before considering retreatment\r<br>[ 50-60 ]: 3.5 mg; [ 40-49 ]: 3.3 mg; \r<br>[30-39]: 3 mg ;[<30 ]: insufficient data\r<br>HEMO: Insuffi","小兒建議劑量":"不可使用\r<br>","提示內容":"惡性腫瘤之高血鈣併發症: 單次投藥, 4 mg 稀釋後輸注>15 min。\r<br>ClCr<30ml\/min之病人不建議使用\r<br>\r<br>不可和鈣或其它含二價陽離子( ex. 乳酸林格氏液) 的靜脈輸注溶液混合\r<br>→使用獨立的靜脈導管給藥","抗生素手冊":"暫無資料"},"ZON01O":{"商品名稱":"Zonegran FC 100 mg Tab","腎功能不良劑量調整":"由於腎功能不全的患者使用之資料有限，因此治療時應謹慎，可能需要減慢調高ZONEGRANR劑量的速度。因為zonisamide及其代謝產物由腎臟排除，有急性腎衰竭的患者或觀察到Scr有臨床上顯著且持續升高時，應停止服用。於Clcr< 20 ml\/min之受試者，zonisamide的AUC增加35%。","小兒建議劑量":"關於兒童與青少年使用zonisamide之安全性與有效性，對照性臨床試驗的數據有限。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOS01I":{"商品名稱":"Zostavax 0.65ml Vial","腎功能不良劑量調整":"No adjustment required","小兒建議劑量":"小兒之使用\r<br>ZOSTAVAX不建議用於此年齡群。","提示內容":"【冷藏藥】只能皮下注射。活性帶狀皰疹疫苗\r<br>自冰箱中取出後應立即進行泡製。接種者應接種單一劑量。並非帶狀皰疹或PHN的治療劑。","抗生素手冊":"暫無資料"},"ZOS02I":{"商品名稱":"Zostavax 0.65ml (員工) Vial","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"\"小兒之使用\r<br>ZOSTAVAX不建議用於此年齡群。\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOV01E":{"商品名稱":"Zovirax Cream 5% 2gm","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZOV01I":{"商品名稱":"Zovirax 250mg Vial","腎功能不良劑量調整":"[Clcr >50 ml\/min]: 5-10mg\/kg Q8h\r<br>[25-50 ml\/min]: 5-10mg\/kg q12h\r<br>[10-25 ml\/min]: 5-10mg\/kg q24h\r<br>[<10 ml\/min]: 2.5 to 5mg\/kg q24h\r<br>HEMO: 2.5 - 5 mg\/kg IV q24h (dose after dialysis).","小兒建議劑量":"兒童劑量\r<br>3個月至12歲之間的兒童，應根據其體重計算劑量。\r<br>單純性皰疹(皰疹性腦炎除外)或是水痘帶狀皰疹的兒童，應每8小時使用20mg\/kg的靜脈輸注。免疫功能不全而腎功能正常，應每8小時，給予20mg\/kg體重的Zovirax靜脈輸注。腎功能不全的兒童，應依受損程度適當調整劑量。\r<br>\r<br>新生兒劑量\r<br>新生兒感染單純皰疹時應每8小時給予20mg\/kg體重。\r<br>Zovirax靜脈輸注療程通常持續5天，但這可根據病人的條件及反應調整治療劑量。\r<br>治療?疹性腦炎通常持續10天。治療新生兒?疹感染通常持續14至21天。\r<br>預防給藥時間視危險期而定。","提示內容":"1 vial以10ml 注射用水溶解，再以至少50ml NS稀釋，輸注大於60分鐘\r<br>腎功能不全患者應調整劑量\r<br>配製後的注射液pH值約11，應在一小時的期間緩慢輸注。","抗生素手冊":"建議量: 10 mg per kg q8h<br>小兒: 20 mg per kg q8h<br>Ccr less than 50: q12h<br>Ccr less than 25: qd<br>Ccr less than 10, HD or PD: 劑量減半 qd"},"ZUL01O":{"商品名稱":"Zulitor 4mg Tab#","腎功能不良劑量調整":"中、重度腎功能不全(腎絲球濾過率分別為30-59 mL\/min\/1.73m2及15–29 mL\/min\/1.73m2)及正接受血液透析的末期腎臟病患者，Pitavastatin起始劑量應為每日一次1mg，最高劑量為每日一次2mg。","小兒建議劑量":"暫無資料","提示內容":"每日一次劑量超過4mg時會增加罹患嚴重肌肉病變(myopathy)的風險\r<br>腎絲球濾過率為30-59 mL\/min\/1.73m2及15–29 mL\/min\/1.73m2)及正接受血液透析病人起始劑量每日一次1mg，最高劑量為每日一次2mg。\r<br>並用Erythromycin每日單次劑量不可超過1mg\r<br>並用Rifampin每日單次劑量不可超過2mg","抗生素手冊":"暫無資料"},"ZYL01O":{"商品名稱":"Zyloric 100mg Tab","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZYP02I":{"商品名稱":"Zyprexa 10mg Vial#","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"\"Bipolar I acute mixed or manic episodes: Adolescents >=13 years: Oral: Initial: 2.5-5 mg once daily; adjust by 2.5-5 mg daily to target dose of 10 mg daily; dosing range: 2.5-20 mg daily<br>adolescents: initial, 2.5~5 mg qd, at increments of 2.5-5 mg at weekly interval to 10 mg, max. 20 mg\/day. \r<br>Schizophrenia：PO.\r<br>adolescents: initially, 2.5-5 mg qd, at increments of 2.5-5 mg at weekly interval to 10 mg, max. 20 mg\/d\"\r<br>","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZYP02O":{"商品名稱":"ZYPREXA ZYDIS 10mg Tab#","腎功能不良劑量調整":"暫無資料","小兒建議劑量":"暫無資料","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZYP03O":{"商品名稱":"Zyprexa 5mg Zydis Orally Tab#","腎功能不良劑量調整":"無須依腎功能不全調整劑量\r<br>","小兒建議劑量":"Bipolar disorder: PO.\r<br>adolescents: initial, 2.5~5 mg qd, at increments of 2.5-5 mg at weekly interval to 10 mg, max. 20 mg\/day. \r<br>Schizophrenia：PO.\r<br>adolescents: initially, 2.5-5 mg qd, at increments of 2.5-5 mg at weekly interval to 10 mg, max. 20 mg\/day","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZYT01O":{"商品名稱":"Zytiga 250mg Tab#","腎功能不良劑量調整":"對腎功能不全的患者，並不須調整劑量","小兒建議劑量":"兒童之使用: ZYTIGAR 並不適用於兒童。","提示內容":"1000 mg (4顆) QD 空腹使用\r<br>(因食物會增加Zytiga吸收, 可能增加副作用)","抗生素手冊":"暫無資料"},"ZYT02O":{"商品名稱":"Zytiga (恩慈) 250mg Tab#","腎功能不良劑量調整":"對腎功能不全的患者，並不須調整劑量","小兒建議劑量":"兒童之使用: ZYTIGAR 並不適用於兒童。","提示內容":"暫無資料","抗生素手冊":"暫無資料"},"ZYV01I":{"商品名稱":"Zyvox 600mg\/300ml Bag#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"\"出生至十一歲10mg\/kg靜脈注射或口服每八小時一次 ,12歲以上600mg靜脈注射或口服每十二小時一次<br> <br>每 12小\"\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 600 mg q12h"},"ZYV01O":{"商品名稱":"Zyvox 600mg Tab#","腎功能不良劑量調整":"不用調整\r<br>","小兒建議劑量":"出生至十一歲10mg\/kg靜脈注射或口服每八小時一次 ,12歲以上600mg靜脈注射或口服每十二小時一次\r<br>","提示內容":"暫無資料","抗生素手冊":"建議量: 600 mg q12h須空腹"}}